data_2mpl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mpl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.212 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -102.19 90.04 3.79 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.26 174.26 22.59 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.527 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.05 166.51 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.214 2.609 . . . . 0.0 112.348 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 43.2 mm-40 -75.58 -10.53 59.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.032 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.1 -20.65 34.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.903 0.858 . . . . 0.0 109.464 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.17 162.69 15.18 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.85 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -148.5 132.78 17.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.081 0.467 . . . . 0.0 111.478 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.7 tm? -95.39 112.68 24.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.94 135.56 49.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 82.2 mt -101.78 101.74 12.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.585 0.707 . . . . 0.0 109.139 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -115.17 104.86 12.26 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.366 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.6 13.78 4.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.206 1.402 . . . . 0.0 110.38 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 -6.82 56.09 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.353 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 8.1 tt0 -85.21 137.92 32.69 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -88.66 109.29 20.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.734 0.646 . . . . 0.0 109.273 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.2 121.7 45.9 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.695 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.0 m -89.26 97.05 6.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.883 0.849 . . . . 0.0 110.287 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -113.19 153.25 28.61 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.035 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.89 122.06 18.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 42.2 ttt180 -84.23 -50.6 7.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.17 173.9 7.0 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 m -89.36 108.56 19.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.9 mm? -74.98 110.07 8.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.094 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 p -83.17 134.61 34.97 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.109 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.88 123.6 14.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.009 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.77 -24.38 13.31 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.752 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.93 146.33 49.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.4 m -144.69 164.86 29.7 Favored 'General case' 0 C--N 1.283 -2.309 0 O-C-N 121.971 -0.456 . . . . 0.0 110.152 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -110.39 169.62 8.62 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.91 176.09 53.28 Favored Glycine 0 N--CA 1.433 -1.559 0 O-C-N 123.795 0.684 . . . . 0.0 111.905 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 51.1 Cg_endo -67.02 144.56 70.37 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 122.768 2.312 . . . . 0.0 113.187 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.32 154.49 32.24 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.26 127.9 46.44 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.91 0.862 . . . . 0.0 112.479 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.49 -157.78 30.25 Favored Glycine 0 N--CA 1.405 -3.405 0 N-CA-C 106.383 -2.687 . . . . 0.0 106.383 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.5 t -158.15 167.84 28.7 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 118.313 1.056 . . . . 0.0 108.807 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.277 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.415 -2.182 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.3 mtp -101.56 87.57 3.21 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.21 165.98 28.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -52.56 140.36 23.13 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 124.143 0.902 . . . . 0.0 109.89 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 43.4 mt-10 -65.4 -14.4 60.82 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.21 -14.12 22.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.488 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 53.2 t -64.66 133.41 52.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.491 0.663 . . . . 0.0 111.848 -174.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -58.72 -25.2 62.7 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.663 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.488 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.6 mt -59.28 -32.21 69.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.078 0.466 . . . . 0.0 111.39 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ptm180 -96.72 1.42 50.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.0 111.245 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 96.2 mmm -91.55 -20.09 22.06 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.43 146.84 45.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.953 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.53 134.61 36.18 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.265 1.977 . . . . 0.0 110.291 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.73 136.29 33.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 30.7 m -136.02 154.4 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.67 -10.89 17.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.516 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.9 p -94.93 169.03 10.42 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.654 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -95.59 -33.91 12.21 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.899 0.88 . . . . 0.0 111.242 -176.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 5.2 mm-40 -66.91 -38.83 86.97 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.67 -30.26 32.77 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.276 0.56 . . . . 0.0 109.892 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.467 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -79.97 119.87 23.4 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-O 121.416 0.627 . . . . 0.0 111.223 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -104.37 -6.1 21.09 Favored 'General case' 0 C--N 1.27 -2.855 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.006 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.0 m -150.42 145.26 25.95 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -125.45 147.66 49.12 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' A' ' 163' ' ' LEU . 29.4 mm -110.1 124.79 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -133.72 155.68 49.32 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -102.55 137.87 40.21 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.14 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 85.5 tttt -140.15 112.87 8.04 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.38 57.31 4.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.257 1.027 . . . . 0.0 111.144 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 73.71 -14.77 0.62 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.746 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.11 158.87 17.86 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.073 -0.392 . . . . 0.0 110.355 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 72.7 mt -96.17 136.8 36.14 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.119 0.262 . . . . 0.0 110.372 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 52.2 m95 -124.52 145.01 49.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.1 t -118.04 130.92 56.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.06 147.44 50.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.9 119.64 37.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 p -95.81 -29.31 14.3 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -130.25 143.56 50.85 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 5.4 p -76.38 113.29 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.52 0.676 . . . . 0.0 111.1 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.4 t -97.58 125.47 44.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.513 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.76 151.33 57.41 Favored 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 121.868 1.712 . . . . 0.0 110.08 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.1 p -62.94 131.1 47.55 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.42 -19.88 52.01 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.84 148.98 35.7 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.96 154.53 19.77 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.415 ' N ' HD21 ' A' ' 200' ' ' LEU . 1.1 pt? -136.13 149.68 48.77 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.06 0.457 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.97 155.86 21.22 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.22 128.54 62.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.381 0.61 . . . . 0.0 111.149 -176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.467 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 2.0 tmt_? -95.36 116.15 28.39 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.75 134.61 34.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 121.283 0.563 . . . . 0.0 111.068 177.558 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.451 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 p-90 . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m 65.44 25.52 11.92 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.22 1.008 . . . . 0.0 112.429 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.35 141.13 15.44 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.928 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.35 150.57 0.69 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.437 3.425 . . . . 0.0 113.027 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.32 -3.97 27.02 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.456 ' HA ' HD21 ' A' ' 122' ' ' LEU . 12.2 mm-40 -81.04 -18.7 45.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.694 HD22 ' CZ2' ' A' ' 130' ' ' TRP . 3.0 mm? -113.31 165.79 12.09 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.284 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -156.83 139.84 15.37 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.9 tm? -89.16 116.77 27.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.96 137.37 42.04 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.91 103.55 15.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -106.18 103.45 12.93 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.15 24.62 14.49 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.951 0.501 . . . . 0.0 111.329 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.68 -4.21 68.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.01 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.96 131.93 35.26 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -84.26 96.42 9.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.4 p -114.27 127.84 56.07 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-O 121.363 0.602 . . . . 0.0 109.798 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.97 118.78 36.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.009 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -115.71 147.57 40.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.54 119.18 32.28 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -80.06 -26.57 39.63 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 106' ' ' GLU . 3.7 mm? -110.35 140.05 44.94 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.586 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 m -69.86 122.19 18.78 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.255 0.55 . . . . 0.0 110.981 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.44 132.51 35.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.21 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 p -95.15 156.84 16.15 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.536 0.522 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.08 117.03 7.83 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.21 -16.57 22.38 Favored Glycine 0 C--N 1.303 -1.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.905 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.2 tp -64.68 125.62 25.33 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.8 m -136.6 144.31 44.05 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.694 ' CZ2' HD22 ' A' ' 107' ' ' LEU . 29.4 m-90 -91.59 172.0 8.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.548 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.84 164.29 54.52 Favored Glycine 0 N--CA 1.435 -1.381 0 O-C-N 123.777 0.673 . . . . 0.0 112.163 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 17.7 Cg_endo -58.54 128.39 28.14 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.408 2.738 . . . . 0.0 113.028 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 51.2 m-85 -102.89 170.89 7.71 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -122.06 142.63 50.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 163.53 -149.38 16.76 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 106.129 -2.789 . . . . 0.0 106.129 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 156' ' ' MET . 24.8 p -161.25 131.2 4.91 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.664 1.232 . . . . 0.0 111.598 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.419 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 1.4 pt . . . . . 0 N--CA 1.395 -3.186 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.091 0.472 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.459 ' HB3' ' O ' ' A' ' 136' ' ' SER . 48.2 ttm -97.17 96.36 8.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.5 m -130.32 159.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.608 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.87 170.13 15.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.569 0.543 . . . . 0.0 110.682 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.9 -8.42 58.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.982 0.896 . . . . 0.0 109.461 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 m -83.77 -2.93 57.33 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.633 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.5 t -109.09 116.79 32.62 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-O 121.77 0.795 . . . . 0.0 109.722 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 p-90 -70.04 -14.44 62.68 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.883 1.273 . . . . 0.0 112.129 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.74 -23.72 66.33 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.382 0.673 . . . . 0.0 112.392 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.95 -0.74 57.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.32 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 mmt -89.13 -13.54 38.23 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.292 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -83.08 144.03 46.65 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.01 142.53 38.69 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.237 1.958 . . . . 0.0 110.464 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -88.7 138.88 31.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.325 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.69 163.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.526 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.01 -46.14 37.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.9 p -115.03 173.01 6.71 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.87 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.74 -12.72 57.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.904 0.383 . . . . 0.0 110.402 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -68.76 -32.55 72.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.455 0.645 . . . . 0.0 110.154 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.89 -0.74 55.53 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.262 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.98 132.34 44.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.592 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -96.6 -12.72 23.6 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.3 m -149.08 132.88 16.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.419 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.27 138.89 38.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 202' ' ' VAL . 1.7 mp -110.76 114.57 47.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -131.36 175.6 9.0 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.257 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -123.43 132.0 53.82 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.586 0.708 . . . . 0.0 111.638 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 17.3 tppt? -136.91 126.82 25.8 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.41 28.26 17.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.447 1.092 . . . . 0.0 109.584 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.12 9.71 6.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.244 1.418 . . . . 0.0 114.15 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -104.7 152.86 22.0 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 40.3 mt -94.42 141.37 28.66 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 78.7 m95 -130.96 149.2 52.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.3 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.4 t -130.35 117.66 20.08 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 177' ' ' SER . 4.0 ptm180 -120.0 144.14 47.68 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.49 116.57 36.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 p -94.22 -37.23 11.65 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.536 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.44 171.25 7.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.477 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.58 106.28 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.728 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.57 108.8 62.29 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.63 176.93 9.33 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.848 2.366 . . . . 0.0 112.354 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.1 m -72.83 115.01 11.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.278 0.561 . . . . 0.0 109.899 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.49 -7.9 47.14 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.47 144.03 31.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.51 145.22 24.67 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.69 144.83 46.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.236 0.541 . . . . 0.0 110.397 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -118.04 152.72 34.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.051 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 179' ' ' ILE . 3.9 p -102.39 129.07 54.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 124.077 0.861 . . . . 0.0 113.103 -174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -109.97 108.07 18.19 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.488 HD11 ' H ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -115.48 154.39 29.41 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.312 -1.031 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.76 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 t-105 . . . . . 0 N--CA 1.423 -1.82 0 CA-C-O 121.184 0.516 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -109.54 92.9 4.24 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -135.61 -168.94 11.7 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.036 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.1 170.24 13.82 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.551 2.834 . . . . 0.0 113.149 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -75.82 -30.62 59.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.904 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.96 -2.61 48.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.726 0.774 . . . . 0.0 111.974 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.89 161.91 18.11 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.616 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.31 148.74 29.89 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.86 122.02 44.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.4 48.55 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.775 0.321 . . . . 0.0 110.346 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 92.6 mt -99.21 101.35 12.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.78 110.29 20.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 67.73 13.09 9.14 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.995 0.902 . . . . 0.0 112.12 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.72 42.8 Favored Glycine 0 C--N 1.317 -0.525 0 O-C-N 121.681 -0.637 . . . . 0.0 112.464 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.7 tt0 -90.02 135.01 33.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -86.59 96.7 10.19 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.2 t -110.63 152.73 26.14 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.29 131.69 72.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -138.52 148.98 44.89 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.093 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.98 120.67 17.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -68.8 -45.97 69.88 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.14 -179.52 3.66 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.5 m -78.14 98.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.617 0.722 . . . . 0.0 109.21 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.9 tp -76.93 112.53 13.64 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 124.898 1.279 . . . . 0.0 108.891 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.4 t -87.8 142.95 27.42 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.466 0.651 . . . . 0.0 110.942 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.38 136.65 46.17 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.051 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.61 -16.02 21.7 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 tp -81.61 140.01 34.69 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.4 p -138.54 152.05 47.87 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -100.03 175.27 5.81 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 123.265 0.353 . . . . 0.0 110.142 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.53 -179.96 39.29 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.828 0.705 . . . . 0.0 113.297 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.58 123.46 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 113.13 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -99.34 158.47 15.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.4 123.39 40.03 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 170.44 -178.23 43.22 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.6 m -121.38 126.12 48.62 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.39 0.614 . . . . 0.0 111.943 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.2 mt . . . . . 0 C--N 1.312 -1.036 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 175.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.495 ' HG ' ' NE2' ' A' ' 168' ' ' GLN . 1.2 pp . . . . . 0 C--O 1.245 0.85 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.9 mmt -123.56 81.99 1.96 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.972 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.61 171.82 10.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -71.5 152.84 42.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -22.61 61.89 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.5 p -96.15 -8.21 33.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.7 t -73.26 124.59 25.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.5 p-90 -59.53 -21.55 60.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.005 0.922 . . . . 0.0 113.066 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.93 -29.44 69.62 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 122.674 0.39 . . . . 0.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 15.9 ptm180 -93.91 2.68 56.09 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.017 0.437 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 mmt -94.96 -11.03 29.29 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.7 mt -86.63 141.97 34.47 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 35.8 Cg_exo -63.6 131.8 32.93 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.436 2.091 . . . . 0.0 110.781 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.495 ' NE2' ' HG ' ' A' ' 155' ' ' LEU . 94.0 mt-30 -89.25 137.88 31.92 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.168 0.508 . . . . 0.0 112.031 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.92 171.07 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.81 -25.01 9.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.2 p -104.09 150.92 23.87 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.958 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 15.9 pt-20 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.9 -20.08 58.31 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.193 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.83 -23.5 36.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.667 0.746 . . . . 0.0 109.229 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.63 22.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.533 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.404 ' C ' HG21 ' A' ' 191' ' ' THR . 16.7 p30 -114.96 -2.66 12.8 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.71 0.767 . . . . 0.0 109.344 172.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.3 p -145.43 136.18 24.45 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.339 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.441 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 16.0 pt-20 -136.03 143.52 44.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.345 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.0 mm -118.28 137.13 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -139.07 164.51 29.57 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -96.58 140.86 30.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.457 0.646 . . . . 0.0 110.06 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 57.6 tptt -140.46 118.53 11.92 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.41 ' OD1' ' HE3' ' A' ' 182' ' ' LYS . 2.8 m-20 53.12 47.17 25.1 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.772 1.295 . . . . 0.0 111.253 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.4 t70 70.59 -13.16 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.803 1.641 . . . . 0.0 113.513 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.89 152.0 20.28 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 44.5 mt -97.24 132.73 42.71 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.628 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 69.4 m95 -121.2 122.76 40.68 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.456 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.67 124.0 37.38 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.574 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -119.64 142.14 48.7 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 123.331 0.394 . . . . 0.0 110.008 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.53 104.43 12.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 176' ' ' ASN . 4.0 t -84.89 -18.52 34.49 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.068 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -142.3 142.03 32.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.77 116.61 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.775 0.798 . . . . 0.0 111.057 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.66 120.45 55.83 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.56 172.38 14.41 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.331 2.021 . . . . 0.0 111.957 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.0 m -67.58 112.16 4.57 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.89 -5.45 53.61 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.979 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.9 138.58 33.4 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.86 128.76 36.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.459 ' H ' HD13 ' A' ' 200' ' ' LEU . 3.8 mp -82.71 153.66 25.21 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.295 0.569 . . . . 0.0 112.226 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.1 126.82 32.61 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.41 129.62 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 123.96 0.788 . . . . 0.0 111.678 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.441 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 61.0 ttt180 -104.66 133.55 49.31 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.408 HD12 HD21 ' A' ' 155' ' ' LEU . 2.7 mm? -112.75 154.03 26.83 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--N 1.297 -1.707 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.123 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 t -90.84 77.89 6.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.87 164.29 24.73 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.08 166.12 16.77 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.69 2.26 . . . . 0.0 112.885 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -74.68 -12.1 60.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.592 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -80.88 -12.48 59.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.729 0.776 . . . . 0.0 109.393 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.69 157.7 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.237 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.5 141.56 46.77 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.98 120.29 29.18 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.8 129.42 56.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.103 0.478 . . . . 0.0 111.455 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.47 108.49 20.43 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -109.76 95.54 5.67 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 51.38 59.35 4.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.141 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.03 -1.5 86.57 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.803 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.4 140.63 47.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 117.276 0.538 . . . . 0.0 110.736 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -80.75 111.51 17.26 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.868 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.59 169.16 11.73 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 129.95 74.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -119.48 145.82 45.97 Favored 'General case' 0 N--CA 1.394 -3.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.0 20.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -89.1 -44.4 10.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.21 165.2 11.8 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 51.0 m -91.84 110.15 21.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.5 mm? -84.02 123.87 30.47 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 t -101.27 157.51 16.73 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 149.39 50.69 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.878 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.14 -26.97 21.38 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.086 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.411 ' C ' ' HG ' ' A' ' 129' ' ' SER . 46.4 tp -75.25 142.35 43.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 128' ' ' LEU . 13.9 m -139.78 162.35 35.34 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -100.45 174.99 5.84 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.292 0.637 . . . . 0.0 109.731 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.39 171.14 55.1 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 119.526 -0.597 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 57.7 Cg_endo -73.09 123.33 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.247 1.964 . . . . 0.0 114.054 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 48.8 m-85 -94.72 149.96 20.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -106.36 106.26 16.7 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.861 0.839 . . . . 0.0 112.189 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.1 -145.02 4.12 Favored Glycine 0 C--N 1.291 -1.949 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -153.45 161.3 42.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.34 1.07 . . . . 0.0 110.832 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--N 1.316 -0.873 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.082 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 155' ' ' LEU . 1.3 pp . . . . . 0 N--CA 1.429 -1.488 0 CA-C-O 121.543 0.687 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -96.3 86.72 4.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.675 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.93 165.62 28.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.182 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -70.09 160.25 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.9 63.96 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 112.245 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 p -88.47 -9.37 52.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 53.1 t -75.97 126.81 31.71 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.023 0.439 . . . . 0.0 110.188 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.529 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 7.8 p-90 -54.01 -30.87 49.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.44 HD21 ' SG ' ' A' ' 188' ' ' CYS . 88.2 mt -59.62 -30.28 68.59 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.35 -2.9 44.77 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.47 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.8 ptp -107.48 4.56 26.3 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.727 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 73.5 mt -83.99 148.86 54.84 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.8 118.23 5.23 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.901 1.734 . . . . 0.0 110.056 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -81.68 129.16 34.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.36 146.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.408 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.04 0.77 25.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.579 0.704 . . . . 0.0 109.466 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.3 p -100.03 134.49 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.585 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.25 -34.37 68.2 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-O 121.167 0.508 . . . . 0.0 110.727 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.95 -12.91 61.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.81 -20.4 17.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.62 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -88.6 127.97 35.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.081 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -94.54 -11.41 29.59 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.205 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 p -152.42 129.43 11.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.475 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.36 134.04 52.32 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.054 0.455 . . . . 0.0 110.25 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.463 HD12 ' SG ' ' A' ' 188' ' ' CYS . 29.8 mm -102.17 125.24 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 187' ' ' TRP . 32.4 p90 -130.29 154.03 48.03 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.606 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -102.66 127.25 49.86 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -137.26 128.04 27.17 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.06 23.41 11.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.76 17.55 11.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.445 1.498 . . . . 0.0 113.376 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -109.61 159.37 17.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 3.4 mm? -93.39 131.36 38.65 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 180' ' ' TYR . 51.2 m95 -128.23 139.56 52.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.463 ' SG ' HD12 ' A' ' 179' ' ' ILE . 49.1 m -109.05 112.77 25.14 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.742 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.4 131.63 54.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.74 126.46 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.0 p -106.54 -19.1 13.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -140.02 146.03 38.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.445 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 76.7 t -69.16 115.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 123.864 0.727 . . . . 0.0 109.717 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -108.8 120.22 46.75 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 153.58 49.41 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.228 1.952 . . . . 0.0 111.988 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.3 m -63.14 122.72 16.79 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.61 -18.1 25.13 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.558 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.78 159.09 23.66 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.579 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.76 153.65 20.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.208 0.528 . . . . 0.0 110.783 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.52 148.85 45.89 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.37 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -114.25 145.08 42.2 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.3 p -102.15 125.63 56.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 123.948 0.78 . . . . 0.0 110.75 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.497 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.2 ttt180 -97.74 134.0 41.5 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.02 135.9 38.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.304 -1.377 0 CA-C-O 122.555 1.169 . . . . 0.0 111.915 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.508 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 36.2 t-105 . . . . . 0 N--CA 1.405 -2.72 0 CA-C-O 121.799 0.809 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -145.2 123.98 12.62 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -171.95 -141.83 3.52 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 118.526 -1.797 . . . . 0.0 113.592 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -82.56 159.2 16.8 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.125 2.55 . . . . 0.0 112.339 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.46 -20.58 39.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.1 -15.45 63.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.324 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.8 mm? -119.53 147.77 44.06 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.697 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.36 141.32 33.83 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -94.3 100.1 12.21 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.11 146.24 32.93 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -172.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 9.0 mp -108.19 110.49 22.13 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.694 176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 117.33 31.42 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.32 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.66 23.75 14.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.048 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.64 2.22 63.35 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.071 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 53.2 tt0 -98.35 137.96 36.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 116' ' ' ARG . 0.2 OUTLIER -98.1 102.64 14.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.3 t -130.8 165.11 23.7 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.077 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -91.0 107.98 19.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.375 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.5 140.82 36.99 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.34 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.84 113.51 7.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -50.17 30.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.08 169.25 8.9 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 m -74.46 112.57 10.77 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.223 0.535 . . . . 0.0 110.46 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.436 ' CD1' HD22 ' A' ' 200' ' ' LEU . 75.4 mt -84.71 114.7 22.22 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.4 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.6 p -88.81 155.26 19.66 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.165 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.55 141.33 55.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.105 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.97 -17.75 58.7 Favored Glycine 0 C--N 1.297 -1.606 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.266 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.67 117.02 9.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.7 m -129.3 141.11 51.19 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -99.37 170.95 8.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.9 -168.56 22.19 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.85 0.719 . . . . 0.0 113.937 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.2 Cg_endo -75.16 144.02 29.24 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.343 2.029 . . . . 0.0 112.864 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 163' ' ' LEU . 76.8 m-85 -123.34 162.52 22.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.199 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -94.38 125.12 38.83 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 -178.74 35.02 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.952 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -126.19 158.85 34.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.2 mt . . . . . 0 N--CA 1.428 -1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 109.819 -177.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.668 0.747 . . . . 0.0 111.952 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.65 90.91 8.55 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 m -110.93 178.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.207 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.604 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 23.5 t70 -66.94 144.5 56.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -10.07 49.74 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -95.51 -12.44 25.79 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.604 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 158' ' ' ASP . 94.0 m -69.94 111.01 5.35 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-O 121.614 0.721 . . . . 0.0 112.926 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.629 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 19.8 p-90 -54.48 -26.15 29.53 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 125.514 1.526 . . . . 0.0 112.569 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 133' ' ' PHE . 75.3 mt -54.21 -32.66 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.464 1.106 . . . . 0.0 112.549 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -85.47 -2.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.618 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 95.9 mmm -86.53 -16.27 37.46 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.577 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.16 143.26 52.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.99 131.35 20.73 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 121.607 1.538 . . . . 0.0 109.426 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -83.95 129.93 34.91 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -112.94 137.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.685 0.755 . . . . 0.0 112.531 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.54 -18.77 56.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.524 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 4.7 p -95.4 134.92 37.66 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.092 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.06 -17.32 37.79 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.72 0.771 . . . . 0.0 109.515 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -66.89 -41.37 87.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.093 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -77.66 -29.21 51.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.52 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.51 140.17 57.02 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.556 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -107.81 -15.48 14.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.533 0.682 . . . . 0.0 109.74 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.7 m -149.36 142.96 25.45 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -116.72 151.56 36.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.893 0.378 . . . . 0.0 111.001 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.96 115.52 49.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -113.19 163.03 15.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -109.92 141.74 42.23 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -148.25 121.27 8.83 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 65.69 20.98 11.6 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.045 0.938 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 73.71 15.68 3.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.743 1.617 . . . . 0.0 111.31 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -109.08 147.87 31.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 70.4 mt -93.87 141.22 28.76 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.851 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.89 136.33 50.27 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.9 126.07 54.71 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 123.282 0.364 . . . . 0.0 110.806 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -123.88 137.22 54.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.63 125.2 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.0 p -90.85 -39.91 12.06 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 175' ' ' ALA . 48.9 mtmt -119.49 153.66 34.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.84 108.69 8.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.66 112.63 48.16 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 121.124 0.487 . . . . 0.0 110.247 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 164.32 35.02 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.441 2.094 . . . . 0.0 112.488 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.3 t -58.6 123.25 15.67 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.679 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.2 -30.69 5.14 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.47 147.32 49.73 Favored Glycine 0 N--CA 1.443 -0.861 0 O-C-N 124.045 0.497 . . . . 0.0 112.157 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.5 mt -105.34 120.39 41.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 124' ' ' LEU . 5.3 mp -73.1 136.49 44.9 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -118.47 137.69 53.0 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.0 130.78 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.487 0.661 . . . . 0.0 111.949 -173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.565 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.4 tpt180 -104.77 130.84 52.78 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.19 124.43 48.59 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 122.416 1.103 . . . . 0.0 108.661 178.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.612 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 5.1 p-90 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 121.536 0.684 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.263 79.1 p 65.94 -51.02 0.4 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.171 2.189 . . . . 0.0 114.669 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.68 -73.05 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.228 -1.463 . . . . 0.0 114.446 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -70.65 119.99 6.75 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.717 1.611 . . . . 0.0 114.443 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -10.31 59.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.345 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.15 -7.74 55.47 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.063 1.345 . . . . 0.0 109.619 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.612 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 0.2 OUTLIER -110.96 138.39 47.43 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.487 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 39.7 tt0 -113.57 119.19 36.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.354 0.597 . . . . 0.0 112.242 -176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.5 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.6 tm? -96.49 110.58 22.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.475 ' HB3' HE21 ' A' ' 112' ' ' GLN . . . -117.49 114.8 24.01 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.088 0.471 . . . . 0.0 110.997 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.67 105.0 17.41 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.145 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.475 HE21 ' HB3' ' A' ' 110' ' ' ALA . 82.2 mm-40 -105.83 105.9 16.16 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 64.44 21.79 12.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.119 0.968 . . . . 0.0 110.861 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.91 2.35 59.55 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.861 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -100.55 137.57 38.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 117.291 0.545 . . . . 0.0 110.181 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -84.68 113.34 21.22 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.616 0.722 . . . . 0.0 112.635 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.3 t -115.3 143.99 44.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.0 t -121.51 112.85 37.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 80.9 mtt180 -118.57 160.1 22.38 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.703 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.17 126.46 32.64 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -64.64 -37.44 87.58 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.516 0.674 . . . . 0.0 110.201 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.95 171.3 14.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -66.61 112.13 4.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.48 117.85 21.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.2 p -79.82 147.34 31.82 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.101 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.27 139.25 54.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.74 -18.8 56.38 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.363 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.26 125.37 26.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m -129.62 149.06 51.55 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -92.1 165.38 13.19 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.097 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.61 158.74 35.76 Favored Glycine 0 N--CA 1.441 -1.002 0 O-C-N 124.41 1.069 . . . . 0.0 112.853 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 123.6 12.03 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.083 2.522 . . . . 0.0 112.681 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -96.36 152.61 18.44 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.83 141.85 31.1 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.791 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.28 -158.78 28.66 Favored Glycine 0 C--N 1.281 -2.514 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -147.28 162.38 39.06 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--N 1.313 -0.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.42 -1.926 0 CA-C-O 120.683 0.278 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.19 95.37 5.16 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.95 -178.63 2.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.445 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 164' ' ' ARG . 11.0 t70 -55.48 142.22 33.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.088 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -55.8 -30.48 61.42 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.8 p -105.95 5.33 30.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.826 0.346 . . . . 0.0 111.899 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.6 t -66.33 124.38 22.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -51.24 -29.23 13.78 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.0 mt -57.09 -35.45 69.42 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.06 0.544 . . . . 0.0 111.508 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 158' ' ' ASP . 16.5 ptm180 -97.31 -2.47 42.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.518 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 93.6 mmm -92.63 -28.32 16.77 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.3 152.54 70.76 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.83 124.72 14.56 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 121.686 1.591 . . . . 0.0 109.653 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -88.86 132.15 34.79 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.573 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.558 ' CG2' ' HB1' ' A' ' 175' ' ' ALA . 33.9 m -125.37 164.37 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.1 mt -111.75 -8.11 14.18 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.188 0.518 . . . . 0.0 110.638 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.9 p -93.2 134.6 35.23 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.052 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.26 -9.21 58.69 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.143 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -80.02 -34.9 37.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.649 0.261 . . . . 0.0 110.783 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.02 23.69 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.614 0.721 . . . . 0.0 109.319 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -78.11 123.32 26.73 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.763 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -90.02 -14.75 33.25 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.061 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.3 m -134.53 136.83 43.34 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.677 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.92 136.67 54.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.271 0.558 . . . . 0.0 110.665 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.49 HD11 HG11 ' A' ' 202' ' ' VAL . 1.4 mp -103.32 120.71 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.545 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -132.1 151.4 51.79 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.057 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 141.25 28.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -155.25 111.89 3.23 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.3 t70 57.2 65.36 1.39 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.266 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.66 8.04 2.78 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.136 -1.393 . . . . 0.0 114.283 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.37 156.53 45.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.3 mt -101.61 131.92 47.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -120.51 150.24 41.16 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.1 t -125.32 114.27 18.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -111.02 146.04 37.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.5 t -83.06 112.46 20.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t -92.17 -34.16 14.43 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.97 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -123.48 135.59 54.14 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.98 108.36 2.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.558 0.536 . . . . 0.0 111.045 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.46 128.14 27.57 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.264 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.29 169.01 17.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.877 2.385 . . . . 0.0 112.779 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.4 t -67.38 131.5 45.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.29 -13.78 64.19 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.413 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.66 154.56 45.62 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.86 142.43 28.86 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.447 0.642 . . . . 0.0 110.753 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -123.22 164.38 18.84 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.392 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -136.03 158.74 43.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.49 HG11 HD11 ' A' ' 179' ' ' ILE . 23.3 t -100.05 119.18 47.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 124.484 1.115 . . . . 0.0 111.361 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.636 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 1.1 tmm_? -106.73 128.0 53.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.24 138.96 31.19 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 122.897 1.332 . . . . 0.0 112.714 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.495 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 162' ' ' TRP . 36.6 m -91.48 93.12 8.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.18 -175.52 38.53 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.687 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.04 151.44 9.62 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.11 2.54 . . . . 0.0 111.966 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 1.6 pm0 -78.42 -0.36 28.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.54 -22.76 60.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.9 161.2 17.26 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.566 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 34.9 tt0 -144.25 122.67 12.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.758 0.313 . . . . 0.0 110.718 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.3 tm? -88.23 109.69 20.13 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 171.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.44 157.75 18.15 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.4 mt -118.03 97.93 6.06 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -113.39 117.51 31.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 66.15 12.51 8.57 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.444 1.116 . . . . 0.0 110.062 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.83 69.06 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.057 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -82.32 136.73 34.97 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 122.665 -0.314 . . . . 0.0 110.185 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.95 110.41 16.46 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.9 p -129.95 136.94 50.04 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.414 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.5 t -96.54 105.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -110.84 149.2 30.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.16 15.15 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 24.3 ttt180 -73.92 -43.22 59.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.83 152.81 25.27 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.7 m -68.41 116.38 8.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 88.6 mt -86.77 113.12 22.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.879 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 p -90.66 144.37 25.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -64.64 148.46 50.9 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.41 -34.1 5.9 Favored Glycine 0 C--N 1.282 -2.434 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.412 ' C ' ' HG ' ' A' ' 129' ' ' SER . 63.9 tp -65.75 138.55 58.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 128' ' ' LEU . 13.2 m -147.55 154.96 41.37 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -98.35 173.11 7.14 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 123.564 0.54 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.6 -179.05 37.94 Favored Glycine 0 N--CA 1.437 -1.289 0 O-C-N 123.81 0.694 . . . . 0.0 112.97 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 123.72 10.08 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.635 2.223 . . . . 0.0 112.579 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 163' ' ' LEU . 80.3 m-85 -96.6 150.01 21.13 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.338 0.589 . . . . 0.0 110.806 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.471 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 147.6 -174.27 27.41 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.0 m -139.15 160.52 39.59 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.989 0.894 . . . . 0.0 111.993 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 170.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.4 ptm -123.6 85.72 2.46 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.953 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.471 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -136.86 164.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.025 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.02 158.24 29.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.96 -19.24 65.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -73.06 -14.22 61.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.494 0.664 . . . . 0.0 109.381 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.8 t -87.25 100.31 12.6 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.45 ' HB3' ' O ' ' A' ' 102' ' ' SER . 16.1 p-90 -44.83 -28.4 0.64 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 114.234 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 133' ' ' PHE . 82.5 mt -52.8 -37.35 59.7 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.89 0.876 . . . . 0.0 112.416 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -87.33 1.07 54.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.111 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 92.0 mmm -92.61 -8.8 43.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.249 0.547 . . . . 0.0 110.23 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.96 155.18 49.97 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.63 118.67 5.67 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.888 1.725 . . . . 0.0 110.089 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.87 136.18 38.02 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.925 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 21.8 m -138.24 149.07 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.34 -10.29 16.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.44 0.638 . . . . 0.0 109.76 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.8 p -88.54 134.55 33.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.86 -29.67 61.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.564 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.25 -32.06 69.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.774 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.32 -20.44 24.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.909 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.597 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.08 154.29 24.45 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.777 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -119.66 -12.75 9.22 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.444 0.64 . . . . 0.0 110.066 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.8 m -154.28 145.67 23.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.69 147.58 49.3 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.1 0.476 . . . . 0.0 111.467 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.59 131.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.06 167.2 21.39 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -97.79 139.64 33.36 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.9 tttt -165.22 138.26 4.52 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 65.72 16.6 10.56 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.845 0.858 . . . . 0.0 110.767 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.19 64.24 0.86 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 111.283 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -173.06 172.92 3.8 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.729 -1.578 . . . . 0.0 106.832 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.81 139.12 40.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.8 m95 -123.29 133.2 54.18 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.7 t -102.7 117.73 35.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -115.8 144.8 43.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.88 132.46 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.0 p -104.42 -39.07 6.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.302 0.572 . . . . 0.0 111.998 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -108.98 149.53 29.08 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.958 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 59.2 t -77.18 98.23 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 t -85.95 125.95 67.06 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 144.99 42.54 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 122.136 1.891 . . . . 0.0 111.689 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.6 p -62.61 116.4 5.13 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.386 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.19 -8.14 30.96 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.569 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.84 33.76 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.0 mt -103.26 163.11 12.45 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 200' ' ' LEU . 1.2 pt? -141.15 148.45 40.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -111.44 144.77 40.12 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.77 123.01 53.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.306 0.574 . . . . 0.0 110.529 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.597 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 55.1 ttt180 -98.04 137.31 37.03 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.805 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.32 138.3 35.78 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.321 -0.666 0 CA-C-O 122.666 1.222 . . . . 0.0 112.817 -178.076 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.477 ' CE2' ' HB2' ' A' ' 109' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -87.83 82.85 7.2 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.89 171.95 29.85 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.23 158.21 11.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.496 2.797 . . . . 0.0 112.012 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.07 -2.29 47.61 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.67 -19.98 54.45 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 160.18 16.18 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 113.506 -1.679 . . . . 0.0 108.9 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.475 ' OE2' ' HD3' ' A' ' 119' ' ' ARG . 36.6 tt0 -136.39 131.2 33.87 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.323 0.582 . . . . 0.0 111.493 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.477 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.5 tm? -96.36 114.31 25.97 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.83 142.91 45.5 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 79.1 mt -99.77 122.47 42.81 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.669 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 10.1 tt0 -121.5 107.19 12.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 13.14 2.77 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.139 1.376 . . . . 0.0 112.439 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.78 2.39 30.46 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.209 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.669 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.4 pt20 -95.65 151.71 19.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -98.2 105.23 17.35 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.245 0.545 . . . . 0.0 109.628 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 8.2 p -111.04 138.4 47.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.5 117.31 45.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD3' ' OE2' ' A' ' 108' ' ' GLU . 3.2 ptm180 -127.18 154.27 45.01 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.558 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.4 121.02 19.81 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -78.02 -43.53 29.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.24 170.09 10.26 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.805 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -69.8 107.68 3.62 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.256 0.551 . . . . 0.0 111.058 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 83.6 mt -74.52 113.75 12.12 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.2 p -85.56 155.47 21.16 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.287 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.51 129.75 40.57 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.117 0.484 . . . . 0.0 109.809 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.74 61.93 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.386 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.67 126.97 30.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 188' ' ' CYS . 36.9 p -135.59 147.51 48.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -97.69 168.18 10.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.934 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.11 159.14 53.47 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.833 0.708 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 23.6 Cg_endo -59.33 123.75 14.08 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 123.471 2.781 . . . . 0.0 112.762 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -92.99 150.65 20.4 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.912 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -90.6 105.0 17.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.146 0.498 . . . . 0.0 110.038 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.84 -168.64 39.11 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -146.9 166.61 26.23 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.298 -1.652 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.0 ttt -102.08 82.05 2.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.21 178.69 4.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.814 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.18 146.27 54.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 123.567 0.542 . . . . 0.0 110.798 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -53.36 -38.83 63.67 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.36 1.064 . . . . 0.0 112.223 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 3.34 54.44 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.77 0.319 . . . . 0.0 110.903 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.42 126.62 31.11 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -54.67 -31.1 57.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 179' ' ' ILE . 49.0 mt -56.13 -40.06 73.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -87.36 -6.52 58.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.4 ptp -100.46 5.41 44.19 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.968 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.88 143.2 31.19 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.53 129.96 16.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.909 1.739 . . . . 0.0 110.786 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -79.99 150.39 30.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.113 0.482 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 m -138.71 147.57 25.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.25 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.97 -21.93 20.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.8 p -94.99 134.83 37.24 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.241 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.4 -6.02 59.25 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.149 0.5 . . . . 0.0 111.651 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.99 -29.4 64.18 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.28 -29.74 18.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.793 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.86 124.67 25.87 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.708 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.22 -18.11 15.65 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.44 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.2 p -141.17 134.33 29.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -120.73 147.68 44.98 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.939 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.437 ' CD1' HD23 ' A' ' 163' ' ' LEU . 18.9 mm -111.1 114.35 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 11.9 p90 -125.84 154.97 41.88 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 33.0 ptt180 -94.26 135.94 35.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.195 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.633 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 52.2 tttm -137.31 122.57 19.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 3.8 m-20 66.63 22.16 10.53 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.6 t70 68.96 5.59 5.13 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.473 1.909 . . . . 0.0 112.214 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -95.8 155.17 16.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 78.5 mt -93.58 123.44 36.9 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.633 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.633 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 55.4 m95 -116.46 137.34 52.24 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' SER . 50.9 t -108.7 119.86 40.77 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -123.14 142.26 51.08 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.781 0.324 . . . . 0.0 110.295 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.49 128.56 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.008 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.1 p -98.35 -47.57 5.38 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -113.9 140.17 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.885 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 48.9 t -74.55 111.46 10.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.239 0.542 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.12 122.84 40.94 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.259 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.02 174.03 13.5 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.529 2.153 . . . . 0.0 112.256 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.9 m -59.45 125.99 25.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.39 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.05 63.37 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.783 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.5 144.78 17.43 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.65 142.14 27.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.4 pt? -110.88 147.26 34.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.23 148.33 37.55 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.8 134.47 46.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 123.653 0.595 . . . . 0.0 111.088 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -109.2 139.33 44.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.35 154.5 18.14 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.145 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 14.2 p . . . . . 0 C--O 1.246 0.9 0 C-N-CA 126.064 1.746 . . . . 0.0 114.286 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.1 t -86.74 84.57 7.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -142.71 177.7 21.61 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.841 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.77 173.3 9.43 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.714 2.943 . . . . 0.0 112.991 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.62 -27.34 51.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 111.511 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.05 -22.93 62.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.095 0.95 . . . . 0.0 110.265 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.9 mm? -102.31 155.03 18.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.688 -173.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -139.64 135.58 33.43 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.405 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.2 114.99 28.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.74 52.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.0 mt -93.25 109.98 21.5 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -106.3 109.43 21.35 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 66.72 22.82 10.3 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.81 1.29 . . . . 0.0 109.036 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.13 -9.84 72.18 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.542 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -89.91 130.33 36.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 122.618 -0.342 . . . . 0.0 110.419 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.42 103.52 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.816 0.817 . . . . 0.0 111.28 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 39.8 m -112.95 153.14 28.48 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.015 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.46 130.99 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -142.4 158.85 43.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.09 113.82 24.1 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -76.01 -33.26 59.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.73 150.43 26.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -69.25 124.39 23.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.128 0.49 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.47 114.1 23.78 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.4 p -88.1 147.39 24.95 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.003 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.46 126.91 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.238 0.542 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.11 -7.72 48.48 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.506 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.32 126.12 30.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -128.8 148.48 50.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -97.81 173.94 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.449 0.166 . . . . 0.0 110.984 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.28 166.53 54.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.06 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.65 130.58 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.149 2.566 . . . . 0.0 113.826 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -107.06 173.74 6.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -120.16 139.05 53.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.68 -176.09 34.85 Favored Glycine 0 N--CA 1.405 -3.37 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.741 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.4 m -126.52 143.88 51.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.2 mm . . . . . 0 N--CA 1.431 -1.413 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.735 0 CA-C-O 122.165 0.983 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 47.6 ttm -80.07 87.71 5.43 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.94 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.31 -174.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.78 155.39 21.04 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.636 -0.825 . . . . 0.0 108.948 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.19 -21.27 66.74 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.7 t -93.01 -7.06 46.86 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.315 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.8 t -71.26 125.14 26.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 109.93 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.478 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 9.7 p-90 -61.9 -21.51 64.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.13 -31.98 72.52 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.645 0.378 . . . . 0.0 111.593 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -85.92 -4.38 59.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -96.3 -5.31 40.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.093 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.2 mt -90.05 147.28 36.81 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.44 122.16 7.28 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 121.966 1.777 . . . . 0.0 111.205 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.14 129.13 35.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.753 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.16 146.54 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.783 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.31 -8.65 26.74 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.046 0.451 . . . . 0.0 109.925 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.9 p -104.47 134.84 46.98 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.464 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.41 -27.09 62.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.522 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.68 -25.97 68.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.985 0.914 . . . . 0.0 110.834 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.52 -38.64 12.39 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.557 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.62 135.49 52.94 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.705 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 200' ' ' LEU . 8.3 p30 -124.17 -10.71 7.56 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.254 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 m -141.61 124.36 16.04 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 188' ' ' CYS . 11.7 pt-20 -108.51 145.06 35.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.564 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 202' ' ' VAL . 2.0 mp -111.1 119.87 60.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -135.01 154.56 51.69 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.643 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -88.23 124.0 33.41 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.195 0.521 . . . . 0.0 109.989 176.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 64.5 tttp -132.94 97.98 4.17 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.2 t70 57.25 72.51 0.51 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.723 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.7 t70 73.46 -5.73 1.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.251 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -130.28 164.26 24.97 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.0 110.3 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.5 mt -98.22 134.44 41.26 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.664 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 49.7 m95 -124.72 152.73 43.39 Favored 'General case' 0 C--N 1.268 -2.949 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 50.3 t -128.89 128.88 44.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -123.69 147.34 47.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.0 t -91.15 115.57 30.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.3 p -86.42 -47.35 9.4 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.226 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -123.3 144.27 49.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.73 120.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.823 0.702 . . . . 0.0 112.473 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.2 p -114.79 120.62 37.07 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.98 162.32 41.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.378 2.052 . . . . 0.0 113.436 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.0 p -56.57 113.36 1.58 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.781 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.91 -14.05 19.62 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.91 159.12 34.01 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.657 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.52 150.15 20.66 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -114.28 153.86 28.98 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.35 142.02 50.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.462 HG23 HD11 ' A' ' 179' ' ' ILE . 5.9 p -96.6 127.68 48.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.87 0.843 . . . . 0.0 111.887 -174.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.557 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.2 ttt180 -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 173.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.92 148.28 24.12 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 110.843 179.471 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -80.51 35.73 0.35 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.021 0.928 . . . . 0.0 111.968 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.8 153.01 16.95 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.993 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.89 152.93 27.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.479 3.453 . . . . 0.0 113.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.11 -0.37 39.77 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.217 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -80.98 -13.43 58.89 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.65 160.08 24.0 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.334 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.421 ' HG3' ' HB2' ' A' ' 121' ' ' ARG . 47.7 mt-10 -130.99 139.48 50.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.664 0.269 . . . . 0.0 111.167 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.23 94.86 6.7 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 168.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.44 130.93 50.89 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.323 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -100.78 113.33 26.15 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -126.43 114.38 18.1 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 71.69 12.86 6.31 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.506 1.146 . . . . 0.0 110.228 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.61 5.04 69.51 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.063 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -94.35 118.89 32.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -73.02 105.29 4.42 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.396 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.9 121.82 42.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.497 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.23 107.17 18.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -119.84 158.89 25.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.388 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 125.65 30.83 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.452 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 8.6 tpm_? -81.63 -48.52 11.64 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.2 mt -110.72 157.18 20.04 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.2 t -76.93 112.03 13.12 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-O 121.266 0.555 . . . . 0.0 109.896 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.56 110.43 7.84 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -109.38 166.85 10.56 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.03 132.79 51.64 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.08 -31.84 4.97 Favored Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.1 tp -85.12 132.02 34.36 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -146.25 154.22 41.48 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -91.49 172.65 8.36 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.146 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.93 169.76 54.34 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.32 123.46 13.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.274 2.649 . . . . 0.0 112.745 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -92.16 147.73 22.71 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.16 95.95 6.19 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.823 1.297 . . . . 0.0 112.771 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.05 -155.34 10.09 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -151.82 164.26 37.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.501 1.15 . . . . 0.0 111.06 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 174.042 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 204' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.391 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.439 ' HE2' ' HA ' ' A' ' 156' ' ' MET . 3.1 tpt -122.47 87.22 2.71 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.429 HG22 HD12 ' A' ' 155' ' ' LEU . 34.8 m -129.52 167.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.495 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.81 156.69 39.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 123.877 0.735 . . . . 0.0 109.721 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -29.98 71.23 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.31 0.644 . . . . 0.0 110.026 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.2 t -77.99 -11.96 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.58 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.98 119.09 22.35 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.62 0.724 . . . . 0.0 109.729 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -64.19 -19.99 65.7 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.128 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.03 -31.35 68.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.696 0.398 . . . . 0.0 112.045 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -87.36 -5.11 59.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.5 mtp -89.86 -9.95 47.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.013 0.435 . . . . 0.0 110.407 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.97 149.79 46.32 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.05 118.75 5.67 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.195 1.93 . . . . 0.0 110.442 176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -81.86 124.55 29.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.355 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.03 147.09 28.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.64 1.07 17.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.673 0.749 . . . . 0.0 109.46 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 174.74 7.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.758 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HA ' ' NH1' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -95.72 -52.47 4.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.237 -177.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -71.07 -39.34 72.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.44 68.38 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.421 0.451 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.72 121.08 26.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.355 0.598 . . . . 0.0 111.339 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -106.13 -5.73 19.14 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.668 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 45.5 m -149.1 140.71 23.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 203' ' ' ARG . 16.2 pt-20 -136.63 155.5 49.83 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.07 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 21.8 mm -112.57 129.96 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.4 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 17.3 p90 -140.02 163.31 33.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.401 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -99.06 138.64 35.87 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 121.725 0.774 . . . . 0.0 110.519 177.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.587 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 65.2 tttp -145.8 114.38 6.78 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t70 66.82 25.54 9.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.195 1.398 . . . . 0.0 109.007 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 73.56 8.31 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.516 1.526 . . . . 0.0 112.442 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -102.73 152.24 21.46 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.19 129.9 40.62 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.678 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.587 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 65.6 m95 -121.82 141.2 51.47 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.526 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 52.8 t -109.04 119.88 40.86 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -117.87 150.3 39.42 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.49 120.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 p -96.01 -32.89 12.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.774 0.321 . . . . 0.0 111.343 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.62 148.11 52.58 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.74 102.62 5.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.794 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.01 126.71 56.34 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.95 170.94 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.55 2.166 . . . . 0.0 113.036 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.8 m -60.69 127.41 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.39 0.23 82.62 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.01 158.08 23.74 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -100.32 146.79 26.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.478 HD21 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -115.57 151.16 35.42 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.623 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -123.03 133.19 54.35 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.1 p -97.4 122.81 49.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.744 0.652 . . . . 0.0 111.367 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.473 ' NH1' ' HA ' ' A' ' 172' ' ' GLU . 43.8 ttp180 -97.79 140.46 32.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.85 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 155' ' ' LEU . 78.6 mt -107.71 127.23 53.49 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 13.0 p . . . . . 0 C--N 1.312 -1.061 0 CA-C-O 121.643 0.735 . . . . 0.0 111.65 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.48 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 1.1 p-90 . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.4 m -88.03 88.16 7.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.672 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.77 178.45 29.9 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.91 160.58 30.51 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.618 2.879 . . . . 0.0 112.946 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.2 -7.95 59.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.504 0.668 . . . . 0.0 111.426 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.51 -24.13 42.46 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.65 162.46 14.13 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.851 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.17 136.87 32.25 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.896 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.48 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -90.32 104.81 17.34 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.7 153.6 21.62 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.7 mt -115.54 112.3 22.01 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -105.0 104.53 14.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 64.55 19.07 11.69 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.464 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.63 -8.83 43.98 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.094 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -94.77 143.25 26.6 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -75.23 133.83 41.29 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.088 0.471 . . . . 0.0 109.874 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.08 121.37 17.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.35 106.81 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -110.05 156.43 20.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.856 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.77 122.07 40.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.335 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.16 -46.46 23.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.1 mt -101.53 139.78 36.72 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.9 t -70.65 126.98 31.11 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.84 145.8 50.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.159 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 p -93.4 150.9 20.11 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.052 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.46 124.07 23.3 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.94 60.19 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.818 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.47 122.02 15.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.0 m -131.53 138.54 48.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -92.18 169.32 10.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.45 179.83 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 123.9 0.75 . . . . 0.0 114.25 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 73.7 Cg_endo -75.44 138.45 22.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.786 2.324 . . . . 0.0 112.536 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.0 149.07 35.91 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -89.4 99.44 12.44 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.476 ' HA3' HG11 ' A' ' 157' ' ' VAL . . . -154.28 -152.44 6.1 Favored Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.7 m -150.93 134.18 16.12 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.411 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.437 -1.098 0 CA-C-O 122.287 1.042 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.9 mtm -79.43 83.12 5.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.649 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.476 HG11 ' HA3' ' A' ' 135' ' ' GLY . 22.9 m -126.38 150.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.626 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.54 160.38 25.31 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.301 0.64 . . . . 0.0 111.287 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -52.82 -32.45 44.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.543 0.737 . . . . 0.0 111.67 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.0 m -85.0 9.81 13.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.199 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 48.3 t -100.1 100.24 11.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -56.43 -19.59 15.75 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.773 1.229 . . . . 0.0 113.205 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.66 -28.16 67.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.374 0.669 . . . . 0.0 111.473 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 8.6 ptm180 -85.06 -2.64 58.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.933 0.397 . . . . 0.0 110.984 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.8 mtt -93.79 -13.99 26.73 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.94 142.13 36.21 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.579 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.23 133.24 27.98 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 122.114 1.876 . . . . 0.0 110.872 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -84.97 128.77 34.77 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.187 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.66 138.33 52.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.564 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.87 -21.31 23.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 p -87.99 134.81 33.65 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.014 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.4 -17.71 31.66 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.35 -34.63 74.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.34 -15.35 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.452 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.95 118.13 19.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.106 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.41 -30.33 16.57 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.0 p -133.72 136.93 44.96 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.953 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.92 146.01 45.29 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.215 0.531 . . . . 0.0 112.019 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.9 mm -104.96 120.92 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -126.19 145.17 50.49 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptp180 -91.42 139.87 30.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -142.23 115.11 8.68 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 67.45 27.28 8.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.595 1.188 . . . . 0.0 107.879 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 68.69 4.88 4.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.054 2.142 . . . . 0.0 111.98 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -90.97 151.89 20.91 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 8.0 mp -93.58 125.76 38.37 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 120.821 0.343 . . . . 0.0 111.158 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -122.92 139.21 54.29 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.532 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.9 t -113.8 116.79 29.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -115.05 135.08 54.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.754 0.311 . . . . 0.0 110.414 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.58 126.11 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.2 p -108.13 -23.42 11.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.321 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -128.78 150.26 50.37 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.035 0.445 . . . . 0.0 111.749 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.04 125.97 37.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.56 127.85 61.46 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-O 120.704 0.287 . . . . 0.0 111.231 -171.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.15 134.06 53.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 111.462 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 18.3 m -75.91 110.06 10.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.217 0.532 . . . . 0.0 109.959 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.57 0.84 32.66 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -114.32 165.05 12.02 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 69.1 mt -101.47 155.23 18.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.218 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.506 HD21 ' H ' ' A' ' 200' ' ' LEU . 1.1 pt? -99.28 143.82 29.1 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.576 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -110.93 148.08 33.25 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.63 130.2 53.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.88 0.848 . . . . 0.0 111.291 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.494 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 69.9 ttt180 -105.18 122.25 45.51 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.699 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.61 118.65 32.69 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.539 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.298 -1.633 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.294 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 m -102.53 100.11 10.18 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.507 -0.746 . . . . 0.0 109.534 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.39 -174.59 22.37 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.5 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.53 163.66 26.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.463 2.775 . . . . 0.0 111.825 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.12 -15.64 55.34 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.188 0.518 . . . . 0.0 111.604 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.95 -15.91 60.66 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.41 151.38 26.74 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.416 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.83 123.77 12.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.207 0.527 . . . . 0.0 111.898 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.46 109.92 20.42 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.12 142.45 47.42 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 56.5 mt -102.2 127.87 48.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -124.09 94.32 4.18 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 60.93 25.92 15.86 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.414 0.626 . . . . 0.0 111.364 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.19 -8.31 38.29 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 74.7 mt-30 -81.39 126.52 31.72 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -86.77 95.92 10.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.2 p -111.44 122.93 49.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.514 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.22 111.14 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -110.37 156.47 20.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.56 133.11 34.08 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -83.04 -32.35 26.9 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.13 169.5 9.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -92.23 105.38 17.61 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.88 124.46 32.38 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.15 0.5 . . . . 0.0 110.858 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -72.24 151.39 42.89 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.739 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.95 140.76 56.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.96 10.39 58.74 Favored Glycine 0 C--N 1.299 -1.501 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.608 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.0 tp -101.34 126.5 48.11 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t -122.53 158.78 29.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -95.69 174.4 6.99 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.662 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.97 177.93 49.5 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 124.209 0.943 . . . . 0.0 112.166 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.02 132.12 20.72 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.711 2.274 . . . . 0.0 114.039 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -110.39 149.71 29.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -106.04 119.32 38.89 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.627 0.727 . . . . 0.0 111.236 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.408 ' C ' ' HG ' ' A' ' 136' ' ' SER . . . -170.87 -160.62 19.83 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 135' ' ' GLY . 34.9 m -148.51 134.63 19.27 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 118.397 1.099 . . . . 0.0 111.089 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.379 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.421 -1.876 0 CA-C-O 122.159 0.981 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.78 87.93 6.32 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.892 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.95 168.96 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.703 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.12 148.19 22.6 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.255 1.022 . . . . 0.0 111.455 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.4 -20.03 65.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.343 0.592 . . . . 0.0 110.581 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 m -83.03 -20.43 35.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.063 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.4 t -74.35 131.36 41.05 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.52 0.676 . . . . 0.0 111.295 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.438 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 13.6 p-90 -66.16 -20.49 66.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.012 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.45 -30.28 71.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.699 0.285 . . . . 0.0 111.487 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -96.4 2.24 52.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.622 . . . . 0.0 110.467 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mmm -99.02 -1.64 39.25 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.199 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 83.2 mt -93.61 145.54 30.12 Favored Pre-proline 0 N--CA 1.425 -1.716 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.96 127.71 11.69 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.441 1.427 . . . . 0.0 109.883 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -84.13 135.22 34.48 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.439 ' CG2' ' HB1' ' A' ' 175' ' ' ALA . 27.1 m -135.47 160.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.3 pp -105.28 -19.52 13.78 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.794 0.807 . . . . 0.0 110.876 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.8 133.86 33.96 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.42 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -76.99 -21.57 54.5 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.139 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -67.53 -25.57 65.89 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.3 -38.61 8.79 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.59 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -76.86 94.41 3.89 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 121.395 0.616 . . . . 0.0 111.109 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -87.04 -13.9 43.05 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.451 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 m -126.88 124.51 39.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.33 150.33 37.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.1 mm -110.05 125.0 67.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 189' ' ' ARG . 11.9 p90 -126.74 176.02 7.56 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.12 140.1 52.5 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 183' ' ' ASP . 24.0 ttpp -156.37 132.05 9.59 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 4.1 m-20 60.32 34.66 20.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.315 0.646 . . . . 0.0 110.805 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 t70 67.62 17.49 9.91 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.436 1.495 . . . . 0.0 111.856 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -126.28 162.17 26.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.197 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.1 mt -97.18 140.4 31.73 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -134.0 153.08 52.02 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -125.88 128.13 47.12 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.602 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.575 ' HG3' ' CE1' ' A' ' 180' ' ' TYR . 51.4 mtp180 -103.44 145.52 29.88 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.96 100.41 11.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 166.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.8 t -82.41 -26.04 33.15 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.61 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.45 141.49 45.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.01 125.19 12.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 123.794 0.684 . . . . 0.0 111.715 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 7.5 p -110.67 114.85 54.34 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 11.1 Cg_exo -72.08 153.6 57.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.466 2.111 . . . . 0.0 112.565 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 p -61.46 115.84 4.21 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.464 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.66 -15.49 45.27 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -81.47 157.58 38.51 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.74 157.06 16.63 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.339 0.59 . . . . 0.0 110.377 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -127.81 157.1 41.34 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.107 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -134.85 148.02 50.03 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.39 133.44 46.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.54 0.686 . . . . 0.0 112.215 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.461 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 27.2 ttt180 -117.39 147.76 42.37 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.09 153.0 33.51 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.099 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 m -96.97 91.64 5.7 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.32 -173.11 29.55 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.044 -1.075 . . . . 0.0 112.176 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -83.14 158.55 15.3 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.287 2.658 . . . . 0.0 112.567 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.07 -19.05 63.29 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.719 0.808 . . . . 0.0 111.837 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -80.21 -22.34 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.096 0.95 . . . . 0.0 109.5 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 200' ' ' LEU . 4.3 mm? -108.4 160.47 15.85 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.266 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 12.8 tp10 -155.71 147.26 22.9 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.772 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 101' ' ' TRP . 1.3 tm? -99.38 103.55 15.35 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.1 146.42 23.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.45 104.62 13.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.43 99.4 8.98 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.57 23.38 11.76 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.213 1.005 . . . . 0.0 111.485 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.16 57.36 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.448 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.37 143.16 26.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.99 0.424 . . . . 0.0 111.475 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -82.98 134.17 35.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.844 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.7 m -131.84 121.53 24.25 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 166' ' ' LEU . 19.8 m -86.47 96.2 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.378 1.085 . . . . 0.0 110.602 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -114.02 158.89 20.59 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.372 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.23 18.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 77.7 ttt180 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.9 mt -119.99 155.53 32.66 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.417 ' HB2' ' OG ' ' A' ' 196' ' ' SER . 47.3 t -77.04 123.92 27.04 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.93 121.99 18.43 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.513 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.6 m -90.62 139.77 30.4 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.872 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.68 120.46 10.09 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.12 16.05 Favored Glycine 0 C--N 1.301 -1.381 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.241 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -64.04 126.88 29.11 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -136.69 145.68 45.02 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -91.72 175.05 7.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.62 -172.46 45.45 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.314 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.99 123.19 6.11 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.208 1.939 . . . . 0.0 112.49 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -103.81 150.39 24.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -104.41 107.13 17.9 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.774 0.797 . . . . 0.0 110.495 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.67 177.49 43.74 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.4 p -129.11 133.55 47.7 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 119.231 1.516 . . . . 0.0 113.127 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 170.616 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.5 mmm -116.42 94.57 4.68 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.35 171.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.022 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.16 147.82 38.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 123.613 0.571 . . . . 0.0 110.473 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.26 -33.27 67.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 111.228 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -100.26 12.78 36.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.652 0.263 . . . . 0.0 111.155 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.52 132.97 36.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -65.05 -23.21 67.12 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.06 -25.52 68.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.104 0.478 . . . . 0.0 112.199 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.04 3.17 55.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 mmt -96.47 -22.63 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.405 ' HA ' HG23 ' A' ' 118' ' ' VAL . 9.9 mp -88.35 153.05 50.76 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.99 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.27 129.69 16.38 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.588 2.192 . . . . 0.0 111.61 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -82.51 138.13 34.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.99 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 29.3 m -140.54 157.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 98.2 mt -115.53 -6.15 12.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 118.204 0.456 . . . . 0.0 112.106 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.8 p -87.85 151.34 22.92 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.393 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.19 -23.68 35.35 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.598 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -69.98 -39.06 76.15 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.433 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.58 -33.36 23.41 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.966 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.617 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -84.84 99.7 11.08 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-O 121.366 0.603 . . . . 0.0 112.499 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.427 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 5.6 p30 -74.76 -19.58 60.16 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.187 175.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.9 p -131.45 142.89 50.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.85 141.14 48.28 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.686 HD13 ' SG ' ' A' ' 188' ' ' CYS . 9.4 mm -110.36 126.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -130.94 177.7 7.23 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -122.27 146.13 47.58 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.227 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.8 129.65 13.35 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.95 25.66 13.97 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.464 1.126 . . . . 0.0 109.401 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 69.36 13.63 8.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.331 1.452 . . . . 0.0 112.267 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.56 156.05 21.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.0 mt -93.6 135.26 35.05 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.219 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -126.32 139.57 53.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 179' ' ' ILE . 53.1 m -116.46 123.49 47.63 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -124.83 148.11 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.725 0.298 . . . . 0.0 110.331 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.06 121.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.0 p -114.25 -21.89 10.22 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 176' ' ' ASN . 64.6 mmtt -125.76 161.69 26.79 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.7 131.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.684 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.7 120.39 43.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.74 140.78 52.26 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.604 2.203 . . . . 0.0 111.791 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 123' ' ' SER . 7.5 m -63.38 114.71 4.02 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.29 -16.57 35.12 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.695 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.83 159.53 38.07 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.876 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.74 125.27 35.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -98.62 163.39 12.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.366 -178.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -121.41 144.95 48.39 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.933 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.08 121.97 52.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.187 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.617 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.1 ttm180 -100.4 137.12 39.25 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.0 mt -96.55 145.97 25.24 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.317 -0.84 0 CA-C-O 121.938 0.875 . . . . 0.0 112.075 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.404 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.034 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.8 t -89.82 96.15 10.56 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.02 -171.25 32.9 Favored Glycine 0 N--CA 1.42 -2.424 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.738 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.83 162.21 12.06 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.245 2.63 . . . . 0.0 111.597 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.28 -16.92 51.14 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.567 0.699 . . . . 0.0 110.539 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.36 -26.41 62.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.173 0.987 . . . . 0.0 109.368 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 1.6 mm? -94.37 156.88 16.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.808 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.44 134.34 37.61 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.185 0.517 . . . . 0.0 111.846 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.3 122.71 42.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.63 151.23 49.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.95 97.7 7.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 11.5 mm100 -109.44 132.88 53.71 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 66.61 12.89 9.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 123.766 0.666 . . . . 0.0 110.916 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.39 22.62 62.26 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.968 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.7 pt20 -133.09 167.98 19.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -75.1 120.0 20.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 38.1 t -122.16 146.57 47.11 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.81 120.06 63.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.294 0.568 . . . . 0.0 110.197 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -129.46 152.73 48.68 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.921 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.24 109.1 20.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -72.11 -48.9 40.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.3 mt -89.13 129.19 35.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.7 m -67.57 126.2 28.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.6 mt -97.99 133.86 41.89 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 -173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.7 t -99.12 161.53 13.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.501 0.501 . . . . 0.0 110.205 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.95 128.87 37.87 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.214 0.606 . . . . 0.0 110.863 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.81 63.7 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.721 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.87 130.69 42.95 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -135.67 160.03 39.8 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.992 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -99.72 175.24 5.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.07 176.13 51.73 Favored Glycine 0 N--CA 1.441 -0.981 0 O-C-N 123.605 0.566 . . . . 0.0 112.56 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.47 123.38 10.14 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.669 2.246 . . . . 0.0 113.496 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.65 149.95 22.27 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.99 105.71 15.88 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.689 0.757 . . . . 0.0 112.335 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.73 8.23 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 p -145.5 138.78 26.34 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.583 0.692 . . . . 0.0 111.82 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mt . . . . . 0 C--O 1.251 1.15 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.179 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.708 0.289 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.9 mtt -109.01 94.69 5.18 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.86 179.0 3.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.361 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.75 140.26 57.62 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 123.473 0.483 . . . . 0.0 111.284 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -51.72 -36.69 47.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.326 1.05 . . . . 0.0 113.399 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -103.6 9.97 37.15 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.819 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.517 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 41.0 t -78.68 137.31 37.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.154 0.502 . . . . 0.0 110.206 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.425 ' O ' HD11 ' A' ' 166' ' ' LEU . 9.1 p-90 -60.96 -27.11 68.01 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.517 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.3 mt -56.98 -32.49 66.14 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.088 0.47 . . . . 0.0 112.088 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.64 -1.17 47.3 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.586 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.4 mtp -95.52 -6.22 41.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 162' ' ' TRP . 8.8 mp -94.73 141.62 23.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.18 122.5 10.99 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.348 2.032 . . . . 0.0 111.389 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -79.26 127.84 32.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.21 156.46 23.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -83.68 -39.89 19.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.385 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.7 p -91.72 155.59 18.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.493 0.663 . . . . 0.0 112.532 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -87.23 -16.97 33.68 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.469 -177.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.9 -26.96 36.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.399 0.619 . . . . 0.0 109.426 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.37 -31.99 22.65 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.71 143.58 37.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 200' ' ' LEU . 16.1 p30 -118.43 2.08 11.81 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.4 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.2 p -151.31 135.72 16.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.41 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 15.8 pt-20 -129.0 149.87 50.65 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.038 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.52 116.36 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -122.67 157.77 31.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -102.16 144.3 30.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.2 tttm -161.71 125.55 3.24 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 65.46 32.73 9.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.127 0.971 . . . . 0.0 111.148 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.1 t70 75.0 9.36 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.378 1.085 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.05 162.25 22.77 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.532 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.68 137.26 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.5 m95 -123.57 133.99 53.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -106.8 126.82 52.79 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -127.39 147.35 50.28 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.436 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.14 115.12 25.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.003 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.8 p -80.83 -33.7 34.46 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -146.3 152.72 39.61 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.1 129.82 20.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 123.994 0.809 . . . . 0.0 111.697 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.59 125.2 36.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.69 164.3 16.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.127 2.551 . . . . 0.0 113.34 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.1 m -66.97 101.45 0.85 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.466 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.31 16.8 52.42 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.37 156.86 35.9 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 mp -95.13 141.09 29.16 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.502 0.668 . . . . 0.0 111.093 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 176' ' ' ASN . 3.2 mp -95.65 149.16 21.76 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.029 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.03 131.67 44.45 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.92 134.44 42.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.46 0.648 . . . . 0.0 111.612 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 43.9 ttt180 -104.61 142.05 35.34 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.912 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.86 139.83 32.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 CA--C 1.547 0.852 0 O-C-N 123.687 0.617 . . . . 0.0 110.821 179.412 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.478 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 m -91.58 82.42 5.31 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.61 160.69 14.39 Favored Glycine 0 N--CA 1.419 -2.453 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.96 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.535 ' HB2' ' OE1' ' A' ' 106' ' ' GLU . 60.7 Cg_endo -84.18 166.47 12.66 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.961 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -63.26 -19.36 64.5 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.801 0.84 . . . . 0.0 113.002 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 104' ' ' PRO . 23.7 mp0 -82.44 -17.99 43.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.611 0.72 . . . . 0.0 110.142 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.9 156.2 24.39 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.018 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.494 ' OE2' ' HD2' ' A' ' 119' ' ' ARG . 33.0 tt0 -141.59 126.27 17.96 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.813 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.18 108.72 20.85 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.24 154.59 50.87 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.769 0.319 . . . . 0.0 110.234 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.9 mp -91.99 101.29 13.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 121.879 0.847 . . . . 0.0 110.167 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.52 ' HB3' ' SG ' ' A' ' 117' ' ' CYS . 50.7 tt0 -106.17 124.62 49.87 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 113.795 -1.548 . . . . 0.0 106.998 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 69.67 12.35 8.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.67 1.224 . . . . 0.0 109.677 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.25 2.23 60.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.024 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 43.8 mt-30 -114.65 146.38 40.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 117.393 0.596 . . . . 0.0 110.147 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -75.86 119.94 20.53 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 112' ' ' GLN . 9.4 p -138.28 149.38 45.65 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.861 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.41 111.15 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.494 ' HD2' ' OE2' ' A' ' 108' ' ' GLU . 3.4 ptp180 -116.69 158.65 23.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.96 124.8 28.6 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -77.26 -33.97 55.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.68 0.753 . . . . 0.0 109.587 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 pp -127.01 155.74 42.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -66.25 113.87 4.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.717 0.77 . . . . 0.0 111.734 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.64 138.66 37.47 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 t -127.19 159.04 35.5 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.83 125.28 22.34 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 124.03 0.831 . . . . 0.0 110.053 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.02 36.03 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.055 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.8 t -129.13 151.77 49.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -96.66 173.86 7.11 Favored 'General case' 0 C--N 1.267 -3.015 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.815 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.5 175.71 54.83 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.8 Cg_endo -69.25 129.93 19.04 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.737 2.292 . . . . 0.0 113.279 -177.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -107.28 160.44 15.61 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.96 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.86 132.64 34.78 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.743 0.782 . . . . 0.0 112.031 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.417 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 162.18 -177.62 38.3 Favored Glycine 0 N--CA 1.414 -2.81 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -144.91 129.48 18.02 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 117.414 0.607 . . . . 0.0 111.597 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.57 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 122.238 1.018 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.1 mtp -87.03 82.67 7.67 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.39 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.417 HG12 ' HA3' ' A' ' 135' ' ' GLY . 32.8 m -105.04 177.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.309 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 161' ' ' CYS . 10.7 t70 -49.37 141.48 8.83 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.089 0.868 . . . . 0.0 110.971 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.57 -20.51 47.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.8 m -114.35 7.37 16.36 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.061 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.2 t -69.76 129.22 38.99 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.949 0.404 . . . . 0.0 109.919 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.8 p-90 -56.08 -27.93 55.59 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.437 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.9 mt -60.86 -32.76 72.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.825 0.45 . . . . 0.0 112.012 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -93.05 -0.96 57.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.931 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.478 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 22.6 ptm -110.56 5.97 21.56 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.552 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 88.7 mt -81.6 143.84 51.69 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.25 126.05 13.17 Favored 'Trans proline' 0 C--O 1.253 1.266 0 C-N-CA 121.722 1.615 . . . . 0.0 109.839 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -87.52 139.78 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 0.0 111.864 -174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 152.27 32.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.584 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.3 tp -97.15 -8.36 30.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.673 0.749 . . . . 0.0 109.766 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.8 p -106.71 134.81 49.28 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.4 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.452 ' HB3' ' NE ' ' A' ' 203' ' ' ARG . 10.9 pt-20 -77.73 -21.73 51.43 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.855 -0.528 . . . . 0.0 111.332 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.55 -28.98 67.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.151 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.59 -10.98 49.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.966 0.412 . . . . 0.0 110.79 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -87.37 158.02 19.12 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.957 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 200' ' ' LEU . 95.4 m-20 -122.16 -24.73 5.04 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.215 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.5 p -130.24 130.98 45.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.24 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.78 123.29 45.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.303 0.573 . . . . 0.0 110.247 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 202' ' ' VAL . 1.8 mp -108.44 123.81 64.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.879 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -143.22 169.52 17.47 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 38.2 ptt180 -106.19 139.15 41.14 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.9 tttp -138.22 122.66 18.38 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.78 26.41 12.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.824 1.297 . . . . 0.0 107.958 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.86 67.78 0.88 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.319 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -159.49 158.22 31.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 4.3 mm? -93.33 129.37 39.47 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.518 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -129.36 150.18 50.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.3 t -135.46 114.35 12.05 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -103.64 138.9 39.66 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.44 120.15 28.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 t -105.0 -1.0 26.29 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -139.69 176.51 8.67 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.55 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.5 t -112.12 112.06 52.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.57 140.61 57.59 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 121.867 1.712 . . . . 0.0 111.094 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.1 p -54.16 124.98 17.35 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.418 0.627 . . . . 0.0 111.411 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.5 -16.93 44.0 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.487 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.42 162.4 30.63 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.98 168.24 10.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.39 0.614 . . . . 0.0 111.304 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.443 ' HA ' HD21 ' A' ' 176' ' ' ASN . 1.2 pt? -132.8 149.09 52.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.471 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.44 147.06 43.97 Favored 'General case' 0 C--O 1.253 1.287 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 179' ' ' ILE . 5.1 p -96.79 128.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.838 0.828 . . . . 0.0 112.949 -173.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.452 ' NE ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 tpt180 -100.4 112.72 25.1 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.489 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.73 116.35 22.64 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.164 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 m -107.36 90.12 3.21 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.62 -176.94 20.84 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 158.04 40.0 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.93 2.42 . . . . 0.0 111.993 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.47 -16.75 57.2 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.257 1.023 . . . . 0.0 111.307 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.4 ' HA ' HD13 ' A' ' 122' ' ' LEU . 11.0 mp0 -75.65 -20.33 58.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.446 1.117 . . . . 0.0 108.232 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.93 159.78 16.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.042 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 121' ' ' ARG . 24.8 mm-40 -137.09 132.04 33.56 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.962 0.505 . . . . 0.0 111.23 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 3.1 tm? -88.49 99.07 12.0 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 170.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.16 144.55 43.5 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.509 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.0 mp -97.09 126.89 42.56 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.347 0.594 . . . . 0.0 110.781 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.86 92.23 4.08 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 36.16 73.22 0.09 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 126.392 1.877 . . . . 0.0 114.08 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.57 -18.7 56.89 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.06 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 85.0 mm-40 -112.27 123.59 50.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.871 0.836 . . . . 0.0 112.005 -177.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -79.41 123.22 27.31 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.9 p -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.947 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.68 111.9 21.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.404 ' HB3' HD23 ' A' ' 199' ' ' LEU . 15.2 ptp180 -127.06 157.16 40.37 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.239 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.11 121.19 17.03 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.0 ttt180 -86.12 -52.5 5.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 106' ' ' GLU . 9.3 mp -94.36 153.25 18.08 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.6 m -76.9 110.89 11.89 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HB3' HG13 ' A' ' 190' ' ' VAL . 3.8 mm? -70.4 117.84 12.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.0 p -96.29 158.67 15.33 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.628 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.05 128.95 36.06 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 124.712 1.205 . . . . 0.0 111.698 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.83 -18.97 54.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.248 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.65 129.99 41.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 m -136.48 161.73 35.04 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -107.71 176.23 5.22 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.501 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.6 -171.63 39.67 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.985 0.803 . . . . 0.0 112.744 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.24 125.09 7.58 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.795 2.33 . . . . 0.0 113.827 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -102.3 168.55 9.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -106.34 135.58 47.59 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 120.955 0.407 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.78 179.21 31.58 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.2 m -139.03 146.05 40.36 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 117.902 0.851 . . . . 0.0 111.474 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.227 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 155' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.431 -1.395 0 CA-C-O 120.952 0.406 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.88 85.81 2.28 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.84 157.8 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.08 148.36 26.68 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 123.856 0.722 . . . . 0.0 112.374 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.13 -43.98 64.28 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.598 1.159 . . . . 0.0 112.014 -175.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.9 m -90.04 11.34 20.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.48 127.37 32.71 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 18.8 p-90 -60.18 -27.29 67.01 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.08 -25.7 68.49 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -95.44 1.13 53.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.409 0.623 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.85 -7.01 55.26 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.502 0.668 . . . . 0.0 109.758 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.28 144.36 27.76 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.06 131.37 19.27 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 122.046 1.831 . . . . 0.0 111.212 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.27 135.25 39.64 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.51 133.88 65.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.56 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.28 -38.16 81.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.289 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -86.48 134.94 33.64 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.211 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -28.43 62.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.044 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -69.44 -22.83 63.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.416 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.1 0.94 56.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.069 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.75 152.84 21.37 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -114.44 -16.03 11.99 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.424 0.63 . . . . 0.0 109.979 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.0 p -145.23 128.23 16.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.234 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.24 141.29 37.83 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.47 HD13 HG23 ' A' ' 202' ' ' VAL . 1.6 mp -116.7 116.72 53.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.446 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 52.5 p90 -115.73 159.85 20.85 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -100.94 138.56 37.82 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -157.59 132.85 8.9 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 67.35 20.88 9.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.157 0.983 . . . . 0.0 108.864 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 70.03 13.57 7.84 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.143 1.777 . . . . 0.0 111.822 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -112.8 164.73 13.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.92 136.62 41.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.419 ' O ' ' HA ' ' A' ' 179' ' ' ILE . 77.6 m95 -124.54 125.59 44.45 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.671 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.4 t -104.03 124.46 49.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -125.53 138.94 53.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 124' ' ' LEU . 49.0 t -90.35 122.03 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.6 p -110.31 3.19 19.65 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.105 0.479 . . . . 0.0 112.166 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -131.11 169.92 15.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.51 108.06 20.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.34 111.03 64.84 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.27 153.6 66.44 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.288 1.992 . . . . 0.0 111.296 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -65.22 126.33 27.83 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.81 -17.23 49.83 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.91 159.41 31.45 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.784 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 119' ' ' ARG . 47.3 mt -95.12 165.47 12.4 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.4 0.619 . . . . 0.0 109.757 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 200' ' ' LEU . 1.2 pt? -134.46 146.01 49.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.967 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.75 151.11 32.4 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.47 HG23 HD13 ' A' ' 179' ' ' ILE . 7.7 p -99.72 129.81 49.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 O-C-N 123.855 0.722 . . . . 0.0 112.183 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -119.28 128.91 54.59 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.17 154.78 19.88 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 11.2 p . . . . . 0 CA--C 1.551 0.992 0 C-N-CA 123.481 0.712 . . . . 0.0 112.432 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.408 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 8.4 p-90 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 62.35 75.84 0.39 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.982 0.896 . . . . 0.0 111.739 -176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.84 174.78 27.46 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.96 161.7 38.45 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -76.46 -0.79 24.21 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -88.65 -24.76 22.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.157 0.979 . . . . 0.0 108.642 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 130' ' ' TRP . 3.2 mm? -96.09 168.21 10.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.376 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.584 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 29.4 tt0 -150.38 128.16 11.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.6 tm? -93.02 118.61 31.38 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.41 135.75 55.03 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.74 101.94 10.43 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.46 119.34 38.86 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 67.83 18.4 9.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.813 1.292 . . . . 0.0 109.935 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.52 -4.35 79.67 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.451 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -114.53 174.9 5.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.243 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.54 136.55 34.22 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.016 0.436 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 43.7 t -147.18 148.45 31.54 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.56 130.72 74.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.584 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -133.87 168.98 17.76 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.843 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.5 120.02 36.05 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -81.71 -40.08 23.3 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.49 145.66 24.64 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.0 m -66.06 118.17 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.94 105.35 6.93 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.7 p -82.7 154.05 25.03 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.916 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.78 124.44 21.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.62 -10.83 57.78 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.649 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.402 ' C ' ' HG ' ' A' ' 129' ' ' SER . 42.5 tp -75.42 143.54 42.65 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 128' ' ' LEU . 24.2 m -150.76 171.53 17.04 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 107' ' ' LEU . 27.2 m-90 -113.93 166.43 11.6 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.29 -177.47 33.9 Favored Glycine 0 N--CA 1.436 -1.33 0 O-C-N 123.817 0.698 . . . . 0.0 113.228 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.68 133.26 23.48 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 122.879 2.386 . . . . 0.0 112.627 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.01 152.45 24.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.81 120.71 37.65 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.42 -168.09 41.0 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.4 p -147.62 135.42 21.07 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.307 -1.253 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 170.592 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.977 0.894 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.6 mmm -88.01 96.07 10.37 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.2 170.1 20.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.56 168.74 19.32 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.83 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -59.21 -34.46 72.19 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 124.192 0.997 . . . . 0.0 112.273 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.0 p -95.54 7.69 45.52 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.6 t -82.45 124.53 30.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.002 0.429 . . . . 0.0 110.013 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -61.37 -22.13 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.668 0.787 . . . . 0.0 112.78 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.55 -32.68 72.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.623 0.369 . . . . 0.0 111.957 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -93.84 2.72 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.924 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mtp -97.1 1.25 49.78 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.11 151.02 37.33 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.88 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.58 124.54 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.277 1.984 . . . . 0.0 110.052 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -81.8 138.8 35.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.44 ' CG2' ' HB1' ' A' ' 175' ' ' ALA . 21.1 m -136.74 148.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.168 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.05 -13.28 17.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.68 0.753 . . . . 0.0 109.114 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -98.77 134.91 40.99 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.636 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.73 -5.3 59.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.417 0.627 . . . . 0.0 110.358 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.04 -29.08 64.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.616 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.04 -26.45 13.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.103 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.87 110.86 18.71 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.812 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -82.89 -25.08 32.82 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.327 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.8 m -127.82 145.5 50.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.39 145.38 50.27 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -102.99 120.64 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -134.0 163.86 28.6 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.564 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -104.58 123.71 48.03 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 40.8 ttmt -118.39 95.73 5.0 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.4 t70 59.02 72.13 0.55 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.962 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 t70 76.37 -27.97 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.119 -1.401 . . . . 0.0 113.998 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -100.36 151.85 21.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.305 -0.247 . . . . 0.0 111.063 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -93.58 128.46 39.74 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.531 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -122.14 138.05 54.6 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.96 124.32 52.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -125.24 147.19 49.19 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.61 118.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.5 p -101.61 -31.89 10.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.207 0.527 . . . . 0.0 110.89 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.26 141.87 51.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.72 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.339 0.59 . . . . 0.0 111.999 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.06 126.9 26.81 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.2 170.84 14.97 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.619 2.213 . . . . 0.0 113.448 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.1 m -59.77 121.82 12.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.558 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.42 -6.8 57.83 Favored Glycine 0 N--CA 1.436 -1.349 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.248 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.9 153.07 44.97 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.52 138.84 31.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.427 HD22 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -106.04 159.35 16.13 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.104 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -134.45 143.3 47.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.11 117.87 42.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.598 0.713 . . . . 0.0 111.187 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.465 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.5 ttt180 -93.06 124.77 37.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.513 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.82 109.65 20.37 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.292 -1.916 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.977 -177.56 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 160' ' ' SER . 19.8 m -88.33 77.91 8.08 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.463 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.28 158.56 27.73 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.259 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.36 162.4 38.43 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.278 2.652 . . . . 0.0 111.977 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.91 -0.04 37.4 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.54 -20.37 50.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.424 HD11 HD23 ' A' ' 200' ' ' LEU . 3.7 mm? -109.78 151.96 26.31 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.215 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -127.32 141.92 51.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.49 122.03 40.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.04 54.58 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.913 0.387 . . . . 0.0 110.59 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.57 104.56 14.41 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -106.25 94.38 5.13 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.777 0.799 . . . . 0.0 109.409 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.37 59.17 4.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.043 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.94 -22.18 19.62 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.962 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.82 128.85 35.34 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.449 -0.442 . . . . 0.0 111.86 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -82.54 113.71 20.45 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.544 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.7 p -122.28 144.86 48.73 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 17.8 m -107.68 125.42 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.19 0.519 . . . . 0.0 109.704 -177.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -138.65 150.75 46.56 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.02 127.77 34.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.57 -34.05 14.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.52 0.676 . . . . 0.0 109.795 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.27 163.67 12.42 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.1 m -88.71 128.47 35.61 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.512 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.2 mm? -90.27 127.81 36.25 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.2 p -112.22 158.9 19.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.05 118.76 8.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.978 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.21 -0.49 55.99 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.371 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.3 tp -82.38 139.7 33.92 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 74.3 p -144.67 157.36 44.23 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.02 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.604 ' HB2' ' SG ' ' A' ' 188' ' ' CYS . 26.3 m-90 -103.76 175.1 5.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.84 -165.66 37.74 Favored Glycine 0 C--N 1.307 -1.052 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.079 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.46 123.32 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.187 1.925 . . . . 0.0 112.85 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.549 ' HE2' ' SG ' ' A' ' 188' ' ' CYS . 78.8 m-85 -98.84 159.09 15.2 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.62 104.22 14.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.351 1.072 . . . . 0.0 112.122 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.53 171.49 44.06 Favored Glycine 0 N--CA 1.409 -3.165 0 N-CA-C 106.785 -2.526 . . . . 0.0 106.785 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.7 m -132.46 137.78 47.36 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 118.096 0.948 . . . . 0.0 112.011 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.661 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 155' ' ' LEU . 1.6 pp . . . . . 0 N--CA 1.428 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.42 89.78 8.12 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.61 177.59 2.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.504 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.0 144.34 57.36 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.706 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -57.03 -29.68 63.58 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.259 1.023 . . . . 0.0 113.457 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 102' ' ' SER . 22.0 t -102.15 -3.33 27.62 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 122.099 -0.376 . . . . 0.0 110.278 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.6 t -65.88 119.86 12.05 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.514 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.4 p-90 -53.03 -26.89 17.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.315 1.046 . . . . 0.0 113.654 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.03 -30.83 66.44 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.156 0.582 . . . . 0.0 111.85 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -94.53 -7.35 41.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.89 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 162' ' ' TRP . 22.8 ptm -102.27 1.28 35.57 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.263 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 86.9 mt -82.69 152.8 67.11 Favored Pre-proline 0 N--CA 1.423 -1.795 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.31 118.08 5.48 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.304 1.336 . . . . 0.0 110.376 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.68 132.07 35.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.037 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.05 164.46 23.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.509 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.3 tp -100.87 -31.3 11.22 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.355 0.598 . . . . 0.0 109.518 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.4 p -88.98 134.99 33.79 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.671 0.748 . . . . 0.0 112.09 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -17.46 62.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.673 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.06 -32.77 63.44 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.399 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.76 -37.22 30.77 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.55 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -71.89 148.95 45.6 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.406 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -121.12 -10.03 9.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.057 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.0 m -152.8 136.96 16.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 203' ' ' ARG . 10.7 pt-20 -116.61 143.41 45.65 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.795 0.331 . . . . 0.0 111.588 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.0 mm -102.03 122.99 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -131.68 160.06 36.53 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.6 tttt -144.03 118.52 9.7 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 64.9 26.71 12.83 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.829 0.823 . . . . 0.0 109.528 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.1 t70 71.21 -1.93 2.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.264 1.826 . . . . 0.0 111.969 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -90.75 155.74 18.58 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.07 128.49 40.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.763 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 62.5 m95 -124.75 139.34 53.94 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 130' ' ' TRP . 4.9 p -121.67 128.45 51.87 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -118.13 144.84 45.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.326 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.38 120.71 36.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.6 p -86.23 -45.39 11.34 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.398 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -136.29 151.84 50.07 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 120.807 0.337 . . . . 0.0 111.663 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 49.2 t -64.29 128.7 27.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.795 -172.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.64 117.67 22.75 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.82 165.61 32.3 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.482 2.122 . . . . 0.0 112.917 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 7.9 m -60.65 129.49 41.78 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.892 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.85 -17.58 48.83 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.32 150.36 23.57 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.693 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 11.1 mp -89.01 146.6 24.76 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.455 ' N ' HD21 ' A' ' 200' ' ' LEU . 0.9 OUTLIER -125.05 146.73 49.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.075 0.464 . . . . 0.0 110.402 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -113.76 144.25 43.28 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.772 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.64 133.63 41.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.975 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.501 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 71.6 ttt180 -108.15 137.96 45.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.45 153.95 18.8 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--O 1.245 0.823 0 CA-C-O 122.463 1.125 . . . . 0.0 112.527 -177.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 1.4 p-90 . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 111.291 0.108 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.0 m 58.95 41.1 21.66 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.981 0.912 . . . . 0.0 111.495 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.45 -169.38 22.83 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.266 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -85.81 175.65 5.82 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.122 2.548 . . . . 0.0 112.569 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.1 -19.45 43.6 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.22 0.533 . . . . 0.0 111.81 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -82.96 -16.96 45.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.781 0.801 . . . . 0.0 109.586 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.401 ' CD1' HD23 ' A' ' 200' ' ' LEU . 4.1 mm? -121.8 152.94 38.96 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.242 -174.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.5 140.7 33.55 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.021 0.439 . . . . 0.0 111.158 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.56 99.01 11.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.06 130.25 50.13 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.6 mt -90.31 112.15 23.61 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.21 97.16 7.01 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 64.27 27.5 13.83 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.087 1.422 . . . . 0.0 109.024 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.46 -11.42 68.68 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.826 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -81.84 130.45 35.07 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -79.64 101.5 8.39 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.73 0.776 . . . . 0.0 110.115 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.8 m -110.14 122.61 48.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.556 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.91 100.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -122.26 146.55 47.18 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.765 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.76 140.35 49.45 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 121' ' ' ARG . 4.5 mmp_? -93.36 -36.74 12.36 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.35 155.95 26.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 m -75.07 105.21 5.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 96.8 mt -70.4 117.04 11.44 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -92.86 147.27 22.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.833 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.81 129.48 39.93 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.617 0.722 . . . . 0.0 111.083 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.96 -20.24 22.14 Favored Glycine 0 C--N 1.301 -1.361 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.807 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.72 125.55 27.14 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 m -134.29 149.93 50.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -92.14 175.24 6.93 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.173 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.28 150.67 48.93 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.929 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.12 127.34 25.32 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.199 2.599 . . . . 0.0 111.912 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CD2' HD12 ' A' ' 163' ' ' LEU . 55.9 m-85 -98.14 153.27 18.56 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.707 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -93.82 116.02 28.46 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.731 0.644 . . . . 0.0 110.024 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.46 45.31 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.8 m -144.58 134.73 24.14 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 117.682 0.741 . . . . 0.0 110.745 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 C--N 1.309 -1.166 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 172.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.41 -2.468 0 CA-C-O 121.497 0.665 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 59.8 ttp -87.87 92.94 9.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.43 173.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.164 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.21 152.99 40.85 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.471 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.76 -24.22 65.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -91.98 10.52 28.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.871 0.367 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.95 111.14 21.15 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 25.4 p-90 -57.97 -21.02 42.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 113.385 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 133' ' ' PHE . 70.8 mt -59.45 -30.74 68.72 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.089 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -96.59 2.4 52.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.195 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 mmt -83.94 -21.32 31.86 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.65 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.06 150.82 65.73 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.467 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 27.3 Cg_exo -63.31 127.16 19.34 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 121.787 1.658 . . . . 0.0 108.967 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -88.43 139.88 30.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.68 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 175' ' ' ALA . 23.5 m -131.2 158.24 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.669 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 82.3 mt -101.96 -26.12 13.53 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.087 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.3 p -87.08 156.04 19.89 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.347 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 13.6 pt-20 -94.27 -19.31 20.81 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.799 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -51.8 -45.45 63.86 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.716 0.807 . . . . 0.0 111.173 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -88.47 -14.61 37.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.647 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.42 ' HB3' ' CG2' ' A' ' 169' ' ' VAL . . . -88.78 115.34 26.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.568 0.699 . . . . 0.0 111.126 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.19 -15.84 22.99 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-O 121.855 0.836 . . . . 0.0 109.295 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.5 m -139.28 146.58 40.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.31 155.47 48.55 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 122.584 0.353 . . . . 0.0 110.271 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.0 mm -112.92 123.57 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -128.15 149.36 50.46 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptt180 -97.24 133.14 42.26 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.097 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.71 126.68 15.45 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 58.72 30.22 19.67 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.393 1.058 . . . . 0.0 110.209 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.8 t70 76.49 -8.96 1.56 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.285 1.434 . . . . 0.0 112.601 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -93.05 154.03 18.35 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.0 mt -93.79 126.16 38.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.959 0.409 . . . . 0.0 110.081 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -116.28 124.43 50.16 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.389 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.89 110.96 23.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.01 144.82 39.52 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.74 113.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 173.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 t -80.63 -34.45 35.01 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.831 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -148.59 160.18 43.37 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 122.358 -0.214 . . . . 0.0 110.669 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 40.6 t -72.03 123.16 25.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 124.262 0.976 . . . . 0.0 112.716 -171.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.9 p -114.18 120.7 37.97 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.53 158.25 54.05 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.015 2.477 . . . . 0.0 113.526 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.3 m -59.38 113.8 2.36 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.749 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.4 -22.95 14.44 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.942 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.99 152.13 43.46 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.6 155.76 16.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.428 ' N ' HD21 ' A' ' 200' ' ' LEU . 1.2 pt? -140.1 147.02 39.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.544 0.688 . . . . 0.0 111.22 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 5.8 m-85 -106.46 154.63 20.55 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.776 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.68 130.66 61.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.039 0.447 . . . . 0.0 110.266 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.415 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 22.5 ttp180 -102.54 139.68 37.82 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.104 -0.372 . . . . 0.0 110.43 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.86 134.71 38.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.526 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 8.3 p-90 . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 162' ' ' TRP . 5.6 t -174.86 178.25 1.87 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.96 -41.45 8.68 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.41 115.47 2.47 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.758 2.779 . . . . 0.0 114.653 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -77.37 -3.04 38.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.674 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.0 mp0 -87.22 -14.75 40.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.965 0.888 . . . . 0.0 109.163 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.31 164.5 15.11 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.114 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -144.55 135.84 25.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.36 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -85.9 130.46 34.54 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.38 132.33 56.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.77 0.319 . . . . 0.0 110.328 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.0 mt -108.5 113.56 26.69 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.96 106.58 14.6 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 65.8 23.94 11.42 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.591 0.71 . . . . 0.0 110.675 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.47 78.8 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.868 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -82.35 121.27 26.48 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.38 118.1 14.86 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.393 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.58 161.14 37.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.57 129.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.894 0.378 . . . . 0.0 110.256 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -125.57 140.82 52.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.584 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.69 119.81 25.68 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 8.3 ptm180 -75.34 -35.15 61.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.603 0.716 . . . . 0.0 111.285 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.5 176.59 5.82 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.5 m -83.22 110.46 18.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.911 0.386 . . . . 0.0 110.479 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.36 132.55 35.22 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -119.4 165.24 14.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.62 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.35 117.69 6.47 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 124.171 0.988 . . . . 0.0 109.943 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.12 -21.82 7.28 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.326 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.5 tp -77.07 129.18 35.71 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -142.55 156.92 45.17 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.614 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -105.4 169.92 8.18 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.73 -174.09 38.83 Favored Glycine 0 N--CA 1.436 -1.329 0 O-C-N 123.898 0.749 . . . . 0.0 113.213 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.22 123.61 7.89 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.524 2.149 . . . . 0.0 113.375 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.411 ' CD2' HD12 ' A' ' 163' ' ' LEU . 67.8 m-85 -97.06 134.47 40.37 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -86.94 96.21 10.17 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.724 0.773 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -166.42 171.21 41.34 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.2 m -133.27 138.59 46.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 118.555 1.178 . . . . 0.0 112.957 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.599 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 155' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.427 -1.604 0 CA-C-O 121.317 0.579 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 ttm -108.9 98.12 7.65 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 135' ' ' GLY . 34.3 m -139.25 164.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.859 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.72 156.39 39.06 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -50.43 -45.09 55.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.246 1.018 . . . . 0.0 110.996 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.6 t -85.78 8.72 18.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.612 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 39.0 t -89.14 96.71 10.83 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 102' ' ' SER . 5.9 p-90 -48.54 -17.79 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.558 1.943 . . . . 0.0 115.157 -173.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 133' ' ' PHE . 48.2 mt -61.12 -30.28 70.28 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.979 0.418 . . . . 0.0 110.001 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.4 ptm180 -83.83 -10.33 58.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 59.8 mtt -89.68 -15.82 31.76 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 50.2 mt -82.99 133.68 47.92 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.78 131.59 22.99 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 121.619 1.546 . . . . 0.0 111.177 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -84.2 131.63 34.74 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 156.95 35.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.52 -2.49 30.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.44 0.638 . . . . 0.0 110.025 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.5 p -108.16 150.2 27.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.767 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.09 -5.44 57.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.06 -36.19 69.5 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.482 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.85 -28.36 14.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.197 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -74.88 111.72 10.37 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.76 -20.57 18.76 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.248 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 11.4 p -130.16 130.23 44.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.394 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.04 146.02 46.28 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.8 119.73 61.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' TYR . . . . . 0.44 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 34.5 p90 -113.33 148.51 35.55 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -96.62 138.71 33.79 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -163.13 118.48 1.73 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.324 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.61 56.36 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 124.686 1.241 . . . . 0.0 111.635 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 62.83 16.26 8.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.686 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -137.76 170.64 15.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.13 137.85 51.77 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -120.98 128.75 53.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.7 t -101.2 123.83 45.94 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.425 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -121.6 143.18 49.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.29 104.74 11.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.8 t -87.14 -26.31 23.67 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.341 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -141.15 145.83 36.23 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.78 120.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 4.4 p -112.14 117.48 47.72 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 21.8 Cg_exo -66.38 167.36 18.85 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.589 2.193 . . . . 0.0 113.188 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.2 m -64.71 129.48 39.96 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.585 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.95 71.13 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.766 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.31 154.54 21.48 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.916 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.6 mt -91.86 145.64 24.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -119.54 144.81 46.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.923 0.392 . . . . 0.0 110.71 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.54 151.84 34.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 177' ' ' SER . 12.0 p -106.99 139.52 28.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.288 0.566 . . . . 0.0 111.069 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 31.6 ttp85 -115.74 134.23 55.23 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.67 152.08 18.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 8.6 p . . . . . 0 C--N 1.316 -0.886 0 CA-C-O 123.075 1.416 . . . . 0.0 112.989 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 N-CA-C 110.23 -0.719 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -169.89 171.75 7.02 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -102.19 90.04 3.79 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.26 174.26 22.59 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.527 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.05 166.51 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.214 2.609 . . . . 0.0 112.348 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 43.2 mm-40 -75.58 -10.53 59.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.032 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.1 -20.65 34.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.903 0.858 . . . . 0.0 109.464 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.17 162.69 15.18 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.85 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -148.5 132.78 17.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.081 0.467 . . . . 0.0 111.478 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.7 tm? -95.39 112.68 24.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.94 135.56 49.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 82.2 mt -101.78 101.74 12.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.585 0.707 . . . . 0.0 109.139 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -115.17 104.86 12.26 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.366 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.6 13.78 4.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.206 1.402 . . . . 0.0 110.38 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 -6.82 56.09 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.353 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 8.1 tt0 -85.21 137.92 32.69 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -88.66 109.29 20.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.734 0.646 . . . . 0.0 109.273 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.2 121.7 45.9 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.695 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.0 m -89.26 97.05 6.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.883 0.849 . . . . 0.0 110.287 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -113.19 153.25 28.61 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.035 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.89 122.06 18.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 42.2 ttt180 -84.23 -50.6 7.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.17 173.9 7.0 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 m -89.36 108.56 19.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.9 mm? -74.98 110.07 8.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.094 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 p -83.17 134.61 34.97 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.109 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.88 123.6 14.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.009 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.77 -24.38 13.31 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.752 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.93 146.33 49.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.4 m -144.69 164.86 29.7 Favored 'General case' 0 C--N 1.283 -2.309 0 O-C-N 121.971 -0.456 . . . . 0.0 110.152 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -110.39 169.62 8.62 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.91 176.09 53.28 Favored Glycine 0 N--CA 1.433 -1.559 0 O-C-N 123.795 0.684 . . . . 0.0 111.905 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 51.1 Cg_endo -67.02 144.56 70.37 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 122.768 2.312 . . . . 0.0 113.187 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.32 154.49 32.24 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.26 127.9 46.44 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.91 0.862 . . . . 0.0 112.479 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.49 -157.78 30.25 Favored Glycine 0 N--CA 1.405 -3.405 0 N-CA-C 106.383 -2.687 . . . . 0.0 106.383 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.5 t -158.15 167.84 28.7 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 118.313 1.056 . . . . 0.0 108.807 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.2 mt -138.55 117.98 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -86.65 99.36 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.74 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 205' ' ' VAL . 31.8 p -62.87 154.21 30.83 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.432 ' HB3' ' CG2' ' A' ' 153' ' ' VAL . 29.5 ptt180 -90.52 114.85 27.14 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.818 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -99.55 12.34 36.72 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.227 1.013 . . . . 0.0 109.087 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.8 mt -124.43 169.49 11.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.6 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.4 m -100.96 113.39 65.78 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.52 -15.38 48.23 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.676 2.917 . . . . 0.0 113.382 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 -12.04 59.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.367 1.08 . . . . 0.0 109.032 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.4 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 23.2 mtp180 -111.09 -74.99 0.63 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.987 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 146' ' ' ARG . 3.4 mp0 -125.47 147.1 49.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 152' ' ' ALA . 8.8 mm-40 63.97 71.45 0.6 Allowed Pre-proline 0 C--N 1.311 -1.094 0 C-N-CA 125.323 1.449 . . . . 0.0 114.795 173.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -104.49 8.86 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.902 2.402 . . . . 0.0 112.834 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.47 -125.96 4.0 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.976 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.66 5.51 3.31 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 123.843 3.028 . . . . 0.0 113.692 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' CB ' ' HB3' ' A' ' 148' ' ' GLU . . . -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.182 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 140' ' ' ARG . 20.2 t -109.49 116.61 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 p -152.21 154.83 36.56 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 123.6 0.563 . . . . 0.0 109.593 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -97.48 130.77 44.54 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.3 mtp -101.56 87.57 3.21 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.21 165.98 28.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -52.56 140.36 23.13 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 124.143 0.902 . . . . 0.0 109.89 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.494 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 43.4 mt-10 -65.4 -14.4 60.82 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.21 -14.12 22.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.488 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 53.2 t -64.66 133.41 52.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.491 0.663 . . . . 0.0 111.848 -174.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -58.72 -25.2 62.7 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.663 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.488 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.6 mt -59.28 -32.21 69.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.078 0.466 . . . . 0.0 111.39 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.494 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ptm180 -96.72 1.42 50.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.0 111.245 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 96.2 mmm -91.55 -20.09 22.06 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.43 146.84 45.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.953 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.53 134.61 36.18 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.265 1.977 . . . . 0.0 110.291 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.73 136.29 33.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.422 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 30.7 m -136.02 154.4 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.67 -10.89 17.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.516 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.9 p -94.93 169.03 10.42 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.654 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -95.59 -33.91 12.21 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.899 0.88 . . . . 0.0 111.242 -176.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 5.2 mm-40 -66.91 -38.83 86.97 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.67 -30.26 32.77 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.276 0.56 . . . . 0.0 109.892 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.467 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -79.97 119.87 23.4 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-O 121.416 0.627 . . . . 0.0 111.223 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -104.37 -6.1 21.09 Favored 'General case' 0 C--N 1.27 -2.855 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.006 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.0 m -150.42 145.26 25.95 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -125.45 147.66 49.12 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.41 ' CD1' HD21 ' A' ' 163' ' ' LEU . 29.4 mm -110.1 124.79 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -133.72 155.68 49.32 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -102.55 137.87 40.21 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.14 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 85.5 tttt -140.15 112.87 8.04 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.38 57.31 4.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.257 1.027 . . . . 0.0 111.144 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 73.71 -14.77 0.62 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.746 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.11 158.87 17.86 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.073 -0.392 . . . . 0.0 110.355 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 72.7 mt -96.17 136.8 36.14 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.119 0.262 . . . . 0.0 110.372 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 52.2 m95 -124.52 145.01 49.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.1 t -118.04 130.92 56.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.06 147.44 50.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.9 119.64 37.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 p -95.81 -29.31 14.3 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -130.25 143.56 50.85 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 5.4 p -76.38 113.29 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.52 0.676 . . . . 0.0 111.1 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.4 t -97.58 125.47 44.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.513 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.76 151.33 57.41 Favored 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 121.868 1.712 . . . . 0.0 110.08 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.1 p -62.94 131.1 47.55 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.42 -19.88 52.01 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.84 148.98 35.7 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.96 154.53 19.77 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 200' ' ' LEU . 1.1 pt? -136.13 149.68 48.77 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.06 0.457 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.97 155.86 21.22 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.22 128.54 62.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.381 0.61 . . . . 0.0 111.149 -176.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.467 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 2.0 tmt_? -95.36 116.15 28.39 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.75 134.61 34.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 139' ' ' THR . 8.9 p -61.38 124.68 16.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-O 121.283 0.563 . . . . 0.0 111.068 177.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.5 p -133.8 69.53 1.47 Allowed 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.902 0.858 . . . . 0.0 109.061 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.1 123.3 63.13 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.585 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.76 92.58 0.37 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.695 1.597 . . . . 0.0 108.438 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.54 -23.11 63.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.158 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 100.35 -45.76 1.43 Allowed Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 51.9 68.66 3.01 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 124.95 1.3 . . . . 0.0 111.435 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -101.24 16.91 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.848 2.365 . . . . 0.0 111.927 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.46 ' NE ' ' HA ' ' A' ' 213' ' ' ARG . 1.8 mmp_? 66.19 -171.7 0.19 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.416 0.687 . . . . 0.0 109.64 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -99.46 133.78 21.67 Favored Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.11 100.95 0.12 Allowed 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 122.861 2.374 . . . . 0.0 112.694 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.55 -28.35 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.39 110.06 20.5 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.38 149.87 81.98 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.742 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.34 132.97 38.16 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.792 1.662 . . . . 0.0 109.616 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.92 114.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.406 0.622 . . . . 0.0 110.747 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 64.76 76.74 0.31 Allowed Pre-proline 0 C--O 1.248 0.988 0 C-N-CA 125.16 1.384 . . . . 0.0 110.118 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.26 178.77 6.55 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.911 2.407 . . . . 0.0 112.06 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.42 -67.17 0.23 Allowed Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.94 -156.56 27.31 Favored Glycine 0 C--O 1.256 1.469 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.975 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 70.75 -49.93 0.67 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.852 1.661 . . . . 0.0 112.574 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.621 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.421 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.451 -1.009 0 N-CA-C 108.023 -1.568 . . . . 0.0 108.023 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.451 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 p-90 -115.96 -1.04 12.62 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.137 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m 65.44 25.52 11.92 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.22 1.008 . . . . 0.0 112.429 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.35 141.13 15.44 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.928 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -44.35 150.57 0.69 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.437 3.425 . . . . 0.0 113.027 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.32 -3.97 27.02 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.456 ' HA ' HD21 ' A' ' 122' ' ' LEU . 12.2 mm-40 -81.04 -18.7 45.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.694 HD22 ' CZ2' ' A' ' 130' ' ' TRP . 3.0 mm? -113.31 165.79 12.09 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.284 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -156.83 139.84 15.37 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.9 tm? -89.16 116.77 27.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.96 137.37 42.04 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.91 103.55 15.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -106.18 103.45 12.93 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.15 24.62 14.49 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.951 0.501 . . . . 0.0 111.329 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.68 -4.21 68.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.01 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.96 131.93 35.26 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -84.26 96.42 9.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.4 p -114.27 127.84 56.07 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-O 121.363 0.602 . . . . 0.0 109.798 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.97 118.78 36.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.009 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -115.71 147.57 40.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.54 119.18 32.28 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -80.06 -26.57 39.63 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 106' ' ' GLU . 3.7 mm? -110.35 140.05 44.94 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.586 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 m -69.86 122.19 18.78 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.255 0.55 . . . . 0.0 110.981 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.44 132.51 35.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.21 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 p -95.15 156.84 16.15 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.536 0.522 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.08 117.03 7.83 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.21 -16.57 22.38 Favored Glycine 0 C--N 1.303 -1.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.905 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.2 tp -64.68 125.62 25.33 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.8 m -136.6 144.31 44.05 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.694 ' CZ2' HD22 ' A' ' 107' ' ' LEU . 29.4 m-90 -91.59 172.0 8.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.548 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.84 164.29 54.52 Favored Glycine 0 N--CA 1.435 -1.381 0 O-C-N 123.777 0.673 . . . . 0.0 112.163 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 17.7 Cg_endo -58.54 128.39 28.14 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.408 2.738 . . . . 0.0 113.028 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 51.2 m-85 -102.89 170.89 7.71 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -122.06 142.63 50.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 163.53 -149.38 16.76 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 106.129 -2.789 . . . . 0.0 106.129 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 156' ' ' MET . 24.8 p -161.25 131.2 4.91 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.664 1.232 . . . . 0.0 111.598 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 207' ' ' GLU . 1.4 pt -144.39 97.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.395 -3.186 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.592 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 3.9 pt20 -149.47 97.37 2.63 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.698 0.761 . . . . 0.0 112.522 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.1 t -77.57 163.23 26.46 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -103.05 -67.74 0.87 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.24 87.51 2.4 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.7 tp -90.41 127.15 36.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.286 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.6 m -100.81 110.66 61.45 Favored Pre-proline 0 N--CA 1.411 -2.392 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.655 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.504 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 41.5 Cg_exo -61.88 -23.79 76.38 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.662 2.241 . . . . 0.0 109.567 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.99 -27.63 68.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.116 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.466 ' C ' ' HD3' ' A' ' 146' ' ' ARG . 2.6 tmt_? -89.68 -48.91 6.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.829 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.51 90.23 2.59 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 144' ' ' PRO . 42.3 mt-10 -116.35 -46.4 0.05 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.856 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.63 -40.8 43.75 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 121.459 1.439 . . . . 0.0 112.149 174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.74 92.88 0.3 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.538 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.22 124.58 11.88 Favored 'Trans proline' 0 C--O 1.252 1.212 0 C-N-CA 122.732 2.288 . . . . 0.0 112.112 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.11 -30.39 10.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 206' ' ' THR . 10.1 t -90.95 116.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -126.69 -177.85 4.16 Favored 'General case' 0 C--O 1.197 -1.667 0 C-N-CA 125.304 1.441 . . . . 0.0 108.42 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.34 134.14 44.03 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.087 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.459 ' HB3' ' O ' ' A' ' 136' ' ' SER . 48.2 ttm -97.17 96.36 8.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.5 m -130.32 159.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.608 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.87 170.13 15.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.569 0.543 . . . . 0.0 110.682 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.9 -8.42 58.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.982 0.896 . . . . 0.0 109.461 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 m -83.77 -2.93 57.33 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.633 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.5 t -109.09 116.79 32.62 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-O 121.77 0.795 . . . . 0.0 109.722 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 p-90 -70.04 -14.44 62.68 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.883 1.273 . . . . 0.0 112.129 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.74 -23.72 66.33 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.382 0.673 . . . . 0.0 112.392 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.95 -0.74 57.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.32 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 mmt -89.13 -13.54 38.23 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.292 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -83.08 144.03 46.65 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.01 142.53 38.69 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.237 1.958 . . . . 0.0 110.464 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -88.7 138.88 31.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.325 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.69 163.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.526 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.01 -46.14 37.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.9 p -115.03 173.01 6.71 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.87 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.74 -12.72 57.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.904 0.383 . . . . 0.0 110.402 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -68.76 -32.55 72.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.455 0.645 . . . . 0.0 110.154 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.89 -0.74 55.53 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.262 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.98 132.34 44.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.592 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -96.6 -12.72 23.6 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.3 m -149.08 132.88 16.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.419 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.27 138.89 38.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.487 HD13 HG23 ' A' ' 202' ' ' VAL . 1.7 mp -110.76 114.57 47.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -131.36 175.6 9.0 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.257 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -123.43 132.0 53.82 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.586 0.708 . . . . 0.0 111.638 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 17.3 tppt? -136.91 126.82 25.8 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.41 28.26 17.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.447 1.092 . . . . 0.0 109.584 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.12 9.71 6.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.244 1.418 . . . . 0.0 114.15 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -104.7 152.86 22.0 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 40.3 mt -94.42 141.37 28.66 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 78.7 m95 -130.96 149.2 52.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.3 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.4 t -130.35 117.66 20.08 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 177' ' ' SER . 4.0 ptm180 -120.0 144.14 47.68 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.49 116.57 36.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 p -94.22 -37.23 11.65 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.536 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.44 171.25 7.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.477 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.58 106.28 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.728 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.57 108.8 62.29 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.63 176.93 9.33 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.848 2.366 . . . . 0.0 112.354 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.1 m -72.83 115.01 11.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.278 0.561 . . . . 0.0 109.899 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.49 -7.9 47.14 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.47 144.03 31.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.51 145.22 24.67 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.69 144.83 46.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.236 0.541 . . . . 0.0 110.397 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -118.04 152.72 34.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.051 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.487 HG23 HD13 ' A' ' 179' ' ' ILE . 3.9 p -102.39 129.07 54.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 124.077 0.861 . . . . 0.0 113.103 -174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -109.97 108.07 18.19 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.488 ' H ' HD11 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -115.48 154.39 29.41 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.33 150.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.484 ' HB ' ' CG1' ' A' ' 153' ' ' VAL . 1.5 p -87.8 149.0 24.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 -173.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -56.69 157.26 10.55 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -176.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.592 ' HA ' ' O ' ' A' ' 138' ' ' GLN . 2.0 Cg_endo -43.32 111.98 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.435 3.423 . . . . 0.0 114.749 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 74.4 m80 73.12 -72.53 0.11 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.102 1.361 . . . . 0.0 111.832 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 150.66 67.02 0.01 OUTLIER Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 75.33 87.41 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 127.014 2.126 . . . . 0.0 111.193 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.64 53.68 2.78 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.105 2.536 . . . . 0.0 112.17 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -122.3 93.46 3.99 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -95.5 132.07 28.32 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -39.93 -47.89 3.79 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 124.689 3.593 . . . . 0.0 112.646 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.16 98.34 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 CA-C-O 121.917 0.865 . . . . 0.0 110.593 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -96.1 9.37 41.1 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 219' ' ' PRO . 34.5 tt0 -49.5 -52.08 53.09 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.699 176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 218' ' ' GLU . 3.0 Cg_endo -86.62 118.14 1.51 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 CA-C-N 120.157 1.092 . . . . 0.0 109.416 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -102.85 -2.03 9.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.45 120.75 80.27 Favored Pre-proline 0 N--CA 1.428 -1.537 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.289 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.89 -42.55 11.26 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.682 1.588 . . . . 0.0 109.212 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -118.01 96.46 0.68 Allowed Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -135.95 113.02 1.03 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.097 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.0 tp 174.64 -46.96 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.192 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.254 177.206 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.429 -2.298 0 N-CA-C 108.619 -1.339 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 t-105 -91.36 106.84 18.79 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.184 0.516 . . . . 0.0 110.731 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -109.54 92.9 4.24 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -135.61 -168.94 11.7 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.036 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.1 170.24 13.82 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.551 2.834 . . . . 0.0 113.149 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -75.82 -30.62 59.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.904 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.96 -2.61 48.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.726 0.774 . . . . 0.0 111.974 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.89 161.91 18.11 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.616 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.31 148.74 29.89 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.86 122.02 44.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.4 48.55 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.775 0.321 . . . . 0.0 110.346 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 92.6 mt -99.21 101.35 12.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.78 110.29 20.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 67.73 13.09 9.14 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.995 0.902 . . . . 0.0 112.12 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.72 42.8 Favored Glycine 0 C--N 1.317 -0.525 0 O-C-N 121.681 -0.637 . . . . 0.0 112.464 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.7 tt0 -90.02 135.01 33.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -86.59 96.7 10.19 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.2 t -110.63 152.73 26.14 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.29 131.69 72.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -138.52 148.98 44.89 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.093 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.98 120.67 17.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -68.8 -45.97 69.88 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.14 -179.52 3.66 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.5 m -78.14 98.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.617 0.722 . . . . 0.0 109.21 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.9 tp -76.93 112.53 13.64 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 124.898 1.279 . . . . 0.0 108.891 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.4 t -87.8 142.95 27.42 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.466 0.651 . . . . 0.0 110.942 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.38 136.65 46.17 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.051 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.61 -16.02 21.7 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 tp -81.61 140.01 34.69 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.4 p -138.54 152.05 47.87 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -100.03 175.27 5.81 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 123.265 0.353 . . . . 0.0 110.142 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.53 -179.96 39.29 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.828 0.705 . . . . 0.0 113.297 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.58 123.46 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 113.13 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -99.34 158.47 15.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.4 123.39 40.03 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 170.44 -178.23 43.22 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.6 m -121.38 126.12 48.62 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.39 0.614 . . . . 0.0 111.943 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.468 ' HA ' ' OG1' ' A' ' 206' ' ' THR . 31.2 mt -140.65 118.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.499 ' H ' HG21 ' A' ' 206' ' ' THR . 26.8 tp60 -149.05 103.16 3.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.409 ' HB ' HG13 ' A' ' 205' ' ' VAL . 1.7 t -61.2 155.77 20.02 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.613 0.765 . . . . 0.0 109.526 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.445 ' HA ' ' HE ' ' A' ' 140' ' ' ARG . 2.8 mmp_? -117.83 -4.22 11.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.65 64.35 0.8 Allowed 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 124.803 1.241 . . . . 0.0 109.962 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.0 mt -85.64 178.12 7.48 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.055 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 20.1 m -66.6 112.1 8.56 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 123.66 0.6 . . . . 0.0 111.707 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.2 -11.21 21.12 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.855 2.37 . . . . 0.0 111.235 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.47 -17.99 61.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.35 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 143' ' ' SER . 25.0 ptt85 -90.25 161.06 15.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.81 143.58 51.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -152.19 123.92 3.81 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.19 7.05 4.65 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.038 2.492 . . . . 0.0 112.026 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -101.33 133.72 11.44 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HA ' HD23 ' A' ' 170' ' ' LEU . 4.6 Cg_exo -71.24 83.52 0.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.996 1.797 . . . . 0.0 113.295 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.18 -47.26 36.83 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 206' ' ' THR . 88.1 t -75.84 117.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.624 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.52 ' O ' ' HB ' ' A' ' 206' ' ' THR . 1.3 p -134.32 -179.62 5.69 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.927 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.495 ' HG ' ' NE2' ' A' ' 168' ' ' GLN . 1.2 pp -126.27 148.47 49.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.9 mmt -123.56 81.99 1.96 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.972 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.61 171.82 10.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -71.5 152.84 42.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -22.61 61.89 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.5 p -96.15 -8.21 33.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.7 t -73.26 124.59 25.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.5 p-90 -59.53 -21.55 60.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.005 0.922 . . . . 0.0 113.066 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.93 -29.44 69.62 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 122.674 0.39 . . . . 0.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 15.9 ptm180 -93.91 2.68 56.09 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.017 0.437 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 mmt -94.96 -11.03 29.29 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.7 mt -86.63 141.97 34.47 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 35.8 Cg_exo -63.6 131.8 32.93 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.436 2.091 . . . . 0.0 110.781 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.495 ' NE2' ' HG ' ' A' ' 155' ' ' LEU . 94.0 mt-30 -89.25 137.88 31.92 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.168 0.508 . . . . 0.0 112.031 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.92 171.07 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 151' ' ' PRO . 92.1 mt -111.81 -25.01 9.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.2 p -104.09 150.92 23.87 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.958 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 15.9 pt-20 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.9 -20.08 58.31 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.193 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.83 -23.5 36.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.667 0.746 . . . . 0.0 109.229 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.63 22.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.533 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.404 ' C ' HG21 ' A' ' 191' ' ' THR . 16.7 p30 -114.96 -2.66 12.8 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.71 0.767 . . . . 0.0 109.344 172.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.3 p -145.43 136.18 24.45 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.339 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.441 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 16.0 pt-20 -136.03 143.52 44.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.345 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.0 mm -118.28 137.13 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -139.07 164.51 29.57 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -96.58 140.86 30.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.457 0.646 . . . . 0.0 110.06 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 57.6 tptt -140.46 118.53 11.92 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.41 ' OD1' ' HE3' ' A' ' 182' ' ' LYS . 2.8 m-20 53.12 47.17 25.1 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.772 1.295 . . . . 0.0 111.253 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.4 t70 70.59 -13.16 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.803 1.641 . . . . 0.0 113.513 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.89 152.0 20.28 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 44.5 mt -97.24 132.73 42.71 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.628 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 69.4 m95 -121.2 122.76 40.68 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.456 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.67 124.0 37.38 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.574 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -119.64 142.14 48.7 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 123.331 0.394 . . . . 0.0 110.008 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.53 104.43 12.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.404 HG21 ' C ' ' A' ' 176' ' ' ASN . 4.0 t -84.89 -18.52 34.49 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.068 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -142.3 142.03 32.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.77 116.61 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.775 0.798 . . . . 0.0 111.057 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.66 120.45 55.83 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.56 172.38 14.41 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.331 2.021 . . . . 0.0 111.957 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.0 m -67.58 112.16 4.57 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.89 -5.45 53.61 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.979 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.9 138.58 33.4 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.86 128.76 36.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.459 HD13 ' H ' ' A' ' 200' ' ' LEU . 3.8 mp -82.71 153.66 25.21 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.295 0.569 . . . . 0.0 112.226 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.1 126.82 32.61 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.41 129.62 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 123.96 0.788 . . . . 0.0 111.678 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.441 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 61.0 ttt180 -104.66 133.55 49.31 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.411 ' O ' HG11 ' A' ' 153' ' ' VAL . 2.7 mm? -112.75 154.03 26.83 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.409 HG13 ' HB ' ' A' ' 139' ' ' THR . 20.4 t -115.82 55.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 17.8 m -123.94 107.52 11.43 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.136 0.974 . . . . 0.0 111.222 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.72 149.43 37.11 Favored Pre-proline 0 C--N 1.284 -2.242 0 O-C-N 121.762 -0.586 . . . . 0.0 109.589 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -91.94 -175.21 0.64 Allowed 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.418 2.079 . . . . 0.0 110.322 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' A' ' 210' ' ' GLY . 15.9 t-80 64.21 -160.52 0.29 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.06 0.944 . . . . 0.0 109.163 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.6 ' H ' ' CG ' ' A' ' 209' ' ' HIS . . . -175.65 -87.46 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -135.34 139.83 32.62 Favored Pre-proline 0 C--N 1.292 -1.897 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -82.24 134.99 8.19 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.602 1.535 . . . . 0.0 110.046 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.57 -29.05 19.16 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 39.8 m80 67.92 173.74 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.648 0 O-C-N 123.93 0.769 . . . . 0.0 109.765 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 214' ' ' HIS . 57.5 Cg_endo -70.34 41.45 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.341 2.027 . . . . 0.0 114.766 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.31 -24.57 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 121.686 0.755 . . . . 0.0 110.568 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -90.71 1.89 56.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.353 0.597 . . . . 0.0 110.513 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.38 141.78 25.77 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.14 118.74 4.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.188 2.592 . . . . 0.0 113.103 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.8 -33.79 5.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 63.1 103.56 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 CA-C-N 113.067 -1.879 . . . . 0.0 112.25 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.14 124.97 15.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.535 2.157 . . . . 0.0 112.374 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -111.66 78.58 0.25 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.7 -125.02 2.2 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp 61.35 87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.355 1.062 . . . . 0.0 110.864 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 N--CA 1.446 -1.318 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.61 157.4 46.69 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 t -90.84 77.89 6.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.87 164.29 24.73 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.08 166.12 16.77 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.69 2.26 . . . . 0.0 112.885 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -74.68 -12.1 60.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.592 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -80.88 -12.48 59.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.729 0.776 . . . . 0.0 109.393 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.69 157.7 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.237 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.5 141.56 46.77 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.98 120.29 29.18 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.8 129.42 56.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.103 0.478 . . . . 0.0 111.455 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.47 108.49 20.43 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -109.76 95.54 5.67 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 51.38 59.35 4.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.141 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.03 -1.5 86.57 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.803 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.4 140.63 47.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 117.276 0.538 . . . . 0.0 110.736 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -80.75 111.51 17.26 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.868 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.59 169.16 11.73 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 129.95 74.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -119.48 145.82 45.97 Favored 'General case' 0 N--CA 1.394 -3.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.0 20.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -89.1 -44.4 10.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.21 165.2 11.8 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 51.0 m -91.84 110.15 21.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.5 mm? -84.02 123.87 30.47 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 t -101.27 157.51 16.73 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 149.39 50.69 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.878 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.14 -26.97 21.38 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.086 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.411 ' C ' ' HG ' ' A' ' 129' ' ' SER . 46.4 tp -75.25 142.35 43.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 128' ' ' LEU . 13.9 m -139.78 162.35 35.34 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -100.45 174.99 5.84 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.292 0.637 . . . . 0.0 109.731 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.39 171.14 55.1 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 119.526 -0.597 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 57.7 Cg_endo -73.09 123.33 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.247 1.964 . . . . 0.0 114.054 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.44 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 48.8 m-85 -94.72 149.96 20.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -106.36 106.26 16.7 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.861 0.839 . . . . 0.0 112.189 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.1 -145.02 4.12 Favored Glycine 0 C--N 1.291 -1.949 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -153.45 161.3 42.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.34 1.07 . . . . 0.0 110.832 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.7 mt -122.23 118.99 57.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -89.61 100.93 13.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.4 t -95.43 162.41 13.67 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -167.52 -45.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.94 41.7 17.28 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.609 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 68.5 tp -73.5 100.24 3.22 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.232 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.9 m -98.47 107.08 40.24 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 147' ' ' GLU . 50.7 Cg_exo -56.03 -71.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.817 2.345 . . . . 0.0 113.113 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -112.63 -35.84 5.39 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.637 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 147' ' ' GLU . 1.8 tmm_? -152.37 -53.38 0.12 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.627 -175.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 38.6 tt0 -111.53 157.75 19.98 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -83.13 110.67 25.09 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.23 -28.07 19.03 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.593 2.195 . . . . 0.0 113.859 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -165.96 -118.41 0.44 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.353 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.2 78.58 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.775 2.317 . . . . 0.0 113.618 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.8 -18.52 27.53 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.119 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.6 t -146.98 126.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.5 m -133.44 134.65 43.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.13 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 155' ' ' LEU . 1.3 pp -81.7 125.14 30.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 0.0 110.38 175.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -96.3 86.72 4.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.675 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.93 165.62 28.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.182 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -70.09 160.25 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.9 63.96 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 112.245 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 p -88.47 -9.37 52.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 53.1 t -75.97 126.81 31.71 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.023 0.439 . . . . 0.0 110.188 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.529 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 7.8 p-90 -54.01 -30.87 49.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.44 HD21 ' SG ' ' A' ' 188' ' ' CYS . 88.2 mt -59.62 -30.28 68.59 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.35 -2.9 44.77 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.47 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.8 ptp -107.48 4.56 26.3 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.727 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 73.5 mt -83.99 148.86 54.84 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.8 118.23 5.23 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.901 1.734 . . . . 0.0 110.056 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -81.68 129.16 34.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.36 146.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.408 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.04 0.77 25.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.579 0.704 . . . . 0.0 109.466 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.3 p -100.03 134.49 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.585 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.25 -34.37 68.2 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-O 121.167 0.508 . . . . 0.0 110.727 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.95 -12.91 61.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.81 -20.4 17.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.62 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -88.6 127.97 35.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.081 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -94.54 -11.41 29.59 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.205 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 p -152.42 129.43 11.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.475 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.36 134.04 52.32 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.054 0.455 . . . . 0.0 110.25 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.463 HD12 ' SG ' ' A' ' 188' ' ' CYS . 29.8 mm -102.17 125.24 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 187' ' ' TRP . 32.4 p90 -130.29 154.03 48.03 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.606 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -102.66 127.25 49.86 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -137.26 128.04 27.17 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.06 23.41 11.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.76 17.55 11.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.445 1.498 . . . . 0.0 113.376 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -109.61 159.37 17.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 3.4 mm? -93.39 131.36 38.65 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 180' ' ' TYR . 51.2 m95 -128.23 139.56 52.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.463 ' SG ' HD12 ' A' ' 179' ' ' ILE . 49.1 m -109.05 112.77 25.14 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.742 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.4 131.63 54.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.74 126.46 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.0 p -106.54 -19.1 13.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -140.02 146.03 38.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.445 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 76.7 t -69.16 115.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 123.864 0.727 . . . . 0.0 109.717 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -108.8 120.22 46.75 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 153.58 49.41 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.228 1.952 . . . . 0.0 111.988 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.3 m -63.14 122.72 16.79 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.61 -18.1 25.13 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.558 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.78 159.09 23.66 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.579 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.76 153.65 20.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.208 0.528 . . . . 0.0 110.783 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.52 148.85 45.89 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.37 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -114.25 145.08 42.2 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.3 p -102.15 125.63 56.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 123.948 0.78 . . . . 0.0 110.75 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.497 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.2 ttt180 -97.74 134.0 41.5 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.02 135.9 38.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.11 97.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.555 1.169 . . . . 0.0 111.915 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 4.94 40.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.41 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.03 120.39 22.54 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.68 32.62 0.16 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 124.141 3.227 . . . . 0.0 115.535 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.457 ' HB3' ' CE1' ' A' ' 214' ' ' HIS . 32.8 m170 74.33 137.1 0.06 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.214 1.406 . . . . 0.0 113.257 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 168.91 36.23 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.608 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.424 ' HB3' ' HD3' ' A' ' 212' ' ' PRO . . . -124.34 -55.06 0.03 OUTLIER Pre-proline 0 C--O 1.213 -0.846 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.98 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 211' ' ' ALA . 64.4 Cg_endo -102.52 -170.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.599 1.533 . . . . 0.0 110.053 174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -105.66 153.87 21.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.457 ' CE1' ' HB3' ' A' ' 209' ' ' HIS . 36.4 m80 -113.08 145.02 32.26 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.27 132.51 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.445 2.097 . . . . 0.0 112.458 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 51.9 t 66.8 87.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.146 1.379 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -103.92 -16.39 15.37 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.344 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.13 128.97 89.85 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.359 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.3 155.49 55.93 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.375 2.05 . . . . 0.0 111.518 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.47 167.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.67 149.77 38.82 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.52 116.2 4.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.102 1.868 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -78.37 145.72 29.56 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.891 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.77 -95.9 1.84 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.8 tp -158.94 135.4 9.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.634 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.693 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.429 -2.287 0 N-CA-C 111.477 -0.24 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.508 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 36.2 t-105 -115.93 109.94 18.29 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 121.799 0.809 . . . . 0.0 111.342 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -145.2 123.98 12.62 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -171.95 -141.83 3.52 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 118.526 -1.797 . . . . 0.0 113.592 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -82.56 159.2 16.8 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.125 2.55 . . . . 0.0 112.339 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.46 -20.58 39.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.1 -15.45 63.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.324 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.629 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.8 mm? -119.53 147.77 44.06 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.697 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.36 141.32 33.83 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -94.3 100.1 12.21 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.11 146.24 32.93 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -172.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 9.0 mp -108.19 110.49 22.13 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.694 176.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 117.33 31.42 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.32 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.66 23.75 14.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.048 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.64 2.22 63.35 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.071 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 53.2 tt0 -98.35 137.96 36.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 116' ' ' ARG . 0.2 OUTLIER -98.1 102.64 14.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.3 t -130.8 165.11 23.7 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.077 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -91.0 107.98 19.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.375 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.5 140.82 36.99 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.34 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.84 113.51 7.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -50.17 30.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.08 169.25 8.9 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 m -74.46 112.57 10.77 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.223 0.535 . . . . 0.0 110.46 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.436 ' CD1' HD22 ' A' ' 200' ' ' LEU . 75.4 mt -84.71 114.7 22.22 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.4 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.6 p -88.81 155.26 19.66 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.165 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.55 141.33 55.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.105 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.97 -17.75 58.7 Favored Glycine 0 C--N 1.297 -1.606 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.266 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.67 117.02 9.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.7 m -129.3 141.11 51.19 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -99.37 170.95 8.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.9 -168.56 22.19 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.85 0.719 . . . . 0.0 113.937 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.2 Cg_endo -75.16 144.02 29.24 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.343 2.029 . . . . 0.0 112.864 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.534 ' CD2' HD11 ' A' ' 163' ' ' LEU . 76.8 m-85 -123.34 162.52 22.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.199 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -94.38 125.12 38.83 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 -178.74 35.02 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.952 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -126.19 158.85 34.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 60.2 mt -97.65 147.51 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 109.819 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.07 98.37 2.08 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.6 t -89.35 162.69 15.67 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.626 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? 65.95 47.45 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.97 0.891 . . . . 0.0 110.08 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.47 41.63 0.63 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.586 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.2 tp -79.8 98.56 7.1 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.4 m -58.8 117.15 18.66 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.4 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -96.98 -154.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.125 0 C-N-CA 122.789 2.326 . . . . 0.0 110.312 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -83.71 -44.89 13.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.198 0.523 . . . . 0.0 109.805 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -89.11 177.79 6.54 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.9 129.02 37.9 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.514 1.525 . . . . 0.0 111.949 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 67.78 148.84 0.12 Allowed Pre-proline 0 N--CA 1.478 0.975 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.86 -5.95 17.49 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.503 2.135 . . . . 0.0 110.397 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.82 116.73 0.71 Allowed Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.546 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.04 -5.97 17.09 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 C-N-CA 122.657 2.238 . . . . 0.0 112.381 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.77 -11.15 37.48 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.329 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.1 p -123.62 119.98 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.631 0.729 . . . . 0.0 109.736 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.5 m -146.67 158.09 43.84 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.14 104.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.668 0.747 . . . . 0.0 111.952 175.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.65 90.91 8.55 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 m -110.93 178.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.207 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.604 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 23.5 t70 -66.94 144.5 56.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -10.07 49.74 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -95.51 -12.44 25.79 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.604 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 158' ' ' ASP . 94.0 m -69.94 111.01 5.35 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-O 121.614 0.721 . . . . 0.0 112.926 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.629 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 19.8 p-90 -54.48 -26.15 29.53 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 125.514 1.526 . . . . 0.0 112.569 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.534 HD11 ' CD2' ' A' ' 133' ' ' PHE . 75.3 mt -54.21 -32.66 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.464 1.106 . . . . 0.0 112.549 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -85.47 -2.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.618 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 95.9 mmm -86.53 -16.27 37.46 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.577 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.16 143.26 52.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.99 131.35 20.73 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 121.607 1.538 . . . . 0.0 109.426 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -83.95 129.93 34.91 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -112.94 137.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.685 0.755 . . . . 0.0 112.531 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.54 -18.77 56.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.524 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 4.7 p -95.4 134.92 37.66 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.092 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.06 -17.32 37.79 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.72 0.771 . . . . 0.0 109.515 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -66.89 -41.37 87.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.093 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -77.66 -29.21 51.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.52 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.51 140.17 57.02 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.556 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -107.81 -15.48 14.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.533 0.682 . . . . 0.0 109.74 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.7 m -149.36 142.96 25.45 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -116.72 151.56 36.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.893 0.378 . . . . 0.0 111.001 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 33.6 mm -115.96 115.52 49.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -113.19 163.03 15.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -109.92 141.74 42.23 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -148.25 121.27 8.83 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 65.69 20.98 11.6 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.045 0.938 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 73.71 15.68 3.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.743 1.617 . . . . 0.0 111.31 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -109.08 147.87 31.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 70.4 mt -93.87 141.22 28.76 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.851 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.89 136.33 50.27 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.9 126.07 54.71 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 123.282 0.364 . . . . 0.0 110.806 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -123.88 137.22 54.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.63 125.2 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.0 p -90.85 -39.91 12.06 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 175' ' ' ALA . 48.9 mtmt -119.49 153.66 34.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.84 108.69 8.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.66 112.63 48.16 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 121.124 0.487 . . . . 0.0 110.247 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 164.32 35.02 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.441 2.094 . . . . 0.0 112.488 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.3 t -58.6 123.25 15.67 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.679 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.2 -30.69 5.14 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.47 147.32 49.73 Favored Glycine 0 N--CA 1.443 -0.861 0 O-C-N 124.045 0.497 . . . . 0.0 112.157 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.5 mt -105.34 120.39 41.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 124' ' ' LEU . 5.3 mp -73.1 136.49 44.9 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -118.47 137.69 53.0 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.0 130.78 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.487 0.661 . . . . 0.0 111.949 -173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.565 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.4 tpt180 -104.77 130.84 52.78 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.19 124.43 48.59 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.92 81.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 122.416 1.103 . . . . 0.0 108.661 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.1 t -83.06 157.5 22.84 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.268 -1.787 . . . . 0.0 109.814 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -121.79 113.2 31.79 Favored Pre-proline 0 N--CA 1.42 -1.972 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.866 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.41 131.39 2.48 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 122.47 2.113 . . . . 0.0 108.754 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -86.88 91.03 8.53 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.35 -26.29 23.77 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.718 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -104.69 112.13 65.29 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 116.852 0.326 . . . . 0.0 110.612 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.02 -21.62 13.84 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.232 1.955 . . . . 0.0 110.601 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -139.6 112.59 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.159 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -87.66 -63.66 0.21 Allowed Pre-proline 0 C--N 1.297 -1.694 0 CA-C-O 118.556 -0.735 . . . . 0.0 112.541 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.73 -17.04 6.27 Favored 'Trans proline' 0 C--N 1.371 1.73 0 CA-C-N 121.283 1.494 . . . . 0.0 112.082 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.2 t 67.51 -69.75 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.375 1.47 . . . . 0.0 112.116 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.41 -179.31 3.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.08 134.25 80.9 Favored Pre-proline 0 C--N 1.315 -0.929 0 O-C-N 123.342 0.401 . . . . 0.0 110.95 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.54 122.86 12.55 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.608 2.206 . . . . 0.0 110.534 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.55 124.47 46.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -124.95 123.13 25.52 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.245 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.83 -26.27 59.91 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.384 2.056 . . . . 0.0 110.599 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.14 -110.73 2.57 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -85.62 99.13 2.34 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 pp -112.38 165.37 12.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.763 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 N--CA 1.444 -1.441 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.612 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 5.1 p-90 -59.88 109.15 0.87 Allowed 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.019 0.824 . . . . 0.0 111.407 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.263 79.1 p 65.94 -51.02 0.4 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.171 2.189 . . . . 0.0 114.669 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.68 -73.05 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.228 -1.463 . . . . 0.0 114.446 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -70.65 119.99 6.75 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.717 1.611 . . . . 0.0 114.443 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -10.31 59.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.345 177.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.15 -7.74 55.47 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.063 1.345 . . . . 0.0 109.619 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.612 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 0.2 OUTLIER -110.96 138.39 47.43 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.487 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 39.7 tt0 -113.57 119.19 36.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.354 0.597 . . . . 0.0 112.242 -176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.5 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.6 tm? -96.49 110.58 22.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.475 ' HB3' HE21 ' A' ' 112' ' ' GLN . . . -117.49 114.8 24.01 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.088 0.471 . . . . 0.0 110.997 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.67 105.0 17.41 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.145 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.475 HE21 ' HB3' ' A' ' 110' ' ' ALA . 82.2 mm-40 -105.83 105.9 16.16 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 64.44 21.79 12.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.119 0.968 . . . . 0.0 110.861 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.91 2.35 59.55 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.861 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -100.55 137.57 38.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 117.291 0.545 . . . . 0.0 110.181 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -84.68 113.34 21.22 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.616 0.722 . . . . 0.0 112.635 -176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.3 t -115.3 143.99 44.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.0 t -121.51 112.85 37.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 80.9 mtt180 -118.57 160.1 22.38 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.703 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.17 126.46 32.64 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -64.64 -37.44 87.58 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.516 0.674 . . . . 0.0 110.201 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.95 171.3 14.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -66.61 112.13 4.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.48 117.85 21.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.2 p -79.82 147.34 31.82 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.101 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.27 139.25 54.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.74 -18.8 56.38 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.363 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.26 125.37 26.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m -129.62 149.06 51.55 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -92.1 165.38 13.19 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.097 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.61 158.74 35.76 Favored Glycine 0 N--CA 1.441 -1.002 0 O-C-N 124.41 1.069 . . . . 0.0 112.853 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 123.6 12.03 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.083 2.522 . . . . 0.0 112.681 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -96.36 152.61 18.44 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.83 141.85 31.1 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.791 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.28 -158.78 28.66 Favored Glycine 0 C--N 1.281 -2.514 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -147.28 162.38 39.06 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 69.2 mt -129.08 114.08 31.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.82 101.66 13.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.6 m -87.13 87.34 7.42 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 122.633 1.206 . . . . 0.0 110.108 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -84.85 80.35 9.3 Favored 'General case' 0 C--N 1.27 -2.891 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.394 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.39 76.58 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.982 0.896 . . . . 0.0 109.41 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 tp -98.81 105.22 17.34 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.028 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 p -71.92 114.71 31.24 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -91.1 -155.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.088 0 C-N-CA 122.205 1.937 . . . . 0.0 112.05 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -97.5 -10.65 24.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -114.9 -169.04 1.47 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.664 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.17 -58.86 3.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.067 0.46 . . . . 0.0 110.199 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HG2' ' H ' ' A' ' 150' ' ' GLY . 43.2 tt0 -94.84 123.4 57.83 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.494 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.24 -15.13 18.25 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.376 2.051 . . . . 0.0 111.546 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.405 ' H ' ' HG2' ' A' ' 148' ' ' GLU . . . 94.14 -159.31 23.46 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -74.09 60.89 4.77 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.175 2.583 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.94 17.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 p -79.13 118.46 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.018 175.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 m -130.81 142.34 50.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.83 151.99 22.44 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.806 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.19 95.37 5.16 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.95 -178.63 2.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.445 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 164' ' ' ARG . 11.0 t70 -55.48 142.22 33.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.088 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -55.8 -30.48 61.42 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.8 p -105.95 5.33 30.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.826 0.346 . . . . 0.0 111.899 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.6 t -66.33 124.38 22.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -51.24 -29.23 13.78 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.0 mt -57.09 -35.45 69.42 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.06 0.544 . . . . 0.0 111.508 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 158' ' ' ASP . 16.5 ptm180 -97.31 -2.47 42.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.518 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 93.6 mmm -92.63 -28.32 16.77 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 -176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.3 152.54 70.76 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.83 124.72 14.56 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 121.686 1.591 . . . . 0.0 109.653 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -88.86 132.15 34.79 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.573 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.558 ' CG2' ' HB1' ' A' ' 175' ' ' ALA . 33.9 m -125.37 164.37 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.1 mt -111.75 -8.11 14.18 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.188 0.518 . . . . 0.0 110.638 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.9 p -93.2 134.6 35.23 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.052 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.26 -9.21 58.69 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.143 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -80.02 -34.9 37.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.649 0.261 . . . . 0.0 110.783 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.02 23.69 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.614 0.721 . . . . 0.0 109.319 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -78.11 123.32 26.73 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.763 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -90.02 -14.75 33.25 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.061 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.3 m -134.53 136.83 43.34 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.677 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.92 136.67 54.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.271 0.558 . . . . 0.0 110.665 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.49 HD11 HG11 ' A' ' 202' ' ' VAL . 1.4 mp -103.32 120.71 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.545 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -132.1 151.4 51.79 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.057 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 141.25 28.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -155.25 111.89 3.23 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.3 t70 57.2 65.36 1.39 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.266 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.66 8.04 2.78 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.136 -1.393 . . . . 0.0 114.283 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.37 156.53 45.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.3 mt -101.61 131.92 47.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -120.51 150.24 41.16 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.1 t -125.32 114.27 18.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -111.02 146.04 37.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.5 t -83.06 112.46 20.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t -92.17 -34.16 14.43 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.97 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -123.48 135.59 54.14 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.98 108.36 2.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.558 0.536 . . . . 0.0 111.045 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.46 128.14 27.57 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.264 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.29 169.01 17.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.877 2.385 . . . . 0.0 112.779 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.4 t -67.38 131.5 45.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.29 -13.78 64.19 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.413 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.66 154.56 45.62 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.86 142.43 28.86 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.447 0.642 . . . . 0.0 110.753 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -123.22 164.38 18.84 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.392 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -136.03 158.74 43.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.49 HG11 HD11 ' A' ' 179' ' ' ILE . 23.3 t -100.05 119.18 47.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 124.484 1.115 . . . . 0.0 111.361 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.636 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 1.1 tmm_? -106.73 128.0 53.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.24 138.96 31.19 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.28 93.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.897 1.332 . . . . 0.0 112.714 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.5 m -98.31 99.68 10.91 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -63.6 142.79 98.0 Favored Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.144 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.37 109.36 0.43 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.991 2.46 . . . . 0.0 110.155 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -101.68 137.22 40.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.432 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 91.14 27.96 16.8 Favored Glycine 0 C--N 1.305 -1.187 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 71.72 145.45 0.11 Allowed Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.348 1.459 . . . . 0.0 112.227 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.38 154.64 68.95 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 121.772 1.648 . . . . 0.0 108.859 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.64 91.56 7.49 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.888 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -135.38 135.21 22.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.91 -57.9 1.32 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.052 1.835 . . . . 0.0 109.258 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.39 123.82 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.133 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.96 108.02 20.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -92.77 121.01 66.87 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.441 -173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.27 132.04 20.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.359 2.039 . . . . 0.0 109.82 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.0 t -102.68 123.34 55.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.838 0.351 . . . . 0.0 110.136 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.57 122.34 35.4 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.97 155.18 48.08 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.061 1.841 . . . . 0.0 111.452 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -90.69 55.45 3.42 Favored Glycine 0 C--N 1.3 -1.438 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -150.85 81.1 0.19 Allowed Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.62 104.17 4.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.439 -1.709 0 N-CA-C 112.432 0.128 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.495 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -154.81 166.81 32.29 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.118 -176.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 162' ' ' TRP . 36.6 m -91.48 93.12 8.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.18 -175.52 38.53 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.687 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.04 151.44 9.62 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.11 2.54 . . . . 0.0 111.966 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 1.6 pm0 -78.42 -0.36 28.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.54 -22.76 60.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.9 161.2 17.26 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.566 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 34.9 tt0 -144.25 122.67 12.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.758 0.313 . . . . 0.0 110.718 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.3 tm? -88.23 109.69 20.13 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 171.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.44 157.75 18.15 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.4 mt -118.03 97.93 6.06 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -113.39 117.51 31.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 66.15 12.51 8.57 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.444 1.116 . . . . 0.0 110.062 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.83 69.06 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.057 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -82.32 136.73 34.97 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 122.665 -0.314 . . . . 0.0 110.185 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.95 110.41 16.46 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.9 p -129.95 136.94 50.04 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.414 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.5 t -96.54 105.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -110.84 149.2 30.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.16 15.15 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 24.3 ttt180 -73.92 -43.22 59.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.83 152.81 25.27 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.7 m -68.41 116.38 8.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 88.6 mt -86.77 113.12 22.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.879 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 p -90.66 144.37 25.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -64.64 148.46 50.9 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.41 -34.1 5.9 Favored Glycine 0 C--N 1.282 -2.434 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.412 ' C ' ' HG ' ' A' ' 129' ' ' SER . 63.9 tp -65.75 138.55 58.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 128' ' ' LEU . 13.2 m -147.55 154.96 41.37 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -98.35 173.11 7.14 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 123.564 0.54 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.6 -179.05 37.94 Favored Glycine 0 N--CA 1.437 -1.289 0 O-C-N 123.81 0.694 . . . . 0.0 112.97 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 123.72 10.08 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.635 2.223 . . . . 0.0 112.579 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.506 ' CD2' HD12 ' A' ' 163' ' ' LEU . 80.3 m-85 -96.6 150.01 21.13 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.338 0.589 . . . . 0.0 110.806 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.471 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 147.6 -174.27 27.41 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.0 m -139.15 160.52 39.59 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.989 0.894 . . . . 0.0 111.993 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.37 130.8 72.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.42 97.57 6.42 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.908 0.861 . . . . 0.0 110.324 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -84.38 132.61 34.57 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.475 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . 0.333 11.5 mmt180 56.71 47.79 17.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.262 1.03 . . . . 0.0 113.069 -172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.97 97.5 7.49 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.46 114.14 27.49 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.084 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 m -74.72 162.86 71.8 Favored Pre-proline 0 C--N 1.292 -1.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.812 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.89 -149.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.259 1.973 . . . . 0.0 109.651 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -85.84 20.38 2.22 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.581 -0.7 . . . . 0.0 111.197 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -75.68 159.94 30.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.229 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.469 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.3 pt-20 -64.73 139.67 58.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.795 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.19 102.56 14.37 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 147' ' ' GLU . 24.3 Cg_exo -65.93 -42.02 12.38 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.72 2.28 . . . . 0.0 112.578 -175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.51 -127.29 0.93 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.87 100.03 0.49 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.243 1.962 . . . . 0.0 111.579 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.14 -29.48 31.59 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.22 117.84 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 204' ' ' LEU . 14.3 t -150.27 179.62 7.96 Favored 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 151.72 21.67 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.89 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.4 ptm -123.6 85.72 2.46 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.953 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.471 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -136.86 164.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.025 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.02 158.24 29.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.96 -19.24 65.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -73.06 -14.22 61.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.494 0.664 . . . . 0.0 109.381 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.8 t -87.25 100.31 12.6 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.45 ' HB3' ' O ' ' A' ' 102' ' ' SER . 16.1 p-90 -44.83 -28.4 0.64 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 114.234 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.506 HD12 ' CD2' ' A' ' 133' ' ' PHE . 82.5 mt -52.8 -37.35 59.7 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.89 0.876 . . . . 0.0 112.416 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -87.33 1.07 54.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.111 -177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 92.0 mmm -92.61 -8.8 43.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.249 0.547 . . . . 0.0 110.23 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.96 155.18 49.97 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.63 118.67 5.67 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.888 1.725 . . . . 0.0 110.089 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.87 136.18 38.02 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.925 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 21.8 m -138.24 149.07 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.34 -10.29 16.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.44 0.638 . . . . 0.0 109.76 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.8 p -88.54 134.55 33.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.86 -29.67 61.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.564 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.25 -32.06 69.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.774 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.32 -20.44 24.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.909 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.597 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.08 154.29 24.45 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.777 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -119.66 -12.75 9.22 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.444 0.64 . . . . 0.0 110.066 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.8 m -154.28 145.67 23.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.69 147.58 49.3 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.1 0.476 . . . . 0.0 111.467 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.59 131.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.06 167.2 21.39 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -97.79 139.64 33.36 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.9 tttt -165.22 138.26 4.52 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 65.72 16.6 10.56 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.845 0.858 . . . . 0.0 110.767 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.19 64.24 0.86 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 111.283 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -173.06 172.92 3.8 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.729 -1.578 . . . . 0.0 106.832 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.81 139.12 40.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.8 m95 -123.29 133.2 54.18 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.7 t -102.7 117.73 35.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -115.8 144.8 43.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.88 132.46 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.0 p -104.42 -39.07 6.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.302 0.572 . . . . 0.0 111.998 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -108.98 149.53 29.08 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.958 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 59.2 t -77.18 98.23 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 t -85.95 125.95 67.06 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 144.99 42.54 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 122.136 1.891 . . . . 0.0 111.689 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.6 p -62.61 116.4 5.13 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.386 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.19 -8.14 30.96 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.569 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.84 33.76 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.0 mt -103.26 163.11 12.45 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 200' ' ' LEU . 1.2 pt? -141.15 148.45 40.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -111.44 144.77 40.12 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.77 123.01 53.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.306 0.574 . . . . 0.0 110.529 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.597 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 55.1 ttt180 -98.04 137.31 37.03 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.805 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.462 ' CD2' ' HA ' ' A' ' 154' ' ' THR . 6.9 mp -98.32 138.3 35.78 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 4.4 p -50.63 104.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 122.666 1.222 . . . . 0.0 112.817 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.5 m -95.5 115.08 26.94 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.516 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 208' ' ' PRO . 33.0 mt-10 -86.68 113.95 55.54 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 207' ' ' GLU . 16.6 Cg_exo -68.57 149.0 73.73 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.185 2.59 . . . . 0.0 112.303 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -99.1 120.61 39.77 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.55 81.41 1.74 Allowed Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.95 112.68 14.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -91.01 19.51 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.664 2.243 . . . . 0.0 111.366 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.427 ' HA ' ' HE ' ' A' ' 213' ' ' ARG . 2.5 mmp_? -125.08 93.27 3.83 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.358 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.435 ' HB3' ' HD3' ' A' ' 215' ' ' PRO . 72.6 t60 -81.48 -60.63 0.41 Allowed Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.747 173.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 214' ' ' HIS . 2.5 Cg_endo -83.88 123.09 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 121.17 1.247 . . . . 0.0 109.313 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.63 63.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.608 1.194 . . . . 0.0 111.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -152.75 108.1 3.27 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.082 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -119.92 166.54 14.67 Favored Pre-proline 0 C--N 1.292 -1.927 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -64.08 157.93 50.61 Favored 'Trans proline' 0 C--O 1.249 1.056 0 N-CA-C 108.289 -1.466 . . . . 0.0 108.289 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.36 123.1 15.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.636 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 71.11 152.81 0.14 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.78 1.232 . . . . 0.0 111.475 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.8 -36.74 43.37 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 123.307 2.671 . . . . 0.0 112.098 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.22 -30.3 6.84 Favored Glycine 0 CA--C 1.491 -1.441 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 175.66 130.14 1.29 Allowed Glycine 0 N--CA 1.414 -2.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 98.1 mt -113.18 -42.17 3.57 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.919 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 176.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.477 ' CE2' ' HB2' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -161.08 157.7 26.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.656 -0.653 . . . . 0.0 109.293 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -87.83 82.85 7.2 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.89 171.95 29.85 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.23 158.21 11.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.496 2.797 . . . . 0.0 112.012 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.07 -2.29 47.61 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.67 -19.98 54.45 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 160.18 16.18 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 113.506 -1.679 . . . . 0.0 108.9 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.475 ' OE2' ' HD3' ' A' ' 119' ' ' ARG . 36.6 tt0 -136.39 131.2 33.87 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.323 0.582 . . . . 0.0 111.493 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.477 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.5 tm? -96.36 114.31 25.97 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.83 142.91 45.5 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 79.1 mt -99.77 122.47 42.81 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.669 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 10.1 tt0 -121.5 107.19 12.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 13.14 2.77 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.139 1.376 . . . . 0.0 112.439 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.78 2.39 30.46 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.209 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.669 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.4 pt20 -95.65 151.71 19.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -98.2 105.23 17.35 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.245 0.545 . . . . 0.0 109.628 176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 8.2 p -111.04 138.4 47.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.5 117.31 45.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HD3' ' OE2' ' A' ' 108' ' ' GLU . 3.2 ptm180 -127.18 154.27 45.01 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.558 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.4 121.02 19.81 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -78.02 -43.53 29.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.24 170.09 10.26 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.805 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -69.8 107.68 3.62 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.256 0.551 . . . . 0.0 111.058 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 83.6 mt -74.52 113.75 12.12 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.2 p -85.56 155.47 21.16 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.287 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.51 129.75 40.57 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.117 0.484 . . . . 0.0 109.809 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.74 61.93 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.386 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.67 126.97 30.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 188' ' ' CYS . 36.9 p -135.59 147.51 48.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -97.69 168.18 10.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.934 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.11 159.14 53.47 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.833 0.708 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 23.6 Cg_endo -59.33 123.75 14.08 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 123.471 2.781 . . . . 0.0 112.762 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -92.99 150.65 20.4 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.912 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -90.6 105.0 17.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.146 0.498 . . . . 0.0 110.038 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.84 -168.64 39.11 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -146.9 166.61 26.23 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.79 118.85 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -111.63 120.01 40.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.369 0.604 . . . . 0.0 111.348 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 140.7 29.56 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.122 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -127.34 68.39 1.29 Allowed 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 122.655 1.217 . . . . 0.0 109.012 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.23 82.92 6.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.779 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.76 116.7 19.91 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.8 m -77.68 109.92 11.23 Favored Pre-proline 0 C--N 1.293 -1.854 0 O-C-N 123.79 0.681 . . . . 0.0 110.089 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.76 -51.0 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.353 2.035 . . . . 0.0 111.221 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -107.85 -46.73 3.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -164.45 -45.99 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 122.287 1.042 . . . . 0.0 108.196 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.37 159.97 32.83 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.146 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 130.96 56.39 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -53.02 -32.56 58.77 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.732 2.954 . . . . 0.0 114.084 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.4 -142.79 3.5 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.43 110.41 2.85 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.947 2.431 . . . . 0.0 110.883 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.32 -18.45 19.96 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.422 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.2 t -75.88 130.11 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 m -118.72 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 122.227 -0.295 . . . . 0.0 110.672 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mp -89.24 124.6 34.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.0 ttt -102.08 82.05 2.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.21 178.69 4.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.814 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.18 146.27 54.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 123.567 0.542 . . . . 0.0 110.798 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -53.36 -38.83 63.67 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.36 1.064 . . . . 0.0 112.223 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 3.34 54.44 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.77 0.319 . . . . 0.0 110.903 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.42 126.62 31.11 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -54.67 -31.1 57.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 179' ' ' ILE . 49.0 mt -56.13 -40.06 73.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -87.36 -6.52 58.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.4 ptp -100.46 5.41 44.19 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.968 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.88 143.2 31.19 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.53 129.96 16.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.909 1.739 . . . . 0.0 110.786 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -79.99 150.39 30.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.113 0.482 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 m -138.71 147.57 25.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.25 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.97 -21.93 20.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.8 p -94.99 134.83 37.24 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.241 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.4 -6.02 59.25 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.149 0.5 . . . . 0.0 111.651 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.99 -29.4 64.18 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.28 -29.74 18.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.793 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.86 124.67 25.87 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.708 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.22 -18.11 15.65 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.44 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.2 p -141.17 134.33 29.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -120.73 147.68 44.98 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.939 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.437 ' CD1' HD23 ' A' ' 163' ' ' LEU . 18.9 mm -111.1 114.35 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.426 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 11.9 p90 -125.84 154.97 41.88 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 33.0 ptt180 -94.26 135.94 35.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.195 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.633 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 52.2 tttm -137.31 122.57 19.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.413 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 3.8 m-20 66.63 22.16 10.53 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.6 t70 68.96 5.59 5.13 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.473 1.909 . . . . 0.0 112.214 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -95.8 155.17 16.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 78.5 mt -93.58 123.44 36.9 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.633 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.633 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 55.4 m95 -116.46 137.34 52.24 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 129' ' ' SER . 50.9 t -108.7 119.86 40.77 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -123.14 142.26 51.08 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.781 0.324 . . . . 0.0 110.295 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.49 128.56 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.008 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.1 p -98.35 -47.57 5.38 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -113.9 140.17 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.885 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 48.9 t -74.55 111.46 10.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.239 0.542 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.12 122.84 40.94 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.259 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.02 174.03 13.5 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.529 2.153 . . . . 0.0 112.256 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.9 m -59.45 125.99 25.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.39 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.05 63.37 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.783 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.5 144.78 17.43 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.65 142.14 27.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.4 pt? -110.88 147.26 34.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.23 148.33 37.55 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.8 134.47 46.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 123.653 0.595 . . . . 0.0 111.088 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -109.2 139.33 44.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.35 154.5 18.14 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.145 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 14.2 p -39.49 132.24 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.9 0 C-N-CA 126.064 1.746 . . . . 0.0 114.286 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.9 t -77.14 179.84 6.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.337 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.74 165.11 36.41 Favored Pre-proline 0 C--N 1.292 -1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.01 94.99 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.121 -1.531 . . . . 0.0 108.121 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -102.98 122.18 44.07 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.053 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 160.85 -100.18 0.18 Allowed Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -172.73 153.91 2.8 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.7 123.89 13.54 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 122.614 2.209 . . . . 0.0 108.733 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.485 ' O ' ' HD3' ' A' ' 213' ' ' ARG . 2.8 tmt_? 76.34 102.1 0.07 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.519 1.128 . . . . 0.0 108.314 -169.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 219' ' ' PRO . 22.3 t-80 -121.75 138.14 28.13 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -66.76 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.114 2.543 . . . . 0.0 114.61 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.49 130.59 73.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 68.37 118.07 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.462 1.105 . . . . 0.0 108.605 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.474 ' N ' ' HD3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER 68.09 52.5 0.57 Allowed Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.354 1.061 . . . . 0.0 109.686 -169.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.622 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 45.0 Cg_endo -94.99 162.45 1.68 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.553 2.169 . . . . 0.0 114.481 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 76.5 t 71.67 -65.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 C-N-CA 125.768 1.627 . . . . 0.0 113.829 176.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.417 ' H ' ' HD2' ' A' ' 222' ' ' PRO . 1.9 tm-20 -158.59 -52.47 0.01 OUTLIER Pre-proline 0 C--N 1.262 -3.217 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.885 -174.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' A' ' 221' ' ' GLU . 11.1 Cg_endo -56.05 138.67 83.36 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 121.728 1.618 . . . . 0.0 111.597 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.66 -86.19 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.69 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -157.24 135.97 4.67 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -82.97 97.26 8.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.114 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -169.68 162.88 9.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.1 t -86.74 84.57 7.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -142.71 177.7 21.61 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.841 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.77 173.3 9.43 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.714 2.943 . . . . 0.0 112.991 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.62 -27.34 51.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 111.511 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.05 -22.93 62.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.095 0.95 . . . . 0.0 110.265 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.478 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.9 mm? -102.31 155.03 18.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.688 -173.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -139.64 135.58 33.43 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.405 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.2 114.99 28.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.74 52.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.0 mt -93.25 109.98 21.5 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -106.3 109.43 21.35 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 66.72 22.82 10.3 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.81 1.29 . . . . 0.0 109.036 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.13 -9.84 72.18 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.542 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -89.91 130.33 36.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 122.618 -0.342 . . . . 0.0 110.419 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.42 103.52 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.816 0.817 . . . . 0.0 111.28 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 39.8 m -112.95 153.14 28.48 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.015 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.46 130.99 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -142.4 158.85 43.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.09 113.82 24.1 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -76.01 -33.26 59.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.73 150.43 26.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -69.25 124.39 23.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.128 0.49 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.47 114.1 23.78 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.4 p -88.1 147.39 24.95 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.003 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.46 126.91 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.238 0.542 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.11 -7.72 48.48 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.506 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.32 126.12 30.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -128.8 148.48 50.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -97.81 173.94 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.449 0.166 . . . . 0.0 110.984 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.28 166.53 54.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.06 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.65 130.58 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.149 2.566 . . . . 0.0 113.826 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -107.06 173.74 6.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -120.16 139.05 53.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.68 -176.09 34.85 Favored Glycine 0 N--CA 1.405 -3.37 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.741 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.4 m -126.52 143.88 51.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.2 mm -88.41 144.87 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.444 ' HG2' HD22 ' A' ' 204' ' ' LEU . 4.6 pt20 -78.25 108.32 11.48 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.914 0.864 . . . . 0.0 109.716 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 58.8 m -135.36 139.87 44.58 Favored 'General case' 0 N--CA 1.391 -3.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -87.43 92.26 9.02 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.695 0.759 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.06 11.4 37.74 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.858 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.4 tp 69.13 165.95 0.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 112.975 -1.921 . . . . 0.0 112.911 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 t -123.03 142.98 39.54 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.58 -16.91 18.7 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.127 1.885 . . . . 0.0 111.791 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.461 ' HG3' ' HG3' ' A' ' 146' ' ' ARG . 10.4 pt-20 -111.48 -38.03 5.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.766 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.461 ' HG3' ' HG3' ' A' ' 145' ' ' GLU . 60.7 mtt180 -105.08 -166.26 1.21 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.8 -150.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.97 141.97 90.05 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -68.38 -36.77 14.97 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 121.64 1.56 . . . . 0.0 112.564 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.32 -121.98 5.68 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.46 0.64 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.639 2.226 . . . . 0.0 111.044 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.03 -16.11 61.06 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.782 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.49 131.68 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 172.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.6 t -143.32 179.64 6.96 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 92.47 0.13 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.165 0.983 . . . . 0.0 110.869 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 47.6 ttm -80.07 87.71 5.43 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.94 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.31 -174.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.78 155.39 21.04 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.636 -0.825 . . . . 0.0 108.948 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.19 -21.27 66.74 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.7 t -93.01 -7.06 46.86 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.315 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.8 t -71.26 125.14 26.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 109.93 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.478 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 9.7 p-90 -61.9 -21.51 64.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 60.7 mt -62.13 -31.98 72.52 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.645 0.378 . . . . 0.0 111.593 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -85.92 -4.38 59.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -96.3 -5.31 40.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.093 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.2 mt -90.05 147.28 36.81 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.44 122.16 7.28 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 121.966 1.777 . . . . 0.0 111.205 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.14 129.13 35.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.753 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.16 146.54 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.783 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.31 -8.65 26.74 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.046 0.451 . . . . 0.0 109.925 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.9 p -104.47 134.84 46.98 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.464 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.41 -27.09 62.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.522 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.68 -25.97 68.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.985 0.914 . . . . 0.0 110.834 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.52 -38.64 12.39 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.557 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.62 135.49 52.94 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.705 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 200' ' ' LEU . 8.3 p30 -124.17 -10.71 7.56 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.254 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 m -141.61 124.36 16.04 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 188' ' ' CYS . 11.7 pt-20 -108.51 145.06 35.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.564 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 202' ' ' VAL . 2.0 mp -111.1 119.87 60.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.408 ' HH ' ' HB2' ' A' ' 226' ' ' ALA . 24.5 p90 -135.01 154.56 51.69 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -175.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.643 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -88.23 124.0 33.41 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.195 0.521 . . . . 0.0 109.989 176.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.664 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 64.5 tttp -132.94 97.98 4.17 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.2 t70 57.25 72.51 0.51 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.723 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.7 t70 73.46 -5.73 1.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.251 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -130.28 164.26 24.97 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.0 110.3 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.5 mt -98.22 134.44 41.26 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.664 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 49.7 m95 -124.72 152.73 43.39 Favored 'General case' 0 C--N 1.268 -2.949 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 50.3 t -128.89 128.88 44.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -123.69 147.34 47.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.0 t -91.15 115.57 30.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.3 p -86.42 -47.35 9.4 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.226 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -123.3 144.27 49.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.73 120.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.823 0.702 . . . . 0.0 112.473 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.2 p -114.79 120.62 37.07 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.98 162.32 41.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.378 2.052 . . . . 0.0 113.436 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.0 p -56.57 113.36 1.58 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.781 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.91 -14.05 19.62 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.91 159.12 34.01 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.657 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.52 150.15 20.66 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -114.28 153.86 28.98 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.35 142.02 50.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.462 HG23 HD11 ' A' ' 179' ' ' ILE . 5.9 p -96.6 127.68 48.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.87 0.843 . . . . 0.0 111.887 -174.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.557 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.2 ttt180 -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 173.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.444 HD22 ' HG2' ' A' ' 138' ' ' GLN . 5.7 mp -98.92 148.28 24.12 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.1 p -55.63 119.84 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 110.843 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 m -84.77 144.55 28.41 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.619 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.49 140.44 13.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.509 1.124 . . . . 0.0 111.563 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.03 93.1 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.828 2.352 . . . . 0.0 112.844 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.29 -27.14 38.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 106.07 -4.24 38.52 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -100.88 111.23 62.91 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.717 -0.742 . . . . 0.0 109.313 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.56 -15.42 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.0 1.8 . . . . 0.0 112.034 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 69.73 -70.37 0.15 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.695 1.598 . . . . 0.0 110.587 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -88.25 132.62 38.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.23 99.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.446 2.097 . . . . 0.0 112.232 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.53 19.06 2.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.433 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -68.58 -54.61 15.54 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.66 125.33 71.56 Favored Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 116.24 4.44 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.091 1.194 . . . . 0.0 112.631 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.71 0.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.681 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -114.05 134.85 22.09 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.129 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.12 104.46 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.639 2.226 . . . . 0.0 111.012 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 89.34 -51.29 3.67 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.812 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.78 -58.61 5.01 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.07 -29.24 11.01 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.408 ' HB2' ' HH ' ' A' ' 180' ' ' TYR . . . . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 N--CA 1.441 -1.594 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -116.43 153.79 31.47 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -80.51 35.73 0.35 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.021 0.928 . . . . 0.0 111.968 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.8 153.01 16.95 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.993 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.89 152.93 27.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.479 3.453 . . . . 0.0 113.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.11 -0.37 39.77 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.217 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -80.98 -13.43 58.89 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.65 160.08 24.0 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.334 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.421 ' HG3' ' HB2' ' A' ' 121' ' ' ARG . 47.7 mt-10 -130.99 139.48 50.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.664 0.269 . . . . 0.0 111.167 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.23 94.86 6.7 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 168.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.44 130.93 50.89 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.323 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -100.78 113.33 26.15 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -126.43 114.38 18.1 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 71.69 12.86 6.31 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.506 1.146 . . . . 0.0 110.228 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.61 5.04 69.51 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.063 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -94.35 118.89 32.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -73.02 105.29 4.42 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.396 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.9 121.82 42.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.497 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.23 107.17 18.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -119.84 158.89 25.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.388 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 125.65 30.83 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.452 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 8.6 tpm_? -81.63 -48.52 11.64 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.2 mt -110.72 157.18 20.04 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.2 t -76.93 112.03 13.12 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-O 121.266 0.555 . . . . 0.0 109.896 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.56 110.43 7.84 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -109.38 166.85 10.56 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.03 132.79 51.64 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.08 -31.84 4.97 Favored Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.1 tp -85.12 132.02 34.36 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -146.25 154.22 41.48 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -91.49 172.65 8.36 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.146 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.93 169.76 54.34 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -58.32 123.46 13.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.274 2.649 . . . . 0.0 112.745 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -92.16 147.73 22.71 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.16 95.95 6.19 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.823 1.297 . . . . 0.0 112.771 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.05 -155.34 10.09 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -151.82 164.26 37.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.501 1.15 . . . . 0.0 111.06 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.76 121.52 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -119.83 142.62 48.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.395 0.617 . . . . 0.0 112.14 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.426 HG22 ' OE2' ' A' ' 207' ' ' GLU . 10.4 p -94.45 87.26 5.1 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-O 122.115 0.96 . . . . 0.0 111.926 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 66.81 69.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.406 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.29 24.49 2.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.032 0.92 . . . . 0.0 108.732 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.8 tp -150.56 -54.64 0.15 Allowed 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.314 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 12.9 m -84.16 107.77 11.92 Favored Pre-proline 0 C--N 1.275 -2.646 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.469 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -96.91 -58.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.704 0 N-CA-C 117.362 2.024 . . . . 0.0 117.362 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.75 9.81 25.82 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 58.13 60.68 2.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.377 1.084 . . . . 0.0 111.196 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -101.92 -20.85 14.69 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -72.71 161.16 80.67 Favored Pre-proline 0 N--CA 1.428 -1.563 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.263 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.35 -48.99 12.36 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.896 3.064 . . . . 0.0 113.097 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.25 83.59 0.08 OUTLIER Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.39 79.63 2.94 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 122.336 2.024 . . . . 0.0 114.104 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.42 -28.91 13.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' THR . 7.9 p -146.0 139.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.474 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.9 m -140.66 144.71 35.84 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 204' ' ' LEU . 0.8 OUTLIER -90.05 147.9 23.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.742 176.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.439 ' HE2' ' HA ' ' A' ' 156' ' ' MET . 3.1 tpt -122.47 87.22 2.71 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.429 HG22 HD12 ' A' ' 155' ' ' LEU . 34.8 m -129.52 167.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.495 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.81 156.69 39.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 123.877 0.735 . . . . 0.0 109.721 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -29.98 71.23 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.31 0.644 . . . . 0.0 110.026 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.2 t -77.99 -11.96 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.58 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.98 119.09 22.35 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.62 0.724 . . . . 0.0 109.729 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -64.19 -19.99 65.7 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.128 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 73.5 mt -59.03 -31.35 68.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.696 0.398 . . . . 0.0 112.045 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -87.36 -5.11 59.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.5 mtp -89.86 -9.95 47.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.013 0.435 . . . . 0.0 110.407 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.97 149.79 46.32 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.05 118.75 5.67 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.195 1.93 . . . . 0.0 110.442 176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -81.86 124.55 29.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.355 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.03 147.09 28.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.64 1.07 17.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.673 0.749 . . . . 0.0 109.46 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 174.74 7.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.758 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HA ' ' NH1' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -95.72 -52.47 4.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.237 -177.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -71.07 -39.34 72.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.44 68.38 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.421 0.451 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.72 121.08 26.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.355 0.598 . . . . 0.0 111.339 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -106.13 -5.73 19.14 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.668 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 45.5 m -149.1 140.71 23.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 203' ' ' ARG . 16.2 pt-20 -136.63 155.5 49.83 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.07 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 21.8 mm -112.57 129.96 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.4 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 17.3 p90 -140.02 163.31 33.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.401 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -99.06 138.64 35.87 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 121.725 0.774 . . . . 0.0 110.519 177.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.587 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 65.2 tttp -145.8 114.38 6.78 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t70 66.82 25.54 9.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.195 1.398 . . . . 0.0 109.007 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 73.56 8.31 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.516 1.526 . . . . 0.0 112.442 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -102.73 152.24 21.46 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 82.6 mt -94.19 129.9 40.62 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.678 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.587 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 65.6 m95 -121.82 141.2 51.47 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.526 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 52.8 t -109.04 119.88 40.86 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -117.87 150.3 39.42 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.49 120.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 p -96.01 -32.89 12.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.774 0.321 . . . . 0.0 111.343 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.62 148.11 52.58 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.74 102.62 5.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.794 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.01 126.71 56.34 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.95 170.94 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.55 2.166 . . . . 0.0 113.036 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.8 m -60.69 127.41 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.39 0.23 82.62 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.01 158.08 23.74 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -100.32 146.79 26.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.478 HD21 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -115.57 151.16 35.42 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.623 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -123.03 133.19 54.35 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.1 p -97.4 122.81 49.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.744 0.652 . . . . 0.0 111.367 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.473 ' NH1' ' HA ' ' A' ' 172' ' ' GLU . 43.8 ttp180 -97.79 140.46 32.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.85 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.466 HD22 HD22 ' A' ' 155' ' ' LEU . 78.6 mt -107.71 127.23 53.49 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 13.0 p -64.84 133.82 29.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.643 0.735 . . . . 0.0 111.65 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 m -116.63 140.07 49.81 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -84.1 135.9 41.58 Favored Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.224 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 207' ' ' GLU . 4.9 Cg_exo -80.22 35.16 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.729 2.286 . . . . 0.0 111.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 207' ' ' GLU . 41.3 t-80 68.26 -66.39 0.23 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.256 1.823 . . . . 0.0 110.025 -176.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 177.29 127.49 1.06 Allowed Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 212' ' ' PRO . . . -64.5 -49.84 69.04 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.774 0.287 . . . . 0.0 111.316 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 211' ' ' ALA . 16.9 Cg_endo -100.43 -141.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.466 2.111 . . . . 0.0 107.196 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -66.94 -63.45 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.768 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -117.43 134.08 23.17 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -79.03 88.64 1.44 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.948 1.765 . . . . 0.0 110.672 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . 0.253 11.6 m 56.01 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 126.435 1.894 . . . . 0.0 111.806 -172.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -139.83 -70.38 0.4 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.241 -177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.489 ' HB3' ' HD3' ' A' ' 219' ' ' PRO . 40.9 tt0 -122.67 -53.94 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.825 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 218' ' ' GLU . 6.2 Cg_endo -93.07 158.93 2.64 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.283 1.322 . . . . 0.0 111.172 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.9 t 70.86 114.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.853 1.261 . . . . 0.0 112.763 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -101.1 -52.73 0.17 Allowed Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.307 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -85.86 124.67 2.63 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.458 1.439 . . . . 0.0 110.606 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.15 95.11 1.79 Allowed Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.457 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 165.81 -65.66 0.21 Allowed Glycine 0 C--N 1.297 -1.618 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.5 tp -103.98 -41.89 5.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.376 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 108.62 -1.338 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.48 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 1.1 p-90 -123.66 154.6 39.15 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.4 m -88.03 88.16 7.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.672 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.77 178.45 29.9 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.91 160.58 30.51 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.618 2.879 . . . . 0.0 112.946 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.2 -7.95 59.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.504 0.668 . . . . 0.0 111.426 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.51 -24.13 42.46 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.65 162.46 14.13 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.851 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.17 136.87 32.25 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.896 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.48 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -90.32 104.81 17.34 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.7 153.6 21.62 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.7 mt -115.54 112.3 22.01 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -105.0 104.53 14.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 64.55 19.07 11.69 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.464 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.63 -8.83 43.98 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.094 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -94.77 143.25 26.6 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -75.23 133.83 41.29 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.088 0.471 . . . . 0.0 109.874 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.08 121.37 17.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.35 106.81 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -110.05 156.43 20.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.856 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.77 122.07 40.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.335 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.16 -46.46 23.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.1 mt -101.53 139.78 36.72 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.9 t -70.65 126.98 31.11 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.84 145.8 50.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.159 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 p -93.4 150.9 20.11 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.052 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.46 124.07 23.3 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.94 60.19 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.818 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.47 122.02 15.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.0 m -131.53 138.54 48.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -92.18 169.32 10.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.45 179.83 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 123.9 0.75 . . . . 0.0 114.25 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 73.7 Cg_endo -75.44 138.45 22.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.786 2.324 . . . . 0.0 112.536 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.0 149.07 35.91 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -89.4 99.44 12.44 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.476 ' HA3' HG11 ' A' ' 157' ' ' VAL . . . -154.28 -152.44 6.1 Favored Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.7 m -150.93 134.18 16.12 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.84 134.29 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.34 97.71 2.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.563 1.173 . . . . 0.0 112.71 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.9 p -103.51 94.44 5.47 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.774 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 122.75 28.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.994 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.01 27.57 3.98 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.605 0.717 . . . . 0.0 110.489 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.95 175.83 6.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.6 t -103.78 137.48 19.25 Favored Pre-proline 0 C--N 1.283 -2.309 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.84 -9.87 24.65 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.982 1.788 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.26 -20.88 23.58 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.238 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -118.71 131.3 56.14 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.46 -78.25 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.254 0.971 . . . . 0.0 112.284 169.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.09 102.71 55.04 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 122.982 0.513 . . . . 0.0 110.098 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.03 -9.0 11.95 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.56 177.94 29.77 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.24 81.85 2.36 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 121.969 1.779 . . . . 0.0 111.762 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.49 86.02 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 108.797 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.36 120.05 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -126.43 167.3 15.76 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.75 100.0 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 122.287 1.042 . . . . 0.0 112.72 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.9 mtm -79.43 83.12 5.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.649 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.476 HG11 ' HA3' ' A' ' 135' ' ' GLY . 22.9 m -126.38 150.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.626 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.54 160.38 25.31 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.301 0.64 . . . . 0.0 111.287 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -52.82 -32.45 44.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.543 0.737 . . . . 0.0 111.67 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.0 m -85.0 9.81 13.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.199 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.539 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 48.3 t -100.1 100.24 11.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -56.43 -19.59 15.75 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.773 1.229 . . . . 0.0 113.205 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.66 -28.16 67.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.374 0.669 . . . . 0.0 111.473 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.539 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 8.6 ptm180 -85.06 -2.64 58.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.933 0.397 . . . . 0.0 110.984 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.8 mtt -93.79 -13.99 26.73 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.94 142.13 36.21 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.579 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.23 133.24 27.98 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 122.114 1.876 . . . . 0.0 110.872 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -84.97 128.77 34.77 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.187 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.66 138.33 52.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.564 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.87 -21.31 23.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 p -87.99 134.81 33.65 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.014 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.4 -17.71 31.66 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.35 -34.63 74.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.34 -15.35 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.452 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.95 118.13 19.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.106 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.41 -30.33 16.57 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.0 p -133.72 136.93 44.96 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.953 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.92 146.01 45.29 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.215 0.531 . . . . 0.0 112.019 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.9 mm -104.96 120.92 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -126.19 145.17 50.49 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptp180 -91.42 139.87 30.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -142.23 115.11 8.68 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 67.45 27.28 8.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.595 1.188 . . . . 0.0 107.879 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 68.69 4.88 4.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.054 2.142 . . . . 0.0 111.98 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -90.97 151.89 20.91 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 8.0 mp -93.58 125.76 38.37 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 120.821 0.343 . . . . 0.0 111.158 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -122.92 139.21 54.29 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.532 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.9 t -113.8 116.79 29.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -115.05 135.08 54.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.754 0.311 . . . . 0.0 110.414 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.58 126.11 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.2 p -108.13 -23.42 11.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.321 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -128.78 150.26 50.37 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.035 0.445 . . . . 0.0 111.749 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.04 125.97 37.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.56 127.85 61.46 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-O 120.704 0.287 . . . . 0.0 111.231 -171.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.15 134.06 53.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 111.462 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 18.3 m -75.91 110.06 10.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.217 0.532 . . . . 0.0 109.959 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.57 0.84 32.66 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -114.32 165.05 12.02 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 69.1 mt -101.47 155.23 18.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.218 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.506 HD21 ' H ' ' A' ' 200' ' ' LEU . 1.1 pt? -99.28 143.82 29.1 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.576 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -110.93 148.08 33.25 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.63 130.2 53.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.88 0.848 . . . . 0.0 111.291 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.494 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 69.9 ttt180 -105.18 122.25 45.51 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.699 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.61 118.65 32.69 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.539 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.84 103.98 7.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 70.6 p -102.83 145.9 29.08 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.434 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -76.27 122.77 87.41 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.24 -62.36 0.08 OUTLIER 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 121.875 1.717 . . . . 0.0 110.674 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.455 ' CG ' ' H ' ' A' ' 210' ' ' GLY . 22.5 t-80 -178.85 -169.87 0.17 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.455 ' H ' ' CG ' ' A' ' 209' ' ' HIS . . . 111.42 -107.22 2.12 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -142.04 75.17 20.92 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 116.772 0.286 . . . . 0.0 111.172 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.73 -41.99 9.81 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.639 1.559 . . . . 0.0 110.832 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.61 19.58 3.32 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 55.8 m80 75.3 132.34 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.874 1.67 . . . . 0.0 109.95 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.99 -44.49 24.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.757 1.638 . . . . 0.0 108.602 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 13.9 m -152.64 154.3 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -107.11 -54.34 2.48 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.601 0.715 . . . . 0.0 109.553 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -162.21 107.88 1.12 Allowed Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.7 118.4 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.903 1.735 . . . . 0.0 112.031 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.2 t -67.91 123.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 61.13 82.15 0.23 Allowed Pre-proline 0 C--O 1.22 -0.461 0 O-C-N 124.373 1.045 . . . . 0.0 110.411 -171.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.65 105.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.336 1.357 . . . . 0.0 110.395 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -81.01 88.32 1.36 Allowed Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.047 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.19 9.07 59.35 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -127.71 164.95 20.98 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.13 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 N--CA 1.438 -1.771 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.437 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.3 OUTLIER -122.49 149.6 43.67 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 m -102.53 100.11 10.18 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.507 -0.746 . . . . 0.0 109.534 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.39 -174.59 22.37 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.5 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.53 163.66 26.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.463 2.775 . . . . 0.0 111.825 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.12 -15.64 55.34 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.188 0.518 . . . . 0.0 111.604 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.95 -15.91 60.66 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.41 151.38 26.74 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.416 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.83 123.77 12.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.207 0.527 . . . . 0.0 111.898 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.46 109.92 20.42 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.12 142.45 47.42 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 56.5 mt -102.2 127.87 48.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -124.09 94.32 4.18 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 60.93 25.92 15.86 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.414 0.626 . . . . 0.0 111.364 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.19 -8.31 38.29 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 74.7 mt-30 -81.39 126.52 31.72 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -86.77 95.92 10.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.2 p -111.44 122.93 49.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.514 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.22 111.14 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -110.37 156.47 20.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.56 133.11 34.08 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -83.04 -32.35 26.9 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.13 169.5 9.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -92.23 105.38 17.61 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.88 124.46 32.38 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.15 0.5 . . . . 0.0 110.858 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -72.24 151.39 42.89 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.739 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.95 140.76 56.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.96 10.39 58.74 Favored Glycine 0 C--N 1.299 -1.501 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.608 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.0 tp -101.34 126.5 48.11 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t -122.53 158.78 29.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -95.69 174.4 6.99 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.662 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.97 177.93 49.5 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 124.209 0.943 . . . . 0.0 112.166 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.02 132.12 20.72 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.711 2.274 . . . . 0.0 114.039 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -110.39 149.71 29.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -106.04 119.32 38.89 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.627 0.727 . . . . 0.0 111.236 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.408 ' C ' ' HG ' ' A' ' 136' ' ' SER . . . -170.87 -160.62 19.83 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 135' ' ' GLY . 34.9 m -148.51 134.63 19.27 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 118.397 1.099 . . . . 0.0 111.089 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.6 113.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.92 105.87 14.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -62.76 138.47 58.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.035 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 142' ' ' LEU . 48.8 ttp85 65.45 -86.9 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.738 1.215 . . . . 0.0 111.174 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 50.26 22.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.441 1.096 . . . . 0.0 112.348 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.505 ' H ' ' HG2' ' A' ' 140' ' ' ARG . 14.7 tp -70.18 156.51 39.12 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 124.581 1.152 . . . . 0.0 108.448 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.6 m -115.42 105.38 52.32 Favored Pre-proline 0 N--CA 1.42 -1.946 0 C-N-CA 118.826 -1.149 . . . . 0.0 113.481 -175.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.417 ' HD2' ' OE1' ' A' ' 145' ' ' GLU . 0.9 OUTLIER -95.51 -7.78 1.47 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.901 2.401 . . . . 0.0 110.462 166.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' OE1' ' HD2' ' A' ' 144' ' ' PRO . 14.7 mp0 -107.33 -44.33 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -94.22 179.9 5.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.853 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -68.76 -14.01 62.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.625 1.17 . . . . 0.0 113.94 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 73.6 113.6 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.553 1.141 . . . . 0.0 108.384 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.66 7.64 4.12 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.636 2.224 . . . . 0.0 112.947 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.9 -111.39 3.86 Favored Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 213' ' ' ARG . 36.6 Cg_endo -69.41 105.74 1.48 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 110.335 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.2 -47.41 35.7 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.509 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 206' ' ' THR . 40.2 t -75.35 117.72 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 m -125.1 136.21 53.43 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 104.91 16.39 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.159 0.981 . . . . 0.0 109.053 172.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.78 87.93 6.32 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.892 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -128.95 168.96 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.703 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.12 148.19 22.6 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.255 1.022 . . . . 0.0 111.455 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.4 -20.03 65.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.343 0.592 . . . . 0.0 110.581 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 m -83.03 -20.43 35.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.063 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.4 t -74.35 131.36 41.05 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.52 0.676 . . . . 0.0 111.295 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.438 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 13.6 p-90 -66.16 -20.49 66.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.012 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.45 -30.28 71.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.699 0.285 . . . . 0.0 111.487 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -96.4 2.24 52.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.622 . . . . 0.0 110.467 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mmm -99.02 -1.64 39.25 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.199 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 83.2 mt -93.61 145.54 30.12 Favored Pre-proline 0 N--CA 1.425 -1.716 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.96 127.71 11.69 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.441 1.427 . . . . 0.0 109.883 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -84.13 135.22 34.48 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.439 ' CG2' ' HB1' ' A' ' 175' ' ' ALA . 27.1 m -135.47 160.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.3 pp -105.28 -19.52 13.78 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.794 0.807 . . . . 0.0 110.876 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.8 133.86 33.96 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.42 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -76.99 -21.57 54.5 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.139 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -67.53 -25.57 65.89 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.3 -38.61 8.79 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.59 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -76.86 94.41 3.89 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 121.395 0.616 . . . . 0.0 111.109 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -87.04 -13.9 43.05 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.451 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 m -126.88 124.51 39.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.33 150.33 37.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.1 mm -110.05 125.0 67.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.575 ' CE1' ' HG3' ' A' ' 189' ' ' ARG . 11.9 p90 -126.74 176.02 7.56 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.12 140.1 52.5 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 183' ' ' ASP . 24.0 ttpp -156.37 132.05 9.59 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 4.1 m-20 60.32 34.66 20.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.315 0.646 . . . . 0.0 110.805 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 t70 67.62 17.49 9.91 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.436 1.495 . . . . 0.0 111.856 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -126.28 162.17 26.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.197 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.1 mt -97.18 140.4 31.73 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -134.0 153.08 52.02 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -125.88 128.13 47.12 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.602 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.575 ' HG3' ' CE1' ' A' ' 180' ' ' TYR . 51.4 mtp180 -103.44 145.52 29.88 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.96 100.41 11.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 166.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.8 t -82.41 -26.04 33.15 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.61 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.45 141.49 45.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.01 125.19 12.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 123.794 0.684 . . . . 0.0 111.715 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 7.5 p -110.67 114.85 54.34 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 11.1 Cg_exo -72.08 153.6 57.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.466 2.111 . . . . 0.0 112.565 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 p -61.46 115.84 4.21 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.464 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.66 -15.49 45.27 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -81.47 157.58 38.51 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.74 157.06 16.63 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.339 0.59 . . . . 0.0 110.377 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -127.81 157.1 41.34 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.107 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -134.85 148.02 50.03 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.39 133.44 46.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.54 0.686 . . . . 0.0 112.215 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.461 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 27.2 ttt180 -117.39 147.76 42.37 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.09 153.0 33.51 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 206' ' ' THR . 7.4 p -62.66 114.28 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.425 ' O ' HG11 ' A' ' 153' ' ' VAL . 91.7 m 71.55 91.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -164.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -83.13 150.73 61.82 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.815 -172.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.87 103.34 1.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.378 2.052 . . . . 0.0 111.613 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -107.76 159.8 16.21 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.068 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.15 -51.66 0.73 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -163.8 95.22 1.03 Allowed Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 123.879 0.872 . . . . 0.0 108.771 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.41 35.57 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.075 2.517 . . . . 0.0 112.903 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 4.3 ptm180 -80.28 128.97 34.16 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.38 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -88.58 127.25 57.2 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.75 118.81 5.76 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.452 2.101 . . . . 0.0 111.789 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.53 -25.96 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.842 0.829 . . . . 0.0 108.989 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -131.59 119.79 21.96 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.39 131.31 62.21 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.63 119.29 6.3 Favored 'Trans proline' 0 C--O 1.253 1.238 0 C-N-CA 122.856 2.37 . . . . 0.0 112.151 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -102.43 107.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.32 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.57 142.71 77.96 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.1 139.72 85.77 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.852 2.368 . . . . 0.0 112.312 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -80.01 -78.89 0.88 Allowed Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.593 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.47 4.98 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 111.731 -0.547 . . . . 0.0 111.731 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 -38.42 71.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.372 0.606 . . . . 0.0 109.584 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--O 1.243 0.756 0 N-CA-C 108.828 -1.258 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 178.09 -179.94 0.3 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 m -96.97 91.64 5.7 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.32 -173.11 29.55 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.044 -1.075 . . . . 0.0 112.176 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -83.14 158.55 15.3 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.287 2.658 . . . . 0.0 112.567 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.07 -19.05 63.29 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.719 0.808 . . . . 0.0 111.837 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -80.21 -22.34 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.096 0.95 . . . . 0.0 109.5 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' CD1' HD21 ' A' ' 200' ' ' LEU . 4.3 mm? -108.4 160.47 15.85 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.266 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 12.8 tp10 -155.71 147.26 22.9 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.772 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.446 ' HB2' ' CG ' ' A' ' 101' ' ' TRP . 1.3 tm? -99.38 103.55 15.35 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.1 146.42 23.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.45 104.62 13.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.43 99.4 8.98 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.57 23.38 11.76 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.213 1.005 . . . . 0.0 111.485 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.16 57.36 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.448 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.37 143.16 26.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.99 0.424 . . . . 0.0 111.475 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -82.98 134.17 35.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.844 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.7 m -131.84 121.53 24.25 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 166' ' ' LEU . 19.8 m -86.47 96.2 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.378 1.085 . . . . 0.0 110.602 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -114.02 158.89 20.59 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.372 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.23 18.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 77.7 ttt180 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.9 mt -119.99 155.53 32.66 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.417 ' HB2' ' OG ' ' A' ' 196' ' ' SER . 47.3 t -77.04 123.92 27.04 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.93 121.99 18.43 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.513 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.6 m -90.62 139.77 30.4 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.872 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.68 120.46 10.09 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.12 16.05 Favored Glycine 0 C--N 1.301 -1.381 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.241 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -64.04 126.88 29.11 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -136.69 145.68 45.02 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -91.72 175.05 7.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.62 -172.46 45.45 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.314 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.99 123.19 6.11 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.208 1.939 . . . . 0.0 112.49 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -103.81 150.39 24.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -104.41 107.13 17.9 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.774 0.797 . . . . 0.0 110.495 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.67 177.49 43.74 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.4 p -129.11 133.55 47.7 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 119.231 1.516 . . . . 0.0 113.127 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.6 mt -110.1 95.52 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -89.66 98.81 11.98 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.878 -172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.5 t -71.79 142.41 49.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -143.65 89.02 2.03 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.165 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.53 90.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.515 ' HG ' ' H ' ' A' ' 143' ' ' SER . 17.6 tp -119.07 -144.27 0.37 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.515 ' H ' ' HG ' ' A' ' 142' ' ' LEU . 18.8 m -68.25 124.56 90.04 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.62 -42.73 42.02 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.794 2.996 . . . . 0.0 113.95 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.39 -20.09 63.82 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.491 ' NH1' ' HB2' ' A' ' 148' ' ' GLU . 7.0 ttt180 62.87 -76.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.101 1.36 . . . . 0.0 112.121 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 177.38 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -171.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HB2' ' NH1' ' A' ' 146' ' ' ARG . 44.8 mt-10 -139.12 157.41 71.26 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.66 -17.8 53.0 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.788 2.325 . . . . 0.0 111.891 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.58 142.21 45.21 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.502 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.91 113.5 3.78 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.876 2.384 . . . . 0.0 113.489 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.58 -7.65 56.06 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.965 0.888 . . . . 0.0 109.148 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.403 ' C ' ' HG1' ' A' ' 154' ' ' THR . 5.7 p -89.32 126.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 153' ' ' VAL . 60.7 m -151.18 146.78 26.34 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -80.53 142.7 33.91 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.5 mmm -116.42 94.57 4.68 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.35 171.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.022 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.16 147.82 38.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 123.613 0.571 . . . . 0.0 110.473 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.26 -33.27 67.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 111.228 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -100.26 12.78 36.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.652 0.263 . . . . 0.0 111.155 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.52 132.97 36.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -65.05 -23.21 67.12 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.06 -25.52 68.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.104 0.478 . . . . 0.0 112.199 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.04 3.17 55.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 mmt -96.47 -22.63 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.405 ' HA ' HG23 ' A' ' 118' ' ' VAL . 9.9 mp -88.35 153.05 50.76 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.99 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.27 129.69 16.38 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.588 2.192 . . . . 0.0 111.61 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -82.51 138.13 34.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.99 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 29.3 m -140.54 157.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 98.2 mt -115.53 -6.15 12.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 118.204 0.456 . . . . 0.0 112.106 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.8 p -87.85 151.34 22.92 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.393 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.19 -23.68 35.35 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.598 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -69.98 -39.06 76.15 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.433 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.58 -33.36 23.41 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.966 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.617 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -84.84 99.7 11.08 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-O 121.366 0.603 . . . . 0.0 112.499 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.427 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 5.6 p30 -74.76 -19.58 60.16 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.187 175.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.9 p -131.45 142.89 50.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.85 141.14 48.28 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.686 HD13 ' SG ' ' A' ' 188' ' ' CYS . 9.4 mm -110.36 126.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -130.94 177.7 7.23 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -122.27 146.13 47.58 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.227 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.8 129.65 13.35 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.95 25.66 13.97 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.464 1.126 . . . . 0.0 109.401 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 69.36 13.63 8.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.331 1.452 . . . . 0.0 112.267 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.56 156.05 21.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.0 mt -93.6 135.26 35.05 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.219 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -126.32 139.57 53.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 179' ' ' ILE . 53.1 m -116.46 123.49 47.63 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -124.83 148.11 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.725 0.298 . . . . 0.0 110.331 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 67.1 t -98.06 121.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.0 p -114.25 -21.89 10.22 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.427 ' CG ' ' HA ' ' A' ' 176' ' ' ASN . 64.6 mmtt -125.76 161.69 26.79 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.7 131.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.684 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.7 120.39 43.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.74 140.78 52.26 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.604 2.203 . . . . 0.0 111.791 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.417 ' OG ' ' HB2' ' A' ' 123' ' ' SER . 7.5 m -63.38 114.71 4.02 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.29 -16.57 35.12 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.695 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.83 159.53 38.07 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.876 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.74 125.27 35.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.499 HD21 ' CD1' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -98.62 163.39 12.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.366 -178.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -121.41 144.95 48.39 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.933 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.08 121.97 52.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.187 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.617 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.1 ttm180 -100.4 137.12 39.25 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 66.0 mt -96.55 145.97 25.24 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.22 121.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.938 0.875 . . . . 0.0 112.075 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.2 p -90.62 178.5 6.06 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.37 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.12 124.49 90.92 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.856 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 120.56 7.4 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.639 2.226 . . . . 0.0 113.213 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -110.68 -4.25 15.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 93.04 -60.24 2.33 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -147.96 134.31 9.87 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.25 -28.53 79.24 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.22 1.946 . . . . 0.0 112.207 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -117.92 99.46 6.93 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 49.35 82.07 0.25 Allowed Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 124.845 1.258 . . . . 0.0 114.331 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.54 -42.14 0.96 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.988 1.792 . . . . 0.0 112.651 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 40.0 t 58.96 67.77 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 122.146 0.974 . . . . 0.0 109.437 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.98 -17.43 3.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.387 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -153.71 114.6 2.61 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.98 118.28 4.97 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 121.557 1.505 . . . . 0.0 110.148 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.61 107.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.803 0.811 . . . . 0.0 110.256 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.82 -49.97 0.37 Allowed Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -58.0 130.72 39.61 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.789 1.66 . . . . 0.0 111.158 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 134.86 17.06 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.364 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 102.36 -3.78 50.93 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.762 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mp -101.41 172.0 7.24 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.509 -0.406 . . . . 0.0 111.572 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.264 1.83 0 C-N-CA 125.458 1.503 . . . . 0.0 111.54 -178.215 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.441 -1.573 0 N-CA-C 109.158 -1.132 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.404 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -157.71 162.06 38.56 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.8 t -89.82 96.15 10.56 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.02 -171.25 32.9 Favored Glycine 0 N--CA 1.42 -2.424 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.738 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.83 162.21 12.06 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.245 2.63 . . . . 0.0 111.597 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.28 -16.92 51.14 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.567 0.699 . . . . 0.0 110.539 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.36 -26.41 62.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.173 0.987 . . . . 0.0 109.368 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 1.6 mm? -94.37 156.88 16.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.808 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.44 134.34 37.61 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.185 0.517 . . . . 0.0 111.846 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.3 122.71 42.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.63 151.23 49.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.95 97.7 7.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 11.5 mm100 -109.44 132.88 53.71 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 66.61 12.89 9.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 123.766 0.666 . . . . 0.0 110.916 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.39 22.62 62.26 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.968 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.7 pt20 -133.09 167.98 19.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -75.1 120.0 20.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 38.1 t -122.16 146.57 47.11 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.81 120.06 63.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.294 0.568 . . . . 0.0 110.197 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -129.46 152.73 48.68 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.921 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.24 109.1 20.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -72.11 -48.9 40.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.3 mt -89.13 129.19 35.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.7 m -67.57 126.2 28.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.6 mt -97.99 133.86 41.89 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 -173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.7 t -99.12 161.53 13.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.501 0.501 . . . . 0.0 110.205 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.95 128.87 37.87 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.214 0.606 . . . . 0.0 110.863 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.81 63.7 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.721 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.87 130.69 42.95 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -135.67 160.03 39.8 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.992 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -99.72 175.24 5.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.07 176.13 51.73 Favored Glycine 0 N--CA 1.441 -0.981 0 O-C-N 123.605 0.566 . . . . 0.0 112.56 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.47 123.38 10.14 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.669 2.246 . . . . 0.0 113.496 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.65 149.95 22.27 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.99 105.71 15.88 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.689 0.757 . . . . 0.0 112.335 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.73 8.23 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 p -145.5 138.78 26.34 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.583 0.692 . . . . 0.0 111.82 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mt -138.76 96.61 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.15 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.66 98.63 10.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.369 1.081 . . . . 0.0 109.912 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.3 p -86.16 109.98 19.26 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.182 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -115.02 -78.56 0.58 Allowed 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 52.39 30.17 7.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.044 0.938 . . . . 0.0 112.027 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.0 tp -108.17 103.39 12.57 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.8 p -123.34 105.82 33.49 Favored Pre-proline 0 N--CA 1.421 -1.897 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.962 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.46 -28.52 17.75 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.14 2.56 . . . . 0.0 111.057 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -8.79 54.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.099 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.99 30.41 19.59 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.972 0.909 . . . . 0.0 112.044 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.32 -28.13 69.8 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.189 0.519 . . . . 0.0 111.084 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.521 ' OE2' ' HA ' ' A' ' 152' ' ' ALA . 26.7 tt0 -154.5 92.72 2.92 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 174.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 73.04 5.47 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 123.163 2.575 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.9 -162.87 30.18 Favored Glycine 0 C--N 1.28 -2.58 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.218 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.33 88.44 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 121.779 1.653 . . . . 0.0 111.486 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.521 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . . . -62.85 -45.98 90.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.913 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.15 126.0 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.7 p -98.1 172.92 7.3 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.916 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.07 137.91 58.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.355 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.9 mtt -109.01 94.69 5.18 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.86 179.0 3.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.361 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.75 140.26 57.62 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 123.473 0.483 . . . . 0.0 111.284 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -51.72 -36.69 47.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.326 1.05 . . . . 0.0 113.399 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -103.6 9.97 37.15 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.819 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.517 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 41.0 t -78.68 137.31 37.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.154 0.502 . . . . 0.0 110.206 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.425 ' O ' HD11 ' A' ' 166' ' ' LEU . 9.1 p-90 -60.96 -27.11 68.01 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.517 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.3 mt -56.98 -32.49 66.14 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.088 0.47 . . . . 0.0 112.088 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.64 -1.17 47.3 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.586 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.4 mtp -95.52 -6.22 41.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 162' ' ' TRP . 8.8 mp -94.73 141.62 23.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.18 122.5 10.99 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.348 2.032 . . . . 0.0 111.389 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -79.26 127.84 32.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.21 156.46 23.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -83.68 -39.89 19.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.385 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.7 p -91.72 155.59 18.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.493 0.663 . . . . 0.0 112.532 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -87.23 -16.97 33.68 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.469 -177.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.9 -26.96 36.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.399 0.619 . . . . 0.0 109.426 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.37 -31.99 22.65 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.71 143.58 37.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 200' ' ' LEU . 16.1 p30 -118.43 2.08 11.81 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.4 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.2 p -151.31 135.72 16.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 15.8 pt-20 -129.0 149.87 50.65 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.038 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 24.1 mm -109.52 116.36 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -122.67 157.77 31.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -102.16 144.3 30.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.2 tttm -161.71 125.55 3.24 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 65.46 32.73 9.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.127 0.971 . . . . 0.0 111.148 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.1 t70 75.0 9.36 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.378 1.085 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.05 162.25 22.77 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.532 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.68 137.26 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.5 m95 -123.57 133.99 53.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -106.8 126.82 52.79 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -127.39 147.35 50.28 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.436 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.14 115.12 25.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.003 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.8 p -80.83 -33.7 34.46 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -146.3 152.72 39.61 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.1 129.82 20.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 123.994 0.809 . . . . 0.0 111.697 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.59 125.2 36.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.69 164.3 16.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.127 2.551 . . . . 0.0 113.34 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.1 m -66.97 101.45 0.85 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.466 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.31 16.8 52.42 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.37 156.86 35.9 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 mp -95.13 141.09 29.16 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.502 0.668 . . . . 0.0 111.093 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' A' ' 176' ' ' ASN . 3.2 mp -95.65 149.16 21.76 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.029 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.03 131.67 44.45 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.92 134.44 42.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.46 0.648 . . . . 0.0 111.612 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 43.9 ttt180 -104.61 142.05 35.34 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.912 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.86 139.83 32.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.0 p -59.14 144.17 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.687 0.617 . . . . 0.0 110.821 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 t -97.26 148.48 23.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.65 116.22 65.79 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.13 122.47 11.51 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.216 2.611 . . . . 0.0 111.647 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -92.29 -58.06 2.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.324 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -111.84 79.84 0.26 Allowed Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.015 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -119.03 95.98 49.79 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.24 -52.76 2.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.717 2.278 . . . . 0.0 112.495 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -110.21 125.8 53.45 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.444 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -117.94 117.68 35.25 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.75 166.96 16.53 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.409 2.073 . . . . 0.0 112.088 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 52.5 t -74.6 122.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.93 -27.32 9.3 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.433 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.09 117.63 59.94 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -67.14 144.95 71.26 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 121.863 1.709 . . . . 0.0 110.929 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.27 123.56 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.352 0.596 . . . . 0.0 109.435 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.91 113.65 57.82 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.499 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -83.88 33.1 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.932 2.421 . . . . 0.0 110.617 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.96 36.63 40.85 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.1 134.93 12.15 Favored Glycine 0 N--CA 1.423 -2.171 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.262 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.44 -26.97 41.69 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.837 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.234 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.446 -1.276 0 N-CA-C 112.379 0.107 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.478 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 0.5 OUTLIER -134.31 161.94 33.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 m -91.58 82.42 5.31 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.61 160.69 14.39 Favored Glycine 0 N--CA 1.419 -2.453 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.96 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.535 ' HB2' ' OE1' ' A' ' 106' ' ' GLU . 60.7 Cg_endo -84.18 166.47 12.66 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.961 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -63.26 -19.36 64.5 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.801 0.84 . . . . 0.0 113.002 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.535 ' OE1' ' HB2' ' A' ' 104' ' ' PRO . 23.7 mp0 -82.44 -17.99 43.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.611 0.72 . . . . 0.0 110.142 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.9 156.2 24.39 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.018 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.494 ' OE2' ' HD2' ' A' ' 119' ' ' ARG . 33.0 tt0 -141.59 126.27 17.96 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.813 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.18 108.72 20.85 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.24 154.59 50.87 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.769 0.319 . . . . 0.0 110.234 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.9 mp -91.99 101.29 13.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 121.879 0.847 . . . . 0.0 110.167 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.52 ' HB3' ' SG ' ' A' ' 117' ' ' CYS . 50.7 tt0 -106.17 124.62 49.87 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 113.795 -1.548 . . . . 0.0 106.998 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 69.67 12.35 8.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.67 1.224 . . . . 0.0 109.677 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.25 2.23 60.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.024 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 43.8 mt-30 -114.65 146.38 40.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 117.393 0.596 . . . . 0.0 110.147 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -75.86 119.94 20.53 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 112' ' ' GLN . 9.4 p -138.28 149.38 45.65 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.861 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.41 111.15 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.494 ' HD2' ' OE2' ' A' ' 108' ' ' GLU . 3.4 ptp180 -116.69 158.65 23.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.96 124.8 28.6 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -77.26 -33.97 55.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.68 0.753 . . . . 0.0 109.587 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 pp -127.01 155.74 42.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -66.25 113.87 4.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.717 0.77 . . . . 0.0 111.734 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -79.64 138.66 37.47 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 t -127.19 159.04 35.5 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.83 125.28 22.34 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 124.03 0.831 . . . . 0.0 110.053 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.02 36.03 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.055 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.8 t -129.13 151.77 49.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -96.66 173.86 7.11 Favored 'General case' 0 C--N 1.267 -3.015 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.815 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.5 175.71 54.83 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.8 Cg_endo -69.25 129.93 19.04 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.737 2.292 . . . . 0.0 113.279 -177.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -107.28 160.44 15.61 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.96 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.86 132.64 34.78 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.743 0.782 . . . . 0.0 112.031 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.417 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 162.18 -177.62 38.3 Favored Glycine 0 N--CA 1.414 -2.81 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -144.91 129.48 18.02 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 117.414 0.607 . . . . 0.0 111.597 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.3 mt -94.82 97.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.88 134.44 44.83 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.594 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.2 m -67.15 113.49 5.14 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -123.92 39.65 3.91 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.81 73.42 9.98 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.633 0.73 . . . . 0.0 109.274 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.6 mt -146.78 172.32 13.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.433 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.3 t -103.79 135.19 19.4 Favored Pre-proline 0 N--CA 1.415 -2.223 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -87.63 -156.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.546 2.164 . . . . 0.0 110.419 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -85.64 -6.67 59.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.978 0.894 . . . . 0.0 109.682 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -96.52 176.37 6.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.133 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.77 -55.1 4.27 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -88.78 121.36 69.93 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.959 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.52 -40.67 1.02 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 121.394 1.396 . . . . 0.0 109.591 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.6 -153.76 37.24 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.17 71.99 6.44 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.397 2.065 . . . . 0.0 109.46 172.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.71 -20.88 49.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.161 -176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.92 120.04 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.3 m -120.45 138.23 53.91 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.339 -172.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.89 91.48 8.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 122.238 1.018 . . . . 0.0 110.274 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.1 mtp -87.03 82.67 7.67 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.39 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.417 HG12 ' HA3' ' A' ' 135' ' ' GLY . 32.8 m -105.04 177.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.309 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 161' ' ' CYS . 10.7 t70 -49.37 141.48 8.83 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.089 0.868 . . . . 0.0 110.971 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.57 -20.51 47.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.8 m -114.35 7.37 16.36 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.061 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.2 t -69.76 129.22 38.99 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.949 0.404 . . . . 0.0 109.919 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.462 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.8 p-90 -56.08 -27.93 55.59 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.437 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.9 mt -60.86 -32.76 72.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.825 0.45 . . . . 0.0 112.012 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -93.05 -0.96 57.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.931 -176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.478 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 22.6 ptm -110.56 5.97 21.56 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.552 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 88.7 mt -81.6 143.84 51.69 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.25 126.05 13.17 Favored 'Trans proline' 0 C--O 1.253 1.266 0 C-N-CA 121.722 1.615 . . . . 0.0 109.839 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -87.52 139.78 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 0.0 111.864 -174.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 152.27 32.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.584 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.3 tp -97.15 -8.36 30.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.673 0.749 . . . . 0.0 109.766 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.8 p -106.71 134.81 49.28 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.4 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.452 ' HB3' ' NE ' ' A' ' 203' ' ' ARG . 10.9 pt-20 -77.73 -21.73 51.43 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.855 -0.528 . . . . 0.0 111.332 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.55 -28.98 67.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.151 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.59 -10.98 49.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.966 0.412 . . . . 0.0 110.79 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.405 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -87.37 158.02 19.12 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.957 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 200' ' ' LEU . 95.4 m-20 -122.16 -24.73 5.04 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.215 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.5 p -130.24 130.98 45.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.24 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.78 123.29 45.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.303 0.573 . . . . 0.0 110.247 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 202' ' ' VAL . 1.8 mp -108.44 123.81 64.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.879 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -143.22 169.52 17.47 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.542 HH21 ' HG2' ' A' ' 207' ' ' GLU . 38.2 ptt180 -106.19 139.15 41.14 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.9 tttp -138.22 122.66 18.38 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.78 26.41 12.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.824 1.297 . . . . 0.0 107.958 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.86 67.78 0.88 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.319 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -159.49 158.22 31.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 4.3 mm? -93.33 129.37 39.47 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.518 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -129.36 150.18 50.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.3 t -135.46 114.35 12.05 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -103.64 138.9 39.66 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.44 120.15 28.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 t -105.0 -1.0 26.29 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -139.69 176.51 8.67 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.55 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.5 t -112.12 112.06 52.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.57 140.61 57.59 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 121.867 1.712 . . . . 0.0 111.094 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.1 p -54.16 124.98 17.35 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.418 0.627 . . . . 0.0 111.411 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.5 -16.93 44.0 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.487 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.42 162.4 30.63 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.98 168.24 10.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.39 0.614 . . . . 0.0 111.304 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.443 ' HA ' HD21 ' A' ' 176' ' ' ASN . 1.2 pt? -132.8 149.09 52.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.471 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.44 147.06 43.97 Favored 'General case' 0 C--O 1.253 1.287 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 179' ' ' ILE . 5.1 p -96.79 128.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.838 0.828 . . . . 0.0 112.949 -173.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.452 ' NE ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 tpt180 -100.4 112.72 25.1 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.489 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.73 116.35 22.64 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -80.71 104.49 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.2 t -65.45 164.31 14.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.111 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.542 ' HG2' HH21 ' A' ' 181' ' ' ARG . 7.1 tp10 -116.65 104.28 51.54 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.74 142.15 31.73 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.147 1.898 . . . . 0.0 110.842 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -104.09 -54.51 2.54 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.757 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -96.38 -62.59 0.95 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.568 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -95.47 115.24 65.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 122.088 0.155 . . . . 0.0 110.775 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.15 99.3 0.78 Allowed 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.759 2.306 . . . . 0.0 112.008 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 61.24 -95.53 0.05 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.025 1.33 . . . . 0.0 112.259 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -149.33 118.54 3.9 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.24 164.32 17.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.761 1.641 . . . . 0.0 110.033 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.19 6.39 10.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 62.02 59.85 1.61 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.889 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.476 ' HB2' ' HD3' ' A' ' 219' ' ' PRO . 1.9 mp0 -51.97 -50.39 78.6 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.383 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 218' ' ' GLU . 5.2 Cg_exo -82.73 117.97 2.73 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.102 -1.538 . . . . 0.0 108.102 168.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.78 -11.77 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.053 0.93 . . . . 0.0 111.199 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.77 116.55 64.01 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.422 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.8 163.32 37.73 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.552 2.168 . . . . 0.0 111.944 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -83.64 53.04 4.81 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -130.13 170.98 20.63 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 94.0 mt -79.78 -57.27 3.74 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 117.721 0.761 . . . . 0.0 110.511 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.236 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 CA-C-O 119.925 -0.114 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -168.14 169.55 10.94 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 m -107.36 90.12 3.21 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.62 -176.94 20.84 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 158.04 40.0 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.93 2.42 . . . . 0.0 111.993 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.47 -16.75 57.2 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.257 1.023 . . . . 0.0 111.307 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.4 ' HA ' HD13 ' A' ' 122' ' ' LEU . 11.0 mp0 -75.65 -20.33 58.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.446 1.117 . . . . 0.0 108.232 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.93 159.78 16.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.042 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HG2' ' HB2' ' A' ' 121' ' ' ARG . 24.8 mm-40 -137.09 132.04 33.56 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.962 0.505 . . . . 0.0 111.23 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 3.1 tm? -88.49 99.07 12.0 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 170.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.16 144.55 43.5 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.509 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.0 mp -97.09 126.89 42.56 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.347 0.594 . . . . 0.0 110.781 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.86 92.23 4.08 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 36.16 73.22 0.09 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 126.392 1.877 . . . . 0.0 114.08 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.57 -18.7 56.89 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.06 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 85.0 mm-40 -112.27 123.59 50.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.871 0.836 . . . . 0.0 112.005 -177.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -79.41 123.22 27.31 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.9 p -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.947 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.68 111.9 21.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.404 ' HB3' HD23 ' A' ' 199' ' ' LEU . 15.2 ptp180 -127.06 157.16 40.37 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.239 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.11 121.19 17.03 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.0 ttt180 -86.12 -52.5 5.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 106' ' ' GLU . 9.3 mp -94.36 153.25 18.08 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.6 m -76.9 110.89 11.89 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.401 ' HB3' HG13 ' A' ' 190' ' ' VAL . 3.8 mm? -70.4 117.84 12.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.0 p -96.29 158.67 15.33 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.628 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.05 128.95 36.06 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 124.712 1.205 . . . . 0.0 111.698 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.83 -18.97 54.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.248 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.65 129.99 41.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 m -136.48 161.73 35.04 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -107.71 176.23 5.22 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.501 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.6 -171.63 39.67 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.985 0.803 . . . . 0.0 112.744 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.24 125.09 7.58 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.795 2.33 . . . . 0.0 113.827 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -102.3 168.55 9.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -106.34 135.58 47.59 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 120.955 0.407 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.78 179.21 31.58 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.2 m -139.03 146.05 40.36 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 117.902 0.851 . . . . 0.0 111.474 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.9 mt -108.66 132.91 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -91.68 98.73 11.81 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.428 0.455 . . . . 0.0 109.788 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.9 p -75.91 119.87 20.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.348 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 69.03 90.2 0.1 Allowed 'General case' 0 C--O 1.242 0.669 0 O-C-N 124.529 1.143 . . . . 0.0 109.389 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.25 166.95 23.36 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt 56.04 -150.63 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 O-C-N 124.062 0.851 . . . . 0.0 110.399 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -125.65 106.13 26.71 Favored Pre-proline 0 N--CA 1.417 -2.119 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -97.42 -17.47 0.24 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.829 2.353 . . . . 0.0 112.845 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -91.02 -23.28 20.42 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.765 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -139.12 147.19 41.6 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 67.77 159.82 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.118 0.886 . . . . 0.0 112.957 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -129.78 93.42 34.51 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.43 -21.91 8.51 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.204 1.936 . . . . 0.0 110.487 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 131.6 -126.5 4.73 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.82 118.17 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.869 1.713 . . . . 0.0 109.452 173.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.64 59.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.44 137.92 20.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 m -113.38 138.96 49.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 155' ' ' LEU . 2.3 pp -108.73 135.94 49.12 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.952 0.406 . . . . 0.0 110.498 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.88 85.81 2.28 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.84 157.8 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.08 148.36 26.68 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 123.856 0.722 . . . . 0.0 112.374 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.13 -43.98 64.28 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.598 1.159 . . . . 0.0 112.014 -175.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.9 m -90.04 11.34 20.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.48 127.37 32.71 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 18.8 p-90 -60.18 -27.29 67.01 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.0 mt -63.08 -25.7 68.49 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -95.44 1.13 53.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.409 0.623 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.85 -7.01 55.26 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.502 0.668 . . . . 0.0 109.758 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.28 144.36 27.76 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.06 131.37 19.27 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 122.046 1.831 . . . . 0.0 111.212 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.27 135.25 39.64 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.51 133.88 65.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.56 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -68.28 -38.16 81.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.289 177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -86.48 134.94 33.64 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.211 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -28.43 62.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.044 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -69.44 -22.83 63.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.416 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.1 0.94 56.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.069 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.75 152.84 21.37 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -114.44 -16.03 11.99 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.424 0.63 . . . . 0.0 109.979 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.0 p -145.23 128.23 16.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.234 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.24 141.29 37.83 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.47 HD13 HG23 ' A' ' 202' ' ' VAL . 1.6 mp -116.7 116.72 53.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.446 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 52.5 p90 -115.73 159.85 20.85 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -100.94 138.56 37.82 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -157.59 132.85 8.9 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 67.35 20.88 9.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.157 0.983 . . . . 0.0 108.864 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 70.03 13.57 7.84 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.143 1.777 . . . . 0.0 111.822 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -112.8 164.73 13.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.92 136.62 41.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.419 ' O ' ' HA ' ' A' ' 179' ' ' ILE . 77.6 m95 -124.54 125.59 44.45 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.671 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.4 t -104.03 124.46 49.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -125.53 138.94 53.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 124' ' ' LEU . 49.0 t -90.35 122.03 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.6 p -110.31 3.19 19.65 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.105 0.479 . . . . 0.0 112.166 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -131.11 169.92 15.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.51 108.06 20.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.34 111.03 64.84 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.27 153.6 66.44 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.288 1.992 . . . . 0.0 111.296 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -65.22 126.33 27.83 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.81 -17.23 49.83 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.91 159.41 31.45 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.784 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 119' ' ' ARG . 47.3 mt -95.12 165.47 12.4 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.4 0.619 . . . . 0.0 109.757 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 200' ' ' LEU . 1.2 pt? -134.46 146.01 49.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.967 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.75 151.11 32.4 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.47 HG23 HD13 ' A' ' 179' ' ' ILE . 7.7 p -99.72 129.81 49.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 O-C-N 123.855 0.722 . . . . 0.0 112.183 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -119.28 128.91 54.59 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.17 154.78 19.88 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 11.2 p -44.05 142.28 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.481 0.712 . . . . 0.0 112.432 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.6 p -80.43 -172.01 3.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.287 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -57.85 154.85 25.56 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 123.932 0.893 . . . . 0.0 108.887 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.65 -33.7 10.33 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.694 2.929 . . . . 0.0 113.947 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -131.05 83.76 2.13 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -154.65 47.68 0.52 Allowed Glycine 0 CA--C 1.492 -1.356 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.913 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 174.81 128.92 0.12 Allowed Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 125.229 1.411 . . . . 0.0 107.402 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -71.61 -50.62 0.28 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 121.34 1.36 . . . . 0.0 108.899 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 175.4 151.61 0.12 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -96.9 138.99 21.32 Favored Pre-proline 0 C--N 1.287 -2.13 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.204 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -37.06 98.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.619 1 C-N-CA 125.684 4.256 . . . . 0.0 116.23 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.03 101.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.125 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -71.13 88.71 0.81 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -62.7 -50.98 75.39 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.786 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.02 120.59 8.0 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 N-CA-C 107.317 -1.84 . . . . 0.0 107.317 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.45 -0.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.198 0.999 . . . . 0.0 110.358 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.7 120.91 81.87 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.57 115.12 2.46 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.589 2.193 . . . . 0.0 111.651 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -125.19 -51.33 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.873 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -113.36 99.92 1.04 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.68 170.21 8.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.321 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.444 -1.413 0 N-CA-C 112.437 0.13 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.408 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 8.4 p-90 -106.04 0.98 26.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 62.35 75.84 0.39 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.982 0.896 . . . . 0.0 111.739 -176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.84 174.78 27.46 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.96 161.7 38.45 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -76.46 -0.79 24.21 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -88.65 -24.76 22.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.157 0.979 . . . . 0.0 108.642 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.516 HD22 ' CZ2' ' A' ' 130' ' ' TRP . 3.2 mm? -96.09 168.21 10.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.376 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.584 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 29.4 tt0 -150.38 128.16 11.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.6 tm? -93.02 118.61 31.38 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.41 135.75 55.03 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.74 101.94 10.43 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.46 119.34 38.86 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 67.83 18.4 9.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.813 1.292 . . . . 0.0 109.935 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.52 -4.35 79.67 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.451 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -114.53 174.9 5.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.243 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.54 136.55 34.22 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.016 0.436 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 43.7 t -147.18 148.45 31.54 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.56 130.72 74.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.584 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -133.87 168.98 17.76 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.843 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.5 120.02 36.05 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -81.71 -40.08 23.3 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.49 145.66 24.64 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.0 m -66.06 118.17 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.94 105.35 6.93 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.7 p -82.7 154.05 25.03 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.916 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.78 124.44 21.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.62 -10.83 57.78 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.649 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.402 ' C ' ' HG ' ' A' ' 129' ' ' SER . 42.5 tp -75.42 143.54 42.65 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 128' ' ' LEU . 24.2 m -150.76 171.53 17.04 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.516 ' CZ2' HD22 ' A' ' 107' ' ' LEU . 27.2 m-90 -113.93 166.43 11.6 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.29 -177.47 33.9 Favored Glycine 0 N--CA 1.436 -1.33 0 O-C-N 123.817 0.698 . . . . 0.0 113.228 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.68 133.26 23.48 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 122.879 2.386 . . . . 0.0 112.627 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.01 152.45 24.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.81 120.71 37.65 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.42 -168.09 41.0 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.4 p -147.62 135.42 21.07 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 80.2 mt -88.01 101.23 11.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -95.38 98.07 10.29 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.8 m -86.74 149.09 25.12 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.1 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.7 37.75 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.92 0.867 . . . . 0.0 109.402 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -93.86 11.89 27.83 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.6 0.714 . . . . 0.0 111.946 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.1 tp -155.49 152.4 28.88 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.0 m -60.46 133.53 91.13 Favored Pre-proline 0 CA--C 1.555 1.157 0 O-C-N 123.911 0.757 . . . . 0.0 109.71 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.97 -19.58 32.95 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 124.441 3.427 . . . . 0.0 116.705 -170.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.81 -14.72 29.33 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 110.088 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 77.8 mtp180 -104.26 159.82 15.39 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.53 -175.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 146' ' ' ARG . 13.4 mt-10 -179.88 78.66 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.095 2.158 . . . . 0.0 109.57 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 4.4 mp0 -107.55 -58.46 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.922 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 148' ' ' GLU . 2.2 Cg_endo -83.19 9.26 4.17 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.364 2.043 . . . . 0.0 112.155 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.51 -168.06 29.75 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.64 168.44 17.85 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.466 2.111 . . . . 0.0 111.344 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.16 60.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.605 0.717 . . . . 0.0 109.376 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.1 p -101.71 117.48 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 170.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.2 m -121.59 136.26 54.96 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.921 -0.487 . . . . 0.0 110.996 -173.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.01 101.01 11.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.977 0.894 . . . . 0.0 110.607 174.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.6 mmm -88.01 96.07 10.37 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.2 170.1 20.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.56 168.74 19.32 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.83 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -59.21 -34.46 72.19 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 124.192 0.997 . . . . 0.0 112.273 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.0 p -95.54 7.69 45.52 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.6 t -82.45 124.53 30.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.002 0.429 . . . . 0.0 110.013 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -61.37 -22.13 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.668 0.787 . . . . 0.0 112.78 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.55 -32.68 72.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.623 0.369 . . . . 0.0 111.957 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -93.84 2.72 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.924 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mtp -97.1 1.25 49.78 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.11 151.02 37.33 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.88 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.58 124.54 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.277 1.984 . . . . 0.0 110.052 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -81.8 138.8 35.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.44 ' CG2' ' HB1' ' A' ' 175' ' ' ALA . 21.1 m -136.74 148.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.168 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.05 -13.28 17.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.68 0.753 . . . . 0.0 109.114 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -98.77 134.91 40.99 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.636 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.73 -5.3 59.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.417 0.627 . . . . 0.0 110.358 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.04 -29.08 64.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.616 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.04 -26.45 13.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.103 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.87 110.86 18.71 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.812 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -82.89 -25.08 32.82 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.327 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.8 m -127.82 145.5 50.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.39 145.38 50.27 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -102.99 120.64 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -134.0 163.86 28.6 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.564 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -104.58 123.71 48.03 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 40.8 ttmt -118.39 95.73 5.0 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.4 t70 59.02 72.13 0.55 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.962 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 t70 76.37 -27.97 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.119 -1.401 . . . . 0.0 113.998 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -100.36 151.85 21.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.305 -0.247 . . . . 0.0 111.063 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -93.58 128.46 39.74 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.531 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -122.14 138.05 54.6 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.96 124.32 52.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -125.24 147.19 49.19 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.61 118.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.5 p -101.61 -31.89 10.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.207 0.527 . . . . 0.0 110.89 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.26 141.87 51.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.72 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.339 0.59 . . . . 0.0 111.999 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 10.4 p -119.06 126.9 26.81 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.2 170.84 14.97 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.619 2.213 . . . . 0.0 113.448 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.1 m -59.77 121.82 12.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.558 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.42 -6.8 57.83 Favored Glycine 0 N--CA 1.436 -1.349 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.248 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.9 153.07 44.97 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.52 138.84 31.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.427 HD22 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -106.04 159.35 16.13 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.104 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -134.45 143.3 47.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.11 117.87 42.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.598 0.713 . . . . 0.0 111.187 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.465 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.5 ttt180 -93.06 124.77 37.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.513 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.82 109.65 20.37 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.88 133.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.977 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.7 t -161.64 177.61 9.82 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -63.94 122.0 74.62 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.1 124.83 16.5 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.583 2.188 . . . . 0.0 110.956 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -74.4 -55.69 5.7 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.292 0.568 . . . . 0.0 109.529 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.37 90.06 0.74 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.329 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 214' ' ' HIS . . . -142.68 123.87 8.45 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -35.54 -57.48 0.49 Allowed 'Trans proline' 0 C--N 1.364 1.354 1 C-N-CA 125.383 4.055 . . . . 0.0 114.653 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -115.72 54.84 0.8 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.71 0.767 . . . . 0.0 111.85 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 211' ' ' ALA . 52.2 t-80 -71.33 -48.46 12.82 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.067 172.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.42 82.95 2.33 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 121.423 1.415 . . . . 0.0 111.549 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.19 94.13 4.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.97 -50.13 6.2 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.909 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.41 105.43 1.35 Allowed Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.52 117.92 4.73 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.116 1.878 . . . . 0.0 110.492 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.406 HG22 HD12 ' A' ' 225' ' ' LEU . 34.8 m -92.36 161.06 2.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.246 0.546 . . . . 0.0 112.209 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -96.2 -47.34 0.25 Allowed Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.989 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.05 129.66 36.53 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.002 1.802 . . . . 0.0 112.744 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -90.7 -10.27 63.43 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -82.2 77.44 2.08 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.406 HD12 HG22 ' A' ' 220' ' ' VAL . 87.6 mt -123.98 89.75 3.14 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.722 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.73 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.442 -1.554 0 N-CA-C 109.185 -1.121 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.7 163.74 34.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.454 ' HB2' ' O ' ' A' ' 160' ' ' SER . 19.8 m -88.33 77.91 8.08 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.463 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.28 158.56 27.73 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.259 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.36 162.4 38.43 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.278 2.652 . . . . 0.0 111.977 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.91 -0.04 37.4 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.54 -20.37 50.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.424 HD11 HD23 ' A' ' 200' ' ' LEU . 3.7 mm? -109.78 151.96 26.31 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.215 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -127.32 141.92 51.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.49 122.03 40.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.04 54.58 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.913 0.387 . . . . 0.0 110.59 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.57 104.56 14.41 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -106.25 94.38 5.13 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.777 0.799 . . . . 0.0 109.409 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.37 59.17 4.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.043 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.94 -22.18 19.62 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.962 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.82 128.85 35.34 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.449 -0.442 . . . . 0.0 111.86 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -82.54 113.71 20.45 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.544 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.7 p -122.28 144.86 48.73 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 17.8 m -107.68 125.42 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.19 0.519 . . . . 0.0 109.704 -177.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -138.65 150.75 46.56 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.02 127.77 34.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.57 -34.05 14.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.52 0.676 . . . . 0.0 109.795 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.27 163.67 12.42 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.1 m -88.71 128.47 35.61 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.512 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.2 mm? -90.27 127.81 36.25 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.2 p -112.22 158.9 19.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.05 118.76 8.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.978 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.21 -0.49 55.99 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.371 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.3 tp -82.38 139.7 33.92 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 74.3 p -144.67 157.36 44.23 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.02 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.604 ' HB2' ' SG ' ' A' ' 188' ' ' CYS . 26.3 m-90 -103.76 175.1 5.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.84 -165.66 37.74 Favored Glycine 0 C--N 1.307 -1.052 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.079 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -79.46 123.32 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.187 1.925 . . . . 0.0 112.85 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.549 ' HE2' ' SG ' ' A' ' 188' ' ' CYS . 78.8 m-85 -98.84 159.09 15.2 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.62 104.22 14.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.351 1.072 . . . . 0.0 112.122 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.53 171.49 44.06 Favored Glycine 0 N--CA 1.409 -3.165 0 N-CA-C 106.785 -2.526 . . . . 0.0 106.785 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.7 m -132.46 137.78 47.36 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 118.096 0.948 . . . . 0.0 112.011 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 77.3 mt -86.49 116.62 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.24 111.82 23.58 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.705 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -96.96 102.96 14.84 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -78.92 3.17 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.36 13.75 7.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.035 1.334 . . . . 0.0 112.582 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp -108.45 -0.66 20.39 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.331 1.062 . . . . 0.0 109.036 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 m -106.28 107.85 60.65 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -96.84 -176.45 0.3 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.03 1.82 . . . . 0.0 111.167 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.477 ' OE1' ' HA ' ' A' ' 209' ' ' HIS . 45.5 mt-10 -103.35 -9.68 19.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.57 -7.98 59.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.067 0.937 . . . . 0.0 109.138 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -134.0 153.11 52.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.248 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.95 97.11 32.77 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.55 -0.3 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.536 2.157 . . . . 0.0 112.724 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.23 -146.16 27.48 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.27 52.1 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.737 2.958 . . . . 0.0 112.507 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.62 -17.16 59.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.06 132.92 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.6 m -125.1 141.15 52.29 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.065 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 155' ' ' LEU . 1.6 pp -104.76 112.12 25.1 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 111.561 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.42 89.78 8.12 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.61 177.59 2.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.504 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.0 144.34 57.36 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.706 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -57.03 -29.68 63.58 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.259 1.023 . . . . 0.0 113.457 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 102' ' ' SER . 22.0 t -102.15 -3.33 27.62 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 122.099 -0.376 . . . . 0.0 110.278 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.6 t -65.88 119.86 12.05 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.514 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.4 p-90 -53.03 -26.89 17.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.315 1.046 . . . . 0.0 113.654 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.03 -30.83 66.44 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.156 0.582 . . . . 0.0 111.85 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -94.53 -7.35 41.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.89 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 162' ' ' TRP . 22.8 ptm -102.27 1.28 35.57 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.263 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 86.9 mt -82.69 152.8 67.11 Favored Pre-proline 0 N--CA 1.423 -1.795 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.31 118.08 5.48 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.304 1.336 . . . . 0.0 110.376 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.68 132.07 35.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.037 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.05 164.46 23.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.509 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.3 tp -100.87 -31.3 11.22 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.355 0.598 . . . . 0.0 109.518 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.4 p -88.98 134.99 33.79 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.671 0.748 . . . . 0.0 112.09 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -17.46 62.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.673 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.06 -32.77 63.44 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.399 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.76 -37.22 30.77 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.55 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.501 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -71.89 148.95 45.6 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.406 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -121.12 -10.03 9.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.057 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.0 m -152.8 136.96 16.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 203' ' ' ARG . 10.7 pt-20 -116.61 143.41 45.65 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.795 0.331 . . . . 0.0 111.588 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.0 mm -102.03 122.99 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -131.68 160.06 36.53 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.55 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.6 tttt -144.03 118.52 9.7 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 64.9 26.71 12.83 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.829 0.823 . . . . 0.0 109.528 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.1 t70 71.21 -1.93 2.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.264 1.826 . . . . 0.0 111.969 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -90.75 155.74 18.58 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 71.9 mt -94.07 128.49 40.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.763 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 62.5 m95 -124.75 139.34 53.94 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 130' ' ' TRP . 4.9 p -121.67 128.45 51.87 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -118.13 144.84 45.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.326 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 62.1 t -86.38 120.71 36.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.6 p -86.23 -45.39 11.34 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.398 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -136.29 151.84 50.07 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 120.807 0.337 . . . . 0.0 111.663 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 49.2 t -64.29 128.7 27.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.795 -172.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.64 117.67 22.75 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.82 165.61 32.3 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.482 2.122 . . . . 0.0 112.917 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 7.9 m -60.65 129.49 41.78 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.892 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.85 -17.58 48.83 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.32 150.36 23.57 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.693 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 11.1 mp -89.01 146.6 24.76 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.455 ' N ' HD21 ' A' ' 200' ' ' LEU . 0.9 OUTLIER -125.05 146.73 49.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.075 0.464 . . . . 0.0 110.402 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -113.76 144.25 43.28 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.772 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.64 133.63 41.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.975 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.501 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 71.6 ttt180 -108.15 137.96 45.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.45 153.95 18.8 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.3 p -42.62 119.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 122.463 1.125 . . . . 0.0 112.527 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.4 m -106.04 103.93 13.52 Favored 'General case' 0 N--CA 1.396 -3.152 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -60.16 124.27 76.72 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.52 43.41 0.91 Allowed 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.246 2.631 . . . . 0.0 112.755 -175.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.477 ' HA ' ' OE1' ' A' ' 145' ' ' GLU . 78.0 m-70 70.77 102.79 0.06 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.106 1.363 . . . . 0.0 111.009 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -91.69 -47.52 3.42 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.621 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.0 14.32 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.92 -30.21 92.5 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.468 2.112 . . . . 0.0 114.509 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -84.35 -1.62 55.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.515 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -125.02 161.48 49.04 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.48 129.03 27.94 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.663 1.575 . . . . 0.0 110.411 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.33 -35.7 3.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.716 0.77 . . . . 0.0 109.676 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -95.43 20.68 9.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 122.082 0.944 . . . . 0.0 110.551 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . 0.545 ' OE1' ' HD2' ' A' ' 219' ' ' PRO . 7.1 tp10 -154.39 138.97 11.51 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.545 ' HD2' ' OE1' ' A' ' 218' ' ' GLU . 40.1 Cg_endo -67.39 158.15 58.39 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.833 1.688 . . . . 0.0 112.179 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.27 82.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.23 1.014 . . . . 0.0 109.962 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.83 -52.86 1.56 Allowed Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.235 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.84 168.01 18.1 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 121.205 1.27 . . . . 0.0 111.942 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.09 -137.47 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 112.61 -137.66 14.41 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 -29.12 9.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.045 0.45 . . . . 0.0 110.034 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.438 -1.784 0 N-CA-C 108.952 -1.211 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 1.4 p-90 -159.42 8.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.457 0.473 . . . . 0.0 111.291 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.0 m 58.95 41.1 21.66 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.981 0.912 . . . . 0.0 111.495 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.45 -169.38 22.83 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.266 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -85.81 175.65 5.82 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.122 2.548 . . . . 0.0 112.569 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.1 -19.45 43.6 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.22 0.533 . . . . 0.0 111.81 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -82.96 -16.96 45.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.781 0.801 . . . . 0.0 109.586 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.401 ' CD1' HD23 ' A' ' 200' ' ' LEU . 4.1 mm? -121.8 152.94 38.96 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.242 -174.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.5 140.7 33.55 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.021 0.439 . . . . 0.0 111.158 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.56 99.01 11.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.06 130.25 50.13 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.6 mt -90.31 112.15 23.61 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.21 97.16 7.01 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 64.27 27.5 13.83 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.087 1.422 . . . . 0.0 109.024 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.46 -11.42 68.68 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.826 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -81.84 130.45 35.07 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -79.64 101.5 8.39 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.73 0.776 . . . . 0.0 110.115 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.8 m -110.14 122.61 48.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.556 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.91 100.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -122.26 146.55 47.18 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.765 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.76 140.35 49.45 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 121' ' ' ARG . 4.5 mmp_? -93.36 -36.74 12.36 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.35 155.95 26.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 m -75.07 105.21 5.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 96.8 mt -70.4 117.04 11.44 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -92.86 147.27 22.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.833 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.81 129.48 39.93 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.617 0.722 . . . . 0.0 111.083 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.96 -20.24 22.14 Favored Glycine 0 C--N 1.301 -1.361 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.807 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.72 125.55 27.14 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 m -134.29 149.93 50.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -92.14 175.24 6.93 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.173 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.28 150.67 48.93 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.929 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.12 127.34 25.32 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.199 2.599 . . . . 0.0 111.912 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CD2' HD12 ' A' ' 163' ' ' LEU . 55.9 m-85 -98.14 153.27 18.56 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.707 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -93.82 116.02 28.46 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.731 0.644 . . . . 0.0 110.024 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.46 45.31 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.8 m -144.58 134.73 24.14 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 117.682 0.741 . . . . 0.0 110.745 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.7 mt -84.6 102.73 10.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -103.89 111.16 23.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -167.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.9 m -71.48 130.57 41.6 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 167.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -129.98 171.41 12.81 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.196 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.44 85.28 5.24 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.29 152.7 0.31 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.593 1.957 . . . . 0.0 105.85 170.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 p -109.59 110.08 59.72 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.362 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 17.0 Cg_exo -68.74 -10.68 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.795 2.33 . . . . 0.0 111.67 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.31 -12.16 47.37 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.443 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -155.95 -33.73 0.09 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.49 -67.87 0.62 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 144' ' ' PRO . 18.6 mm-40 -120.72 99.72 47.14 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.9 67.76 3.94 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.345 2.697 . . . . 0.0 112.409 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -162.35 -170.49 27.22 Favored Glycine 0 C--N 1.286 -2.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.846 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.83 81.92 2.07 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.336 2.691 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.52 -40.6 7.76 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.774 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.94 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 t -164.32 179.83 6.55 Favored 'General case' 0 N--CA 1.421 -1.884 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.242 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.94 131.92 33.96 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.809 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 59.8 ttp -87.87 92.94 9.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.43 173.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.164 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.21 152.99 40.85 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.471 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.76 -24.22 65.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -91.98 10.52 28.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.871 0.367 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.95 111.14 21.15 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 25.4 p-90 -57.97 -21.02 42.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 113.385 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 133' ' ' PHE . 70.8 mt -59.45 -30.74 68.72 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.089 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -96.59 2.4 52.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.195 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 mmt -83.94 -21.32 31.86 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.65 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.06 150.82 65.73 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.467 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 27.3 Cg_exo -63.31 127.16 19.34 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 121.787 1.658 . . . . 0.0 108.967 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -88.43 139.88 30.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.68 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' CG2' ' HB3' ' A' ' 175' ' ' ALA . 23.5 m -131.2 158.24 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.669 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 82.3 mt -101.96 -26.12 13.53 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.087 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.3 p -87.08 156.04 19.89 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.347 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 13.6 pt-20 -94.27 -19.31 20.81 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.799 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -51.8 -45.45 63.86 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.716 0.807 . . . . 0.0 111.173 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -88.47 -14.61 37.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.647 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.42 ' HB3' ' CG2' ' A' ' 169' ' ' VAL . . . -88.78 115.34 26.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.568 0.699 . . . . 0.0 111.126 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.19 -15.84 22.99 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-O 121.855 0.836 . . . . 0.0 109.295 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.5 m -139.28 146.58 40.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.31 155.47 48.55 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 122.584 0.353 . . . . 0.0 110.271 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.0 mm -112.92 123.57 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -128.15 149.36 50.46 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptt180 -97.24 133.14 42.26 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.097 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.71 126.68 15.45 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 58.72 30.22 19.67 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.393 1.058 . . . . 0.0 110.209 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.8 t70 76.49 -8.96 1.56 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.285 1.434 . . . . 0.0 112.601 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -93.05 154.03 18.35 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.0 mt -93.79 126.16 38.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.959 0.409 . . . . 0.0 110.081 -179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -116.28 124.43 50.16 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.389 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.89 110.96 23.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.01 144.82 39.52 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.74 113.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 173.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 t -80.63 -34.45 35.01 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.831 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -148.59 160.18 43.37 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 122.358 -0.214 . . . . 0.0 110.669 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 40.6 t -72.03 123.16 25.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 124.262 0.976 . . . . 0.0 112.716 -171.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 5.9 p -114.18 120.7 37.97 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.53 158.25 54.05 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.015 2.477 . . . . 0.0 113.526 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.3 m -59.38 113.8 2.36 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.749 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.4 -22.95 14.44 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.942 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.99 152.13 43.46 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.6 155.76 16.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.428 ' N ' HD21 ' A' ' 200' ' ' LEU . 1.2 pt? -140.1 147.02 39.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.544 0.688 . . . . 0.0 111.22 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 5.8 m-85 -106.46 154.63 20.55 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.776 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.68 130.66 61.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.039 0.447 . . . . 0.0 110.266 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.415 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 22.5 ttp180 -102.54 139.68 37.82 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.104 -0.372 . . . . 0.0 110.43 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.86 134.71 38.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.8 p -42.44 111.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.4 p -98.2 111.4 23.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.185 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 151.35 87.78 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.7 43.35 1.47 Allowed 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 123.389 2.726 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 67.35 77.89 0.26 Allowed 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.004 1.322 . . . . 0.0 108.008 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -99.74 -28.7 7.3 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.487 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -142.72 110.19 5.66 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.4 -49.29 7.82 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.302 2.002 . . . . 0.0 109.547 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -125.3 105.26 8.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -58.49 -53.49 65.67 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.79 121.24 8.12 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 121.066 1.177 . . . . 0.0 110.336 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.3 87.73 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 122.863 1.316 . . . . 0.0 111.17 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.504 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.9 tt0 -138.45 136.76 36.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -95.08 109.44 44.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.708 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 217' ' ' GLN . 3.7 Cg_exo -77.79 130.17 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.07 84.4 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.843 0.83 . . . . 0.0 111.168 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.62 122.52 62.37 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.52 11.62 1.83 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.058 2.505 . . . . 0.0 114.735 -172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.5 -70.35 3.19 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.135 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 164.21 -170.87 39.59 Favored Glycine 0 N--CA 1.419 -2.453 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 pp -141.56 142.9 33.51 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 122.859 0.464 . . . . 0.0 109.792 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.564 0 CA-C-O 118.585 -0.722 . . . . 0.0 109.819 -177.068 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.453 -0.864 0 N-CA-C 108.919 -1.223 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.526 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 8.3 p-90 -99.26 -46.75 5.43 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.344 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 162' ' ' TRP . 5.6 t -174.86 178.25 1.87 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.96 -41.45 8.68 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.41 115.47 2.47 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.758 2.779 . . . . 0.0 114.653 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -77.37 -3.04 38.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.674 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.0 mp0 -87.22 -14.75 40.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.965 0.888 . . . . 0.0 109.163 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.31 164.5 15.11 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.114 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -144.55 135.84 25.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.36 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -85.9 130.46 34.54 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.38 132.33 56.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.77 0.319 . . . . 0.0 110.328 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.0 mt -108.5 113.56 26.69 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.96 106.58 14.6 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 65.8 23.94 11.42 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.591 0.71 . . . . 0.0 110.675 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.47 78.8 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.868 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -82.35 121.27 26.48 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -72.38 118.1 14.86 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.393 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.58 161.14 37.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.57 129.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.894 0.378 . . . . 0.0 110.256 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -125.57 140.82 52.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.584 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.69 119.81 25.68 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 8.3 ptm180 -75.34 -35.15 61.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.603 0.716 . . . . 0.0 111.285 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -122.5 176.59 5.82 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.5 m -83.22 110.46 18.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.911 0.386 . . . . 0.0 110.479 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.8 mt -82.36 132.55 35.22 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -119.4 165.24 14.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.62 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -62.35 117.69 6.47 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 124.171 0.988 . . . . 0.0 109.943 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.12 -21.82 7.28 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.326 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.5 tp -77.07 129.18 35.71 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -142.55 156.92 45.17 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.614 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -105.4 169.92 8.18 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.73 -174.09 38.83 Favored Glycine 0 N--CA 1.436 -1.329 0 O-C-N 123.898 0.749 . . . . 0.0 113.213 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.22 123.61 7.89 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.524 2.149 . . . . 0.0 113.375 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.411 ' CD2' HD12 ' A' ' 163' ' ' LEU . 67.8 m-85 -97.06 134.47 40.37 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -86.94 96.21 10.17 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.724 0.773 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -166.42 171.21 41.34 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.2 m -133.27 138.59 46.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 118.555 1.178 . . . . 0.0 112.957 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.74 99.55 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -91.79 106.84 18.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.1 p -82.85 123.34 29.28 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.995 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.5 HH22 ' HB2' ' A' ' 148' ' ' GLU . 30.9 ttp85 -113.9 30.32 7.35 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.81 76.53 5.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.262 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.488 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 63.9 tp -156.98 111.41 2.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -87.96 107.32 15.35 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 123.609 0.568 . . . . 0.0 109.934 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 142' ' ' LEU . 2.8 Cg_exo -76.38 -75.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.259 1.973 . . . . 0.0 110.332 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -110.61 -9.01 14.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.119 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -148.79 155.48 41.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.75 -55.26 5.81 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.541 0.526 . . . . 0.0 109.742 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.5 ' HB2' HH22 ' A' ' 140' ' ' ARG . 31.9 mt-10 63.48 81.71 0.22 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.481 1.112 . . . . 0.0 111.301 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.13 41.38 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.688 3.592 . . . . 0.0 113.286 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -123.67 -112.33 2.02 Favored Glycine 0 C--N 1.283 -2.383 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -68.91 47.13 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.81 3.007 . . . . 0.0 113.83 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -38.67 62.16 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.9 t -126.27 121.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.2 p -126.74 131.77 51.26 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.164 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 155' ' ' LEU . 1.4 pp -98.28 127.93 44.46 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.317 0.579 . . . . 0.0 111.124 175.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 ttm -108.9 98.12 7.65 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 135' ' ' GLY . 34.3 m -139.25 164.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.859 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.72 156.39 39.06 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -50.43 -45.09 55.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.246 1.018 . . . . 0.0 110.996 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.6 t -85.78 8.72 18.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.612 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 39.0 t -89.14 96.71 10.83 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 102' ' ' SER . 5.9 p-90 -48.54 -17.79 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.558 1.943 . . . . 0.0 115.157 -173.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 133' ' ' PHE . 48.2 mt -61.12 -30.28 70.28 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.979 0.418 . . . . 0.0 110.001 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.4 ptm180 -83.83 -10.33 58.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 59.8 mtt -89.68 -15.82 31.76 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 50.2 mt -82.99 133.68 47.92 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.78 131.59 22.99 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 121.619 1.546 . . . . 0.0 111.177 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -84.2 131.63 34.74 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 156.95 35.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.52 -2.49 30.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.44 0.638 . . . . 0.0 110.025 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.5 p -108.16 150.2 27.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.767 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.09 -5.44 57.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.06 -36.19 69.5 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.482 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.85 -28.36 14.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.197 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.546 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -74.88 111.72 10.37 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.76 -20.57 18.76 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.248 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 11.4 p -130.16 130.23 44.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.394 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.04 146.02 46.28 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.8 119.73 61.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.44 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 34.5 p90 -113.33 148.51 35.55 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -96.62 138.71 33.79 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -163.13 118.48 1.73 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.324 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.61 56.36 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 124.686 1.241 . . . . 0.0 111.635 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 62.83 16.26 8.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.686 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -137.76 170.64 15.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.13 137.85 51.77 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -120.98 128.75 53.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.7 t -101.2 123.83 45.94 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.425 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -121.6 143.18 49.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.29 104.74 11.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 170.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.8 t -87.14 -26.31 23.67 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.341 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -141.15 145.83 36.23 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.78 120.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 4.4 p -112.14 117.48 47.72 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 21.8 Cg_exo -66.38 167.36 18.85 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.589 2.193 . . . . 0.0 113.188 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.2 m -64.71 129.48 39.96 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.585 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.95 71.13 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.766 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.31 154.54 21.48 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.916 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.6 mt -91.86 145.64 24.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -119.54 144.81 46.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.923 0.392 . . . . 0.0 110.71 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.54 151.84 34.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 177' ' ' SER . 12.0 p -106.99 139.52 28.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.288 0.566 . . . . 0.0 111.069 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 31.6 ttp85 -115.74 134.23 55.23 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.67 152.08 18.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 8.6 p -73.28 76.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 123.075 1.416 . . . . 0.0 112.989 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 205' ' ' VAL . 41.4 m -160.79 137.42 8.73 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.788 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -96.19 146.04 30.62 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.76 -38.86 78.05 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.966 2.444 . . . . 0.0 111.072 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -151.68 -48.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 50.85 57.34 Favored Glycine 0 CA--C 1.488 -1.604 0 CA-C-N 113.585 -1.643 . . . . 0.0 114.613 170.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.27 114.9 29.33 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.76 -5.26 16.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.0 113.17 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -113.95 150.85 33.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -103.11 139.13 19.83 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -19.78 66.16 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.035 2.49 . . . . 0.0 113.058 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 12.3 m -97.65 88.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 111.721 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -86.96 -42.55 13.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 65.21 135.7 0.04 OUTLIER Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 126.18 1.792 . . . . 0.0 115.238 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.57 151.15 41.44 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.801 2.334 . . . . 0.0 110.767 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.429 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 31.0 m -104.07 164.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -102.62 99.6 13.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 4.1 Cg_exo -75.54 101.36 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.627 2.218 . . . . 0.0 112.367 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.86 -9.55 65.91 Favored Glycine 0 C--O 1.22 -0.757 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.792 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.67 -77.7 0.24 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.47 148.9 26.69 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.445 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.212 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -102.19 90.04 3.79 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.26 174.26 22.59 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.527 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.05 166.51 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.214 2.609 . . . . 0.0 112.348 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 43.2 mm-40 -75.58 -10.53 59.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.032 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.1 -20.65 34.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.903 0.858 . . . . 0.0 109.464 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.17 162.69 15.18 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.85 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -148.5 132.78 17.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.081 0.467 . . . . 0.0 111.478 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.7 tm? -95.39 112.68 24.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.94 135.56 49.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 82.2 mt -101.78 101.74 12.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.585 0.707 . . . . 0.0 109.139 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -115.17 104.86 12.26 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.366 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.6 13.78 4.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.206 1.402 . . . . 0.0 110.38 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 -6.82 56.09 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.353 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.3 tt0 -85.21 137.92 32.69 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -88.66 109.29 20.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.734 0.646 . . . . 0.0 109.273 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.2 121.7 45.9 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.695 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 166' ' ' LEU . 16.0 m -89.26 97.05 6.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.883 0.849 . . . . 0.0 110.287 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -113.19 153.25 28.61 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.035 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.89 122.06 18.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 42.2 ttt180 -84.23 -50.6 7.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.17 173.9 7.0 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 m -89.36 108.56 19.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.9 mm? -74.98 110.07 8.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.094 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 p -83.17 134.61 34.97 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.109 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.88 123.6 14.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.009 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.77 -24.38 13.31 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.752 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.93 146.33 49.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.4 m -144.69 164.86 29.7 Favored 'General case' 0 C--N 1.283 -2.309 0 O-C-N 121.971 -0.456 . . . . 0.0 110.152 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -110.39 169.62 8.62 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.91 176.09 53.28 Favored Glycine 0 N--CA 1.433 -1.559 0 O-C-N 123.795 0.684 . . . . 0.0 111.905 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 51.1 Cg_endo -67.02 144.56 70.37 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 122.768 2.312 . . . . 0.0 113.187 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.32 154.49 32.24 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.26 127.9 46.44 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.91 0.862 . . . . 0.0 112.479 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.49 -157.78 30.25 Favored Glycine 0 N--CA 1.405 -3.405 0 N-CA-C 106.383 -2.687 . . . . 0.0 106.383 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.5 t -158.15 167.84 28.7 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 118.313 1.056 . . . . 0.0 108.807 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.277 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 155' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.415 -2.182 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.3 mtp -101.56 87.57 3.21 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.21 165.98 28.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -52.56 140.36 23.13 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 124.143 0.902 . . . . 0.0 109.89 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 43.4 mt-10 -65.4 -14.4 60.82 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.21 -14.12 22.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 53.2 t -64.66 133.41 52.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.491 0.663 . . . . 0.0 111.848 -174.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -58.72 -25.2 62.7 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.663 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.6 mt -59.28 -32.21 69.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.078 0.466 . . . . 0.0 111.39 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ptm180 -96.72 1.42 50.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.0 111.245 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 96.2 mmm -91.55 -20.09 22.06 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 118' ' ' VAL . 10.4 mp -85.43 146.84 45.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.953 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.53 134.61 36.18 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.265 1.977 . . . . 0.0 110.291 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.73 136.29 33.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 30.7 m -136.02 154.4 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.67 -10.89 17.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.516 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.9 p -94.93 169.03 10.42 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.654 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -95.59 -33.91 12.21 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.899 0.88 . . . . 0.0 111.242 -176.081 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 5.2 mm-40 -66.91 -38.83 86.97 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.67 -30.26 32.77 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.276 0.56 . . . . 0.0 109.892 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 203' ' ' ARG . . . -79.97 119.87 23.4 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-O 121.416 0.627 . . . . 0.0 111.223 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -104.37 -6.1 21.09 Favored 'General case' 0 C--N 1.27 -2.855 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.006 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.0 m -150.42 145.26 25.95 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -125.45 147.66 49.12 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.425 ' CD1' HD22 ' A' ' 163' ' ' LEU . 29.4 mm -110.1 124.79 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -133.72 155.68 49.32 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -102.55 137.87 40.21 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.14 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 85.5 tttt -140.15 112.87 8.04 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.38 57.31 4.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.257 1.027 . . . . 0.0 111.144 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 73.71 -14.77 0.62 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.746 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.11 158.87 17.86 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.073 -0.392 . . . . 0.0 110.355 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 72.7 mt -96.17 136.8 36.14 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.119 0.262 . . . . 0.0 110.372 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 52.2 m95 -124.52 145.01 49.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.1 t -118.04 130.92 56.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.06 147.44 50.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.9 119.64 37.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 p -95.81 -29.31 14.3 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -130.25 143.56 50.85 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 5.4 p -76.38 113.29 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.52 0.676 . . . . 0.0 111.1 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.4 t -97.58 125.47 44.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.513 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.76 151.33 57.41 Favored 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 121.868 1.712 . . . . 0.0 110.08 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.1 p -62.94 131.1 47.55 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.42 -19.88 52.01 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.84 148.98 35.7 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.96 154.53 19.77 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.1 pt? -136.13 149.68 48.77 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.06 0.457 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.97 155.86 21.22 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.4 ' CG2' HG12 ' A' ' 179' ' ' ILE . 8.8 p -107.22 128.54 62.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.381 0.61 . . . . 0.0 111.149 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 2.0 tmt_? -95.36 116.15 28.39 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.75 134.61 34.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 121.283 0.563 . . . . 0.0 111.068 177.558 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 p-90 . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m 65.44 25.52 11.92 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.22 1.008 . . . . 0.0 112.429 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.35 141.13 15.44 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.928 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HG2' HD23 ' A' ' 107' ' ' LEU . 7.9 Cg_exo -44.35 150.57 0.69 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.437 3.425 . . . . 0.0 113.027 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.32 -3.97 27.02 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 122' ' ' LEU . 12.2 mm-40 -81.04 -18.7 45.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.777 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.0 mm? -113.31 165.79 12.09 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.284 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -156.83 139.84 15.37 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.9 tm? -89.16 116.77 27.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.96 137.37 42.04 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.91 103.55 15.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -106.18 103.45 12.93 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.15 24.62 14.49 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.951 0.501 . . . . 0.0 111.329 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.68 -4.21 68.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.01 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.96 131.93 35.26 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -84.26 96.42 9.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.4 p -114.27 127.84 56.07 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-O 121.363 0.602 . . . . 0.0 109.798 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.97 118.78 36.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.009 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -115.71 147.57 40.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.54 119.18 32.28 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -80.06 -26.57 39.63 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 106' ' ' GLU . 3.7 mm? -110.35 140.05 44.94 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.586 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 m -69.86 122.19 18.78 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.255 0.55 . . . . 0.0 110.981 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.44 132.51 35.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.21 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 p -95.15 156.84 16.15 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.536 0.522 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.08 117.03 7.83 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.21 -16.57 22.38 Favored Glycine 0 C--N 1.303 -1.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.905 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.2 tp -64.68 125.62 25.33 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.8 m -136.6 144.31 44.05 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.777 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 29.4 m-90 -91.59 172.0 8.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.548 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.84 164.29 54.52 Favored Glycine 0 N--CA 1.435 -1.381 0 O-C-N 123.777 0.673 . . . . 0.0 112.163 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 17.7 Cg_endo -58.54 128.39 28.14 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.408 2.738 . . . . 0.0 113.028 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 51.2 m-85 -102.89 170.89 7.71 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -122.06 142.63 50.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 163.53 -149.38 16.76 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 106.129 -2.789 . . . . 0.0 106.129 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 156' ' ' MET . 24.8 p -161.25 131.2 4.91 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.664 1.232 . . . . 0.0 111.598 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.44 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 1.4 pt . . . . . 0 N--CA 1.395 -3.186 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.091 0.472 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 136' ' ' SER . 48.2 ttm -97.17 96.36 8.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.5 m -130.32 159.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.608 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.87 170.13 15.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.569 0.543 . . . . 0.0 110.682 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.9 -8.42 58.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.982 0.896 . . . . 0.0 109.461 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 m -83.77 -2.93 57.33 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.633 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.5 t -109.09 116.79 32.62 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-O 121.77 0.795 . . . . 0.0 109.722 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 p-90 -70.04 -14.44 62.68 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.883 1.273 . . . . 0.0 112.129 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.74 -23.72 66.33 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.382 0.673 . . . . 0.0 112.392 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.95 -0.74 57.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.32 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 mmt -89.13 -13.54 38.23 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.292 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -83.08 144.03 46.65 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.01 142.53 38.69 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.237 1.958 . . . . 0.0 110.464 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -88.7 138.88 31.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.325 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.69 163.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.526 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.01 -46.14 37.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.9 p -115.03 173.01 6.71 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.87 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.74 -12.72 57.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.904 0.383 . . . . 0.0 110.402 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -68.76 -32.55 72.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.455 0.645 . . . . 0.0 110.154 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.89 -0.74 55.53 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.262 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.98 132.34 44.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.592 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -96.6 -12.72 23.6 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.3 m -149.08 132.88 16.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.419 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.27 138.89 38.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 202' ' ' VAL . 1.7 mp -110.76 114.57 47.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -131.36 175.6 9.0 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.257 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.476 ' O ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -123.43 132.0 53.82 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.586 0.708 . . . . 0.0 111.638 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 17.3 tppt? -136.91 126.82 25.8 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.41 28.26 17.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.447 1.092 . . . . 0.0 109.584 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.12 9.71 6.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.244 1.418 . . . . 0.0 114.15 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -104.7 152.86 22.0 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 40.3 mt -94.42 141.37 28.66 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.495 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 78.7 m95 -130.96 149.2 52.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.3 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.4 t -130.35 117.66 20.08 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 177' ' ' SER . 4.0 ptm180 -120.0 144.14 47.68 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.49 116.57 36.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 p -94.22 -37.23 11.65 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.536 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.44 171.25 7.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.477 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.58 106.28 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.728 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.57 108.8 62.29 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.63 176.93 9.33 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.848 2.366 . . . . 0.0 112.354 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.1 m -72.83 115.01 11.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.278 0.561 . . . . 0.0 109.899 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.49 -7.9 47.14 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.47 144.03 31.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.51 145.22 24.67 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.69 144.83 46.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.236 0.541 . . . . 0.0 110.397 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -118.04 152.72 34.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.051 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 179' ' ' ILE . 3.9 p -102.39 129.07 54.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 124.077 0.861 . . . . 0.0 113.103 -174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -109.97 108.07 18.19 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.592 HD13 ' H ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -115.48 154.39 29.41 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 137' ' ' ILE . 59.2 t . . . . . 0 C--N 1.312 -1.031 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 t-105 . . . . . 0 N--CA 1.423 -1.82 0 CA-C-O 121.184 0.516 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -109.54 92.9 4.24 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -135.61 -168.94 11.7 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.036 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.1 170.24 13.82 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.551 2.834 . . . . 0.0 113.149 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -75.82 -30.62 59.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.904 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.96 -2.61 48.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.726 0.774 . . . . 0.0 111.974 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.89 161.91 18.11 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.616 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.31 148.74 29.89 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.86 122.02 44.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.4 48.55 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.775 0.321 . . . . 0.0 110.346 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 92.6 mt -99.21 101.35 12.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -112.78 110.29 20.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 67.73 13.09 9.14 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.995 0.902 . . . . 0.0 112.12 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.72 42.8 Favored Glycine 0 C--N 1.317 -0.525 0 O-C-N 121.681 -0.637 . . . . 0.0 112.464 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.7 tt0 -90.02 135.01 33.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -86.59 96.7 10.19 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.2 t -110.63 152.73 26.14 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.29 131.69 72.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -138.52 148.98 44.89 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.093 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.98 120.67 17.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -68.8 -45.97 69.88 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.14 -179.52 3.66 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.5 m -78.14 98.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.617 0.722 . . . . 0.0 109.21 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.9 tp -76.93 112.53 13.64 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 124.898 1.279 . . . . 0.0 108.891 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.4 t -87.8 142.95 27.42 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.466 0.651 . . . . 0.0 110.942 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.38 136.65 46.17 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.051 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.61 -16.02 21.7 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 tp -81.61 140.01 34.69 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.4 p -138.54 152.05 47.87 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -100.03 175.27 5.81 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 123.265 0.353 . . . . 0.0 110.142 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.53 -179.96 39.29 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.828 0.705 . . . . 0.0 113.297 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.58 123.46 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 113.13 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -99.34 158.47 15.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.4 123.39 40.03 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 170.44 -178.23 43.22 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.6 m -121.38 126.12 48.62 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.39 0.614 . . . . 0.0 111.943 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.2 mt . . . . . 0 C--N 1.312 -1.036 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 175.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.478 ' HG ' ' NE2' ' A' ' 168' ' ' GLN . 1.2 pp . . . . . 0 C--O 1.245 0.85 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.9 mmt -123.56 81.99 1.96 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.972 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.61 171.82 10.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -71.5 152.84 42.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -22.61 61.89 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.5 p -96.15 -8.21 33.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.7 t -73.26 124.59 25.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.5 p-90 -59.53 -21.55 60.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.005 0.922 . . . . 0.0 113.066 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.93 -29.44 69.62 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 122.674 0.39 . . . . 0.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 15.9 ptm180 -93.91 2.68 56.09 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.017 0.437 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 mmt -94.96 -11.03 29.29 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.7 mt -86.63 141.97 34.47 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 35.8 Cg_exo -63.6 131.8 32.93 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.436 2.091 . . . . 0.0 110.781 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' NE2' ' HG ' ' A' ' 155' ' ' LEU . 94.0 mt-30 -89.25 137.88 31.92 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.168 0.508 . . . . 0.0 112.031 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.92 171.07 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.81 -25.01 9.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.2 p -104.09 150.92 23.87 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.958 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 15.9 pt-20 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.9 -20.08 58.31 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.193 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.83 -23.5 36.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.667 0.746 . . . . 0.0 109.229 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.63 22.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.533 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.417 ' C ' HG22 ' A' ' 191' ' ' THR . 16.7 p30 -114.96 -2.66 12.8 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.71 0.767 . . . . 0.0 109.344 172.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.3 p -145.43 136.18 24.45 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.339 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.457 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 16.0 pt-20 -136.03 143.52 44.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.345 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.0 mm -118.28 137.13 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -139.07 164.51 29.57 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -96.58 140.86 30.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.457 0.646 . . . . 0.0 110.06 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 57.6 tptt -140.46 118.53 11.92 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 53.12 47.17 25.1 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.772 1.295 . . . . 0.0 111.253 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.4 t70 70.59 -13.16 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.803 1.641 . . . . 0.0 113.513 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.89 152.0 20.28 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 44.5 mt -97.24 132.73 42.71 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.643 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 69.4 m95 -121.2 122.76 40.68 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.456 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.67 124.0 37.38 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.574 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -119.64 142.14 48.7 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 123.331 0.394 . . . . 0.0 110.008 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.53 104.43 12.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.417 HG22 ' C ' ' A' ' 176' ' ' ASN . 4.0 t -84.89 -18.52 34.49 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.068 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -142.3 142.03 32.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.77 116.61 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.775 0.798 . . . . 0.0 111.057 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.66 120.45 55.83 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.56 172.38 14.41 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.331 2.021 . . . . 0.0 111.957 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.0 m -67.58 112.16 4.57 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.89 -5.45 53.61 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.979 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.9 138.58 33.4 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.86 128.76 36.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.493 HD12 ' H ' ' A' ' 200' ' ' LEU . 3.8 mp -82.71 153.66 25.21 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.295 0.569 . . . . 0.0 112.226 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.1 126.82 32.61 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.41 129.62 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 123.96 0.788 . . . . 0.0 111.678 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 61.0 ttt180 -104.66 133.55 49.31 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.462 HD11 HD23 ' A' ' 155' ' ' LEU . 2.7 mm? -112.75 154.03 26.83 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--N 1.297 -1.707 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.123 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 t -90.84 77.89 6.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.87 164.29 24.73 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.08 166.12 16.77 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.69 2.26 . . . . 0.0 112.885 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -74.68 -12.1 60.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.592 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 122' ' ' LEU . 31.8 mp0 -80.88 -12.48 59.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.729 0.776 . . . . 0.0 109.393 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.69 157.7 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.237 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.5 141.56 46.77 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.98 120.29 29.18 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.8 129.42 56.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.103 0.478 . . . . 0.0 111.455 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.47 108.49 20.43 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -109.76 95.54 5.67 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 51.38 59.35 4.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.141 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.03 -1.5 86.57 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.803 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.4 140.63 47.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 117.276 0.538 . . . . 0.0 110.736 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -80.75 111.51 17.26 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.868 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.59 169.16 11.73 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 166' ' ' LEU . 59.0 t -123.95 129.95 74.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -119.48 145.82 45.97 Favored 'General case' 0 N--CA 1.394 -3.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.0 20.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -89.1 -44.4 10.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 106' ' ' GLU . 4.4 mm? -109.21 165.2 11.8 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 51.0 m -91.84 110.15 21.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.5 mm? -84.02 123.87 30.47 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 t -101.27 157.51 16.73 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 149.39 50.69 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.878 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.14 -26.97 21.38 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.086 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.4 tp -75.25 142.35 43.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -139.78 162.35 35.34 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -100.45 174.99 5.84 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.292 0.637 . . . . 0.0 109.731 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.39 171.14 55.1 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 119.526 -0.597 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 57.7 Cg_endo -73.09 123.33 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.247 1.964 . . . . 0.0 114.054 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.528 ' HE1' ' HG ' ' A' ' 188' ' ' CYS . 48.8 m-85 -94.72 149.96 20.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -106.36 106.26 16.7 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.861 0.839 . . . . 0.0 112.189 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.1 -145.02 4.12 Favored Glycine 0 C--N 1.291 -1.949 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -153.45 161.3 42.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.34 1.07 . . . . 0.0 110.832 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--N 1.316 -0.873 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.082 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.429 -1.488 0 CA-C-O 121.543 0.687 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -96.3 86.72 4.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.675 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.93 165.62 28.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.182 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -70.09 160.25 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.9 63.96 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 112.245 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 p -88.47 -9.37 52.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 53.1 t -75.97 126.81 31.71 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.023 0.439 . . . . 0.0 110.188 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 7.8 p-90 -54.01 -30.87 49.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 188' ' ' CYS . 88.2 mt -59.62 -30.28 68.59 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.35 -2.9 44.77 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.47 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.8 ptp -107.48 4.56 26.3 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.727 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 73.5 mt -83.99 148.86 54.84 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.8 118.23 5.23 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.901 1.734 . . . . 0.0 110.056 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -81.68 129.16 34.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.36 146.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.408 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.04 0.77 25.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.579 0.704 . . . . 0.0 109.466 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.3 p -100.03 134.49 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.585 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.25 -34.37 68.2 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-O 121.167 0.508 . . . . 0.0 110.727 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.95 -12.91 61.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.81 -20.4 17.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.62 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -88.6 127.97 35.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.081 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 192' ' ' LYS . 86.3 m-20 -94.54 -11.41 29.59 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.205 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 p -152.42 129.43 11.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.475 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.36 134.04 52.32 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.054 0.455 . . . . 0.0 110.25 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 188' ' ' CYS . 29.8 mm -102.17 125.24 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 187' ' ' TRP . 32.4 p90 -130.29 154.03 48.03 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.606 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -102.66 127.25 49.86 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -137.26 128.04 27.17 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.06 23.41 11.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.76 17.55 11.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.445 1.498 . . . . 0.0 113.376 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -109.61 159.37 17.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 3.4 mm? -93.39 131.36 38.65 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 180' ' ' TYR . 51.2 m95 -128.23 139.56 52.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.528 ' HG ' ' HE1' ' A' ' 133' ' ' PHE . 49.1 m -109.05 112.77 25.14 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.742 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.4 131.63 54.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.74 126.46 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.0 p -106.54 -19.1 13.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 176' ' ' ASN . 68.0 mttm -140.02 146.03 38.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.445 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 76.7 t -69.16 115.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 123.864 0.727 . . . . 0.0 109.717 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -108.8 120.22 46.75 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 153.58 49.41 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.228 1.952 . . . . 0.0 111.988 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.3 m -63.14 122.72 16.79 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.61 -18.1 25.13 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.558 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.78 159.09 23.66 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.579 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.76 153.65 20.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.208 0.528 . . . . 0.0 110.783 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.3 pt? -123.52 148.85 45.89 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.37 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -114.25 145.08 42.2 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.411 HG23 HG12 ' A' ' 179' ' ' ILE . 14.3 p -102.15 125.63 56.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 123.948 0.78 . . . . 0.0 110.75 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.2 ttt180 -97.74 134.0 41.5 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.02 135.9 38.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.304 -1.377 0 CA-C-O 122.555 1.169 . . . . 0.0 111.915 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 36.2 t-105 . . . . . 0 N--CA 1.405 -2.72 0 CA-C-O 121.799 0.809 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -145.2 123.98 12.62 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 104' ' ' PRO . . . -171.95 -141.83 3.52 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 118.526 -1.797 . . . . 0.0 113.592 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' A' ' 103' ' ' GLY . 7.4 Cg_endo -82.56 159.2 16.8 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.125 2.55 . . . . 0.0 112.339 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.46 -20.58 39.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.1 -15.45 63.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.324 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.633 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.8 mm? -119.53 147.77 44.06 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.697 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.36 141.32 33.83 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -94.3 100.1 12.21 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.11 146.24 32.93 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -172.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 9.0 mp -108.19 110.49 22.13 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.694 176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 117.33 31.42 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.32 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.66 23.75 14.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.048 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.64 2.22 63.35 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.071 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 53.2 tt0 -98.35 137.96 36.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.1 102.64 14.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.3 t -130.8 165.11 23.7 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.077 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -91.0 107.98 19.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.375 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.5 140.82 36.99 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.34 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.84 113.51 7.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -50.17 30.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.08 169.25 8.9 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 m -74.46 112.57 10.77 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.223 0.535 . . . . 0.0 110.46 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 200' ' ' LEU . 75.4 mt -84.71 114.7 22.22 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.4 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.6 p -88.81 155.26 19.66 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.165 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.55 141.33 55.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.105 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.97 -17.75 58.7 Favored Glycine 0 C--N 1.297 -1.606 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.266 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.67 117.02 9.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.7 m -129.3 141.11 51.19 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -99.37 170.95 8.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.9 -168.56 22.19 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.85 0.719 . . . . 0.0 113.937 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.2 Cg_endo -75.16 144.02 29.24 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.343 2.029 . . . . 0.0 112.864 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 163' ' ' LEU . 76.8 m-85 -123.34 162.52 22.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.199 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -94.38 125.12 38.83 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 -178.74 35.02 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.952 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -126.19 158.85 34.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 204' ' ' LEU . 60.2 mt . . . . . 0 N--CA 1.428 -1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 109.819 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 204' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.668 0.747 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.65 90.91 8.55 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 m -110.93 178.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.207 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.615 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 23.5 t70 -66.94 144.5 56.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -10.07 49.74 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -95.51 -12.44 25.79 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.604 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 158' ' ' ASP . 94.0 m -69.94 111.01 5.35 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-O 121.614 0.721 . . . . 0.0 112.926 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.633 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 19.8 p-90 -54.48 -26.15 29.53 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 125.514 1.526 . . . . 0.0 112.569 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 133' ' ' PHE . 75.3 mt -54.21 -32.66 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.464 1.106 . . . . 0.0 112.549 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -85.47 -2.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.618 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 95.9 mmm -86.53 -16.27 37.46 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.577 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.16 143.26 52.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.99 131.35 20.73 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 121.607 1.538 . . . . 0.0 109.426 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -83.95 129.93 34.91 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -112.94 137.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.685 0.755 . . . . 0.0 112.531 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.54 -18.77 56.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.524 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 4.7 p -95.4 134.92 37.66 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.092 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.06 -17.32 37.79 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.72 0.771 . . . . 0.0 109.515 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -66.89 -41.37 87.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.093 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -77.66 -29.21 51.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.52 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.51 140.17 57.02 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.556 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 200' ' ' LEU . 85.1 m-20 -107.81 -15.48 14.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.533 0.682 . . . . 0.0 109.74 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.7 m -149.36 142.96 25.45 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -116.72 151.56 36.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.893 0.378 . . . . 0.0 111.001 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 163' ' ' LEU . 33.6 mm -115.96 115.52 49.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -113.19 163.03 15.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -109.92 141.74 42.23 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -148.25 121.27 8.83 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 65.69 20.98 11.6 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.045 0.938 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 73.71 15.68 3.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.743 1.617 . . . . 0.0 111.31 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -109.08 147.87 31.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 70.4 mt -93.87 141.22 28.76 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.851 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.89 136.33 50.27 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.9 126.07 54.71 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 123.282 0.364 . . . . 0.0 110.806 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -123.88 137.22 54.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.63 125.2 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.0 p -90.85 -39.91 12.06 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 175' ' ' ALA . 48.9 mtmt -119.49 153.66 34.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.84 108.69 8.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.66 112.63 48.16 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 121.124 0.487 . . . . 0.0 110.247 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 164.32 35.02 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.441 2.094 . . . . 0.0 112.488 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.3 t -58.6 123.25 15.67 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.679 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.2 -30.69 5.14 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.47 147.32 49.73 Favored Glycine 0 N--CA 1.443 -0.861 0 O-C-N 124.045 0.497 . . . . 0.0 112.157 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.5 mt -105.34 120.39 41.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 176' ' ' ASN . 5.3 mp -73.1 136.49 44.9 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -118.47 137.69 53.0 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.0 130.78 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.487 0.661 . . . . 0.0 111.949 -173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.4 tpt180 -104.77 130.84 52.78 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 155' ' ' LEU . 83.8 mt -103.19 124.43 48.59 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 122.416 1.103 . . . . 0.0 108.661 178.841 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 5.1 p-90 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 121.536 0.684 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.263 79.1 p 65.94 -51.02 0.4 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.171 2.189 . . . . 0.0 114.669 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.68 -73.05 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.228 -1.463 . . . . 0.0 114.446 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -70.65 119.99 6.75 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.717 1.611 . . . . 0.0 114.443 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 0.4 OUTLIER -81.99 -10.31 59.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.345 177.058 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.15 -7.74 55.47 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.063 1.345 . . . . 0.0 109.619 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 0.2 OUTLIER -110.96 138.39 47.43 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 39.7 tt0 -113.57 119.19 36.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.354 0.597 . . . . 0.0 112.242 -176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.6 tm? -96.49 110.58 22.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -117.49 114.8 24.01 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.088 0.471 . . . . 0.0 110.997 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 116' ' ' ARG . 90.4 mt -91.67 105.0 17.41 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.145 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -105.83 105.9 16.16 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 64.44 21.79 12.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.119 0.968 . . . . 0.0 110.861 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.91 2.35 59.55 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.861 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -100.55 137.57 38.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 117.291 0.545 . . . . 0.0 110.181 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HA ' HD23 ' A' ' 111' ' ' LEU . 3.2 ptp180 -84.68 113.34 21.22 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.616 0.722 . . . . 0.0 112.635 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.3 t -115.3 143.99 44.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 57.0 t -121.51 112.85 37.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 80.9 mtt180 -118.57 160.1 22.38 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.703 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.17 126.46 32.64 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -64.64 -37.44 87.58 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.516 0.674 . . . . 0.0 110.201 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.95 171.3 14.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -66.61 112.13 4.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.48 117.85 21.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.2 p -79.82 147.34 31.82 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.101 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.27 139.25 54.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.74 -18.8 56.38 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.363 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.26 125.37 26.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m -129.62 149.06 51.55 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -92.1 165.38 13.19 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.097 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.61 158.74 35.76 Favored Glycine 0 N--CA 1.441 -1.002 0 O-C-N 124.41 1.069 . . . . 0.0 112.853 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 123.6 12.03 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.083 2.522 . . . . 0.0 112.681 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -96.36 152.61 18.44 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.83 141.85 31.1 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.791 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.28 -158.78 28.66 Favored Glycine 0 C--N 1.281 -2.514 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -147.28 162.38 39.06 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--N 1.313 -0.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.303 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.42 -1.926 0 CA-C-O 120.683 0.278 . . . . 0.0 110.806 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.19 95.37 5.16 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 155' ' ' LEU . 26.8 m -133.95 -178.63 2.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.445 -176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.557 ' O ' ' HD3' ' A' ' 164' ' ' ARG . 11.0 t70 -55.48 142.22 33.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.088 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -55.8 -30.48 61.42 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.8 p -105.95 5.33 30.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.826 0.346 . . . . 0.0 111.899 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.6 t -66.33 124.38 22.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -51.24 -29.23 13.78 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.0 mt -57.09 -35.45 69.42 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.06 0.544 . . . . 0.0 111.508 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' A' ' 158' ' ' ASP . 16.5 ptm180 -97.31 -2.47 42.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.518 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 93.6 mmm -92.63 -28.32 16.77 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.3 152.54 70.76 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.83 124.72 14.56 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 121.686 1.591 . . . . 0.0 109.653 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -88.86 132.15 34.79 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.573 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.565 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 33.9 m -125.37 164.37 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.1 mt -111.75 -8.11 14.18 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.188 0.518 . . . . 0.0 110.638 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.9 p -93.2 134.6 35.23 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.052 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.26 -9.21 58.69 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.143 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -80.02 -34.9 37.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.649 0.261 . . . . 0.0 110.783 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.02 23.69 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.614 0.721 . . . . 0.0 109.319 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.656 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -78.11 123.32 26.73 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.763 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 200' ' ' LEU . 54.2 m-80 -90.02 -14.75 33.25 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.061 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.3 m -134.53 136.83 43.34 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.677 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.92 136.67 54.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.271 0.558 . . . . 0.0 110.665 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.73 HD13 HG13 ' A' ' 202' ' ' VAL . 1.4 mp -103.32 120.71 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.545 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -132.1 151.4 51.79 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.057 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -88.11 141.25 28.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -155.25 111.89 3.23 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.3 t70 57.2 65.36 1.39 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.266 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.66 8.04 2.78 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.136 -1.393 . . . . 0.0 114.283 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.37 156.53 45.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.3 mt -101.61 131.92 47.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -120.51 150.24 41.16 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.1 t -125.32 114.27 18.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -111.02 146.04 37.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.5 t -83.06 112.46 20.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t -92.17 -34.16 14.43 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.97 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -123.48 135.59 54.14 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.98 108.36 2.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.558 0.536 . . . . 0.0 111.045 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.46 128.14 27.57 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.264 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.29 169.01 17.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.877 2.385 . . . . 0.0 112.779 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.4 t -67.38 131.5 45.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.29 -13.78 64.19 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.413 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.66 154.56 45.62 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 8.8 mp -96.86 142.43 28.86 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.447 0.642 . . . . 0.0 110.753 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 176' ' ' ASN . 1.1 pt? -123.22 164.38 18.84 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.392 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -136.03 158.74 43.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.73 HG13 HD13 ' A' ' 179' ' ' ILE . 23.3 t -100.05 119.18 47.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 124.484 1.115 . . . . 0.0 111.361 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 1.1 tmm_? -106.73 128.0 53.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.24 138.96 31.19 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 122.897 1.332 . . . . 0.0 112.714 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.505 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 162' ' ' TRP . 36.6 m -91.48 93.12 8.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.18 -175.52 38.53 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.687 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.04 151.44 9.62 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.11 2.54 . . . . 0.0 111.966 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 1.6 pm0 -78.42 -0.36 28.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.54 -22.76 60.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.9 161.2 17.26 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.566 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 34.9 tt0 -144.25 122.67 12.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.758 0.313 . . . . 0.0 110.718 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.3 tm? -88.23 109.69 20.13 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 171.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.44 157.75 18.15 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.4 mt -118.03 97.93 6.06 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -113.39 117.51 31.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 66.15 12.51 8.57 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.444 1.116 . . . . 0.0 110.062 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.83 69.06 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.057 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -82.32 136.73 34.97 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 122.665 -0.314 . . . . 0.0 110.185 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.95 110.41 16.46 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.9 p -129.95 136.94 50.04 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.414 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.5 t -96.54 105.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -110.84 149.2 30.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.16 15.15 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 24.3 ttt180 -73.92 -43.22 59.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.83 152.81 25.27 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.7 m -68.41 116.38 8.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 88.6 mt -86.77 113.12 22.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.879 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 p -90.66 144.37 25.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -64.64 148.46 50.9 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.41 -34.1 5.9 Favored Glycine 0 C--N 1.282 -2.434 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.9 tp -65.75 138.55 58.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.2 m -147.55 154.96 41.37 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -98.35 173.11 7.14 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 123.564 0.54 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.6 -179.05 37.94 Favored Glycine 0 N--CA 1.437 -1.289 0 O-C-N 123.81 0.694 . . . . 0.0 112.97 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 123.72 10.08 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.635 2.223 . . . . 0.0 112.579 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' CD2' HD11 ' A' ' 163' ' ' LEU . 80.3 m-85 -96.6 150.01 21.13 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.338 0.589 . . . . 0.0 110.806 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.616 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 147.6 -174.27 27.41 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.0 m -139.15 160.52 39.59 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.989 0.894 . . . . 0.0 111.993 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 170.882 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.4 ptm -123.6 85.72 2.46 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.953 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.616 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -136.86 164.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.025 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.02 158.24 29.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.96 -19.24 65.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -73.06 -14.22 61.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.494 0.664 . . . . 0.0 109.381 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.8 t -87.25 100.31 12.6 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.456 ' HB3' ' O ' ' A' ' 102' ' ' SER . 16.1 p-90 -44.83 -28.4 0.64 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 114.234 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 133' ' ' PHE . 82.5 mt -52.8 -37.35 59.7 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.89 0.876 . . . . 0.0 112.416 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HD2' HG23 ' A' ' 157' ' ' VAL . 15.3 ptm180 -87.33 1.07 54.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.111 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 92.0 mmm -92.61 -8.8 43.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.249 0.547 . . . . 0.0 110.23 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.96 155.18 49.97 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.63 118.67 5.67 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.888 1.725 . . . . 0.0 110.089 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.87 136.18 38.02 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.925 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 21.8 m -138.24 149.07 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.34 -10.29 16.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.44 0.638 . . . . 0.0 109.76 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.8 p -88.54 134.55 33.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.86 -29.67 61.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.564 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.25 -32.06 69.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.774 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.32 -20.44 24.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.909 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.08 154.29 24.45 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.777 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 6.1 m-20 -119.66 -12.75 9.22 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.444 0.64 . . . . 0.0 110.066 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.8 m -154.28 145.67 23.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.69 147.58 49.3 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.1 0.476 . . . . 0.0 111.467 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.59 131.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.06 167.2 21.39 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -97.79 139.64 33.36 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.9 tttt -165.22 138.26 4.52 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 65.72 16.6 10.56 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.845 0.858 . . . . 0.0 110.767 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.19 64.24 0.86 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 111.283 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -173.06 172.92 3.8 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.729 -1.578 . . . . 0.0 106.832 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.81 139.12 40.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.8 m95 -123.29 133.2 54.18 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.7 t -102.7 117.73 35.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -115.8 144.8 43.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.88 132.46 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.0 p -104.42 -39.07 6.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.302 0.572 . . . . 0.0 111.998 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -108.98 149.53 29.08 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.958 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 59.2 t -77.18 98.23 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 t -85.95 125.95 67.06 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 144.99 42.54 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 122.136 1.891 . . . . 0.0 111.689 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.6 p -62.61 116.4 5.13 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.386 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.19 -8.14 30.96 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.569 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.84 33.76 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.0 mt -103.26 163.11 12.45 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 176' ' ' ASN . 1.2 pt? -141.15 148.45 40.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -111.44 144.77 40.12 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.77 123.01 53.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.306 0.574 . . . . 0.0 110.529 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.609 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 55.1 ttt180 -98.04 137.31 37.03 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.805 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.32 138.3 35.78 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.321 -0.666 0 CA-C-O 122.666 1.222 . . . . 0.0 112.817 -178.076 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CE2' ' HB2' ' A' ' 109' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -87.83 82.85 7.2 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.89 171.95 29.85 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.23 158.21 11.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.496 2.797 . . . . 0.0 112.012 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.07 -2.29 47.61 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.67 -19.98 54.45 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 160.18 16.18 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 113.506 -1.679 . . . . 0.0 108.9 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' A' ' 119' ' ' ARG . 36.6 tt0 -136.39 131.2 33.87 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.323 0.582 . . . . 0.0 111.493 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.488 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.5 tm? -96.36 114.31 25.97 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.83 142.91 45.5 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 79.1 mt -99.77 122.47 42.81 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 10.1 tt0 -121.5 107.19 12.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 13.14 2.77 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.139 1.376 . . . . 0.0 112.439 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.78 2.39 30.46 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.209 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.4 pt20 -95.65 151.71 19.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.5 ptt180 -98.2 105.23 17.35 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.245 0.545 . . . . 0.0 109.628 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 8.2 p -111.04 138.4 47.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.5 117.31 45.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' A' ' 108' ' ' GLU . 3.2 ptm180 -127.18 154.27 45.01 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.558 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.4 121.02 19.81 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -78.02 -43.53 29.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.24 170.09 10.26 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.805 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -69.8 107.68 3.62 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.256 0.551 . . . . 0.0 111.058 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 83.6 mt -74.52 113.75 12.12 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.2 p -85.56 155.47 21.16 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.287 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.51 129.75 40.57 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.117 0.484 . . . . 0.0 109.809 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.74 61.93 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.386 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.67 126.97 30.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 188' ' ' CYS . 36.9 p -135.59 147.51 48.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -97.69 168.18 10.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.934 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.11 159.14 53.47 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.833 0.708 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 23.6 Cg_endo -59.33 123.75 14.08 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 123.471 2.781 . . . . 0.0 112.762 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -92.99 150.65 20.4 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.912 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -90.6 105.0 17.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.146 0.498 . . . . 0.0 110.038 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.84 -168.64 39.11 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -146.9 166.61 26.23 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.298 -1.652 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.628 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.0 ttt -102.08 82.05 2.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.21 178.69 4.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.814 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.18 146.27 54.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 123.567 0.542 . . . . 0.0 110.798 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -53.36 -38.83 63.67 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.36 1.064 . . . . 0.0 112.223 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 3.34 54.44 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.77 0.319 . . . . 0.0 110.903 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.42 126.62 31.11 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -54.67 -31.1 57.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 179' ' ' ILE . 49.0 mt -56.13 -40.06 73.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -87.36 -6.52 58.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.4 ptp -100.46 5.41 44.19 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.968 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.88 143.2 31.19 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.53 129.96 16.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.909 1.739 . . . . 0.0 110.786 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -79.99 150.39 30.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.113 0.482 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 m -138.71 147.57 25.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.25 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.97 -21.93 20.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.8 p -94.99 134.83 37.24 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.241 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.4 -6.02 59.25 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.149 0.5 . . . . 0.0 111.651 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.99 -29.4 64.18 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.28 -29.74 18.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.793 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.86 124.67 25.87 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.708 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.22 -18.11 15.65 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.44 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.2 p -141.17 134.33 29.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -120.73 147.68 44.98 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.939 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.456 ' CD1' HD22 ' A' ' 163' ' ' LEU . 18.9 mm -111.1 114.35 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 11.9 p90 -125.84 154.97 41.88 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.472 ' HG2' HG21 ' A' ' 205' ' ' VAL . 33.0 ptt180 -94.26 135.94 35.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.195 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 52.2 tttm -137.31 122.57 19.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 3.8 m-20 66.63 22.16 10.53 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.6 t70 68.96 5.59 5.13 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.473 1.909 . . . . 0.0 112.214 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -95.8 155.17 16.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 78.5 mt -93.58 123.44 36.9 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.633 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 55.4 m95 -116.46 137.34 52.24 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' SER . 50.9 t -108.7 119.86 40.77 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -123.14 142.26 51.08 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.781 0.324 . . . . 0.0 110.295 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.49 128.56 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.008 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.1 p -98.35 -47.57 5.38 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -113.9 140.17 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.885 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 48.9 t -74.55 111.46 10.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.239 0.542 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.12 122.84 40.94 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.259 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.02 174.03 13.5 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.529 2.153 . . . . 0.0 112.256 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.9 m -59.45 125.99 25.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.39 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.05 63.37 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.783 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.5 144.78 17.43 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.65 142.14 27.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.4 pt? -110.88 147.26 34.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.23 148.33 37.55 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.8 134.47 46.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 123.653 0.595 . . . . 0.0 111.088 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -109.2 139.33 44.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.35 154.5 18.14 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.145 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 181' ' ' ARG . 14.2 p . . . . . 0 C--O 1.246 0.9 0 C-N-CA 126.064 1.746 . . . . 0.0 114.286 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.1 t -86.74 84.57 7.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -142.71 177.7 21.61 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.841 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.77 173.3 9.43 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.714 2.943 . . . . 0.0 112.991 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.62 -27.34 51.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 111.511 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.05 -22.93 62.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.095 0.95 . . . . 0.0 110.265 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.48 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.9 mm? -102.31 155.03 18.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.688 -173.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -139.64 135.58 33.43 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.405 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.2 114.99 28.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.74 52.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.0 mt -93.25 109.98 21.5 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -106.3 109.43 21.35 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 66.72 22.82 10.3 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.81 1.29 . . . . 0.0 109.036 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.13 -9.84 72.18 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.542 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -89.91 130.33 36.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 122.618 -0.342 . . . . 0.0 110.419 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.42 103.52 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.816 0.817 . . . . 0.0 111.28 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 39.8 m -112.95 153.14 28.48 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.015 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.46 130.99 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -142.4 158.85 43.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.09 113.82 24.1 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -76.01 -33.26 59.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.73 150.43 26.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -69.25 124.39 23.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.128 0.49 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.47 114.1 23.78 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.4 p -88.1 147.39 24.95 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.003 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.46 126.91 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.238 0.542 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.11 -7.72 48.48 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.506 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.32 126.12 30.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -128.8 148.48 50.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -97.81 173.94 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.449 0.166 . . . . 0.0 110.984 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.28 166.53 54.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.06 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.65 130.58 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.149 2.566 . . . . 0.0 113.826 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -107.06 173.74 6.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -120.16 139.05 53.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.68 -176.09 34.85 Favored Glycine 0 N--CA 1.405 -3.37 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.741 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.4 m -126.52 143.88 51.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 179' ' ' ILE . 43.2 mm . . . . . 0 N--CA 1.431 -1.413 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.735 0 CA-C-O 122.165 0.983 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 47.6 ttm -80.07 87.71 5.43 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.94 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.31 -174.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.78 155.39 21.04 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.636 -0.825 . . . . 0.0 108.948 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.19 -21.27 66.74 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.7 t -93.01 -7.06 46.86 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.315 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.8 t -71.26 125.14 26.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 109.93 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.48 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 9.7 p-90 -61.9 -21.51 64.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.443 HD22 HG12 ' A' ' 179' ' ' ILE . 60.7 mt -62.13 -31.98 72.52 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.645 0.378 . . . . 0.0 111.593 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -85.92 -4.38 59.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -96.3 -5.31 40.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.093 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.2 mt -90.05 147.28 36.81 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.44 122.16 7.28 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 121.966 1.777 . . . . 0.0 111.205 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.14 129.13 35.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.753 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.16 146.54 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.783 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.31 -8.65 26.74 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.046 0.451 . . . . 0.0 109.925 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.9 p -104.47 134.84 46.98 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.464 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.41 -27.09 62.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.522 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 173' ' ' GLU . 2.1 mp0 -62.68 -25.97 68.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.985 0.914 . . . . 0.0 110.834 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.52 -38.64 12.39 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.62 135.49 52.94 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.705 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 200' ' ' LEU . 8.3 p30 -124.17 -10.71 7.56 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.254 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 m -141.61 124.36 16.04 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 188' ' ' CYS . 11.7 pt-20 -108.51 145.06 35.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.564 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 202' ' ' VAL . 2.0 mp -111.1 119.87 60.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -135.01 154.56 51.69 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.654 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -88.23 124.0 33.41 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.195 0.521 . . . . 0.0 109.989 176.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.668 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 64.5 tttp -132.94 97.98 4.17 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.2 t70 57.25 72.51 0.51 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.723 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.7 t70 73.46 -5.73 1.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.251 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -130.28 164.26 24.97 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.0 110.3 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.5 mt -98.22 134.44 41.26 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.668 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 49.7 m95 -124.72 152.73 43.39 Favored 'General case' 0 C--N 1.268 -2.949 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 50.3 t -128.89 128.88 44.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -123.69 147.34 47.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.0 t -91.15 115.57 30.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.3 p -86.42 -47.35 9.4 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.226 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -123.3 144.27 49.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.73 120.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.823 0.702 . . . . 0.0 112.473 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.2 p -114.79 120.62 37.07 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.98 162.32 41.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.378 2.052 . . . . 0.0 113.436 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.0 p -56.57 113.36 1.58 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.781 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.91 -14.05 19.62 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.91 159.12 34.01 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.657 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.52 150.15 20.66 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -114.28 153.86 28.98 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.35 142.02 50.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.796 HG23 HD13 ' A' ' 179' ' ' ILE . 5.9 p -96.6 127.68 48.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.87 0.843 . . . . 0.0 111.887 -174.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.576 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.2 ttt180 -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 173.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.92 148.28 24.12 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 110.843 179.471 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -80.51 35.73 0.35 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.021 0.928 . . . . 0.0 111.968 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.8 153.01 16.95 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.993 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.89 152.93 27.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.479 3.453 . . . . 0.0 113.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.11 -0.37 39.77 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.217 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -80.98 -13.43 58.89 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.65 160.08 24.0 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.334 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 121' ' ' ARG . 47.7 mt-10 -130.99 139.48 50.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.664 0.269 . . . . 0.0 111.167 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.23 94.86 6.7 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 168.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.44 130.93 50.89 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.323 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -100.78 113.33 26.15 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -126.43 114.38 18.1 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 71.69 12.86 6.31 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.506 1.146 . . . . 0.0 110.228 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.61 5.04 69.51 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.063 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -94.35 118.89 32.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -73.02 105.29 4.42 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.396 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.9 121.82 42.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.497 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.23 107.17 18.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -119.84 158.89 25.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.388 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 125.65 30.83 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.452 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 8.6 tpm_? -81.63 -48.52 11.64 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.2 mt -110.72 157.18 20.04 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.2 t -76.93 112.03 13.12 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-O 121.266 0.555 . . . . 0.0 109.896 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.56 110.43 7.84 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -109.38 166.85 10.56 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.03 132.79 51.64 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.08 -31.84 4.97 Favored Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.1 tp -85.12 132.02 34.36 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -146.25 154.22 41.48 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -91.49 172.65 8.36 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.146 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.93 169.76 54.34 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 20.7 Cg_endo -58.32 123.46 13.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.274 2.649 . . . . 0.0 112.745 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 91.5 m-85 -92.16 147.73 22.71 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.16 95.95 6.19 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.823 1.297 . . . . 0.0 112.771 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.05 -155.34 10.09 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -151.82 164.26 37.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.501 1.15 . . . . 0.0 111.06 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 174.042 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 204' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.391 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.47 87.22 2.71 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.492 HG22 HD13 ' A' ' 155' ' ' LEU . 34.8 m -129.52 167.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.495 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.81 156.69 39.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 123.877 0.735 . . . . 0.0 109.721 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -29.98 71.23 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.31 0.644 . . . . 0.0 110.026 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.2 t -77.99 -11.96 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.58 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.98 119.09 22.35 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.62 0.724 . . . . 0.0 109.729 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -64.19 -19.99 65.7 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.128 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.401 HD22 HD11 ' A' ' 179' ' ' ILE . 73.5 mt -59.03 -31.35 68.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.696 0.398 . . . . 0.0 112.045 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -87.36 -5.11 59.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.5 mtp -89.86 -9.95 47.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.013 0.435 . . . . 0.0 110.407 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.97 149.79 46.32 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 31.9 Cg_exo -60.05 118.75 5.67 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.195 1.93 . . . . 0.0 110.442 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -81.86 124.55 29.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.355 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.03 147.09 28.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.64 1.07 17.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.673 0.749 . . . . 0.0 109.46 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 174.74 7.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.758 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' NH1' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -95.72 -52.47 4.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.237 -177.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -71.07 -39.34 72.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.44 68.38 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.421 0.451 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.72 121.08 26.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.355 0.598 . . . . 0.0 111.339 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -106.13 -5.73 19.14 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.668 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 45.5 m -149.1 140.71 23.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 203' ' ' ARG . 16.2 pt-20 -136.63 155.5 49.83 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.07 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 163' ' ' LEU . 21.8 mm -112.57 129.96 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.431 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 17.3 p90 -140.02 163.31 33.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.459 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -99.06 138.64 35.87 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 121.725 0.774 . . . . 0.0 110.519 177.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 65.2 tttp -145.8 114.38 6.78 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t70 66.82 25.54 9.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.195 1.398 . . . . 0.0 109.007 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 73.56 8.31 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.516 1.526 . . . . 0.0 112.442 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -102.73 152.24 21.46 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 82.6 mt -94.19 129.9 40.62 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.678 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 65.6 m95 -121.82 141.2 51.47 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.526 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 52.8 t -109.04 119.88 40.86 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -117.87 150.3 39.42 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.49 120.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 p -96.01 -32.89 12.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.774 0.321 . . . . 0.0 111.343 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.62 148.11 52.58 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.74 102.62 5.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.794 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.01 126.71 56.34 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.95 170.94 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.55 2.166 . . . . 0.0 113.036 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.8 m -60.69 127.41 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.39 0.23 82.62 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.01 158.08 23.74 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -100.32 146.79 26.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -115.57 151.16 35.42 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.623 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -123.03 133.19 54.35 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.1 p -97.4 122.81 49.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.744 0.652 . . . . 0.0 111.367 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 172' ' ' GLU . 43.8 ttp180 -97.79 140.46 32.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.85 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.603 HD21 HD23 ' A' ' 155' ' ' LEU . 78.6 mt -107.71 127.23 53.49 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 13.0 p . . . . . 0 C--N 1.312 -1.061 0 CA-C-O 121.643 0.735 . . . . 0.0 111.65 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.491 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 1.1 p-90 . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.4 m -88.03 88.16 7.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.672 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.77 178.45 29.9 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.91 160.58 30.51 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.618 2.879 . . . . 0.0 112.946 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.2 -7.95 59.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.504 0.668 . . . . 0.0 111.426 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.51 -24.13 42.46 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.65 162.46 14.13 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.851 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.17 136.87 32.25 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.896 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -90.32 104.81 17.34 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.7 153.6 21.62 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.7 mt -115.54 112.3 22.01 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -105.0 104.53 14.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 64.55 19.07 11.69 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.464 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.63 -8.83 43.98 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.094 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -94.77 143.25 26.6 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -75.23 133.83 41.29 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.088 0.471 . . . . 0.0 109.874 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.08 121.37 17.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.35 106.81 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -110.05 156.43 20.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.856 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.77 122.07 40.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.335 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.16 -46.46 23.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.1 mt -101.53 139.78 36.72 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.9 t -70.65 126.98 31.11 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.84 145.8 50.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.159 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 p -93.4 150.9 20.11 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.052 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.46 124.07 23.3 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.94 60.19 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.818 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.47 122.02 15.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.0 m -131.53 138.54 48.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -92.18 169.32 10.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.45 179.83 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 123.9 0.75 . . . . 0.0 114.25 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 73.7 Cg_endo -75.44 138.45 22.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.786 2.324 . . . . 0.0 112.536 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 163' ' ' LEU . 56.2 m-85 -114.0 149.07 35.91 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -89.4 99.44 12.44 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -154.28 -152.44 6.1 Favored Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.7 m -150.93 134.18 16.12 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.411 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.437 -1.098 0 CA-C-O 122.287 1.042 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.9 mtm -79.43 83.12 5.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.649 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.539 HG12 ' HA3' ' A' ' 135' ' ' GLY . 22.9 m -126.38 150.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.626 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.54 160.38 25.31 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.301 0.64 . . . . 0.0 111.287 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -52.82 -32.45 44.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.543 0.737 . . . . 0.0 111.67 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.0 m -85.0 9.81 13.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.199 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 48.3 t -100.1 100.24 11.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 8.6 p-90 -56.43 -19.59 15.75 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.773 1.229 . . . . 0.0 113.205 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.449 HD22 HD11 ' A' ' 179' ' ' ILE . 65.0 mt -59.66 -28.16 67.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.374 0.669 . . . . 0.0 111.473 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 8.6 ptm180 -85.06 -2.64 58.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.933 0.397 . . . . 0.0 110.984 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.8 mtt -93.79 -13.99 26.73 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.94 142.13 36.21 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.579 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.23 133.24 27.98 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 122.114 1.876 . . . . 0.0 110.872 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -84.97 128.77 34.77 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.187 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.66 138.33 52.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.564 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.87 -21.31 23.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 p -87.99 134.81 33.65 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.014 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.4 -17.71 31.66 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.35 -34.63 74.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.34 -15.35 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.452 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.95 118.13 19.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.106 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 0.8 OUTLIER -91.41 -30.33 16.57 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.0 p -133.72 136.93 44.96 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.953 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.92 146.01 45.29 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.215 0.531 . . . . 0.0 112.019 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.449 HD11 HD22 ' A' ' 163' ' ' LEU . 28.9 mm -104.96 120.92 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -126.19 145.17 50.49 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptp180 -91.42 139.87 30.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -142.23 115.11 8.68 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 67.45 27.28 8.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.595 1.188 . . . . 0.0 107.879 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 68.69 4.88 4.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.054 2.142 . . . . 0.0 111.98 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -90.97 151.89 20.91 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 8.0 mp -93.58 125.76 38.37 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 120.821 0.343 . . . . 0.0 111.158 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -122.92 139.21 54.29 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.532 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.9 t -113.8 116.79 29.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -115.05 135.08 54.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.754 0.311 . . . . 0.0 110.414 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.58 126.11 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.2 p -108.13 -23.42 11.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.321 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -128.78 150.26 50.37 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.035 0.445 . . . . 0.0 111.749 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.04 125.97 37.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.56 127.85 61.46 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-O 120.704 0.287 . . . . 0.0 111.231 -171.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.15 134.06 53.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 111.462 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 18.3 m -75.91 110.06 10.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.217 0.532 . . . . 0.0 109.959 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.57 0.84 32.66 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -114.32 165.05 12.02 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 69.1 mt -101.47 155.23 18.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.218 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.1 pt? -99.28 143.82 29.1 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.576 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -110.93 148.08 33.25 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.63 130.2 53.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.88 0.848 . . . . 0.0 111.291 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 69.9 ttt180 -105.18 122.25 45.51 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.699 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.61 118.65 32.69 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.539 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.298 -1.633 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.294 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.462 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 m -102.53 100.11 10.18 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.507 -0.746 . . . . 0.0 109.534 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.39 -174.59 22.37 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.5 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.53 163.66 26.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.463 2.775 . . . . 0.0 111.825 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.12 -15.64 55.34 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.188 0.518 . . . . 0.0 111.604 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.95 -15.91 60.66 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 200' ' ' LEU . 3.4 mm? -109.41 151.38 26.74 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.416 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.83 123.77 12.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.207 0.527 . . . . 0.0 111.898 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.46 109.92 20.42 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.12 142.45 47.42 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 56.5 mt -102.2 127.87 48.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -124.09 94.32 4.18 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 60.93 25.92 15.86 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.414 0.626 . . . . 0.0 111.364 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.19 -8.31 38.29 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 74.7 mt-30 -81.39 126.52 31.72 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -86.77 95.92 10.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.2 p -111.44 122.93 49.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.514 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.22 111.14 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -110.37 156.47 20.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.56 133.11 34.08 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -83.04 -32.35 26.9 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.13 169.5 9.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -92.23 105.38 17.61 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.88 124.46 32.38 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.15 0.5 . . . . 0.0 110.858 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -72.24 151.39 42.89 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.739 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.95 140.76 56.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.96 10.39 58.74 Favored Glycine 0 C--N 1.299 -1.501 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.608 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.0 tp -101.34 126.5 48.11 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t -122.53 158.78 29.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -95.69 174.4 6.99 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.662 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.97 177.93 49.5 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 124.209 0.943 . . . . 0.0 112.166 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.02 132.12 20.72 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.711 2.274 . . . . 0.0 114.039 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -110.39 149.71 29.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -106.04 119.32 38.89 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.627 0.727 . . . . 0.0 111.236 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -170.87 -160.62 19.83 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -148.51 134.63 19.27 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 118.397 1.099 . . . . 0.0 111.089 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.379 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.421 -1.876 0 CA-C-O 122.159 0.981 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.78 87.93 6.32 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.892 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -128.95 168.96 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.703 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.12 148.19 22.6 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.255 1.022 . . . . 0.0 111.455 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 46.0 mt-10 -63.4 -20.03 65.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.343 0.592 . . . . 0.0 110.581 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 m -83.03 -20.43 35.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.063 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.4 t -74.35 131.36 41.05 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.52 0.676 . . . . 0.0 111.295 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 p-90 -66.16 -20.49 66.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.012 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.45 -30.28 71.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.699 0.285 . . . . 0.0 111.487 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 17.0 ptm180 -96.4 2.24 52.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.622 . . . . 0.0 110.467 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mmm -99.02 -1.64 39.25 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.199 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 83.2 mt -93.61 145.54 30.12 Favored Pre-proline 0 N--CA 1.425 -1.716 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.96 127.71 11.69 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.441 1.427 . . . . 0.0 109.883 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -84.13 135.22 34.48 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 27.1 m -135.47 160.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.3 pp -105.28 -19.52 13.78 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.794 0.807 . . . . 0.0 110.876 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.8 133.86 33.96 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.42 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 1.4 pm0 -76.99 -21.57 54.5 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.139 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -67.53 -25.57 65.89 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.3 -38.61 8.79 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.59 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -76.86 94.41 3.89 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 121.395 0.616 . . . . 0.0 111.109 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 200' ' ' LEU . 27.6 p30 -87.04 -13.9 43.05 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.451 175.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 m -126.88 124.51 39.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.33 150.33 37.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.1 mm -110.05 125.0 67.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.62 ' CE1' ' HG3' ' A' ' 189' ' ' ARG . 11.9 p90 -126.74 176.02 7.56 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.12 140.1 52.5 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.496 ' HG2' ' OD1' ' A' ' 183' ' ' ASP . 24.0 ttpp -156.37 132.05 9.59 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.496 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 4.1 m-20 60.32 34.66 20.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.315 0.646 . . . . 0.0 110.805 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 t70 67.62 17.49 9.91 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.436 1.495 . . . . 0.0 111.856 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -126.28 162.17 26.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.197 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.1 mt -97.18 140.4 31.73 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -134.0 153.08 52.02 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -125.88 128.13 47.12 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.602 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.62 ' HG3' ' CE1' ' A' ' 180' ' ' TYR . 51.4 mtp180 -103.44 145.52 29.88 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.96 100.41 11.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 166.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.8 t -82.41 -26.04 33.15 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.61 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.45 141.49 45.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.01 125.19 12.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 123.794 0.684 . . . . 0.0 111.715 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 7.5 p -110.67 114.85 54.34 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 11.1 Cg_exo -72.08 153.6 57.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.466 2.111 . . . . 0.0 112.565 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 p -61.46 115.84 4.21 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.464 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.66 -15.49 45.27 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -81.47 157.58 38.51 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.74 157.06 16.63 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.339 0.59 . . . . 0.0 110.377 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 107' ' ' LEU . 1.5 pt? -127.81 157.1 41.34 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.107 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -134.85 148.02 50.03 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.39 133.44 46.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.54 0.686 . . . . 0.0 112.215 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 27.2 ttt180 -117.39 147.76 42.37 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.09 153.0 33.51 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.099 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 m -96.97 91.64 5.7 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.32 -173.11 29.55 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.044 -1.075 . . . . 0.0 112.176 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -83.14 158.55 15.3 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.287 2.658 . . . . 0.0 112.567 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.07 -19.05 63.29 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.719 0.808 . . . . 0.0 111.837 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -80.21 -22.34 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.096 0.95 . . . . 0.0 109.5 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.52 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 4.3 mm? -108.4 160.47 15.85 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.266 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 12.8 tp10 -155.71 147.26 22.9 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.772 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 101' ' ' TRP . 1.3 tm? -99.38 103.55 15.35 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.1 146.42 23.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.45 104.62 13.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.43 99.4 8.98 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.57 23.38 11.76 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.213 1.005 . . . . 0.0 111.485 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.16 57.36 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.448 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.37 143.16 26.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.99 0.424 . . . . 0.0 111.475 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -82.98 134.17 35.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.844 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.7 m -131.84 121.53 24.25 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 166' ' ' LEU . 19.8 m -86.47 96.2 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.378 1.085 . . . . 0.0 110.602 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -114.02 158.89 20.59 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.372 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.23 18.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 77.7 ttt180 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.9 mt -119.99 155.53 32.66 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' OG ' ' A' ' 196' ' ' SER . 47.3 t -77.04 123.92 27.04 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.5 mm? -69.93 121.99 18.43 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.513 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.6 m -90.62 139.77 30.4 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.872 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.68 120.46 10.09 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.12 16.05 Favored Glycine 0 C--N 1.301 -1.381 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.241 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -64.04 126.88 29.11 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -136.69 145.68 45.02 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -91.72 175.05 7.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.62 -172.46 45.45 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.314 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.99 123.19 6.11 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.208 1.939 . . . . 0.0 112.49 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -103.81 150.39 24.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -104.41 107.13 17.9 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.774 0.797 . . . . 0.0 110.495 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.67 177.49 43.74 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.4 p -129.11 133.55 47.7 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 119.231 1.516 . . . . 0.0 113.127 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 170.616 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 204' ' ' LEU . 1.8 pp . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.5 mmm -116.42 94.57 4.68 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.35 171.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.022 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.16 147.82 38.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 123.613 0.571 . . . . 0.0 110.473 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.26 -33.27 67.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 111.228 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -100.26 12.78 36.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.652 0.263 . . . . 0.0 111.155 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.4 t -79.52 132.97 36.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 24.4 p-90 -65.05 -23.21 67.12 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.06 -25.52 68.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.104 0.478 . . . . 0.0 112.199 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 1.6 ptm180 -95.04 3.17 55.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 mmt -96.47 -22.63 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 118' ' ' VAL . 9.9 mp -88.35 153.05 50.76 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.99 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.27 129.69 16.38 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.588 2.192 . . . . 0.0 111.61 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -82.51 138.13 34.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.99 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 175' ' ' ALA . 29.3 m -140.54 157.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 98.2 mt -115.53 -6.15 12.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 118.204 0.456 . . . . 0.0 112.106 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.8 p -87.85 151.34 22.92 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.393 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.19 -23.68 35.35 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.598 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -69.98 -39.06 76.15 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.433 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.58 -33.36 23.41 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.966 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.631 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -84.84 99.7 11.08 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-O 121.366 0.603 . . . . 0.0 112.499 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.443 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 5.6 p30 -74.76 -19.58 60.16 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.187 175.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.9 p -131.45 142.89 50.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.85 141.14 48.28 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 188' ' ' CYS . 9.4 mm -110.36 126.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -130.94 177.7 7.23 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -122.27 146.13 47.58 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.227 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.8 129.65 13.35 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.95 25.66 13.97 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.464 1.126 . . . . 0.0 109.401 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 69.36 13.63 8.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.331 1.452 . . . . 0.0 112.267 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.56 156.05 21.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.0 mt -93.6 135.26 35.05 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.219 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -126.32 139.57 53.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.69 ' SG ' HD12 ' A' ' 179' ' ' ILE . 53.1 m -116.46 123.49 47.63 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -124.83 148.11 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.725 0.298 . . . . 0.0 110.331 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 124' ' ' LEU . 67.1 t -98.06 121.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.0 p -114.25 -21.89 10.22 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 176' ' ' ASN . 64.6 mmtt -125.76 161.69 26.79 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.7 131.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.684 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.7 120.39 43.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.74 140.78 52.26 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.604 2.203 . . . . 0.0 111.791 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 123' ' ' SER . 7.5 m -63.38 114.71 4.02 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.29 -16.57 35.12 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.695 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.83 159.53 38.07 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.876 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.74 125.27 35.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 200' ' ' LEU . 0.7 OUTLIER -98.62 163.39 12.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.366 -178.461 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -121.41 144.95 48.39 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.933 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.08 121.97 52.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.187 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.631 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.1 ttm180 -100.4 137.12 39.25 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 155' ' ' LEU . 66.0 mt -96.55 145.97 25.24 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.317 -0.84 0 CA-C-O 121.938 0.875 . . . . 0.0 112.075 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.034 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.8 t -89.82 96.15 10.56 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.02 -171.25 32.9 Favored Glycine 0 N--CA 1.42 -2.424 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.738 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.83 162.21 12.06 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.245 2.63 . . . . 0.0 111.597 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.28 -16.92 51.14 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.567 0.699 . . . . 0.0 110.539 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.36 -26.41 62.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.173 0.987 . . . . 0.0 109.368 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 1.6 mm? -94.37 156.88 16.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.808 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.44 134.34 37.61 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.185 0.517 . . . . 0.0 111.846 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.3 122.71 42.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.63 151.23 49.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.95 97.7 7.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 11.5 mm100 -109.44 132.88 53.71 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 66.61 12.89 9.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 123.766 0.666 . . . . 0.0 110.916 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.39 22.62 62.26 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.968 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 14.0 pt20 -133.09 167.98 19.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -75.1 120.0 20.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 38.1 t -122.16 146.57 47.11 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.81 120.06 63.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.294 0.568 . . . . 0.0 110.197 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -129.46 152.73 48.68 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.921 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.24 109.1 20.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -72.11 -48.9 40.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.3 mt -89.13 129.19 35.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.7 m -67.57 126.2 28.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 190' ' ' VAL . 58.6 mt -97.99 133.86 41.89 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.7 t -99.12 161.53 13.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.501 0.501 . . . . 0.0 110.205 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.95 128.87 37.87 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.214 0.606 . . . . 0.0 110.863 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.81 63.7 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.721 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.87 130.69 42.95 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -135.67 160.03 39.8 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.992 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -99.72 175.24 5.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.07 176.13 51.73 Favored Glycine 0 N--CA 1.441 -0.981 0 O-C-N 123.605 0.566 . . . . 0.0 112.56 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.47 123.38 10.14 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.669 2.246 . . . . 0.0 113.496 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.65 149.95 22.27 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.99 105.71 15.88 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.689 0.757 . . . . 0.0 112.335 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.73 8.23 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 p -145.5 138.78 26.34 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.583 0.692 . . . . 0.0 111.82 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mt . . . . . 0 C--O 1.251 1.15 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.179 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.708 0.289 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.9 mtt -109.01 94.69 5.18 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.86 179.0 3.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.361 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.75 140.26 57.62 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 123.473 0.483 . . . . 0.0 111.284 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -51.72 -36.69 47.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.326 1.05 . . . . 0.0 113.399 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -103.6 9.97 37.15 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.819 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.516 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 41.0 t -78.68 137.31 37.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.154 0.502 . . . . 0.0 110.206 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' LEU . 9.1 p-90 -60.96 -27.11 68.01 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.3 mt -56.98 -32.49 66.14 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.088 0.47 . . . . 0.0 112.088 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.64 -1.17 47.3 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.586 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.4 mtp -95.52 -6.22 41.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 162' ' ' TRP . 8.8 mp -94.73 141.62 23.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.18 122.5 10.99 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.348 2.032 . . . . 0.0 111.389 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -79.26 127.84 32.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.21 156.46 23.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -83.68 -39.89 19.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.385 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.7 p -91.72 155.59 18.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.493 0.663 . . . . 0.0 112.532 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -87.23 -16.97 33.68 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.469 -177.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.9 -26.96 36.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.399 0.619 . . . . 0.0 109.426 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.37 -31.99 22.65 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.71 143.58 37.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' A' ' 200' ' ' LEU . 16.1 p30 -118.43 2.08 11.81 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.4 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.2 p -151.31 135.72 16.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 15.8 pt-20 -129.0 149.87 50.65 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.038 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 163' ' ' LEU . 24.1 mm -109.52 116.36 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -122.67 157.77 31.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -102.16 144.3 30.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.2 tttm -161.71 125.55 3.24 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 65.46 32.73 9.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.127 0.971 . . . . 0.0 111.148 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.1 t70 75.0 9.36 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.378 1.085 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.05 162.25 22.77 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.532 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.68 137.26 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.559 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.5 m95 -123.57 133.99 53.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 54.0 t -106.8 126.82 52.79 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -127.39 147.35 50.28 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.436 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 124' ' ' LEU . 60.0 t -84.14 115.12 25.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.003 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.8 p -80.83 -33.7 34.46 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 176' ' ' ASN . 20.2 ptmt -146.3 152.72 39.61 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.1 129.82 20.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 123.994 0.809 . . . . 0.0 111.697 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.59 125.2 36.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.69 164.3 16.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.127 2.551 . . . . 0.0 113.34 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.1 m -66.97 101.45 0.85 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.466 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.31 16.8 52.42 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.37 156.86 35.9 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 mp -95.13 141.09 29.16 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.502 0.668 . . . . 0.0 111.093 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 176' ' ' ASN . 3.2 mp -95.65 149.16 21.76 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.029 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.03 131.67 44.45 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.92 134.44 42.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.46 0.648 . . . . 0.0 111.612 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.419 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.9 ttt180 -104.61 142.05 35.34 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.912 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.86 139.83 32.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 CA--C 1.547 0.852 0 O-C-N 123.687 0.617 . . . . 0.0 110.821 179.412 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.477 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 m -91.58 82.42 5.31 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.61 160.69 14.39 Favored Glycine 0 N--CA 1.419 -2.453 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.96 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.553 ' HB2' ' OE1' ' A' ' 106' ' ' GLU . 60.7 Cg_endo -84.18 166.47 12.66 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.961 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -63.26 -19.36 64.5 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.801 0.84 . . . . 0.0 113.002 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 104' ' ' PRO . 23.7 mp0 -82.44 -17.99 43.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.611 0.72 . . . . 0.0 110.142 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.9 156.2 24.39 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.018 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.504 ' OE2' ' HD2' ' A' ' 119' ' ' ARG . 33.0 tt0 -141.59 126.27 17.96 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.813 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.18 108.72 20.85 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.24 154.59 50.87 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.769 0.319 . . . . 0.0 110.234 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.9 mp -91.99 101.29 13.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 121.879 0.847 . . . . 0.0 110.167 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.534 ' HB3' ' SG ' ' A' ' 117' ' ' CYS . 50.7 tt0 -106.17 124.62 49.87 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 113.795 -1.548 . . . . 0.0 106.998 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 69.67 12.35 8.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.67 1.224 . . . . 0.0 109.677 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.25 2.23 60.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.024 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 43.8 mt-30 -114.65 146.38 40.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 117.393 0.596 . . . . 0.0 110.147 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -75.86 119.94 20.53 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 112' ' ' GLN . 9.4 p -138.28 149.38 45.65 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.861 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.41 111.15 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 108' ' ' GLU . 3.4 ptp180 -116.69 158.65 23.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.96 124.8 28.6 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -77.26 -33.97 55.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.68 0.753 . . . . 0.0 109.587 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 pp -127.01 155.74 42.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -66.25 113.87 4.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.717 0.77 . . . . 0.0 111.734 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 190' ' ' VAL . 86.0 mt -79.64 138.66 37.47 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 t -127.19 159.04 35.5 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.83 125.28 22.34 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 124.03 0.831 . . . . 0.0 110.053 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.02 36.03 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.055 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.8 t -129.13 151.77 49.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -96.66 173.86 7.11 Favored 'General case' 0 C--N 1.267 -3.015 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.815 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.5 175.71 54.83 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.8 Cg_endo -69.25 129.93 19.04 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.737 2.292 . . . . 0.0 113.279 -177.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -107.28 160.44 15.61 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.96 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.86 132.64 34.78 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.743 0.782 . . . . 0.0 112.031 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 162.18 -177.62 38.3 Favored Glycine 0 N--CA 1.414 -2.81 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -144.91 129.48 18.02 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 117.414 0.607 . . . . 0.0 111.597 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.57 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 122.238 1.018 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.1 mtp -87.03 82.67 7.67 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.39 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.44 HG12 ' HA3' ' A' ' 135' ' ' GLY . 32.8 m -105.04 177.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.309 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 161' ' ' CYS . 10.7 t70 -49.37 141.48 8.83 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.089 0.868 . . . . 0.0 110.971 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.57 -20.51 47.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.8 m -114.35 7.37 16.36 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.061 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.2 t -69.76 129.22 38.99 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.949 0.404 . . . . 0.0 109.919 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.8 p-90 -56.08 -27.93 55.59 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.437 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.9 mt -60.86 -32.76 72.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.825 0.45 . . . . 0.0 112.012 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.7 ptm180 -93.05 -0.96 57.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.931 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.477 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 22.6 ptm -110.56 5.97 21.56 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.552 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 88.7 mt -81.6 143.84 51.69 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.25 126.05 13.17 Favored 'Trans proline' 0 C--O 1.253 1.266 0 C-N-CA 121.722 1.615 . . . . 0.0 109.839 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -87.52 139.78 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 0.0 111.864 -174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 152.27 32.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.584 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.3 tp -97.15 -8.36 30.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.673 0.749 . . . . 0.0 109.766 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.8 p -106.71 134.81 49.28 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.4 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.46 ' HB3' ' NE ' ' A' ' 203' ' ' ARG . 10.9 pt-20 -77.73 -21.73 51.43 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.855 -0.528 . . . . 0.0 111.332 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.55 -28.98 67.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.151 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.59 -10.98 49.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.966 0.412 . . . . 0.0 110.79 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -87.37 158.02 19.12 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.957 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -122.16 -24.73 5.04 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.215 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.5 p -130.24 130.98 45.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.24 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.78 123.29 45.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.303 0.573 . . . . 0.0 110.247 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.791 HD13 HG23 ' A' ' 202' ' ' VAL . 1.8 mp -108.44 123.81 64.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.879 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -143.22 169.52 17.47 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 38.2 ptt180 -106.19 139.15 41.14 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.9 tttp -138.22 122.66 18.38 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.78 26.41 12.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.824 1.297 . . . . 0.0 107.958 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.86 67.78 0.88 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.319 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -159.49 158.22 31.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 4.3 mm? -93.33 129.37 39.47 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -129.36 150.18 50.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.3 t -135.46 114.35 12.05 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -103.64 138.9 39.66 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 124' ' ' LEU . 33.0 t -78.44 120.15 28.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 t -105.0 -1.0 26.29 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.42 ' O ' HG12 ' A' ' 190' ' ' VAL . 30.3 mmtp -139.69 176.51 8.67 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.55 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.5 t -112.12 112.06 52.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.57 140.61 57.59 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 121.867 1.712 . . . . 0.0 111.094 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.1 p -54.16 124.98 17.35 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.418 0.627 . . . . 0.0 111.411 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.5 -16.93 44.0 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.487 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.42 162.4 30.63 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 117' ' ' CYS . 7.7 mp -97.98 168.24 10.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.39 0.614 . . . . 0.0 111.304 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 200' ' ' LEU . 1.2 pt? -132.8 149.09 52.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.471 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.44 147.06 43.97 Favored 'General case' 0 C--O 1.253 1.287 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.791 HG23 HD13 ' A' ' 179' ' ' ILE . 5.1 p -96.79 128.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.838 0.828 . . . . 0.0 112.949 -173.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.46 ' NE ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 tpt180 -100.4 112.72 25.1 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.489 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.73 116.35 22.64 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.164 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.446 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 m -107.36 90.12 3.21 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.62 -176.94 20.84 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 158.04 40.0 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.93 2.42 . . . . 0.0 111.993 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.47 -16.75 57.2 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.257 1.023 . . . . 0.0 111.307 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 122' ' ' LEU . 11.0 mp0 -75.65 -20.33 58.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.446 1.117 . . . . 0.0 108.232 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.93 159.78 16.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.042 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 121' ' ' ARG . 24.8 mm-40 -137.09 132.04 33.56 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.962 0.505 . . . . 0.0 111.23 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 3.1 tm? -88.49 99.07 12.0 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 170.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.16 144.55 43.5 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.509 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.09 126.89 42.56 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.347 0.594 . . . . 0.0 110.781 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -105.86 92.23 4.08 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 36.16 73.22 0.09 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 126.392 1.877 . . . . 0.0 114.08 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.57 -18.7 56.89 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.06 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -112.27 123.59 50.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.871 0.836 . . . . 0.0 112.005 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -79.41 123.22 27.31 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.9 p -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.947 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.68 111.9 21.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 199' ' ' LEU . 15.2 ptp180 -127.06 157.16 40.37 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.239 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.11 121.19 17.03 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.0 ttt180 -86.12 -52.5 5.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 106' ' ' GLU . 9.3 mp -94.36 153.25 18.08 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.6 m -76.9 110.89 11.89 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.8 mm? -70.4 117.84 12.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.0 p -96.29 158.67 15.33 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.628 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.05 128.95 36.06 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 124.712 1.205 . . . . 0.0 111.698 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.83 -18.97 54.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.248 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.65 129.99 41.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 m -136.48 161.73 35.04 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -107.71 176.23 5.22 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.501 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.6 -171.63 39.67 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.985 0.803 . . . . 0.0 112.744 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.24 125.09 7.58 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.795 2.33 . . . . 0.0 113.827 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -102.3 168.55 9.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -106.34 135.58 47.59 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 120.955 0.407 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 156.78 179.21 31.58 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.2 m -139.03 146.05 40.36 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 117.902 0.851 . . . . 0.0 111.474 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.227 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 157' ' ' VAL . 2.3 pp . . . . . 0 N--CA 1.431 -1.395 0 CA-C-O 120.952 0.406 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.88 85.81 2.28 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.489 HG22 HD13 ' A' ' 155' ' ' LEU . 12.0 m -130.84 157.8 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.08 148.36 26.68 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 123.856 0.722 . . . . 0.0 112.374 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.13 -43.98 64.28 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.598 1.159 . . . . 0.0 112.014 -175.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.9 m -90.04 11.34 20.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.48 127.37 32.71 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 18.8 p-90 -60.18 -27.29 67.01 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 179' ' ' ILE . 98.0 mt -63.08 -25.7 68.49 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -95.44 1.13 53.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.409 0.623 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.85 -7.01 55.26 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.502 0.668 . . . . 0.0 109.758 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.28 144.36 27.76 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.06 131.37 19.27 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 122.046 1.831 . . . . 0.0 111.212 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.27 135.25 39.64 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.51 133.88 65.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.56 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.468 HD23 ' H ' ' A' ' 170' ' ' LEU . 2.4 pt? -68.28 -38.16 81.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.289 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -86.48 134.94 33.64 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.211 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -28.43 62.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.044 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -69.44 -22.83 63.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.416 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.1 0.94 56.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.069 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.75 152.84 21.37 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 200' ' ' LEU . 94.3 m-20 -114.44 -16.03 11.99 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.424 0.63 . . . . 0.0 109.979 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.0 p -145.23 128.23 16.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.234 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 179' ' ' ILE . 10.3 pt-20 -106.24 141.29 37.83 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.798 HD13 HG23 ' A' ' 202' ' ' VAL . 1.6 mp -116.7 116.72 53.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.513 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 52.5 p90 -115.73 159.85 20.85 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -100.94 138.56 37.82 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -157.59 132.85 8.9 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 67.35 20.88 9.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.157 0.983 . . . . 0.0 108.864 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 70.03 13.57 7.84 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.143 1.777 . . . . 0.0 111.822 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -112.8 164.73 13.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.92 136.62 41.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 179' ' ' ILE . 77.6 m95 -124.54 125.59 44.45 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.671 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.4 t -104.03 124.46 49.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -125.53 138.94 53.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' A' ' 124' ' ' LEU . 49.0 t -90.35 122.03 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.6 p -110.31 3.19 19.65 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.105 0.479 . . . . 0.0 112.166 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -131.11 169.92 15.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.51 108.06 20.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 124' ' ' LEU . 19.2 t -103.34 111.03 64.84 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.27 153.6 66.44 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.288 1.992 . . . . 0.0 111.296 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -65.22 126.33 27.83 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.81 -17.23 49.83 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.91 159.41 31.45 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.784 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 119' ' ' ARG . 47.3 mt -95.12 165.47 12.4 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.4 0.619 . . . . 0.0 109.757 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.2 pt? -134.46 146.01 49.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.967 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.75 151.11 32.4 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.798 HG23 HD13 ' A' ' 179' ' ' ILE . 7.7 p -99.72 129.81 49.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 O-C-N 123.855 0.722 . . . . 0.0 112.183 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -119.28 128.91 54.59 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.17 154.78 19.88 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 11.2 p . . . . . 0 CA--C 1.551 0.992 0 C-N-CA 123.481 0.712 . . . . 0.0 112.432 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 8.4 p-90 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 62.35 75.84 0.39 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.982 0.896 . . . . 0.0 111.739 -176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.84 174.78 27.46 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.96 161.7 38.45 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -76.46 -0.79 24.21 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -88.65 -24.76 22.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.157 0.979 . . . . 0.0 108.642 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.551 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.2 mm? -96.09 168.21 10.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.376 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.599 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 29.4 tt0 -150.38 128.16 11.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.6 tm? -93.02 118.61 31.38 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.41 135.75 55.03 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.74 101.94 10.43 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -110.46 119.34 38.86 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 67.83 18.4 9.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.813 1.292 . . . . 0.0 109.935 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.52 -4.35 79.67 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.451 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -114.53 174.9 5.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.243 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.54 136.55 34.22 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.016 0.436 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 43.7 t -147.18 148.45 31.54 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 200' ' ' LEU . 12.8 t -120.56 130.72 74.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.599 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -133.87 168.98 17.76 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.843 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.5 120.02 36.05 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -81.71 -40.08 23.3 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.49 145.66 24.64 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.0 m -66.06 118.17 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.406 ' HB2' HG12 ' A' ' 194' ' ' VAL . 82.6 mt -75.94 105.35 6.93 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.7 p -82.7 154.05 25.03 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.916 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.78 124.44 21.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.62 -10.83 57.78 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.649 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -75.42 143.54 42.65 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 m -150.76 171.53 17.04 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.551 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 27.2 m-90 -113.93 166.43 11.6 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.29 -177.47 33.9 Favored Glycine 0 N--CA 1.436 -1.33 0 O-C-N 123.817 0.698 . . . . 0.0 113.228 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.68 133.26 23.48 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 122.879 2.386 . . . . 0.0 112.627 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.01 152.45 24.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.81 120.71 37.65 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.42 -168.09 41.0 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.4 p -147.62 135.42 21.07 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.307 -1.253 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 170.592 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.977 0.894 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.6 mmm -88.01 96.07 10.37 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.2 170.1 20.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.56 168.74 19.32 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.83 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -59.21 -34.46 72.19 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 124.192 0.997 . . . . 0.0 112.273 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.0 p -95.54 7.69 45.52 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.6 t -82.45 124.53 30.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.002 0.429 . . . . 0.0 110.013 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -61.37 -22.13 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.668 0.787 . . . . 0.0 112.78 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.55 -32.68 72.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.623 0.369 . . . . 0.0 111.957 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -93.84 2.72 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.924 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mtp -97.1 1.25 49.78 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.11 151.02 37.33 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.88 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.58 124.54 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.277 1.984 . . . . 0.0 110.052 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -81.8 138.8 35.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 21.1 m -136.74 148.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.168 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.05 -13.28 17.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.68 0.753 . . . . 0.0 109.114 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -98.77 134.91 40.99 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.636 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 8.5 pt-20 -83.73 -5.3 59.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.417 0.627 . . . . 0.0 110.358 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.04 -29.08 64.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.616 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.04 -26.45 13.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.103 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.493 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -83.87 110.86 18.71 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.812 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 200' ' ' LEU . 11.2 p30 -82.89 -25.08 32.82 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.327 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.8 m -127.82 145.5 50.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.39 145.38 50.27 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -102.99 120.64 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -134.0 163.86 28.6 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.628 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -104.58 123.71 48.03 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 40.8 ttmt -118.39 95.73 5.0 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.4 t70 59.02 72.13 0.55 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.962 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 t70 76.37 -27.97 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.119 -1.401 . . . . 0.0 113.998 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -100.36 151.85 21.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.305 -0.247 . . . . 0.0 111.063 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -93.58 128.46 39.74 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.568 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -122.14 138.05 54.6 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.96 124.32 52.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -125.24 147.19 49.19 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.61 118.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.5 p -101.61 -31.89 10.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.207 0.527 . . . . 0.0 110.89 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.26 141.87 51.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.72 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.339 0.59 . . . . 0.0 111.999 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 124' ' ' LEU . 10.4 p -119.06 126.9 26.81 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.2 170.84 14.97 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.619 2.213 . . . . 0.0 113.448 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.1 m -59.77 121.82 12.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.558 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.42 -6.8 57.83 Favored Glycine 0 N--CA 1.436 -1.349 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.248 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.9 153.07 44.97 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.52 138.84 31.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -106.04 159.35 16.13 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.104 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -134.45 143.3 47.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.11 117.87 42.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.598 0.713 . . . . 0.0 111.187 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.5 ttt180 -93.06 124.77 37.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.513 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.82 109.65 20.37 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.292 -1.916 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.977 -177.56 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 160' ' ' SER . 19.8 m -88.33 77.91 8.08 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.463 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.28 158.56 27.73 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.259 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.36 162.4 38.43 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.278 2.652 . . . . 0.0 111.977 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.91 -0.04 37.4 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.54 -20.37 50.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 200' ' ' LEU . 3.7 mm? -109.78 151.96 26.31 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.215 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -127.32 141.92 51.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.49 122.03 40.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.04 54.58 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.913 0.387 . . . . 0.0 110.59 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.57 104.56 14.41 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -106.25 94.38 5.13 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.777 0.799 . . . . 0.0 109.409 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.37 59.17 4.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.043 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.94 -22.18 19.62 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.962 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -87.82 128.85 35.34 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.449 -0.442 . . . . 0.0 111.86 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -82.54 113.71 20.45 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.544 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.7 p -122.28 144.86 48.73 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 17.8 m -107.68 125.42 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.19 0.519 . . . . 0.0 109.704 -177.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -138.65 150.75 46.56 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.02 127.77 34.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.57 -34.05 14.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.52 0.676 . . . . 0.0 109.795 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.27 163.67 12.42 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.1 m -88.71 128.47 35.61 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.512 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.431 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.2 mm? -90.27 127.81 36.25 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.2 p -112.22 158.9 19.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.05 118.76 8.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.978 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.21 -0.49 55.99 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.371 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.3 tp -82.38 139.7 33.92 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 74.3 p -144.67 157.36 44.23 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.02 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.613 ' HB2' ' SG ' ' A' ' 188' ' ' CYS . 26.3 m-90 -103.76 175.1 5.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.84 -165.66 37.74 Favored Glycine 0 C--N 1.307 -1.052 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.079 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 61.8 Cg_endo -79.46 123.32 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.187 1.925 . . . . 0.0 112.85 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.549 ' HE2' ' SG ' ' A' ' 188' ' ' CYS . 78.8 m-85 -98.84 159.09 15.2 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.62 104.22 14.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.351 1.072 . . . . 0.0 112.122 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.53 171.49 44.06 Favored Glycine 0 N--CA 1.409 -3.165 0 N-CA-C 106.785 -2.526 . . . . 0.0 106.785 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.7 m -132.46 137.78 47.36 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 118.096 0.948 . . . . 0.0 112.011 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.661 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp . . . . . 0 N--CA 1.428 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.42 89.78 8.12 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.61 177.59 2.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.504 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.0 144.34 57.36 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.706 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -57.03 -29.68 63.58 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.259 1.023 . . . . 0.0 113.457 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 102' ' ' SER . 22.0 t -102.15 -3.33 27.62 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 122.099 -0.376 . . . . 0.0 110.278 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.6 t -65.88 119.86 12.05 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.522 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.4 p-90 -53.03 -26.89 17.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.315 1.046 . . . . 0.0 113.654 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.03 -30.83 66.44 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.156 0.582 . . . . 0.0 111.85 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -94.53 -7.35 41.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.89 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 162' ' ' TRP . 22.8 ptm -102.27 1.28 35.57 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.263 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 86.9 mt -82.69 152.8 67.11 Favored Pre-proline 0 N--CA 1.423 -1.795 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 8.4 Cg_exo -71.31 118.08 5.48 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.304 1.336 . . . . 0.0 110.376 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.68 132.07 35.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.037 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.05 164.46 23.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.509 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.3 tp -100.87 -31.3 11.22 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.355 0.598 . . . . 0.0 109.518 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.4 p -88.98 134.99 33.79 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.671 0.748 . . . . 0.0 112.09 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -71.45 -17.46 62.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.673 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.06 -32.77 63.44 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.399 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.76 -37.22 30.77 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.55 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -71.89 148.95 45.6 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.406 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -121.12 -10.03 9.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.057 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.0 m -152.8 136.96 16.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 203' ' ' ARG . 10.7 pt-20 -116.61 143.41 45.65 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.795 0.331 . . . . 0.0 111.588 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 188' ' ' CYS . 27.0 mm -102.03 122.99 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 51.7 p90 -131.68 160.06 36.53 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.6 tttt -144.03 118.52 9.7 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 64.9 26.71 12.83 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.829 0.823 . . . . 0.0 109.528 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.1 t70 71.21 -1.93 2.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.264 1.826 . . . . 0.0 111.969 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -90.75 155.74 18.58 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 71.9 mt -94.07 128.49 40.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.763 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 62.5 m95 -124.75 139.34 53.94 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 130' ' ' TRP . 4.9 p -121.67 128.45 51.87 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -118.13 144.84 45.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.326 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 124' ' ' LEU . 62.1 t -86.38 120.71 36.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.6 p -86.23 -45.39 11.34 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.398 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -136.29 151.84 50.07 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 120.807 0.337 . . . . 0.0 111.663 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 49.2 t -64.29 128.7 27.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.795 -172.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.64 117.67 22.75 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.82 165.61 32.3 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.482 2.122 . . . . 0.0 112.917 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 7.9 m -60.65 129.49 41.78 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.892 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.85 -17.58 48.83 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.32 150.36 23.57 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.693 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 11.1 mp -89.01 146.6 24.76 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -125.05 146.73 49.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.075 0.464 . . . . 0.0 110.402 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 43.2 m-85 -113.76 144.25 43.28 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.772 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.64 133.63 41.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.975 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 71.6 ttt180 -108.15 137.96 45.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.45 153.95 18.8 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 12.3 p . . . . . 0 C--O 1.245 0.823 0 CA-C-O 122.463 1.125 . . . . 0.0 112.527 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 1.4 p-90 . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 111.291 0.108 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.0 m 58.95 41.1 21.66 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.981 0.912 . . . . 0.0 111.495 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.45 -169.38 22.83 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.266 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -85.81 175.65 5.82 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.122 2.548 . . . . 0.0 112.569 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.1 -19.45 43.6 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.22 0.533 . . . . 0.0 111.81 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -82.96 -16.96 45.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.781 0.801 . . . . 0.0 109.586 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 200' ' ' LEU . 4.1 mm? -121.8 152.94 38.96 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.242 -174.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.5 140.7 33.55 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.021 0.439 . . . . 0.0 111.158 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.56 99.01 11.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.06 130.25 50.13 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.6 mt -90.31 112.15 23.61 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.21 97.16 7.01 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 64.27 27.5 13.83 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.087 1.422 . . . . 0.0 109.024 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.46 -11.42 68.68 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.826 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -81.84 130.45 35.07 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -79.64 101.5 8.39 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.73 0.776 . . . . 0.0 110.115 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.8 m -110.14 122.61 48.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.556 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 166' ' ' LEU . 25.3 t -94.91 100.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -122.26 146.55 47.18 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.765 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.76 140.35 49.45 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.577 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 4.5 mmp_? -93.36 -36.74 12.36 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.35 155.95 26.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 m -75.07 105.21 5.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 96.8 mt -70.4 117.04 11.44 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -92.86 147.27 22.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.833 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.81 129.48 39.93 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.617 0.722 . . . . 0.0 111.083 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.96 -20.24 22.14 Favored Glycine 0 C--N 1.301 -1.361 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.807 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.72 125.55 27.14 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 m -134.29 149.93 50.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -92.14 175.24 6.93 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.173 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.28 150.67 48.93 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.929 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.12 127.34 25.32 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.199 2.599 . . . . 0.0 111.912 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 163' ' ' LEU . 55.9 m-85 -98.14 153.27 18.56 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.707 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -93.82 116.02 28.46 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.731 0.644 . . . . 0.0 110.024 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.46 45.31 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.8 m -144.58 134.73 24.14 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 117.682 0.741 . . . . 0.0 110.745 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 C--N 1.309 -1.166 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 172.484 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.41 -2.468 0 CA-C-O 121.497 0.665 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 59.8 ttp -87.87 92.94 9.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.43 173.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.164 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.21 152.99 40.85 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.471 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.76 -24.22 65.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -91.98 10.52 28.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.871 0.367 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.95 111.14 21.15 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 25.4 p-90 -57.97 -21.02 42.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 113.385 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 133' ' ' PHE . 70.8 mt -59.45 -30.74 68.72 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.089 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -96.59 2.4 52.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.195 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 mmt -83.94 -21.32 31.86 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.65 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' HG11 ' A' ' 118' ' ' VAL . 8.3 mp -82.06 150.82 65.73 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 27.3 Cg_exo -63.31 127.16 19.34 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 121.787 1.658 . . . . 0.0 108.967 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -88.43 139.88 30.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.68 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 23.5 m -131.2 158.24 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.669 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 82.3 mt -101.96 -26.12 13.53 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.087 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.3 p -87.08 156.04 19.89 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.347 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 13.6 pt-20 -94.27 -19.31 20.81 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.799 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -51.8 -45.45 63.86 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.716 0.807 . . . . 0.0 111.173 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -88.47 -14.61 37.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.647 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.435 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -88.78 115.34 26.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.568 0.699 . . . . 0.0 111.126 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.19 -15.84 22.99 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-O 121.855 0.836 . . . . 0.0 109.295 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.5 m -139.28 146.58 40.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.31 155.47 48.55 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 122.584 0.353 . . . . 0.0 110.271 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.0 mm -112.92 123.57 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -128.15 149.36 50.46 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptt180 -97.24 133.14 42.26 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.097 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.71 126.68 15.45 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 58.72 30.22 19.67 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.393 1.058 . . . . 0.0 110.209 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.8 t70 76.49 -8.96 1.56 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.285 1.434 . . . . 0.0 112.601 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -93.05 154.03 18.35 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 80.0 mt -93.79 126.16 38.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.959 0.409 . . . . 0.0 110.081 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -116.28 124.43 50.16 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.389 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.89 110.96 23.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.01 144.82 39.52 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.74 113.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 173.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 t -80.63 -34.45 35.01 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.831 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -148.59 160.18 43.37 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 122.358 -0.214 . . . . 0.0 110.669 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 40.6 t -72.03 123.16 25.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 124.262 0.976 . . . . 0.0 112.716 -171.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 5.9 p -114.18 120.7 37.97 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 23.9 Cg_exo -65.53 158.25 54.05 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.015 2.477 . . . . 0.0 113.526 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.3 m -59.38 113.8 2.36 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.749 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.4 -22.95 14.44 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.942 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.99 152.13 43.46 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.6 155.76 16.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 107' ' ' LEU . 1.2 pt? -140.1 147.02 39.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.544 0.688 . . . . 0.0 111.22 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 5.8 m-85 -106.46 154.63 20.55 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.776 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.68 130.66 61.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.039 0.447 . . . . 0.0 110.266 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 ttp180 -102.54 139.68 37.82 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.104 -0.372 . . . . 0.0 110.43 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.86 134.71 38.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.526 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 8.3 p-90 . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 162' ' ' TRP . 5.6 t -174.86 178.25 1.87 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.96 -41.45 8.68 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.41 115.47 2.47 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.758 2.779 . . . . 0.0 114.653 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 37.5 mt-10 -77.37 -3.04 38.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.674 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.0 mp0 -87.22 -14.75 40.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.965 0.888 . . . . 0.0 109.163 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.31 164.5 15.11 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.114 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -144.55 135.84 25.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.36 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -85.9 130.46 34.54 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.38 132.33 56.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.77 0.319 . . . . 0.0 110.328 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.0 mt -108.5 113.56 26.69 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.96 106.58 14.6 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 65.8 23.94 11.42 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.591 0.71 . . . . 0.0 110.675 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.47 78.8 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.868 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.35 121.27 26.48 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 116' ' ' ARG . 11.1 ptm180 -72.38 118.1 14.86 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.393 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.58 161.14 37.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.57 129.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.894 0.378 . . . . 0.0 110.256 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -125.57 140.82 52.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.584 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.69 119.81 25.68 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 8.3 ptm180 -75.34 -35.15 61.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.603 0.716 . . . . 0.0 111.285 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 122' ' ' LEU . 2.6 pt? -122.5 176.59 5.82 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.5 m -83.22 110.46 18.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.911 0.386 . . . . 0.0 110.479 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 190' ' ' VAL . 85.8 mt -82.36 132.55 35.22 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -119.4 165.24 14.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.62 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 190' ' ' VAL . 56.7 mt-10 -62.35 117.69 6.47 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 124.171 0.988 . . . . 0.0 109.943 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.12 -21.82 7.28 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.326 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.5 tp -77.07 129.18 35.71 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -142.55 156.92 45.17 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.614 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -105.4 169.92 8.18 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.73 -174.09 38.83 Favored Glycine 0 N--CA 1.436 -1.329 0 O-C-N 123.898 0.749 . . . . 0.0 113.213 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.22 123.61 7.89 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.524 2.149 . . . . 0.0 113.375 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 163' ' ' LEU . 67.8 m-85 -97.06 134.47 40.37 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -86.94 96.21 10.17 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.724 0.773 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -166.42 171.21 41.34 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.2 m -133.27 138.59 46.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 118.555 1.178 . . . . 0.0 112.957 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.599 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 155' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.427 -1.604 0 CA-C-O 121.317 0.579 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 ttm -108.9 98.12 7.65 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.445 HG12 ' HA3' ' A' ' 135' ' ' GLY . 34.3 m -139.25 164.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.859 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.72 156.39 39.06 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -50.43 -45.09 55.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.246 1.018 . . . . 0.0 110.996 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.6 t -85.78 8.72 18.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 39.0 t -89.14 96.71 10.83 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 102' ' ' SER . 5.9 p-90 -48.54 -17.79 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.558 1.943 . . . . 0.0 115.157 -173.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.42 HD11 ' CD2' ' A' ' 133' ' ' PHE . 48.2 mt -61.12 -30.28 70.28 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.979 0.418 . . . . 0.0 110.001 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.4 ptm180 -83.83 -10.33 58.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 59.8 mtt -89.68 -15.82 31.76 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 50.2 mt -82.99 133.68 47.92 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.78 131.59 22.99 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 121.619 1.546 . . . . 0.0 111.177 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -84.2 131.63 34.74 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 156.95 35.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.52 -2.49 30.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.44 0.638 . . . . 0.0 110.025 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.5 p -108.16 150.2 27.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.767 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.09 -5.44 57.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.06 -36.19 69.5 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.482 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.85 -28.36 14.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.197 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -74.88 111.72 10.37 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.76 -20.57 18.76 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.248 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 11.4 p -130.16 130.23 44.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.394 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.04 146.02 46.28 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.8 119.73 61.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' TYR . . . . . 0.474 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 34.5 p90 -113.33 148.51 35.55 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -96.62 138.71 33.79 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -163.13 118.48 1.73 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.324 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.61 56.36 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 124.686 1.241 . . . . 0.0 111.635 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 62.83 16.26 8.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.686 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -137.76 170.64 15.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.13 137.85 51.77 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -120.98 128.75 53.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.7 t -101.2 123.83 45.94 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.425 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -121.6 143.18 49.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 124' ' ' LEU . 46.5 t -82.29 104.74 11.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.8 t -87.14 -26.31 23.67 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.341 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -141.15 145.83 36.23 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.78 120.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 4.4 p -112.14 117.48 47.72 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 21.8 Cg_exo -66.38 167.36 18.85 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.589 2.193 . . . . 0.0 113.188 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.2 m -64.71 129.48 39.96 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.585 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.95 71.13 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.766 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.31 154.54 21.48 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.916 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.6 mt -91.86 145.64 24.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -119.54 144.81 46.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.923 0.392 . . . . 0.0 110.71 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.54 151.84 34.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 177' ' ' SER . 12.0 p -106.99 139.52 28.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.288 0.566 . . . . 0.0 111.069 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.558 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 31.6 ttp85 -115.74 134.23 55.23 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.67 152.08 18.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 8.6 p . . . . . 0 C--N 1.316 -0.886 0 CA-C-O 123.075 1.416 . . . . 0.0 112.989 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 N-CA-C 110.23 -0.719 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -169.89 171.75 7.02 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -102.19 90.04 3.79 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.26 174.26 22.59 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.527 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.05 166.51 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.214 2.609 . . . . 0.0 112.348 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 43.2 mm-40 -75.58 -10.53 59.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.032 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.1 -20.65 34.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.903 0.858 . . . . 0.0 109.464 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.17 162.69 15.18 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.85 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -148.5 132.78 17.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.081 0.467 . . . . 0.0 111.478 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.7 tm? -95.39 112.68 24.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.94 135.56 49.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 82.2 mt -101.78 101.74 12.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.585 0.707 . . . . 0.0 109.139 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -115.17 104.86 12.26 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.366 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.6 13.78 4.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.206 1.402 . . . . 0.0 110.38 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 -6.82 56.09 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.353 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.3 tt0 -85.21 137.92 32.69 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -88.66 109.29 20.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.734 0.646 . . . . 0.0 109.273 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.2 121.7 45.9 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.695 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 166' ' ' LEU . 16.0 m -89.26 97.05 6.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.883 0.849 . . . . 0.0 110.287 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -113.19 153.25 28.61 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.035 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.89 122.06 18.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 42.2 ttt180 -84.23 -50.6 7.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.17 173.9 7.0 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 m -89.36 108.56 19.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.9 mm? -74.98 110.07 8.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.094 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 p -83.17 134.61 34.97 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.109 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.88 123.6 14.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.009 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.77 -24.38 13.31 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.752 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.93 146.33 49.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.4 m -144.69 164.86 29.7 Favored 'General case' 0 C--N 1.283 -2.309 0 O-C-N 121.971 -0.456 . . . . 0.0 110.152 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -110.39 169.62 8.62 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.91 176.09 53.28 Favored Glycine 0 N--CA 1.433 -1.559 0 O-C-N 123.795 0.684 . . . . 0.0 111.905 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 51.1 Cg_endo -67.02 144.56 70.37 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 122.768 2.312 . . . . 0.0 113.187 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.32 154.49 32.24 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.26 127.9 46.44 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.91 0.862 . . . . 0.0 112.479 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.49 -157.78 30.25 Favored Glycine 0 N--CA 1.405 -3.405 0 N-CA-C 106.383 -2.687 . . . . 0.0 106.383 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.5 t -158.15 167.84 28.7 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 118.313 1.056 . . . . 0.0 108.807 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.2 mt -138.55 117.98 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -86.65 99.36 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.74 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 205' ' ' VAL . 31.8 p -62.87 154.21 30.83 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.447 ' HB3' ' CG2' ' A' ' 153' ' ' VAL . 29.5 ptt180 -90.52 114.85 27.14 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.818 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -99.55 12.34 36.72 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.227 1.013 . . . . 0.0 109.087 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.8 mt -124.43 169.49 11.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.6 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.4 m -100.96 113.39 65.78 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.52 -15.38 48.23 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.676 2.917 . . . . 0.0 113.382 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 -12.04 59.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.367 1.08 . . . . 0.0 109.032 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.408 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 23.2 mtp180 -111.09 -74.99 0.63 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.987 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 146' ' ' ARG . 3.4 mp0 -125.47 147.1 49.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HB3' ' CB ' ' A' ' 152' ' ' ALA . 8.8 mm-40 63.97 71.45 0.6 Allowed Pre-proline 0 C--N 1.311 -1.094 0 C-N-CA 125.323 1.449 . . . . 0.0 114.795 173.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -104.49 8.86 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.902 2.402 . . . . 0.0 112.834 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.445 ' HA3' ' HD3' ' A' ' 151' ' ' PRO . . . -115.47 -125.96 4.0 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.445 ' HD3' ' HA3' ' A' ' 150' ' ' GLY . 7.9 Cg_exo -73.66 5.51 3.31 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 123.843 3.028 . . . . 0.0 113.692 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 148' ' ' GLU . . . -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.182 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 140' ' ' ARG . 20.2 t -109.49 116.61 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 p -152.21 154.83 36.56 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 123.6 0.563 . . . . 0.0 109.593 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -97.48 130.77 44.54 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.3 mtp -101.56 87.57 3.21 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.21 165.98 28.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -52.56 140.36 23.13 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 124.143 0.902 . . . . 0.0 109.89 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 43.4 mt-10 -65.4 -14.4 60.82 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.21 -14.12 22.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 53.2 t -64.66 133.41 52.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.491 0.663 . . . . 0.0 111.848 -174.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -58.72 -25.2 62.7 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.663 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.6 mt -59.28 -32.21 69.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.078 0.466 . . . . 0.0 111.39 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ptm180 -96.72 1.42 50.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.0 111.245 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 96.2 mmm -91.55 -20.09 22.06 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 118' ' ' VAL . 10.4 mp -85.43 146.84 45.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.953 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.53 134.61 36.18 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.265 1.977 . . . . 0.0 110.291 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.73 136.29 33.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 30.7 m -136.02 154.4 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.67 -10.89 17.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.516 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.9 p -94.93 169.03 10.42 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.654 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -95.59 -33.91 12.21 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.899 0.88 . . . . 0.0 111.242 -176.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 5.2 mm-40 -66.91 -38.83 86.97 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.67 -30.26 32.77 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.276 0.56 . . . . 0.0 109.892 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 203' ' ' ARG . . . -79.97 119.87 23.4 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-O 121.416 0.627 . . . . 0.0 111.223 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -104.37 -6.1 21.09 Favored 'General case' 0 C--N 1.27 -2.855 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.006 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.0 m -150.42 145.26 25.95 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -125.45 147.66 49.12 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.425 ' CD1' HD22 ' A' ' 163' ' ' LEU . 29.4 mm -110.1 124.79 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -133.72 155.68 49.32 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -102.55 137.87 40.21 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.14 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 85.5 tttt -140.15 112.87 8.04 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.38 57.31 4.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.257 1.027 . . . . 0.0 111.144 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 73.71 -14.77 0.62 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.746 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.11 158.87 17.86 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.073 -0.392 . . . . 0.0 110.355 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 72.7 mt -96.17 136.8 36.14 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.119 0.262 . . . . 0.0 110.372 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 52.2 m95 -124.52 145.01 49.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.1 t -118.04 130.92 56.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.06 147.44 50.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.9 119.64 37.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 p -95.81 -29.31 14.3 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -130.25 143.56 50.85 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 5.4 p -76.38 113.29 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.52 0.676 . . . . 0.0 111.1 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.4 t -97.58 125.47 44.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.513 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.76 151.33 57.41 Favored 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 121.868 1.712 . . . . 0.0 110.08 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.1 p -62.94 131.1 47.55 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.42 -19.88 52.01 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.84 148.98 35.7 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.96 154.53 19.77 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.1 pt? -136.13 149.68 48.77 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.06 0.457 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.97 155.86 21.22 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.4 ' CG2' HG12 ' A' ' 179' ' ' ILE . 8.8 p -107.22 128.54 62.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.381 0.61 . . . . 0.0 111.149 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 2.0 tmt_? -95.36 116.15 28.39 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.75 134.61 34.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 139' ' ' THR . 8.9 p -61.38 124.68 16.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-O 121.283 0.563 . . . . 0.0 111.068 177.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.5 p -133.8 69.53 1.47 Allowed 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.902 0.858 . . . . 0.0 109.061 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.1 123.3 63.13 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.585 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.76 92.58 0.37 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.695 1.597 . . . . 0.0 108.438 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.54 -23.11 63.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.158 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 100.35 -45.76 1.43 Allowed Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 51.9 68.66 3.01 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 124.95 1.3 . . . . 0.0 111.435 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -101.24 16.91 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.848 2.365 . . . . 0.0 111.927 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.502 ' HA ' ' NE ' ' A' ' 213' ' ' ARG . 1.8 mmp_? 66.19 -171.7 0.19 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.416 0.687 . . . . 0.0 109.64 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -99.46 133.78 21.67 Favored Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.11 100.95 0.12 Allowed 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 122.861 2.374 . . . . 0.0 112.694 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.55 -28.35 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.39 110.06 20.5 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.38 149.87 81.98 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.742 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.34 132.97 38.16 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.792 1.662 . . . . 0.0 109.616 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.92 114.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.406 0.622 . . . . 0.0 110.747 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 64.76 76.74 0.31 Allowed Pre-proline 0 C--O 1.248 0.988 0 C-N-CA 125.16 1.384 . . . . 0.0 110.118 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.26 178.77 6.55 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.911 2.407 . . . . 0.0 112.06 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.42 -67.17 0.23 Allowed Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.94 -156.56 27.31 Favored Glycine 0 C--O 1.256 1.469 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.975 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 70.75 -49.93 0.67 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.852 1.661 . . . . 0.0 112.574 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.621 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.421 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.451 -1.009 0 N-CA-C 108.023 -1.568 . . . . 0.0 108.023 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 p-90 -115.96 -1.04 12.62 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.137 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m 65.44 25.52 11.92 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.22 1.008 . . . . 0.0 112.429 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.35 141.13 15.44 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.928 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HG2' HD23 ' A' ' 107' ' ' LEU . 7.9 Cg_exo -44.35 150.57 0.69 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.437 3.425 . . . . 0.0 113.027 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.32 -3.97 27.02 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 122' ' ' LEU . 12.2 mm-40 -81.04 -18.7 45.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.777 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.0 mm? -113.31 165.79 12.09 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.284 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -156.83 139.84 15.37 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.9 tm? -89.16 116.77 27.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.96 137.37 42.04 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.91 103.55 15.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -106.18 103.45 12.93 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.15 24.62 14.49 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.951 0.501 . . . . 0.0 111.329 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.68 -4.21 68.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.01 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.96 131.93 35.26 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -84.26 96.42 9.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.4 p -114.27 127.84 56.07 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-O 121.363 0.602 . . . . 0.0 109.798 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.97 118.78 36.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.009 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -115.71 147.57 40.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.54 119.18 32.28 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -80.06 -26.57 39.63 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 106' ' ' GLU . 3.7 mm? -110.35 140.05 44.94 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.586 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 m -69.86 122.19 18.78 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.255 0.55 . . . . 0.0 110.981 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.44 132.51 35.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.21 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 p -95.15 156.84 16.15 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.536 0.522 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.08 117.03 7.83 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.21 -16.57 22.38 Favored Glycine 0 C--N 1.303 -1.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.905 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.2 tp -64.68 125.62 25.33 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.8 m -136.6 144.31 44.05 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.777 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 29.4 m-90 -91.59 172.0 8.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.548 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.84 164.29 54.52 Favored Glycine 0 N--CA 1.435 -1.381 0 O-C-N 123.777 0.673 . . . . 0.0 112.163 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 17.7 Cg_endo -58.54 128.39 28.14 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.408 2.738 . . . . 0.0 113.028 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 51.2 m-85 -102.89 170.89 7.71 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -122.06 142.63 50.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 163.53 -149.38 16.76 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 106.129 -2.789 . . . . 0.0 106.129 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 156' ' ' MET . 24.8 p -161.25 131.2 4.91 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.664 1.232 . . . . 0.0 111.598 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 207' ' ' GLU . 1.4 pt -144.39 97.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.395 -3.186 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 12.6 pt20 -149.47 97.37 2.63 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.698 0.761 . . . . 0.0 112.522 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.1 t -77.57 163.23 26.46 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' HA ' ' HE ' ' A' ' 140' ' ' ARG . 2.5 mmp_? -103.05 -67.74 0.87 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.24 87.51 2.4 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.7 tp -90.41 127.15 36.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.286 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.6 m -100.81 110.66 61.45 Favored Pre-proline 0 N--CA 1.411 -2.392 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.655 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 41.5 Cg_exo -61.88 -23.79 76.38 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.662 2.241 . . . . 0.0 109.567 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.99 -27.63 68.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.116 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.461 ' HD3' ' C ' ' A' ' 146' ' ' ARG . 2.6 tmt_? -89.68 -48.91 6.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.829 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.51 90.23 2.59 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 144' ' ' PRO . 42.3 mt-10 -116.35 -46.4 0.05 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.856 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.421 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 41.8 Cg_exo -61.63 -40.8 43.75 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 121.459 1.439 . . . . 0.0 112.149 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.74 92.88 0.3 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.538 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.22 124.58 11.88 Favored 'Trans proline' 0 C--O 1.252 1.212 0 C-N-CA 122.732 2.288 . . . . 0.0 112.112 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.11 -30.39 10.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 206' ' ' THR . 10.1 t -90.95 116.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -126.69 -177.85 4.16 Favored 'General case' 0 C--O 1.197 -1.667 0 C-N-CA 125.304 1.441 . . . . 0.0 108.42 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.34 134.14 44.03 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.087 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 136' ' ' SER . 48.2 ttm -97.17 96.36 8.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.5 m -130.32 159.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.608 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.87 170.13 15.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.569 0.543 . . . . 0.0 110.682 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.9 -8.42 58.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.982 0.896 . . . . 0.0 109.461 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 m -83.77 -2.93 57.33 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.633 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.5 t -109.09 116.79 32.62 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-O 121.77 0.795 . . . . 0.0 109.722 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 p-90 -70.04 -14.44 62.68 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.883 1.273 . . . . 0.0 112.129 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.74 -23.72 66.33 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.382 0.673 . . . . 0.0 112.392 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.95 -0.74 57.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.32 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 mmt -89.13 -13.54 38.23 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.292 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -83.08 144.03 46.65 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.01 142.53 38.69 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.237 1.958 . . . . 0.0 110.464 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -88.7 138.88 31.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.325 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.69 163.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.526 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.01 -46.14 37.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.9 p -115.03 173.01 6.71 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.87 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.74 -12.72 57.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.904 0.383 . . . . 0.0 110.402 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -68.76 -32.55 72.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.455 0.645 . . . . 0.0 110.154 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.89 -0.74 55.53 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.262 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.98 132.34 44.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.592 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -96.6 -12.72 23.6 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.3 m -149.08 132.88 16.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.419 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.27 138.89 38.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 202' ' ' VAL . 1.7 mp -110.76 114.57 47.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -131.36 175.6 9.0 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.257 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -123.43 132.0 53.82 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.586 0.708 . . . . 0.0 111.638 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 17.3 tppt? -136.91 126.82 25.8 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.41 28.26 17.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.447 1.092 . . . . 0.0 109.584 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.12 9.71 6.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.244 1.418 . . . . 0.0 114.15 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -104.7 152.86 22.0 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 40.3 mt -94.42 141.37 28.66 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.495 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 78.7 m95 -130.96 149.2 52.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.3 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.4 t -130.35 117.66 20.08 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 177' ' ' SER . 4.0 ptm180 -120.0 144.14 47.68 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.49 116.57 36.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 p -94.22 -37.23 11.65 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.536 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.44 171.25 7.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.477 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.58 106.28 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.728 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.57 108.8 62.29 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.63 176.93 9.33 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.848 2.366 . . . . 0.0 112.354 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.1 m -72.83 115.01 11.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.278 0.561 . . . . 0.0 109.899 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.49 -7.9 47.14 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.47 144.03 31.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.51 145.22 24.67 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.69 144.83 46.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.236 0.541 . . . . 0.0 110.397 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -118.04 152.72 34.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.051 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 179' ' ' ILE . 3.9 p -102.39 129.07 54.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 124.077 0.861 . . . . 0.0 113.103 -174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -109.97 108.07 18.19 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.592 HD13 ' H ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -115.48 154.39 29.41 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 137' ' ' ILE . 59.2 t -82.33 150.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.506 ' HB ' ' CG1' ' A' ' 153' ' ' VAL . 1.5 p -87.8 149.0 24.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 -173.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -56.69 157.26 10.55 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -176.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 138' ' ' GLN . 2.0 Cg_endo -43.32 111.98 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.435 3.423 . . . . 0.0 114.749 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 74.4 m80 73.12 -72.53 0.11 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.102 1.361 . . . . 0.0 111.832 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 150.66 67.02 0.01 OUTLIER Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 75.33 87.41 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 127.014 2.126 . . . . 0.0 111.193 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.64 53.68 2.78 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.105 2.536 . . . . 0.0 112.17 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -122.3 93.46 3.99 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -95.5 132.07 28.32 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -39.93 -47.89 3.79 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 124.689 3.593 . . . . 0.0 112.646 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.16 98.34 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 CA-C-O 121.917 0.865 . . . . 0.0 110.593 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -96.1 9.37 41.1 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.52 ' HB3' ' HD3' ' A' ' 219' ' ' PRO . 34.5 tt0 -49.5 -52.08 53.09 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.699 176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 218' ' ' GLU . 3.0 Cg_endo -86.62 118.14 1.51 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 CA-C-N 120.157 1.092 . . . . 0.0 109.416 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -102.85 -2.03 9.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.45 120.75 80.27 Favored Pre-proline 0 N--CA 1.428 -1.537 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.289 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.89 -42.55 11.26 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.682 1.588 . . . . 0.0 109.212 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -118.01 96.46 0.68 Allowed Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -135.95 113.02 1.03 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.097 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.0 tp 174.64 -46.96 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.192 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.254 177.206 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.429 -2.298 0 N-CA-C 108.619 -1.339 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 t-105 -91.36 106.84 18.79 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.184 0.516 . . . . 0.0 110.731 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -109.54 92.9 4.24 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -135.61 -168.94 11.7 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.036 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.1 170.24 13.82 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.551 2.834 . . . . 0.0 113.149 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -75.82 -30.62 59.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.904 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.96 -2.61 48.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.726 0.774 . . . . 0.0 111.974 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.89 161.91 18.11 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.616 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.31 148.74 29.89 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.86 122.02 44.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.4 48.55 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.775 0.321 . . . . 0.0 110.346 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 92.6 mt -99.21 101.35 12.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -112.78 110.29 20.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 67.73 13.09 9.14 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.995 0.902 . . . . 0.0 112.12 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.72 42.8 Favored Glycine 0 C--N 1.317 -0.525 0 O-C-N 121.681 -0.637 . . . . 0.0 112.464 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.7 tt0 -90.02 135.01 33.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -86.59 96.7 10.19 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.2 t -110.63 152.73 26.14 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.29 131.69 72.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -138.52 148.98 44.89 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.093 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.98 120.67 17.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -68.8 -45.97 69.88 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.14 -179.52 3.66 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.5 m -78.14 98.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.617 0.722 . . . . 0.0 109.21 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.9 tp -76.93 112.53 13.64 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 124.898 1.279 . . . . 0.0 108.891 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.4 t -87.8 142.95 27.42 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.466 0.651 . . . . 0.0 110.942 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.38 136.65 46.17 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.051 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.61 -16.02 21.7 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 tp -81.61 140.01 34.69 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.4 p -138.54 152.05 47.87 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -100.03 175.27 5.81 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 123.265 0.353 . . . . 0.0 110.142 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.53 -179.96 39.29 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.828 0.705 . . . . 0.0 113.297 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.58 123.46 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 113.13 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -99.34 158.47 15.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.4 123.39 40.03 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 170.44 -178.23 43.22 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.6 m -121.38 126.12 48.62 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.39 0.614 . . . . 0.0 111.943 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.515 ' HA ' ' OG1' ' A' ' 206' ' ' THR . 31.2 mt -140.65 118.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.589 ' H ' HG23 ' A' ' 206' ' ' THR . 26.8 tp60 -149.05 103.16 3.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.501 ' HB ' HG12 ' A' ' 205' ' ' VAL . 1.7 t -61.2 155.77 20.02 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.613 0.765 . . . . 0.0 109.526 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 140' ' ' ARG . 2.8 mmp_? -117.83 -4.22 11.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.65 64.35 0.8 Allowed 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 124.803 1.241 . . . . 0.0 109.962 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.0 mt -85.64 178.12 7.48 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.055 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.572 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 20.1 m -66.6 112.1 8.56 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 123.66 0.6 . . . . 0.0 111.707 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.2 -11.21 21.12 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.855 2.37 . . . . 0.0 111.235 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 143' ' ' SER . 10.0 pt-20 -73.47 -17.99 61.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.35 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 143' ' ' SER . 25.0 ptt85 -90.25 161.06 15.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.81 143.58 51.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HG2' ' H ' ' A' ' 150' ' ' GLY . 41.4 tt0 -152.19 123.92 3.81 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.19 7.05 4.65 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.038 2.492 . . . . 0.0 112.026 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.462 ' H ' ' HG2' ' A' ' 148' ' ' GLU . . . -101.33 133.72 11.44 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.506 ' HA ' HD21 ' A' ' 170' ' ' LEU . 4.6 Cg_exo -71.24 83.52 0.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.996 1.797 . . . . 0.0 113.295 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.18 -47.26 36.83 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 206' ' ' THR . 88.1 t -75.84 117.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.624 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 206' ' ' THR . 1.3 p -134.32 -179.62 5.69 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.927 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.478 ' HG ' ' NE2' ' A' ' 168' ' ' GLN . 1.2 pp -126.27 148.47 49.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.9 mmt -123.56 81.99 1.96 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.972 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.61 171.82 10.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -71.5 152.84 42.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -22.61 61.89 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.5 p -96.15 -8.21 33.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.7 t -73.26 124.59 25.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.5 p-90 -59.53 -21.55 60.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.005 0.922 . . . . 0.0 113.066 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.93 -29.44 69.62 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 122.674 0.39 . . . . 0.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 15.9 ptm180 -93.91 2.68 56.09 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.017 0.437 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 mmt -94.96 -11.03 29.29 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.7 mt -86.63 141.97 34.47 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 35.8 Cg_exo -63.6 131.8 32.93 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.436 2.091 . . . . 0.0 110.781 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' NE2' ' HG ' ' A' ' 155' ' ' LEU . 94.0 mt-30 -89.25 137.88 31.92 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.168 0.508 . . . . 0.0 112.031 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.92 171.07 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 151' ' ' PRO . 92.1 mt -111.81 -25.01 9.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.2 p -104.09 150.92 23.87 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.958 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 15.9 pt-20 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.9 -20.08 58.31 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.193 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.83 -23.5 36.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.667 0.746 . . . . 0.0 109.229 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.63 22.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.533 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.417 ' C ' HG22 ' A' ' 191' ' ' THR . 16.7 p30 -114.96 -2.66 12.8 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.71 0.767 . . . . 0.0 109.344 172.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.3 p -145.43 136.18 24.45 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.339 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.457 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 16.0 pt-20 -136.03 143.52 44.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.345 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.0 mm -118.28 137.13 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -139.07 164.51 29.57 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -96.58 140.86 30.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.457 0.646 . . . . 0.0 110.06 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 57.6 tptt -140.46 118.53 11.92 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 53.12 47.17 25.1 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.772 1.295 . . . . 0.0 111.253 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.4 t70 70.59 -13.16 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.803 1.641 . . . . 0.0 113.513 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.89 152.0 20.28 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 44.5 mt -97.24 132.73 42.71 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.643 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 69.4 m95 -121.2 122.76 40.68 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.456 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.67 124.0 37.38 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.574 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -119.64 142.14 48.7 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 123.331 0.394 . . . . 0.0 110.008 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.53 104.43 12.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.417 HG22 ' C ' ' A' ' 176' ' ' ASN . 4.0 t -84.89 -18.52 34.49 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.068 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -142.3 142.03 32.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.77 116.61 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.775 0.798 . . . . 0.0 111.057 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.66 120.45 55.83 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.56 172.38 14.41 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.331 2.021 . . . . 0.0 111.957 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.0 m -67.58 112.16 4.57 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.89 -5.45 53.61 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.979 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.9 138.58 33.4 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.86 128.76 36.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 200' ' ' LEU . 3.8 mp -82.71 153.66 25.21 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.295 0.569 . . . . 0.0 112.226 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.1 126.82 32.61 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.41 129.62 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 123.96 0.788 . . . . 0.0 111.678 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 61.0 ttt180 -104.66 133.55 49.31 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.462 HD11 HD23 ' A' ' 155' ' ' LEU . 2.7 mm? -112.75 154.03 26.83 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.501 HG12 ' HB ' ' A' ' 139' ' ' THR . 20.4 t -115.82 55.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 17.8 m -123.94 107.52 11.43 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.136 0.974 . . . . 0.0 111.222 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.72 149.43 37.11 Favored Pre-proline 0 C--N 1.284 -2.242 0 O-C-N 121.762 -0.586 . . . . 0.0 109.589 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -91.94 -175.21 0.64 Allowed 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.418 2.079 . . . . 0.0 110.322 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' A' ' 210' ' ' GLY . 15.9 t-80 64.21 -160.52 0.29 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.06 0.944 . . . . 0.0 109.163 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' A' ' 209' ' ' HIS . . . -175.65 -87.46 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -135.34 139.83 32.62 Favored Pre-proline 0 C--N 1.292 -1.897 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -82.24 134.99 8.19 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.602 1.535 . . . . 0.0 110.046 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.57 -29.05 19.16 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.624 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 39.8 m80 67.92 173.74 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.648 0 O-C-N 123.93 0.769 . . . . 0.0 109.765 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 214' ' ' HIS . 57.5 Cg_endo -70.34 41.45 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.341 2.027 . . . . 0.0 114.766 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.31 -24.57 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 121.686 0.755 . . . . 0.0 110.568 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 217' ' ' GLN . 4.6 pm0 -90.71 1.89 56.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.353 0.597 . . . . 0.0 110.513 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.38 141.78 25.77 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.14 118.74 4.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.188 2.592 . . . . 0.0 113.103 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.8 -33.79 5.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 222' ' ' PRO . 13.7 mm-40 63.1 103.56 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 CA-C-N 113.067 -1.879 . . . . 0.0 112.25 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 221' ' ' GLU . 25.1 Cg_endo -62.14 124.97 15.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.535 2.157 . . . . 0.0 112.374 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -111.66 78.58 0.25 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.7 -125.02 2.2 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp 61.35 87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.355 1.062 . . . . 0.0 110.864 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 N--CA 1.446 -1.318 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.61 157.4 46.69 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 t -90.84 77.89 6.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.87 164.29 24.73 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.08 166.12 16.77 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.69 2.26 . . . . 0.0 112.885 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -74.68 -12.1 60.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.592 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 122' ' ' LEU . 31.8 mp0 -80.88 -12.48 59.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.729 0.776 . . . . 0.0 109.393 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.69 157.7 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.237 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.5 141.56 46.77 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.98 120.29 29.18 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.8 129.42 56.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.103 0.478 . . . . 0.0 111.455 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.47 108.49 20.43 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -109.76 95.54 5.67 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 51.38 59.35 4.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.141 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.03 -1.5 86.57 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.803 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.4 140.63 47.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 117.276 0.538 . . . . 0.0 110.736 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -80.75 111.51 17.26 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.868 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.59 169.16 11.73 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 166' ' ' LEU . 59.0 t -123.95 129.95 74.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -119.48 145.82 45.97 Favored 'General case' 0 N--CA 1.394 -3.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.0 20.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -89.1 -44.4 10.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 106' ' ' GLU . 4.4 mm? -109.21 165.2 11.8 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 51.0 m -91.84 110.15 21.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.5 mm? -84.02 123.87 30.47 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 t -101.27 157.51 16.73 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 149.39 50.69 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.878 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.14 -26.97 21.38 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.086 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.4 tp -75.25 142.35 43.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -139.78 162.35 35.34 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -100.45 174.99 5.84 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.292 0.637 . . . . 0.0 109.731 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.39 171.14 55.1 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 119.526 -0.597 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 57.7 Cg_endo -73.09 123.33 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.247 1.964 . . . . 0.0 114.054 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.528 ' HE1' ' HG ' ' A' ' 188' ' ' CYS . 48.8 m-85 -94.72 149.96 20.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -106.36 106.26 16.7 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.861 0.839 . . . . 0.0 112.189 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.1 -145.02 4.12 Favored Glycine 0 C--N 1.291 -1.949 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -153.45 161.3 42.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.34 1.07 . . . . 0.0 110.832 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.7 mt -122.23 118.99 57.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -89.61 100.93 13.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.4 t -95.43 162.41 13.67 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -167.52 -45.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.94 41.7 17.28 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.609 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 68.5 tp -73.5 100.24 3.22 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.232 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.9 m -98.47 107.08 40.24 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 147' ' ' GLU . 50.7 Cg_exo -56.03 -71.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.817 2.345 . . . . 0.0 113.113 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -112.63 -35.84 5.39 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.637 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 147' ' ' GLU . 1.8 tmm_? -152.37 -53.38 0.12 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.627 -175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 38.6 tt0 -111.53 157.75 19.98 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -83.13 110.67 25.09 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.23 -28.07 19.03 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.593 2.195 . . . . 0.0 113.859 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -165.96 -118.41 0.44 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.353 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.2 78.58 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.775 2.317 . . . . 0.0 113.618 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.8 -18.52 27.53 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.119 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.6 t -146.98 126.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.5 m -133.44 134.65 43.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.13 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.7 125.14 30.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 0.0 110.38 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -96.3 86.72 4.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.675 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.93 165.62 28.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.182 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -70.09 160.25 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.9 63.96 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 112.245 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 p -88.47 -9.37 52.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 53.1 t -75.97 126.81 31.71 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.023 0.439 . . . . 0.0 110.188 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 7.8 p-90 -54.01 -30.87 49.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 188' ' ' CYS . 88.2 mt -59.62 -30.28 68.59 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.35 -2.9 44.77 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.47 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.8 ptp -107.48 4.56 26.3 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.727 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 73.5 mt -83.99 148.86 54.84 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.8 118.23 5.23 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.901 1.734 . . . . 0.0 110.056 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -81.68 129.16 34.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.36 146.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.408 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.04 0.77 25.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.579 0.704 . . . . 0.0 109.466 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.3 p -100.03 134.49 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.585 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.25 -34.37 68.2 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-O 121.167 0.508 . . . . 0.0 110.727 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.95 -12.91 61.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.81 -20.4 17.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.62 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -88.6 127.97 35.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.081 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 192' ' ' LYS . 86.3 m-20 -94.54 -11.41 29.59 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.205 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 p -152.42 129.43 11.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.475 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.36 134.04 52.32 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.054 0.455 . . . . 0.0 110.25 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 188' ' ' CYS . 29.8 mm -102.17 125.24 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 187' ' ' TRP . 32.4 p90 -130.29 154.03 48.03 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.606 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -102.66 127.25 49.86 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -137.26 128.04 27.17 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.06 23.41 11.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.76 17.55 11.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.445 1.498 . . . . 0.0 113.376 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -109.61 159.37 17.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 3.4 mm? -93.39 131.36 38.65 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 180' ' ' TYR . 51.2 m95 -128.23 139.56 52.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.528 ' HG ' ' HE1' ' A' ' 133' ' ' PHE . 49.1 m -109.05 112.77 25.14 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.742 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.4 131.63 54.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.74 126.46 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.0 p -106.54 -19.1 13.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 176' ' ' ASN . 68.0 mttm -140.02 146.03 38.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.445 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 76.7 t -69.16 115.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 123.864 0.727 . . . . 0.0 109.717 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -108.8 120.22 46.75 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 153.58 49.41 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.228 1.952 . . . . 0.0 111.988 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.3 m -63.14 122.72 16.79 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.61 -18.1 25.13 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.558 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.78 159.09 23.66 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.579 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.76 153.65 20.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.208 0.528 . . . . 0.0 110.783 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.3 pt? -123.52 148.85 45.89 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.37 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -114.25 145.08 42.2 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.411 HG23 HG12 ' A' ' 179' ' ' ILE . 14.3 p -102.15 125.63 56.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 123.948 0.78 . . . . 0.0 110.75 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.2 ttt180 -97.74 134.0 41.5 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.02 135.9 38.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.11 97.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.555 1.169 . . . . 0.0 111.915 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 4.94 40.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.41 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.03 120.39 22.54 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.68 32.62 0.16 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 124.141 3.227 . . . . 0.0 115.535 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 32.8 m170 74.33 137.1 0.06 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.214 1.406 . . . . 0.0 113.257 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 168.91 36.23 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.608 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.462 ' HB3' ' HD3' ' A' ' 212' ' ' PRO . . . -124.34 -55.06 0.03 OUTLIER Pre-proline 0 C--O 1.213 -0.846 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.98 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 211' ' ' ALA . 64.4 Cg_endo -102.52 -170.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.599 1.533 . . . . 0.0 110.053 174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -105.66 153.87 21.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -113.08 145.02 32.26 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.27 132.51 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.445 2.097 . . . . 0.0 112.458 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 51.9 t 66.8 87.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.146 1.379 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -103.92 -16.39 15.37 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.344 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.13 128.97 89.85 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.359 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.3 155.49 55.93 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.375 2.05 . . . . 0.0 111.518 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.47 167.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.67 149.77 38.82 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.52 116.2 4.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.102 1.868 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -78.37 145.72 29.56 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.891 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.77 -95.9 1.84 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.8 tp -158.94 135.4 9.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.634 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.693 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.429 -2.287 0 N-CA-C 111.477 -0.24 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 36.2 t-105 -115.93 109.94 18.29 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 121.799 0.809 . . . . 0.0 111.342 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -145.2 123.98 12.62 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 104' ' ' PRO . . . -171.95 -141.83 3.52 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 118.526 -1.797 . . . . 0.0 113.592 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' A' ' 103' ' ' GLY . 7.4 Cg_endo -82.56 159.2 16.8 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.125 2.55 . . . . 0.0 112.339 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.46 -20.58 39.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.1 -15.45 63.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.324 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.633 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.8 mm? -119.53 147.77 44.06 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.697 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.36 141.32 33.83 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -94.3 100.1 12.21 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.11 146.24 32.93 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -172.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 9.0 mp -108.19 110.49 22.13 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.694 176.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 117.33 31.42 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.32 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.66 23.75 14.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.048 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.64 2.22 63.35 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.071 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 53.2 tt0 -98.35 137.96 36.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.1 102.64 14.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.3 t -130.8 165.11 23.7 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.077 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -91.0 107.98 19.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.375 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.5 140.82 36.99 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.34 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.84 113.51 7.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -50.17 30.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.08 169.25 8.9 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 m -74.46 112.57 10.77 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.223 0.535 . . . . 0.0 110.46 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 200' ' ' LEU . 75.4 mt -84.71 114.7 22.22 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.4 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.6 p -88.81 155.26 19.66 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.165 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.55 141.33 55.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.105 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.97 -17.75 58.7 Favored Glycine 0 C--N 1.297 -1.606 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.266 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.67 117.02 9.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.7 m -129.3 141.11 51.19 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -99.37 170.95 8.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.9 -168.56 22.19 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.85 0.719 . . . . 0.0 113.937 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.2 Cg_endo -75.16 144.02 29.24 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.343 2.029 . . . . 0.0 112.864 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 163' ' ' LEU . 76.8 m-85 -123.34 162.52 22.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.199 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -94.38 125.12 38.83 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 -178.74 35.02 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.952 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -126.19 158.85 34.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 204' ' ' LEU . 60.2 mt -97.65 147.51 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 109.819 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.417 ' HG2' HG22 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -72.07 98.37 2.08 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.417 ' HA ' ' OG1' ' A' ' 206' ' ' THR . 9.6 t -89.35 162.69 15.67 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.626 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? 65.95 47.45 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.97 0.891 . . . . 0.0 110.08 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.47 41.63 0.63 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.586 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.2 tp -79.8 98.56 7.1 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.4 m -58.8 117.15 18.66 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.4 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -96.98 -154.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.125 0 C-N-CA 122.789 2.326 . . . . 0.0 110.312 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -83.71 -44.89 13.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.198 0.523 . . . . 0.0 109.805 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -89.11 177.79 6.54 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.9 129.02 37.9 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.514 1.525 . . . . 0.0 111.949 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 67.78 148.84 0.12 Allowed Pre-proline 0 N--CA 1.478 0.975 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.86 -5.95 17.49 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.503 2.135 . . . . 0.0 110.397 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.82 116.73 0.71 Allowed Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.546 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.04 -5.97 17.09 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 C-N-CA 122.657 2.238 . . . . 0.0 112.381 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.77 -11.15 37.48 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.329 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.417 HG22 ' HG2' ' A' ' 138' ' ' GLN . 11.1 p -123.62 119.98 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.631 0.729 . . . . 0.0 109.736 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.5 m -146.67 158.09 43.84 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 204' ' ' LEU . 0.4 OUTLIER -63.14 104.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.668 0.747 . . . . 0.0 111.952 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.65 90.91 8.55 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 m -110.93 178.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.207 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.615 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 23.5 t70 -66.94 144.5 56.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -10.07 49.74 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -95.51 -12.44 25.79 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.604 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 158' ' ' ASP . 94.0 m -69.94 111.01 5.35 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-O 121.614 0.721 . . . . 0.0 112.926 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.633 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 19.8 p-90 -54.48 -26.15 29.53 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 125.514 1.526 . . . . 0.0 112.569 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 133' ' ' PHE . 75.3 mt -54.21 -32.66 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.464 1.106 . . . . 0.0 112.549 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -85.47 -2.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.618 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 95.9 mmm -86.53 -16.27 37.46 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.577 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.16 143.26 52.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.99 131.35 20.73 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 121.607 1.538 . . . . 0.0 109.426 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -83.95 129.93 34.91 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -112.94 137.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.685 0.755 . . . . 0.0 112.531 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.54 -18.77 56.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.524 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 4.7 p -95.4 134.92 37.66 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.092 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.06 -17.32 37.79 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.72 0.771 . . . . 0.0 109.515 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -66.89 -41.37 87.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.093 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -77.66 -29.21 51.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.52 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.51 140.17 57.02 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.556 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 200' ' ' LEU . 85.1 m-20 -107.81 -15.48 14.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.533 0.682 . . . . 0.0 109.74 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.7 m -149.36 142.96 25.45 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -116.72 151.56 36.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.893 0.378 . . . . 0.0 111.001 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 163' ' ' LEU . 33.6 mm -115.96 115.52 49.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -113.19 163.03 15.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -109.92 141.74 42.23 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -148.25 121.27 8.83 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 65.69 20.98 11.6 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.045 0.938 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 73.71 15.68 3.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.743 1.617 . . . . 0.0 111.31 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -109.08 147.87 31.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 70.4 mt -93.87 141.22 28.76 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.851 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.89 136.33 50.27 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.9 126.07 54.71 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 123.282 0.364 . . . . 0.0 110.806 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -123.88 137.22 54.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.63 125.2 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.0 p -90.85 -39.91 12.06 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 175' ' ' ALA . 48.9 mtmt -119.49 153.66 34.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.84 108.69 8.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.66 112.63 48.16 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 121.124 0.487 . . . . 0.0 110.247 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 164.32 35.02 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.441 2.094 . . . . 0.0 112.488 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.3 t -58.6 123.25 15.67 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.679 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.2 -30.69 5.14 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.47 147.32 49.73 Favored Glycine 0 N--CA 1.443 -0.861 0 O-C-N 124.045 0.497 . . . . 0.0 112.157 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.5 mt -105.34 120.39 41.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 176' ' ' ASN . 5.3 mp -73.1 136.49 44.9 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -118.47 137.69 53.0 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.0 130.78 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.487 0.661 . . . . 0.0 111.949 -173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.4 tpt180 -104.77 130.84 52.78 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 155' ' ' LEU . 83.8 mt -103.19 124.43 48.59 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.92 81.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 122.416 1.103 . . . . 0.0 108.661 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 139' ' ' THR . 5.1 t -83.06 157.5 22.84 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.268 -1.787 . . . . 0.0 109.814 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -121.79 113.2 31.79 Favored Pre-proline 0 N--CA 1.42 -1.972 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.866 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.41 131.39 2.48 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 122.47 2.113 . . . . 0.0 108.754 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -86.88 91.03 8.53 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.35 -26.29 23.77 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.718 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -104.69 112.13 65.29 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 116.852 0.326 . . . . 0.0 110.612 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.02 -21.62 13.84 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.232 1.955 . . . . 0.0 110.601 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -139.6 112.59 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.159 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.433 ' HB3' ' HD3' ' A' ' 215' ' ' PRO . 12.2 t-80 -87.66 -63.66 0.21 Allowed Pre-proline 0 C--N 1.297 -1.694 0 CA-C-O 118.556 -0.735 . . . . 0.0 112.541 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 214' ' ' HIS . 74.2 Cg_endo -83.73 -17.04 6.27 Favored 'Trans proline' 0 C--N 1.371 1.73 0 CA-C-N 121.283 1.494 . . . . 0.0 112.082 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.2 t 67.51 -69.75 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.375 1.47 . . . . 0.0 112.116 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.41 -179.31 3.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.08 134.25 80.9 Favored Pre-proline 0 C--N 1.315 -0.929 0 O-C-N 123.342 0.401 . . . . 0.0 110.95 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.54 122.86 12.55 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.608 2.206 . . . . 0.0 110.534 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.55 124.47 46.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -124.95 123.13 25.52 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.245 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.83 -26.27 59.91 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.384 2.056 . . . . 0.0 110.599 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.14 -110.73 2.57 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -85.62 99.13 2.34 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 pp -112.38 165.37 12.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.763 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 N--CA 1.444 -1.441 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 5.1 p-90 -59.88 109.15 0.87 Allowed 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.019 0.824 . . . . 0.0 111.407 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.263 79.1 p 65.94 -51.02 0.4 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.171 2.189 . . . . 0.0 114.669 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.68 -73.05 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.228 -1.463 . . . . 0.0 114.446 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -70.65 119.99 6.75 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.717 1.611 . . . . 0.0 114.443 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 0.4 OUTLIER -81.99 -10.31 59.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.345 177.058 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.15 -7.74 55.47 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.063 1.345 . . . . 0.0 109.619 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 0.2 OUTLIER -110.96 138.39 47.43 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 39.7 tt0 -113.57 119.19 36.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.354 0.597 . . . . 0.0 112.242 -176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.6 tm? -96.49 110.58 22.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -117.49 114.8 24.01 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.088 0.471 . . . . 0.0 110.997 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 116' ' ' ARG . 90.4 mt -91.67 105.0 17.41 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.145 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -105.83 105.9 16.16 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 64.44 21.79 12.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.119 0.968 . . . . 0.0 110.861 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.91 2.35 59.55 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.861 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -100.55 137.57 38.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 117.291 0.545 . . . . 0.0 110.181 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HA ' HD23 ' A' ' 111' ' ' LEU . 3.2 ptp180 -84.68 113.34 21.22 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.616 0.722 . . . . 0.0 112.635 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.3 t -115.3 143.99 44.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 57.0 t -121.51 112.85 37.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 80.9 mtt180 -118.57 160.1 22.38 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.703 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.17 126.46 32.64 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -64.64 -37.44 87.58 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.516 0.674 . . . . 0.0 110.201 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.95 171.3 14.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -66.61 112.13 4.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.48 117.85 21.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.2 p -79.82 147.34 31.82 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.101 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.27 139.25 54.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.74 -18.8 56.38 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.363 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.26 125.37 26.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m -129.62 149.06 51.55 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -92.1 165.38 13.19 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.097 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.61 158.74 35.76 Favored Glycine 0 N--CA 1.441 -1.002 0 O-C-N 124.41 1.069 . . . . 0.0 112.853 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 123.6 12.03 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.083 2.522 . . . . 0.0 112.681 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -96.36 152.61 18.44 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.83 141.85 31.1 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.791 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.28 -158.78 28.66 Favored Glycine 0 C--N 1.281 -2.514 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -147.28 162.38 39.06 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 69.2 mt -129.08 114.08 31.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -86.82 101.66 13.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.442 ' HA ' HG23 ' A' ' 153' ' ' VAL . 5.6 m -87.13 87.34 7.42 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 122.633 1.206 . . . . 0.0 110.108 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -84.85 80.35 9.3 Favored 'General case' 0 C--N 1.27 -2.891 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.394 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.39 76.58 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.982 0.896 . . . . 0.0 109.41 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 tp -98.81 105.22 17.34 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.028 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 p -71.92 114.71 31.24 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -91.1 -155.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.088 0 C-N-CA 122.205 1.937 . . . . 0.0 112.05 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -97.5 -10.65 24.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -114.9 -169.04 1.47 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.664 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.17 -58.86 3.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.067 0.46 . . . . 0.0 110.199 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 150' ' ' GLY . 43.2 tt0 -94.84 123.4 57.83 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.494 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.24 -15.13 18.25 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.376 2.051 . . . . 0.0 111.546 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.508 ' H ' ' HG2' ' A' ' 148' ' ' GLU . . . 94.14 -159.31 23.46 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -74.09 60.89 4.77 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.175 2.583 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.94 17.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 139' ' ' THR . 2.5 p -79.13 118.46 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.018 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 m -130.81 142.34 50.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -87.83 151.99 22.44 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.806 177.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.19 95.37 5.16 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 155' ' ' LEU . 26.8 m -133.95 -178.63 2.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.445 -176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.557 ' O ' ' HD3' ' A' ' 164' ' ' ARG . 11.0 t70 -55.48 142.22 33.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.088 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -55.8 -30.48 61.42 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.8 p -105.95 5.33 30.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.826 0.346 . . . . 0.0 111.899 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.6 t -66.33 124.38 22.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -51.24 -29.23 13.78 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.0 mt -57.09 -35.45 69.42 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.06 0.544 . . . . 0.0 111.508 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' A' ' 158' ' ' ASP . 16.5 ptm180 -97.31 -2.47 42.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.518 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 93.6 mmm -92.63 -28.32 16.77 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.3 152.54 70.76 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.83 124.72 14.56 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 121.686 1.591 . . . . 0.0 109.653 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -88.86 132.15 34.79 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.573 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.565 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 33.9 m -125.37 164.37 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.1 mt -111.75 -8.11 14.18 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.188 0.518 . . . . 0.0 110.638 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.9 p -93.2 134.6 35.23 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.052 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.26 -9.21 58.69 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.143 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -80.02 -34.9 37.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.649 0.261 . . . . 0.0 110.783 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.02 23.69 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.614 0.721 . . . . 0.0 109.319 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.656 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -78.11 123.32 26.73 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.763 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 200' ' ' LEU . 54.2 m-80 -90.02 -14.75 33.25 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.061 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.3 m -134.53 136.83 43.34 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.677 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.92 136.67 54.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.271 0.558 . . . . 0.0 110.665 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.73 HD13 HG13 ' A' ' 202' ' ' VAL . 1.4 mp -103.32 120.71 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.545 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -132.1 151.4 51.79 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.057 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -88.11 141.25 28.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -155.25 111.89 3.23 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.3 t70 57.2 65.36 1.39 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.266 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.66 8.04 2.78 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.136 -1.393 . . . . 0.0 114.283 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.37 156.53 45.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.3 mt -101.61 131.92 47.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -120.51 150.24 41.16 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.1 t -125.32 114.27 18.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -111.02 146.04 37.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.5 t -83.06 112.46 20.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t -92.17 -34.16 14.43 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.97 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -123.48 135.59 54.14 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.98 108.36 2.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.558 0.536 . . . . 0.0 111.045 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.46 128.14 27.57 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.264 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.29 169.01 17.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.877 2.385 . . . . 0.0 112.779 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.4 t -67.38 131.5 45.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.29 -13.78 64.19 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.413 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.66 154.56 45.62 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 8.8 mp -96.86 142.43 28.86 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.447 0.642 . . . . 0.0 110.753 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 176' ' ' ASN . 1.1 pt? -123.22 164.38 18.84 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.392 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -136.03 158.74 43.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.73 HG13 HD13 ' A' ' 179' ' ' ILE . 23.3 t -100.05 119.18 47.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 124.484 1.115 . . . . 0.0 111.361 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 1.1 tmm_? -106.73 128.0 53.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.24 138.96 31.19 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.28 93.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.897 1.332 . . . . 0.0 112.714 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.5 m -98.31 99.68 10.91 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -63.6 142.79 98.0 Favored Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.144 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.37 109.36 0.43 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.991 2.46 . . . . 0.0 110.155 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -101.68 137.22 40.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.432 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 91.14 27.96 16.8 Favored Glycine 0 C--N 1.305 -1.187 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 71.72 145.45 0.11 Allowed Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.348 1.459 . . . . 0.0 112.227 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.38 154.64 68.95 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 121.772 1.648 . . . . 0.0 108.859 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.64 91.56 7.49 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.888 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -135.38 135.21 22.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.91 -57.9 1.32 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.052 1.835 . . . . 0.0 109.258 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.39 123.82 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.133 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -96.96 108.02 20.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 219' ' ' PRO . 18.2 mm-40 -92.77 121.01 66.87 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.441 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 218' ' ' GLU . 12.9 Cg_exo -71.27 132.04 20.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.359 2.039 . . . . 0.0 109.82 173.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.0 t -102.68 123.34 55.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.838 0.351 . . . . 0.0 110.136 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.57 122.34 35.4 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.97 155.18 48.08 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.061 1.841 . . . . 0.0 111.452 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -90.69 55.45 3.42 Favored Glycine 0 C--N 1.3 -1.438 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -150.85 81.1 0.19 Allowed Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.62 104.17 4.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.439 -1.709 0 N-CA-C 112.432 0.128 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.505 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -154.81 166.81 32.29 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.118 -176.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 162' ' ' TRP . 36.6 m -91.48 93.12 8.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.18 -175.52 38.53 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.687 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.04 151.44 9.62 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.11 2.54 . . . . 0.0 111.966 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 1.6 pm0 -78.42 -0.36 28.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.54 -22.76 60.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.9 161.2 17.26 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.566 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 34.9 tt0 -144.25 122.67 12.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.758 0.313 . . . . 0.0 110.718 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.3 tm? -88.23 109.69 20.13 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 171.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.44 157.75 18.15 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.4 mt -118.03 97.93 6.06 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -113.39 117.51 31.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 66.15 12.51 8.57 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.444 1.116 . . . . 0.0 110.062 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.83 69.06 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.057 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -82.32 136.73 34.97 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 122.665 -0.314 . . . . 0.0 110.185 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.95 110.41 16.46 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.9 p -129.95 136.94 50.04 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.414 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.5 t -96.54 105.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -110.84 149.2 30.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.16 15.15 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 24.3 ttt180 -73.92 -43.22 59.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.83 152.81 25.27 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.7 m -68.41 116.38 8.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 88.6 mt -86.77 113.12 22.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.879 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 p -90.66 144.37 25.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -64.64 148.46 50.9 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.41 -34.1 5.9 Favored Glycine 0 C--N 1.282 -2.434 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.9 tp -65.75 138.55 58.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.2 m -147.55 154.96 41.37 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -98.35 173.11 7.14 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 123.564 0.54 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.6 -179.05 37.94 Favored Glycine 0 N--CA 1.437 -1.289 0 O-C-N 123.81 0.694 . . . . 0.0 112.97 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 123.72 10.08 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.635 2.223 . . . . 0.0 112.579 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' CD2' HD11 ' A' ' 163' ' ' LEU . 80.3 m-85 -96.6 150.01 21.13 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.338 0.589 . . . . 0.0 110.806 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.616 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 147.6 -174.27 27.41 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.0 m -139.15 160.52 39.59 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.989 0.894 . . . . 0.0 111.993 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.37 130.8 72.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.42 97.57 6.42 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.908 0.861 . . . . 0.0 110.324 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -84.38 132.61 34.57 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.475 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.456 ' HA ' ' HD3' ' A' ' 140' ' ' ARG 0.333 11.5 mmt180 56.71 47.79 17.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.262 1.03 . . . . 0.0 113.069 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.97 97.5 7.49 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.46 114.14 27.49 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.084 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 m -74.72 162.86 71.8 Favored Pre-proline 0 C--N 1.292 -1.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.812 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.89 -149.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.259 1.973 . . . . 0.0 109.651 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -85.84 20.38 2.22 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.581 -0.7 . . . . 0.0 111.197 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -75.68 159.94 30.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.229 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.3 pt-20 -64.73 139.67 58.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.795 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.19 102.56 14.37 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 147' ' ' GLU . 24.3 Cg_exo -65.93 -42.02 12.38 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.72 2.28 . . . . 0.0 112.578 -175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.51 -127.29 0.93 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.87 100.03 0.49 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.243 1.962 . . . . 0.0 111.579 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.14 -29.48 31.59 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.22 117.84 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.464 ' HA ' ' CD2' ' A' ' 204' ' ' LEU . 14.3 t -150.27 179.62 7.96 Favored 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 151.72 21.67 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.89 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.4 ptm -123.6 85.72 2.46 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.953 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.616 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -136.86 164.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.025 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.02 158.24 29.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.96 -19.24 65.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -73.06 -14.22 61.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.494 0.664 . . . . 0.0 109.381 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.8 t -87.25 100.31 12.6 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.456 ' HB3' ' O ' ' A' ' 102' ' ' SER . 16.1 p-90 -44.83 -28.4 0.64 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 114.234 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 133' ' ' PHE . 82.5 mt -52.8 -37.35 59.7 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.89 0.876 . . . . 0.0 112.416 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HD2' HG23 ' A' ' 157' ' ' VAL . 15.3 ptm180 -87.33 1.07 54.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.111 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 92.0 mmm -92.61 -8.8 43.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.249 0.547 . . . . 0.0 110.23 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.96 155.18 49.97 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.63 118.67 5.67 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.888 1.725 . . . . 0.0 110.089 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.87 136.18 38.02 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.925 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 21.8 m -138.24 149.07 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.34 -10.29 16.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.44 0.638 . . . . 0.0 109.76 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.8 p -88.54 134.55 33.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.86 -29.67 61.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.564 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.25 -32.06 69.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.774 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.32 -20.44 24.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.909 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.08 154.29 24.45 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.777 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 6.1 m-20 -119.66 -12.75 9.22 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.444 0.64 . . . . 0.0 110.066 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.8 m -154.28 145.67 23.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.69 147.58 49.3 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.1 0.476 . . . . 0.0 111.467 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.59 131.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.06 167.2 21.39 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -97.79 139.64 33.36 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.9 tttt -165.22 138.26 4.52 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 65.72 16.6 10.56 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.845 0.858 . . . . 0.0 110.767 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.19 64.24 0.86 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 111.283 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -173.06 172.92 3.8 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.729 -1.578 . . . . 0.0 106.832 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.81 139.12 40.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.8 m95 -123.29 133.2 54.18 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.7 t -102.7 117.73 35.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -115.8 144.8 43.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.88 132.46 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.0 p -104.42 -39.07 6.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.302 0.572 . . . . 0.0 111.998 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -108.98 149.53 29.08 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.958 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 59.2 t -77.18 98.23 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 t -85.95 125.95 67.06 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 144.99 42.54 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 122.136 1.891 . . . . 0.0 111.689 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.6 p -62.61 116.4 5.13 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.386 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.19 -8.14 30.96 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.569 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.84 33.76 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.0 mt -103.26 163.11 12.45 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 176' ' ' ASN . 1.2 pt? -141.15 148.45 40.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -111.44 144.77 40.12 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.77 123.01 53.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.306 0.574 . . . . 0.0 110.529 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.609 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 55.1 ttt180 -98.04 137.31 37.03 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.805 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.464 ' CD2' ' HA ' ' A' ' 154' ' ' THR . 6.9 mp -98.32 138.3 35.78 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 4.4 p -50.63 104.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 122.666 1.222 . . . . 0.0 112.817 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.5 m -95.5 115.08 26.94 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.516 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.68 113.95 55.54 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.57 149.0 73.73 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.185 2.59 . . . . 0.0 112.303 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -99.1 120.61 39.77 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.55 81.41 1.74 Allowed Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.95 112.68 14.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -91.01 19.51 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.664 2.243 . . . . 0.0 111.366 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.444 ' HA ' ' HE ' ' A' ' 213' ' ' ARG . 2.5 mmp_? -125.08 93.27 3.83 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.358 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 215' ' ' PRO . 72.6 t60 -81.48 -60.63 0.41 Allowed Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.747 173.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 214' ' ' HIS . 2.5 Cg_endo -83.88 123.09 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 121.17 1.247 . . . . 0.0 109.313 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.63 63.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.608 1.194 . . . . 0.0 111.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -152.75 108.1 3.27 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.082 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -119.92 166.54 14.67 Favored Pre-proline 0 C--N 1.292 -1.927 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -64.08 157.93 50.61 Favored 'Trans proline' 0 C--O 1.249 1.056 0 N-CA-C 108.289 -1.466 . . . . 0.0 108.289 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.36 123.1 15.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.636 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 71.11 152.81 0.14 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.78 1.232 . . . . 0.0 111.475 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.8 -36.74 43.37 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 123.307 2.671 . . . . 0.0 112.098 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.22 -30.3 6.84 Favored Glycine 0 CA--C 1.491 -1.441 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 175.66 130.14 1.29 Allowed Glycine 0 N--CA 1.414 -2.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 98.1 mt -113.18 -42.17 3.57 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.919 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 176.636 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CE2' ' HB2' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -161.08 157.7 26.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.656 -0.653 . . . . 0.0 109.293 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -87.83 82.85 7.2 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.89 171.95 29.85 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.23 158.21 11.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.496 2.797 . . . . 0.0 112.012 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.07 -2.29 47.61 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.67 -19.98 54.45 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 160.18 16.18 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 113.506 -1.679 . . . . 0.0 108.9 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' A' ' 119' ' ' ARG . 36.6 tt0 -136.39 131.2 33.87 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.323 0.582 . . . . 0.0 111.493 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.488 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.5 tm? -96.36 114.31 25.97 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.83 142.91 45.5 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 79.1 mt -99.77 122.47 42.81 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 10.1 tt0 -121.5 107.19 12.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 13.14 2.77 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.139 1.376 . . . . 0.0 112.439 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.78 2.39 30.46 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.209 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.4 pt20 -95.65 151.71 19.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.5 ptt180 -98.2 105.23 17.35 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.245 0.545 . . . . 0.0 109.628 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 8.2 p -111.04 138.4 47.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.5 117.31 45.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' A' ' 108' ' ' GLU . 3.2 ptm180 -127.18 154.27 45.01 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.558 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.4 121.02 19.81 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -78.02 -43.53 29.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.24 170.09 10.26 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.805 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -69.8 107.68 3.62 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.256 0.551 . . . . 0.0 111.058 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 83.6 mt -74.52 113.75 12.12 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.2 p -85.56 155.47 21.16 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.287 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.51 129.75 40.57 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.117 0.484 . . . . 0.0 109.809 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.74 61.93 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.386 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.67 126.97 30.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 188' ' ' CYS . 36.9 p -135.59 147.51 48.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -97.69 168.18 10.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.934 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.11 159.14 53.47 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.833 0.708 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 23.6 Cg_endo -59.33 123.75 14.08 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 123.471 2.781 . . . . 0.0 112.762 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -92.99 150.65 20.4 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.912 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -90.6 105.0 17.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.146 0.498 . . . . 0.0 110.038 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.84 -168.64 39.11 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -146.9 166.61 26.23 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.79 118.85 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -111.63 120.01 40.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.369 0.604 . . . . 0.0 111.348 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 140.7 29.56 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.122 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -127.34 68.39 1.29 Allowed 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 122.655 1.217 . . . . 0.0 109.012 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.23 82.92 6.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.779 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.76 116.7 19.91 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.8 m -77.68 109.92 11.23 Favored Pre-proline 0 C--N 1.293 -1.854 0 O-C-N 123.79 0.681 . . . . 0.0 110.089 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.76 -51.0 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.353 2.035 . . . . 0.0 111.221 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -107.85 -46.73 3.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -164.45 -45.99 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 122.287 1.042 . . . . 0.0 108.196 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.37 159.97 32.83 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.146 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 130.96 56.39 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -53.02 -32.56 58.77 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.732 2.954 . . . . 0.0 114.084 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.4 -142.79 3.5 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.43 110.41 2.85 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.947 2.431 . . . . 0.0 110.883 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.32 -18.45 19.96 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.422 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.2 t -75.88 130.11 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 m -118.72 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 122.227 -0.295 . . . . 0.0 110.672 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 155' ' ' LEU . 2.3 mp -89.24 124.6 34.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.0 ttt -102.08 82.05 2.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.21 178.69 4.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.814 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.18 146.27 54.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 123.567 0.542 . . . . 0.0 110.798 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -53.36 -38.83 63.67 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.36 1.064 . . . . 0.0 112.223 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 3.34 54.44 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.77 0.319 . . . . 0.0 110.903 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.42 126.62 31.11 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -54.67 -31.1 57.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 179' ' ' ILE . 49.0 mt -56.13 -40.06 73.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -87.36 -6.52 58.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.4 ptp -100.46 5.41 44.19 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.968 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.88 143.2 31.19 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.53 129.96 16.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.909 1.739 . . . . 0.0 110.786 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -79.99 150.39 30.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.113 0.482 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 m -138.71 147.57 25.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.25 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.97 -21.93 20.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.8 p -94.99 134.83 37.24 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.241 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.4 -6.02 59.25 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.149 0.5 . . . . 0.0 111.651 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.99 -29.4 64.18 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.28 -29.74 18.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.793 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.86 124.67 25.87 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.708 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.22 -18.11 15.65 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.44 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.2 p -141.17 134.33 29.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -120.73 147.68 44.98 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.939 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.456 ' CD1' HD22 ' A' ' 163' ' ' LEU . 18.9 mm -111.1 114.35 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 11.9 p90 -125.84 154.97 41.88 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.472 ' HG2' HG21 ' A' ' 205' ' ' VAL . 33.0 ptt180 -94.26 135.94 35.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.195 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 52.2 tttm -137.31 122.57 19.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 3.8 m-20 66.63 22.16 10.53 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.6 t70 68.96 5.59 5.13 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.473 1.909 . . . . 0.0 112.214 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -95.8 155.17 16.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 78.5 mt -93.58 123.44 36.9 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.633 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 55.4 m95 -116.46 137.34 52.24 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' SER . 50.9 t -108.7 119.86 40.77 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -123.14 142.26 51.08 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.781 0.324 . . . . 0.0 110.295 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.49 128.56 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.008 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.1 p -98.35 -47.57 5.38 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -113.9 140.17 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.885 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 48.9 t -74.55 111.46 10.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.239 0.542 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.12 122.84 40.94 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.259 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.02 174.03 13.5 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.529 2.153 . . . . 0.0 112.256 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.9 m -59.45 125.99 25.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.39 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.05 63.37 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.783 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.5 144.78 17.43 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.65 142.14 27.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.4 pt? -110.88 147.26 34.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.23 148.33 37.55 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.8 134.47 46.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 123.653 0.595 . . . . 0.0 111.088 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -109.2 139.33 44.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.35 154.5 18.14 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.145 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 181' ' ' ARG . 14.2 p -39.49 132.24 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.9 0 C-N-CA 126.064 1.746 . . . . 0.0 114.286 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.9 t -77.14 179.84 6.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.337 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.74 165.11 36.41 Favored Pre-proline 0 C--N 1.292 -1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.01 94.99 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.121 -1.531 . . . . 0.0 108.121 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -102.98 122.18 44.07 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.053 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 160.85 -100.18 0.18 Allowed Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -172.73 153.91 2.8 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.7 123.89 13.54 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 122.614 2.209 . . . . 0.0 108.733 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 213' ' ' ARG . 2.8 tmt_? 76.34 102.1 0.07 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.519 1.128 . . . . 0.0 108.314 -169.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 219' ' ' PRO . 22.3 t-80 -121.75 138.14 28.13 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -66.76 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.114 2.543 . . . . 0.0 114.61 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.49 130.59 73.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 217' ' ' GLN . 6.4 tp60 68.37 118.07 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.462 1.105 . . . . 0.0 108.605 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.466 ' N ' ' HD3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER 68.09 52.5 0.57 Allowed Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.354 1.061 . . . . 0.0 109.686 -169.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 45.0 Cg_endo -94.99 162.45 1.68 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.553 2.169 . . . . 0.0 114.481 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 76.5 t 71.67 -65.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 C-N-CA 125.768 1.627 . . . . 0.0 113.829 176.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.546 ' H ' ' HD2' ' A' ' 222' ' ' PRO . 1.9 tm-20 -158.59 -52.47 0.01 OUTLIER Pre-proline 0 C--N 1.262 -3.217 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.885 -174.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 221' ' ' GLU . 11.1 Cg_endo -56.05 138.67 83.36 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 121.728 1.618 . . . . 0.0 111.597 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.66 -86.19 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.69 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -157.24 135.97 4.67 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -82.97 97.26 8.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.114 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -169.68 162.88 9.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.1 t -86.74 84.57 7.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -142.71 177.7 21.61 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.841 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.77 173.3 9.43 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.714 2.943 . . . . 0.0 112.991 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.62 -27.34 51.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 111.511 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.05 -22.93 62.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.095 0.95 . . . . 0.0 110.265 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.48 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.9 mm? -102.31 155.03 18.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.688 -173.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -139.64 135.58 33.43 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.405 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.2 114.99 28.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.74 52.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.0 mt -93.25 109.98 21.5 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -106.3 109.43 21.35 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 66.72 22.82 10.3 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.81 1.29 . . . . 0.0 109.036 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.13 -9.84 72.18 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.542 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -89.91 130.33 36.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 122.618 -0.342 . . . . 0.0 110.419 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.42 103.52 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.816 0.817 . . . . 0.0 111.28 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 39.8 m -112.95 153.14 28.48 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.015 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.46 130.99 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -142.4 158.85 43.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.09 113.82 24.1 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -76.01 -33.26 59.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.73 150.43 26.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -69.25 124.39 23.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.128 0.49 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.47 114.1 23.78 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.4 p -88.1 147.39 24.95 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.003 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.46 126.91 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.238 0.542 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.11 -7.72 48.48 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.506 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.32 126.12 30.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -128.8 148.48 50.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -97.81 173.94 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.449 0.166 . . . . 0.0 110.984 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.28 166.53 54.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.06 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.65 130.58 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.149 2.566 . . . . 0.0 113.826 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -107.06 173.74 6.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -120.16 139.05 53.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.68 -176.09 34.85 Favored Glycine 0 N--CA 1.405 -3.37 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.741 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.4 m -126.52 143.88 51.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 179' ' ' ILE . 43.2 mm -88.41 144.87 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.519 ' HG2' HD22 ' A' ' 204' ' ' LEU . 4.6 pt20 -78.25 108.32 11.48 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.914 0.864 . . . . 0.0 109.716 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 58.8 m -135.36 139.87 44.58 Favored 'General case' 0 N--CA 1.391 -3.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -87.43 92.26 9.02 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.695 0.759 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.06 11.4 37.74 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.858 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.4 tp 69.13 165.95 0.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 112.975 -1.921 . . . . 0.0 112.911 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 t -123.03 142.98 39.54 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.58 -16.91 18.7 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.127 1.885 . . . . 0.0 111.791 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' A' ' 146' ' ' ARG . 10.4 pt-20 -111.48 -38.03 5.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.766 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.483 ' HG3' ' HG3' ' A' ' 145' ' ' GLU . 60.7 mtt180 -105.08 -166.26 1.21 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.8 -150.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.97 141.97 90.05 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -68.38 -36.77 14.97 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 121.64 1.56 . . . . 0.0 112.564 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.32 -121.98 5.68 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.46 0.64 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.639 2.226 . . . . 0.0 111.044 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.03 -16.11 61.06 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.782 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.49 131.68 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 172.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.426 ' CA ' ' HB3' ' A' ' 138' ' ' GLN . 10.6 t -143.32 179.64 6.96 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -174.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 92.47 0.13 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.165 0.983 . . . . 0.0 110.869 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 47.6 ttm -80.07 87.71 5.43 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.94 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.31 -174.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.78 155.39 21.04 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.636 -0.825 . . . . 0.0 108.948 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.19 -21.27 66.74 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.7 t -93.01 -7.06 46.86 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.315 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.8 t -71.26 125.14 26.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 109.93 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.48 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 9.7 p-90 -61.9 -21.51 64.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD22 HG12 ' A' ' 179' ' ' ILE . 60.7 mt -62.13 -31.98 72.52 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.645 0.378 . . . . 0.0 111.593 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -85.92 -4.38 59.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -96.3 -5.31 40.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.093 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.2 mt -90.05 147.28 36.81 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.44 122.16 7.28 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 121.966 1.777 . . . . 0.0 111.205 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.14 129.13 35.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.753 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.16 146.54 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.783 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.31 -8.65 26.74 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.046 0.451 . . . . 0.0 109.925 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.9 p -104.47 134.84 46.98 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.464 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.41 -27.09 62.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.522 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 173' ' ' GLU . 2.1 mp0 -62.68 -25.97 68.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.985 0.914 . . . . 0.0 110.834 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.52 -38.64 12.39 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.62 135.49 52.94 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.705 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 200' ' ' LEU . 8.3 p30 -124.17 -10.71 7.56 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.254 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 m -141.61 124.36 16.04 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 188' ' ' CYS . 11.7 pt-20 -108.51 145.06 35.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.564 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 202' ' ' VAL . 2.0 mp -111.1 119.87 60.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -135.01 154.56 51.69 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.654 ' O ' ' HD2' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -88.23 124.0 33.41 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.195 0.521 . . . . 0.0 109.989 176.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.668 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 64.5 tttp -132.94 97.98 4.17 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.2 t70 57.25 72.51 0.51 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.723 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.7 t70 73.46 -5.73 1.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.251 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -130.28 164.26 24.97 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.0 110.3 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.5 mt -98.22 134.44 41.26 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.668 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 49.7 m95 -124.72 152.73 43.39 Favored 'General case' 0 C--N 1.268 -2.949 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 50.3 t -128.89 128.88 44.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -123.69 147.34 47.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.0 t -91.15 115.57 30.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.3 p -86.42 -47.35 9.4 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.226 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -123.3 144.27 49.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.73 120.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.823 0.702 . . . . 0.0 112.473 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.2 p -114.79 120.62 37.07 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.98 162.32 41.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.378 2.052 . . . . 0.0 113.436 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.0 p -56.57 113.36 1.58 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.781 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.91 -14.05 19.62 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.91 159.12 34.01 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.657 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.52 150.15 20.66 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -114.28 153.86 28.98 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.35 142.02 50.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.796 HG23 HD13 ' A' ' 179' ' ' ILE . 5.9 p -96.6 127.68 48.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.87 0.843 . . . . 0.0 111.887 -174.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.576 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.2 ttt180 -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 173.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.519 HD22 ' HG2' ' A' ' 138' ' ' GLN . 5.7 mp -98.92 148.28 24.12 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.1 p -55.63 119.84 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 110.843 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 m -84.77 144.55 28.41 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.619 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 208' ' ' PRO . 12.6 pt-20 -49.49 140.44 13.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.509 1.124 . . . . 0.0 111.563 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 207' ' ' GLU . 22.7 Cg_exo -63.03 93.1 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.828 2.352 . . . . 0.0 112.844 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.29 -27.14 38.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 106.07 -4.24 38.52 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -100.88 111.23 62.91 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.717 -0.742 . . . . 0.0 109.313 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.56 -15.42 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.0 1.8 . . . . 0.0 112.034 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 69.73 -70.37 0.15 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.695 1.598 . . . . 0.0 110.587 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -88.25 132.62 38.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.23 99.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.446 2.097 . . . . 0.0 112.232 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.53 19.06 2.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.433 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -68.58 -54.61 15.54 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.66 125.33 71.56 Favored Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 116.24 4.44 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.091 1.194 . . . . 0.0 112.631 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.71 0.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.681 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -114.05 134.85 22.09 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.129 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.12 104.46 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.639 2.226 . . . . 0.0 111.012 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 89.34 -51.29 3.67 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.812 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.78 -58.61 5.01 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.07 -29.24 11.01 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.55 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 N--CA 1.441 -1.594 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -116.43 153.79 31.47 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -80.51 35.73 0.35 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.021 0.928 . . . . 0.0 111.968 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.8 153.01 16.95 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.993 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.89 152.93 27.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.479 3.453 . . . . 0.0 113.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.11 -0.37 39.77 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.217 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -80.98 -13.43 58.89 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.65 160.08 24.0 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.334 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 121' ' ' ARG . 47.7 mt-10 -130.99 139.48 50.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.664 0.269 . . . . 0.0 111.167 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.23 94.86 6.7 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 168.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.44 130.93 50.89 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.323 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -100.78 113.33 26.15 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -126.43 114.38 18.1 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 71.69 12.86 6.31 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.506 1.146 . . . . 0.0 110.228 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.61 5.04 69.51 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.063 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -94.35 118.89 32.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -73.02 105.29 4.42 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.396 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.9 121.82 42.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.497 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.23 107.17 18.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -119.84 158.89 25.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.388 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 125.65 30.83 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.452 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 8.6 tpm_? -81.63 -48.52 11.64 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.2 mt -110.72 157.18 20.04 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.2 t -76.93 112.03 13.12 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-O 121.266 0.555 . . . . 0.0 109.896 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.56 110.43 7.84 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -109.38 166.85 10.56 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.03 132.79 51.64 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.08 -31.84 4.97 Favored Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.1 tp -85.12 132.02 34.36 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -146.25 154.22 41.48 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -91.49 172.65 8.36 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.146 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.93 169.76 54.34 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 20.7 Cg_endo -58.32 123.46 13.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.274 2.649 . . . . 0.0 112.745 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 91.5 m-85 -92.16 147.73 22.71 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.16 95.95 6.19 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.823 1.297 . . . . 0.0 112.771 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.05 -155.34 10.09 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -151.82 164.26 37.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.501 1.15 . . . . 0.0 111.06 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.76 121.52 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 156' ' ' MET . 1.2 pp0? -119.83 142.62 48.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.395 0.617 . . . . 0.0 112.14 -176.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 153' ' ' VAL . 10.4 p -94.45 87.26 5.1 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-O 122.115 0.96 . . . . 0.0 111.926 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 66.81 69.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.406 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.29 24.49 2.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.032 0.92 . . . . 0.0 108.732 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.8 tp -150.56 -54.64 0.15 Allowed 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.314 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 12.9 m -84.16 107.77 11.92 Favored Pre-proline 0 C--N 1.275 -2.646 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.469 177.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 143' ' ' SER . 35.0 Cg_endo -96.91 -58.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.704 0 N-CA-C 117.362 2.024 . . . . 0.0 117.362 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.75 9.81 25.82 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 58.13 60.68 2.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.377 1.084 . . . . 0.0 111.196 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -101.92 -20.85 14.69 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -72.71 161.16 80.67 Favored Pre-proline 0 N--CA 1.428 -1.563 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.263 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.35 -48.99 12.36 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.896 3.064 . . . . 0.0 113.097 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.25 83.59 0.08 OUTLIER Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.39 79.63 2.94 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 122.336 2.024 . . . . 0.0 114.104 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.42 -28.91 13.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 139' ' ' THR . 7.9 p -146.0 139.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.474 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.9 m -140.66 144.71 35.84 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 204' ' ' LEU . 0.8 OUTLIER -90.05 147.9 23.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.742 176.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.407 ' HB2' HE21 ' A' ' 138' ' ' GLN . 3.1 tpt -122.47 87.22 2.71 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.492 HG22 HD13 ' A' ' 155' ' ' LEU . 34.8 m -129.52 167.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.495 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.81 156.69 39.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 123.877 0.735 . . . . 0.0 109.721 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -29.98 71.23 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.31 0.644 . . . . 0.0 110.026 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.2 t -77.99 -11.96 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.58 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.98 119.09 22.35 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.62 0.724 . . . . 0.0 109.729 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -64.19 -19.99 65.7 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.128 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.401 HD22 HD11 ' A' ' 179' ' ' ILE . 73.5 mt -59.03 -31.35 68.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.696 0.398 . . . . 0.0 112.045 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -87.36 -5.11 59.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.5 mtp -89.86 -9.95 47.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.013 0.435 . . . . 0.0 110.407 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.97 149.79 46.32 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 31.9 Cg_exo -60.05 118.75 5.67 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.195 1.93 . . . . 0.0 110.442 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -81.86 124.55 29.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.355 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.03 147.09 28.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.64 1.07 17.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.673 0.749 . . . . 0.0 109.46 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 174.74 7.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.758 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' NH1' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -95.72 -52.47 4.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.237 -177.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -71.07 -39.34 72.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.44 68.38 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.421 0.451 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.72 121.08 26.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.355 0.598 . . . . 0.0 111.339 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -106.13 -5.73 19.14 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.668 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 45.5 m -149.1 140.71 23.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 203' ' ' ARG . 16.2 pt-20 -136.63 155.5 49.83 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.07 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 163' ' ' LEU . 21.8 mm -112.57 129.96 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.431 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 17.3 p90 -140.02 163.31 33.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -99.06 138.64 35.87 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 121.725 0.774 . . . . 0.0 110.519 177.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 65.2 tttp -145.8 114.38 6.78 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t70 66.82 25.54 9.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.195 1.398 . . . . 0.0 109.007 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 73.56 8.31 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.516 1.526 . . . . 0.0 112.442 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -102.73 152.24 21.46 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 82.6 mt -94.19 129.9 40.62 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.678 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 65.6 m95 -121.82 141.2 51.47 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.526 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 52.8 t -109.04 119.88 40.86 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -117.87 150.3 39.42 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.49 120.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 p -96.01 -32.89 12.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.774 0.321 . . . . 0.0 111.343 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.62 148.11 52.58 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.74 102.62 5.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.794 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.01 126.71 56.34 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.95 170.94 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.55 2.166 . . . . 0.0 113.036 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.8 m -60.69 127.41 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.39 0.23 82.62 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.01 158.08 23.74 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -100.32 146.79 26.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -115.57 151.16 35.42 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.623 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -123.03 133.19 54.35 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.1 p -97.4 122.81 49.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.744 0.652 . . . . 0.0 111.367 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 172' ' ' GLU . 43.8 ttp180 -97.79 140.46 32.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.85 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.603 HD21 HD23 ' A' ' 155' ' ' LEU . 78.6 mt -107.71 127.23 53.49 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 13.0 p -64.84 133.82 29.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.643 0.735 . . . . 0.0 111.65 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 m -116.63 140.07 49.81 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -84.1 135.9 41.58 Favored Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.224 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 207' ' ' GLU . 4.9 Cg_exo -80.22 35.16 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.729 2.286 . . . . 0.0 111.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 68.26 -66.39 0.23 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.256 1.823 . . . . 0.0 110.025 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 177.29 127.49 1.06 Allowed Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.491 ' HB3' ' HD3' ' A' ' 212' ' ' PRO . . . -64.5 -49.84 69.04 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.774 0.287 . . . . 0.0 111.316 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 211' ' ' ALA . 16.9 Cg_endo -100.43 -141.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.466 2.111 . . . . 0.0 107.196 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -66.94 -63.45 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.768 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -117.43 134.08 23.17 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -79.03 88.64 1.44 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.948 1.765 . . . . 0.0 110.672 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . 0.253 11.6 m 56.01 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 126.435 1.894 . . . . 0.0 111.806 -172.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -139.83 -70.38 0.4 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.241 -177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.544 ' HB3' ' HD3' ' A' ' 219' ' ' PRO . 40.9 tt0 -122.67 -53.94 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.825 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 218' ' ' GLU . 6.2 Cg_endo -93.07 158.93 2.64 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.283 1.322 . . . . 0.0 111.172 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.9 t 70.86 114.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.853 1.261 . . . . 0.0 112.763 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 222' ' ' PRO . 41.7 tt0 -101.1 -52.73 0.17 Allowed Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.307 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 221' ' ' GLU . 2.9 Cg_endo -85.86 124.67 2.63 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.458 1.439 . . . . 0.0 110.606 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.15 95.11 1.79 Allowed Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.457 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 165.81 -65.66 0.21 Allowed Glycine 0 C--N 1.297 -1.618 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.5 tp -103.98 -41.89 5.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.376 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 108.62 -1.338 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.491 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 1.1 p-90 -123.66 154.6 39.15 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.4 m -88.03 88.16 7.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.672 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.77 178.45 29.9 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.91 160.58 30.51 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.618 2.879 . . . . 0.0 112.946 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.2 -7.95 59.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.504 0.668 . . . . 0.0 111.426 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.51 -24.13 42.46 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.65 162.46 14.13 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.851 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.17 136.87 32.25 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.896 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -90.32 104.81 17.34 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.7 153.6 21.62 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.7 mt -115.54 112.3 22.01 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -105.0 104.53 14.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 64.55 19.07 11.69 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.464 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.63 -8.83 43.98 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.094 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -94.77 143.25 26.6 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -75.23 133.83 41.29 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.088 0.471 . . . . 0.0 109.874 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.08 121.37 17.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.35 106.81 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -110.05 156.43 20.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.856 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.77 122.07 40.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.335 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.16 -46.46 23.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.1 mt -101.53 139.78 36.72 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.9 t -70.65 126.98 31.11 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.84 145.8 50.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.159 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 p -93.4 150.9 20.11 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.052 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.46 124.07 23.3 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.94 60.19 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.818 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.47 122.02 15.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.0 m -131.53 138.54 48.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -92.18 169.32 10.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.45 179.83 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 123.9 0.75 . . . . 0.0 114.25 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 73.7 Cg_endo -75.44 138.45 22.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.786 2.324 . . . . 0.0 112.536 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 163' ' ' LEU . 56.2 m-85 -114.0 149.07 35.91 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -89.4 99.44 12.44 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -154.28 -152.44 6.1 Favored Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.7 m -150.93 134.18 16.12 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.84 134.29 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.34 97.71 2.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.563 1.173 . . . . 0.0 112.71 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.9 p -103.51 94.44 5.47 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.774 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.405 ' H ' ' NE ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -82.44 122.75 28.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.994 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.01 27.57 3.98 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.605 0.717 . . . . 0.0 110.489 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.95 175.83 6.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.6 t -103.78 137.48 19.25 Favored Pre-proline 0 C--N 1.283 -2.309 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.84 -9.87 24.65 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.982 1.788 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.26 -20.88 23.58 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.238 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -118.71 131.3 56.14 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.46 -78.25 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.254 0.971 . . . . 0.0 112.284 169.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.09 102.71 55.04 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 122.982 0.513 . . . . 0.0 110.098 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.03 -9.0 11.95 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.56 177.94 29.77 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.24 81.85 2.36 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 121.969 1.779 . . . . 0.0 111.762 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.49 86.02 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 108.797 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.36 120.05 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -126.43 167.3 15.76 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.75 100.0 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 122.287 1.042 . . . . 0.0 112.72 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.9 mtm -79.43 83.12 5.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.649 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.539 HG12 ' HA3' ' A' ' 135' ' ' GLY . 22.9 m -126.38 150.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.626 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.54 160.38 25.31 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.301 0.64 . . . . 0.0 111.287 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -52.82 -32.45 44.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.543 0.737 . . . . 0.0 111.67 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.0 m -85.0 9.81 13.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.199 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 48.3 t -100.1 100.24 11.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 8.6 p-90 -56.43 -19.59 15.75 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.773 1.229 . . . . 0.0 113.205 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.449 HD22 HD11 ' A' ' 179' ' ' ILE . 65.0 mt -59.66 -28.16 67.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.374 0.669 . . . . 0.0 111.473 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 8.6 ptm180 -85.06 -2.64 58.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.933 0.397 . . . . 0.0 110.984 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.8 mtt -93.79 -13.99 26.73 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.94 142.13 36.21 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.579 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.23 133.24 27.98 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 122.114 1.876 . . . . 0.0 110.872 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -84.97 128.77 34.77 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.187 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.66 138.33 52.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.564 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.87 -21.31 23.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 p -87.99 134.81 33.65 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.014 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.4 -17.71 31.66 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.35 -34.63 74.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.34 -15.35 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.452 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.95 118.13 19.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.106 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 0.8 OUTLIER -91.41 -30.33 16.57 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.0 p -133.72 136.93 44.96 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.953 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.92 146.01 45.29 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.215 0.531 . . . . 0.0 112.019 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.449 HD11 HD22 ' A' ' 163' ' ' LEU . 28.9 mm -104.96 120.92 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -126.19 145.17 50.49 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptp180 -91.42 139.87 30.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -142.23 115.11 8.68 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 67.45 27.28 8.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.595 1.188 . . . . 0.0 107.879 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 68.69 4.88 4.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.054 2.142 . . . . 0.0 111.98 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -90.97 151.89 20.91 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 8.0 mp -93.58 125.76 38.37 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 120.821 0.343 . . . . 0.0 111.158 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -122.92 139.21 54.29 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.532 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.9 t -113.8 116.79 29.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -115.05 135.08 54.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.754 0.311 . . . . 0.0 110.414 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.58 126.11 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.2 p -108.13 -23.42 11.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.321 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -128.78 150.26 50.37 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.035 0.445 . . . . 0.0 111.749 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.04 125.97 37.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.56 127.85 61.46 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-O 120.704 0.287 . . . . 0.0 111.231 -171.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.15 134.06 53.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 111.462 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 18.3 m -75.91 110.06 10.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.217 0.532 . . . . 0.0 109.959 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.57 0.84 32.66 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -114.32 165.05 12.02 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 69.1 mt -101.47 155.23 18.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.218 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.1 pt? -99.28 143.82 29.1 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.576 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -110.93 148.08 33.25 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.63 130.2 53.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.88 0.848 . . . . 0.0 111.291 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 69.9 ttt180 -105.18 122.25 45.51 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.699 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.61 118.65 32.69 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.539 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.84 103.98 7.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 70.6 p -102.83 145.9 29.08 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.434 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -76.27 122.77 87.41 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.24 -62.36 0.08 OUTLIER 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 121.875 1.717 . . . . 0.0 110.674 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.424 ' CG ' ' H ' ' A' ' 210' ' ' GLY . 22.5 t-80 -178.85 -169.87 0.17 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 209' ' ' HIS . . . 111.42 -107.22 2.12 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -142.04 75.17 20.92 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 116.772 0.286 . . . . 0.0 111.172 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.73 -41.99 9.81 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.639 1.559 . . . . 0.0 110.832 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.61 19.58 3.32 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 55.8 m80 75.3 132.34 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.874 1.67 . . . . 0.0 109.95 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.99 -44.49 24.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.757 1.638 . . . . 0.0 108.602 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 13.9 m -152.64 154.3 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -107.11 -54.34 2.48 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.601 0.715 . . . . 0.0 109.553 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -162.21 107.88 1.12 Allowed Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.7 118.4 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.903 1.735 . . . . 0.0 112.031 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.2 t -67.91 123.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 61.13 82.15 0.23 Allowed Pre-proline 0 C--O 1.22 -0.461 0 O-C-N 124.373 1.045 . . . . 0.0 110.411 -171.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.65 105.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.336 1.357 . . . . 0.0 110.395 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -81.01 88.32 1.36 Allowed Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.047 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.19 9.07 59.35 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 225' ' ' LEU . 2.3 pt? -127.71 164.95 20.98 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.13 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 N--CA 1.438 -1.771 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.462 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.3 OUTLIER -122.49 149.6 43.67 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 m -102.53 100.11 10.18 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.507 -0.746 . . . . 0.0 109.534 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.39 -174.59 22.37 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.5 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.53 163.66 26.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.463 2.775 . . . . 0.0 111.825 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.12 -15.64 55.34 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.188 0.518 . . . . 0.0 111.604 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.95 -15.91 60.66 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 200' ' ' LEU . 3.4 mm? -109.41 151.38 26.74 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.416 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.83 123.77 12.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.207 0.527 . . . . 0.0 111.898 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.46 109.92 20.42 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.12 142.45 47.42 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 56.5 mt -102.2 127.87 48.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -124.09 94.32 4.18 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 60.93 25.92 15.86 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.414 0.626 . . . . 0.0 111.364 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.19 -8.31 38.29 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 74.7 mt-30 -81.39 126.52 31.72 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -86.77 95.92 10.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.2 p -111.44 122.93 49.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.514 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.22 111.14 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -110.37 156.47 20.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.56 133.11 34.08 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -83.04 -32.35 26.9 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.13 169.5 9.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -92.23 105.38 17.61 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.88 124.46 32.38 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.15 0.5 . . . . 0.0 110.858 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -72.24 151.39 42.89 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.739 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.95 140.76 56.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.96 10.39 58.74 Favored Glycine 0 C--N 1.299 -1.501 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.608 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.0 tp -101.34 126.5 48.11 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t -122.53 158.78 29.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -95.69 174.4 6.99 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.662 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.97 177.93 49.5 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 124.209 0.943 . . . . 0.0 112.166 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.02 132.12 20.72 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.711 2.274 . . . . 0.0 114.039 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -110.39 149.71 29.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -106.04 119.32 38.89 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.627 0.727 . . . . 0.0 111.236 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -170.87 -160.62 19.83 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -148.51 134.63 19.27 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 118.397 1.099 . . . . 0.0 111.089 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.6 113.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.92 105.87 14.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -62.76 138.47 58.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.035 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.589 ' HG2' ' H ' ' A' ' 142' ' ' LEU . 48.8 ttp85 65.45 -86.9 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.738 1.215 . . . . 0.0 111.174 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 50.26 22.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.441 1.096 . . . . 0.0 112.348 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.589 ' H ' ' HG2' ' A' ' 140' ' ' ARG . 14.7 tp -70.18 156.51 39.12 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 124.581 1.152 . . . . 0.0 108.448 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.6 m -115.42 105.38 52.32 Favored Pre-proline 0 N--CA 1.42 -1.946 0 C-N-CA 118.826 -1.149 . . . . 0.0 113.481 -175.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HD2' ' OE1' ' A' ' 145' ' ' GLU . 0.9 OUTLIER -95.51 -7.78 1.47 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.901 2.401 . . . . 0.0 110.462 166.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.432 ' OE1' ' HD2' ' A' ' 144' ' ' PRO . 14.7 mp0 -107.33 -44.33 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -94.22 179.9 5.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.853 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -68.76 -14.01 62.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.625 1.17 . . . . 0.0 113.94 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 73.6 113.6 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.553 1.141 . . . . 0.0 108.384 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.66 7.64 4.12 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.636 2.224 . . . . 0.0 112.947 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.9 -111.39 3.86 Favored Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 213' ' ' ARG . 36.6 Cg_endo -69.41 105.74 1.48 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 110.335 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.2 -47.41 35.7 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.509 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 206' ' ' THR . 40.2 t -75.35 117.72 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 m -125.1 136.21 53.43 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 104.91 16.39 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.159 0.981 . . . . 0.0 109.053 172.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.78 87.93 6.32 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.892 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -128.95 168.96 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.703 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.12 148.19 22.6 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.255 1.022 . . . . 0.0 111.455 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 46.0 mt-10 -63.4 -20.03 65.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.343 0.592 . . . . 0.0 110.581 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 m -83.03 -20.43 35.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.063 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.4 t -74.35 131.36 41.05 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.52 0.676 . . . . 0.0 111.295 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 p-90 -66.16 -20.49 66.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.012 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.45 -30.28 71.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.699 0.285 . . . . 0.0 111.487 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 17.0 ptm180 -96.4 2.24 52.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.622 . . . . 0.0 110.467 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mmm -99.02 -1.64 39.25 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.199 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 83.2 mt -93.61 145.54 30.12 Favored Pre-proline 0 N--CA 1.425 -1.716 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.96 127.71 11.69 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.441 1.427 . . . . 0.0 109.883 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -84.13 135.22 34.48 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 27.1 m -135.47 160.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.3 pp -105.28 -19.52 13.78 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.794 0.807 . . . . 0.0 110.876 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.8 133.86 33.96 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.42 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 1.4 pm0 -76.99 -21.57 54.5 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.139 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -67.53 -25.57 65.89 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.3 -38.61 8.79 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.59 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -76.86 94.41 3.89 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 121.395 0.616 . . . . 0.0 111.109 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 200' ' ' LEU . 27.6 p30 -87.04 -13.9 43.05 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.451 175.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 m -126.88 124.51 39.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.33 150.33 37.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.1 mm -110.05 125.0 67.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.62 ' CE1' ' HG3' ' A' ' 189' ' ' ARG . 11.9 p90 -126.74 176.02 7.56 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.12 140.1 52.5 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.496 ' HG2' ' OD1' ' A' ' 183' ' ' ASP . 24.0 ttpp -156.37 132.05 9.59 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.496 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 4.1 m-20 60.32 34.66 20.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.315 0.646 . . . . 0.0 110.805 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 t70 67.62 17.49 9.91 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.436 1.495 . . . . 0.0 111.856 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -126.28 162.17 26.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.197 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.1 mt -97.18 140.4 31.73 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -134.0 153.08 52.02 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -125.88 128.13 47.12 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.602 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.62 ' HG3' ' CE1' ' A' ' 180' ' ' TYR . 51.4 mtp180 -103.44 145.52 29.88 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.96 100.41 11.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 166.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.8 t -82.41 -26.04 33.15 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.61 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.45 141.49 45.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.01 125.19 12.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 123.794 0.684 . . . . 0.0 111.715 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 7.5 p -110.67 114.85 54.34 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 11.1 Cg_exo -72.08 153.6 57.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.466 2.111 . . . . 0.0 112.565 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 p -61.46 115.84 4.21 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.464 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.66 -15.49 45.27 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -81.47 157.58 38.51 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.74 157.06 16.63 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.339 0.59 . . . . 0.0 110.377 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 107' ' ' LEU . 1.5 pt? -127.81 157.1 41.34 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.107 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -134.85 148.02 50.03 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.39 133.44 46.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.54 0.686 . . . . 0.0 112.215 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 27.2 ttt180 -117.39 147.76 42.37 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.09 153.0 33.51 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 206' ' ' THR . 7.4 p -62.66 114.28 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.434 ' O ' HG11 ' A' ' 153' ' ' VAL . 91.7 m 71.55 91.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -164.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -83.13 150.73 61.82 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.815 -172.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.87 103.34 1.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.378 2.052 . . . . 0.0 111.613 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -107.76 159.8 16.21 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.068 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.15 -51.66 0.73 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -163.8 95.22 1.03 Allowed Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 123.879 0.872 . . . . 0.0 108.771 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.41 35.57 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.075 2.517 . . . . 0.0 112.903 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.489 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 4.3 ptm180 -80.28 128.97 34.16 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.38 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -88.58 127.25 57.2 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.75 118.81 5.76 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.452 2.101 . . . . 0.0 111.789 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.53 -25.96 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.842 0.829 . . . . 0.0 108.989 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -131.59 119.79 21.96 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.39 131.31 62.21 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.63 119.29 6.3 Favored 'Trans proline' 0 C--O 1.253 1.238 0 C-N-CA 122.856 2.37 . . . . 0.0 112.151 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -102.43 107.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.32 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.57 142.71 77.96 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.1 139.72 85.77 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.852 2.368 . . . . 0.0 112.312 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -80.01 -78.89 0.88 Allowed Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.593 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.47 4.98 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 111.731 -0.547 . . . . 0.0 111.731 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 -38.42 71.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.372 0.606 . . . . 0.0 109.584 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.91 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--O 1.243 0.756 0 N-CA-C 108.828 -1.258 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 178.09 -179.94 0.3 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 m -96.97 91.64 5.7 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.32 -173.11 29.55 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.044 -1.075 . . . . 0.0 112.176 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -83.14 158.55 15.3 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.287 2.658 . . . . 0.0 112.567 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.07 -19.05 63.29 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.719 0.808 . . . . 0.0 111.837 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -80.21 -22.34 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.096 0.95 . . . . 0.0 109.5 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.52 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 4.3 mm? -108.4 160.47 15.85 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.266 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 12.8 tp10 -155.71 147.26 22.9 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.772 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 101' ' ' TRP . 1.3 tm? -99.38 103.55 15.35 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.1 146.42 23.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.45 104.62 13.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.43 99.4 8.98 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.57 23.38 11.76 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.213 1.005 . . . . 0.0 111.485 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.16 57.36 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.448 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.37 143.16 26.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.99 0.424 . . . . 0.0 111.475 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -82.98 134.17 35.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.844 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.7 m -131.84 121.53 24.25 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 166' ' ' LEU . 19.8 m -86.47 96.2 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.378 1.085 . . . . 0.0 110.602 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -114.02 158.89 20.59 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.372 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.23 18.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 77.7 ttt180 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.9 mt -119.99 155.53 32.66 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' OG ' ' A' ' 196' ' ' SER . 47.3 t -77.04 123.92 27.04 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.5 mm? -69.93 121.99 18.43 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.513 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.6 m -90.62 139.77 30.4 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.872 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.68 120.46 10.09 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.12 16.05 Favored Glycine 0 C--N 1.301 -1.381 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.241 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -64.04 126.88 29.11 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -136.69 145.68 45.02 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -91.72 175.05 7.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.62 -172.46 45.45 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.314 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.99 123.19 6.11 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.208 1.939 . . . . 0.0 112.49 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -103.81 150.39 24.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -104.41 107.13 17.9 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.774 0.797 . . . . 0.0 110.495 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.67 177.49 43.74 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.4 p -129.11 133.55 47.7 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 119.231 1.516 . . . . 0.0 113.127 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.6 mt -110.1 95.52 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -89.66 98.81 11.98 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.878 -172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.5 t -71.79 142.41 49.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -143.65 89.02 2.03 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.165 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.53 90.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 143' ' ' SER . 17.6 tp -119.07 -144.27 0.37 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.559 ' H ' ' HG ' ' A' ' 142' ' ' LEU . 18.8 m -68.25 124.56 90.04 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.62 -42.73 42.02 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.794 2.996 . . . . 0.0 113.95 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.39 -20.09 63.82 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 148' ' ' GLU . 7.0 ttt180 62.87 -76.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.101 1.36 . . . . 0.0 112.121 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 177.38 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -171.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' HB2' ' NH1' ' A' ' 146' ' ' ARG . 44.8 mt-10 -139.12 157.41 71.26 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.66 -17.8 53.0 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.788 2.325 . . . . 0.0 111.891 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.58 142.21 45.21 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.502 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.91 113.5 3.78 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.876 2.384 . . . . 0.0 113.489 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.58 -7.65 56.06 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.965 0.888 . . . . 0.0 109.148 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -89.32 126.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.7 m -151.18 146.78 26.34 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 204' ' ' LEU . 1.8 pp -80.53 142.7 33.91 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.5 mmm -116.42 94.57 4.68 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.35 171.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.022 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.16 147.82 38.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 123.613 0.571 . . . . 0.0 110.473 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.26 -33.27 67.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 111.228 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -100.26 12.78 36.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.652 0.263 . . . . 0.0 111.155 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.4 t -79.52 132.97 36.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 24.4 p-90 -65.05 -23.21 67.12 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.06 -25.52 68.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.104 0.478 . . . . 0.0 112.199 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 1.6 ptm180 -95.04 3.17 55.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 mmt -96.47 -22.63 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 118' ' ' VAL . 9.9 mp -88.35 153.05 50.76 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.99 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.27 129.69 16.38 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.588 2.192 . . . . 0.0 111.61 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -82.51 138.13 34.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.99 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 175' ' ' ALA . 29.3 m -140.54 157.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 98.2 mt -115.53 -6.15 12.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 118.204 0.456 . . . . 0.0 112.106 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.8 p -87.85 151.34 22.92 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.393 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.19 -23.68 35.35 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.598 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -69.98 -39.06 76.15 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.433 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.58 -33.36 23.41 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.966 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.631 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -84.84 99.7 11.08 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-O 121.366 0.603 . . . . 0.0 112.499 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.443 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 5.6 p30 -74.76 -19.58 60.16 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.187 175.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.9 p -131.45 142.89 50.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.85 141.14 48.28 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 188' ' ' CYS . 9.4 mm -110.36 126.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -130.94 177.7 7.23 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -122.27 146.13 47.58 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.227 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.8 129.65 13.35 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.95 25.66 13.97 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.464 1.126 . . . . 0.0 109.401 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 69.36 13.63 8.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.331 1.452 . . . . 0.0 112.267 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.56 156.05 21.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.0 mt -93.6 135.26 35.05 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.219 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -126.32 139.57 53.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.69 ' SG ' HD12 ' A' ' 179' ' ' ILE . 53.1 m -116.46 123.49 47.63 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -124.83 148.11 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.725 0.298 . . . . 0.0 110.331 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 124' ' ' LEU . 67.1 t -98.06 121.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.0 p -114.25 -21.89 10.22 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 176' ' ' ASN . 64.6 mmtt -125.76 161.69 26.79 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.7 131.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.684 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.7 120.39 43.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.74 140.78 52.26 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.604 2.203 . . . . 0.0 111.791 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 123' ' ' SER . 7.5 m -63.38 114.71 4.02 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.29 -16.57 35.12 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.695 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.83 159.53 38.07 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.876 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.74 125.27 35.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 200' ' ' LEU . 0.7 OUTLIER -98.62 163.39 12.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.366 -178.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -121.41 144.95 48.39 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.933 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.08 121.97 52.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.187 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.631 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.1 ttm180 -100.4 137.12 39.25 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 155' ' ' LEU . 66.0 mt -96.55 145.97 25.24 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.22 121.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.938 0.875 . . . . 0.0 112.075 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.2 p -90.62 178.5 6.06 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.37 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.12 124.49 90.92 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.856 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 120.56 7.4 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.639 2.226 . . . . 0.0 113.213 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -110.68 -4.25 15.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 93.04 -60.24 2.33 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -147.96 134.31 9.87 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.25 -28.53 79.24 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.22 1.946 . . . . 0.0 112.207 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -117.92 99.46 6.93 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 49.35 82.07 0.25 Allowed Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 124.845 1.258 . . . . 0.0 114.331 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.54 -42.14 0.96 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.988 1.792 . . . . 0.0 112.651 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 40.0 t 58.96 67.77 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 122.146 0.974 . . . . 0.0 109.437 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.98 -17.43 3.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.387 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -153.71 114.6 2.61 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.98 118.28 4.97 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 121.557 1.505 . . . . 0.0 110.148 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.61 107.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.803 0.811 . . . . 0.0 110.256 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 43.9 mt-10 -89.82 -49.97 0.37 Allowed Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 221' ' ' GLU . 55.7 Cg_exo -58.0 130.72 39.61 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.789 1.66 . . . . 0.0 111.158 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 134.86 17.06 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.364 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 102.36 -3.78 50.93 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.762 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mp -101.41 172.0 7.24 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.509 -0.406 . . . . 0.0 111.572 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.264 1.83 0 C-N-CA 125.458 1.503 . . . . 0.0 111.54 -178.215 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.441 -1.573 0 N-CA-C 109.158 -1.132 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -157.71 162.06 38.56 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.8 t -89.82 96.15 10.56 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.02 -171.25 32.9 Favored Glycine 0 N--CA 1.42 -2.424 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.738 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.83 162.21 12.06 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.245 2.63 . . . . 0.0 111.597 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.28 -16.92 51.14 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.567 0.699 . . . . 0.0 110.539 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.36 -26.41 62.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.173 0.987 . . . . 0.0 109.368 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 1.6 mm? -94.37 156.88 16.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.808 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.44 134.34 37.61 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.185 0.517 . . . . 0.0 111.846 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.3 122.71 42.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.63 151.23 49.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.95 97.7 7.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 11.5 mm100 -109.44 132.88 53.71 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 66.61 12.89 9.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 123.766 0.666 . . . . 0.0 110.916 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.39 22.62 62.26 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.968 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 14.0 pt20 -133.09 167.98 19.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -75.1 120.0 20.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 38.1 t -122.16 146.57 47.11 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.81 120.06 63.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.294 0.568 . . . . 0.0 110.197 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -129.46 152.73 48.68 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.921 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.24 109.1 20.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -72.11 -48.9 40.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.3 mt -89.13 129.19 35.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.7 m -67.57 126.2 28.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 190' ' ' VAL . 58.6 mt -97.99 133.86 41.89 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.7 t -99.12 161.53 13.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.501 0.501 . . . . 0.0 110.205 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.95 128.87 37.87 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.214 0.606 . . . . 0.0 110.863 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.81 63.7 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.721 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.87 130.69 42.95 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -135.67 160.03 39.8 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.992 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -99.72 175.24 5.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.07 176.13 51.73 Favored Glycine 0 N--CA 1.441 -0.981 0 O-C-N 123.605 0.566 . . . . 0.0 112.56 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.47 123.38 10.14 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.669 2.246 . . . . 0.0 113.496 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.65 149.95 22.27 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.99 105.71 15.88 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.689 0.757 . . . . 0.0 112.335 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.73 8.23 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 p -145.5 138.78 26.34 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.583 0.692 . . . . 0.0 111.82 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.423 HG22 HG23 ' A' ' 139' ' ' THR . 46.0 mt -138.76 96.61 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.15 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.66 98.63 10.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.369 1.081 . . . . 0.0 109.912 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.423 HG23 HG22 ' A' ' 137' ' ' ILE . 4.3 p -86.16 109.98 19.26 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.182 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -115.02 -78.56 0.58 Allowed 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 52.39 30.17 7.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.044 0.938 . . . . 0.0 112.027 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.0 tp -108.17 103.39 12.57 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.8 p -123.34 105.82 33.49 Favored Pre-proline 0 N--CA 1.421 -1.897 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.962 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.46 -28.52 17.75 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.14 2.56 . . . . 0.0 111.057 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -88.23 -8.79 54.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.099 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.99 30.41 19.59 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.972 0.909 . . . . 0.0 112.044 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.32 -28.13 69.8 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.189 0.519 . . . . 0.0 111.084 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 152' ' ' ALA . 26.7 tt0 -154.5 92.72 2.92 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 174.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 73.04 5.47 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 123.163 2.575 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.9 -162.87 30.18 Favored Glycine 0 C--N 1.28 -2.58 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.218 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.33 88.44 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 121.779 1.653 . . . . 0.0 111.486 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.538 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . . . -62.85 -45.98 90.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.913 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.15 126.0 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.7 p -98.1 172.92 7.3 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.916 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.07 137.91 58.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.355 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.9 mtt -109.01 94.69 5.18 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.86 179.0 3.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.361 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.75 140.26 57.62 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 123.473 0.483 . . . . 0.0 111.284 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -51.72 -36.69 47.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.326 1.05 . . . . 0.0 113.399 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -103.6 9.97 37.15 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.819 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.516 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 41.0 t -78.68 137.31 37.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.154 0.502 . . . . 0.0 110.206 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' LEU . 9.1 p-90 -60.96 -27.11 68.01 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.3 mt -56.98 -32.49 66.14 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.088 0.47 . . . . 0.0 112.088 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.64 -1.17 47.3 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.586 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.4 mtp -95.52 -6.22 41.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 162' ' ' TRP . 8.8 mp -94.73 141.62 23.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.18 122.5 10.99 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.348 2.032 . . . . 0.0 111.389 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -79.26 127.84 32.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.21 156.46 23.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -83.68 -39.89 19.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.385 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.7 p -91.72 155.59 18.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.493 0.663 . . . . 0.0 112.532 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -87.23 -16.97 33.68 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.469 -177.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.9 -26.96 36.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.399 0.619 . . . . 0.0 109.426 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.37 -31.99 22.65 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.71 143.58 37.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' A' ' 200' ' ' LEU . 16.1 p30 -118.43 2.08 11.81 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.4 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.2 p -151.31 135.72 16.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 15.8 pt-20 -129.0 149.87 50.65 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.038 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 163' ' ' LEU . 24.1 mm -109.52 116.36 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -122.67 157.77 31.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -102.16 144.3 30.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.2 tttm -161.71 125.55 3.24 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 65.46 32.73 9.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.127 0.971 . . . . 0.0 111.148 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.1 t70 75.0 9.36 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.378 1.085 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.05 162.25 22.77 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.532 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.68 137.26 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.559 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.5 m95 -123.57 133.99 53.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 54.0 t -106.8 126.82 52.79 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -127.39 147.35 50.28 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.436 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 124' ' ' LEU . 60.0 t -84.14 115.12 25.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.003 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.8 p -80.83 -33.7 34.46 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 176' ' ' ASN . 20.2 ptmt -146.3 152.72 39.61 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.1 129.82 20.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 123.994 0.809 . . . . 0.0 111.697 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.59 125.2 36.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.69 164.3 16.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.127 2.551 . . . . 0.0 113.34 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.1 m -66.97 101.45 0.85 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.466 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.31 16.8 52.42 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.37 156.86 35.9 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 mp -95.13 141.09 29.16 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.502 0.668 . . . . 0.0 111.093 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 176' ' ' ASN . 3.2 mp -95.65 149.16 21.76 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.029 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.03 131.67 44.45 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.92 134.44 42.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.46 0.648 . . . . 0.0 111.612 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.419 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.9 ttt180 -104.61 142.05 35.34 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.912 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.86 139.83 32.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.0 p -59.14 144.17 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.687 0.617 . . . . 0.0 110.821 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 t -97.26 148.48 23.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.65 116.22 65.79 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.13 122.47 11.51 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.216 2.611 . . . . 0.0 111.647 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -92.29 -58.06 2.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.324 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -111.84 79.84 0.26 Allowed Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.015 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -119.03 95.98 49.79 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.24 -52.76 2.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.717 2.278 . . . . 0.0 112.495 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -110.21 125.8 53.45 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.444 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -117.94 117.68 35.25 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.75 166.96 16.53 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.409 2.073 . . . . 0.0 112.088 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 52.5 t -74.6 122.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.93 -27.32 9.3 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.433 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.09 117.63 59.94 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -67.14 144.95 71.26 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 121.863 1.709 . . . . 0.0 110.929 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.27 123.56 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.352 0.596 . . . . 0.0 109.435 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.91 113.65 57.82 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.499 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -83.88 33.1 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.932 2.421 . . . . 0.0 110.617 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.96 36.63 40.85 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.1 134.93 12.15 Favored Glycine 0 N--CA 1.423 -2.171 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.262 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.44 -26.97 41.69 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.837 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.234 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.446 -1.276 0 N-CA-C 112.379 0.107 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.477 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 0.5 OUTLIER -134.31 161.94 33.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 m -91.58 82.42 5.31 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.61 160.69 14.39 Favored Glycine 0 N--CA 1.419 -2.453 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.96 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.553 ' HB2' ' OE1' ' A' ' 106' ' ' GLU . 60.7 Cg_endo -84.18 166.47 12.66 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.961 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -63.26 -19.36 64.5 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.801 0.84 . . . . 0.0 113.002 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 104' ' ' PRO . 23.7 mp0 -82.44 -17.99 43.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.611 0.72 . . . . 0.0 110.142 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.9 156.2 24.39 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.018 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.504 ' OE2' ' HD2' ' A' ' 119' ' ' ARG . 33.0 tt0 -141.59 126.27 17.96 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.813 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.18 108.72 20.85 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.24 154.59 50.87 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.769 0.319 . . . . 0.0 110.234 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.9 mp -91.99 101.29 13.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 121.879 0.847 . . . . 0.0 110.167 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.534 ' HB3' ' SG ' ' A' ' 117' ' ' CYS . 50.7 tt0 -106.17 124.62 49.87 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 113.795 -1.548 . . . . 0.0 106.998 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 69.67 12.35 8.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.67 1.224 . . . . 0.0 109.677 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.25 2.23 60.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.024 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 43.8 mt-30 -114.65 146.38 40.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 117.393 0.596 . . . . 0.0 110.147 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -75.86 119.94 20.53 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 112' ' ' GLN . 9.4 p -138.28 149.38 45.65 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.861 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.41 111.15 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 108' ' ' GLU . 3.4 ptp180 -116.69 158.65 23.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.96 124.8 28.6 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -77.26 -33.97 55.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.68 0.753 . . . . 0.0 109.587 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 pp -127.01 155.74 42.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -66.25 113.87 4.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.717 0.77 . . . . 0.0 111.734 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 190' ' ' VAL . 86.0 mt -79.64 138.66 37.47 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 t -127.19 159.04 35.5 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.83 125.28 22.34 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 124.03 0.831 . . . . 0.0 110.053 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.02 36.03 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.055 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.8 t -129.13 151.77 49.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -96.66 173.86 7.11 Favored 'General case' 0 C--N 1.267 -3.015 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.815 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.5 175.71 54.83 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.8 Cg_endo -69.25 129.93 19.04 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.737 2.292 . . . . 0.0 113.279 -177.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -107.28 160.44 15.61 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.96 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.86 132.64 34.78 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.743 0.782 . . . . 0.0 112.031 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 162.18 -177.62 38.3 Favored Glycine 0 N--CA 1.414 -2.81 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -144.91 129.48 18.02 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 117.414 0.607 . . . . 0.0 111.597 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.3 mt -94.82 97.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -72.88 134.44 44.83 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.594 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.2 m -67.15 113.49 5.14 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -123.92 39.65 3.91 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.81 73.42 9.98 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.633 0.73 . . . . 0.0 109.274 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.6 mt -146.78 172.32 13.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.433 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 t -103.79 135.19 19.4 Favored Pre-proline 0 N--CA 1.415 -2.223 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 143' ' ' SER . 6.9 Cg_endo -87.63 -156.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.546 2.164 . . . . 0.0 110.419 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -85.64 -6.67 59.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.978 0.894 . . . . 0.0 109.682 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -96.52 176.37 6.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.133 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.77 -55.1 4.27 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -88.78 121.36 69.93 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.959 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.52 -40.67 1.02 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 121.394 1.396 . . . . 0.0 109.591 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.6 -153.76 37.24 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.17 71.99 6.44 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.397 2.065 . . . . 0.0 109.46 172.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.71 -20.88 49.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.161 -176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.92 120.04 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.3 m -120.45 138.23 53.91 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.339 -172.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.89 91.48 8.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 122.238 1.018 . . . . 0.0 110.274 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.1 mtp -87.03 82.67 7.67 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.39 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.44 HG12 ' HA3' ' A' ' 135' ' ' GLY . 32.8 m -105.04 177.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.309 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 161' ' ' CYS . 10.7 t70 -49.37 141.48 8.83 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.089 0.868 . . . . 0.0 110.971 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.57 -20.51 47.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.8 m -114.35 7.37 16.36 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.061 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.2 t -69.76 129.22 38.99 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.949 0.404 . . . . 0.0 109.919 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.8 p-90 -56.08 -27.93 55.59 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.437 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.9 mt -60.86 -32.76 72.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.825 0.45 . . . . 0.0 112.012 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.7 ptm180 -93.05 -0.96 57.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.931 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.477 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 22.6 ptm -110.56 5.97 21.56 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.552 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 88.7 mt -81.6 143.84 51.69 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.25 126.05 13.17 Favored 'Trans proline' 0 C--O 1.253 1.266 0 C-N-CA 121.722 1.615 . . . . 0.0 109.839 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -87.52 139.78 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 0.0 111.864 -174.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 152.27 32.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.584 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.3 tp -97.15 -8.36 30.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.673 0.749 . . . . 0.0 109.766 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.8 p -106.71 134.81 49.28 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.4 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.46 ' HB3' ' NE ' ' A' ' 203' ' ' ARG . 10.9 pt-20 -77.73 -21.73 51.43 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.855 -0.528 . . . . 0.0 111.332 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.55 -28.98 67.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.151 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.59 -10.98 49.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.966 0.412 . . . . 0.0 110.79 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -87.37 158.02 19.12 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.957 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -122.16 -24.73 5.04 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.215 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.5 p -130.24 130.98 45.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.24 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.78 123.29 45.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.303 0.573 . . . . 0.0 110.247 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.791 HD13 HG23 ' A' ' 202' ' ' VAL . 1.8 mp -108.44 123.81 64.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.879 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -143.22 169.52 17.47 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.585 HH21 ' HG2' ' A' ' 207' ' ' GLU . 38.2 ptt180 -106.19 139.15 41.14 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.9 tttp -138.22 122.66 18.38 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.78 26.41 12.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.824 1.297 . . . . 0.0 107.958 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.86 67.78 0.88 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.319 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -159.49 158.22 31.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 4.3 mm? -93.33 129.37 39.47 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -129.36 150.18 50.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.3 t -135.46 114.35 12.05 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -103.64 138.9 39.66 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 124' ' ' LEU . 33.0 t -78.44 120.15 28.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 t -105.0 -1.0 26.29 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.42 ' O ' HG12 ' A' ' 190' ' ' VAL . 30.3 mmtp -139.69 176.51 8.67 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.55 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.5 t -112.12 112.06 52.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.57 140.61 57.59 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 121.867 1.712 . . . . 0.0 111.094 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.1 p -54.16 124.98 17.35 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.418 0.627 . . . . 0.0 111.411 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.5 -16.93 44.0 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.487 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.42 162.4 30.63 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 117' ' ' CYS . 7.7 mp -97.98 168.24 10.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.39 0.614 . . . . 0.0 111.304 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 200' ' ' LEU . 1.2 pt? -132.8 149.09 52.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.471 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.44 147.06 43.97 Favored 'General case' 0 C--O 1.253 1.287 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.791 HG23 HD13 ' A' ' 179' ' ' ILE . 5.1 p -96.79 128.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.838 0.828 . . . . 0.0 112.949 -173.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.46 ' NE ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 tpt180 -100.4 112.72 25.1 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.489 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.73 116.35 22.64 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -80.71 104.49 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.2 t -65.45 164.31 14.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.111 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.585 ' HG2' HH21 ' A' ' 181' ' ' ARG . 7.1 tp10 -116.65 104.28 51.54 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.74 142.15 31.73 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.147 1.898 . . . . 0.0 110.842 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -104.09 -54.51 2.54 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.757 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -96.38 -62.59 0.95 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.568 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -95.47 115.24 65.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 122.088 0.155 . . . . 0.0 110.775 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.15 99.3 0.78 Allowed 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.759 2.306 . . . . 0.0 112.008 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 61.24 -95.53 0.05 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.025 1.33 . . . . 0.0 112.259 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -149.33 118.54 3.9 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.24 164.32 17.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.761 1.641 . . . . 0.0 110.033 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.19 6.39 10.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 62.02 59.85 1.61 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.889 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 219' ' ' PRO . 1.9 mp0 -51.97 -50.39 78.6 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.383 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 218' ' ' GLU . 5.2 Cg_exo -82.73 117.97 2.73 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.102 -1.538 . . . . 0.0 108.102 168.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.78 -11.77 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.053 0.93 . . . . 0.0 111.199 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.77 116.55 64.01 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.422 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.8 163.32 37.73 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.552 2.168 . . . . 0.0 111.944 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -83.64 53.04 4.81 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -130.13 170.98 20.63 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 94.0 mt -79.78 -57.27 3.74 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 117.721 0.761 . . . . 0.0 110.511 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.236 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 CA-C-O 119.925 -0.114 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.446 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -168.14 169.55 10.94 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 m -107.36 90.12 3.21 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.62 -176.94 20.84 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 158.04 40.0 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.93 2.42 . . . . 0.0 111.993 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.47 -16.75 57.2 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.257 1.023 . . . . 0.0 111.307 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 122' ' ' LEU . 11.0 mp0 -75.65 -20.33 58.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.446 1.117 . . . . 0.0 108.232 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.93 159.78 16.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.042 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 121' ' ' ARG . 24.8 mm-40 -137.09 132.04 33.56 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.962 0.505 . . . . 0.0 111.23 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 3.1 tm? -88.49 99.07 12.0 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 170.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.16 144.55 43.5 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.509 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.09 126.89 42.56 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.347 0.594 . . . . 0.0 110.781 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -105.86 92.23 4.08 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 36.16 73.22 0.09 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 126.392 1.877 . . . . 0.0 114.08 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.57 -18.7 56.89 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.06 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -112.27 123.59 50.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.871 0.836 . . . . 0.0 112.005 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -79.41 123.22 27.31 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.9 p -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.947 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.68 111.9 21.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 199' ' ' LEU . 15.2 ptp180 -127.06 157.16 40.37 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.239 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.11 121.19 17.03 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.0 ttt180 -86.12 -52.5 5.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 106' ' ' GLU . 9.3 mp -94.36 153.25 18.08 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.6 m -76.9 110.89 11.89 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.8 mm? -70.4 117.84 12.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.0 p -96.29 158.67 15.33 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.628 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.05 128.95 36.06 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 124.712 1.205 . . . . 0.0 111.698 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.83 -18.97 54.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.248 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.65 129.99 41.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 m -136.48 161.73 35.04 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -107.71 176.23 5.22 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.501 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.6 -171.63 39.67 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.985 0.803 . . . . 0.0 112.744 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.24 125.09 7.58 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.795 2.33 . . . . 0.0 113.827 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -102.3 168.55 9.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -106.34 135.58 47.59 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 120.955 0.407 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 156.78 179.21 31.58 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.2 m -139.03 146.05 40.36 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 117.902 0.851 . . . . 0.0 111.474 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.9 mt -108.66 132.91 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -91.68 98.73 11.81 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.428 0.455 . . . . 0.0 109.788 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.9 p -75.91 119.87 20.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.348 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 69.03 90.2 0.1 Allowed 'General case' 0 C--O 1.242 0.669 0 O-C-N 124.529 1.143 . . . . 0.0 109.389 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.25 166.95 23.36 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt 56.04 -150.63 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 O-C-N 124.062 0.851 . . . . 0.0 110.399 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -125.65 106.13 26.71 Favored Pre-proline 0 N--CA 1.417 -2.119 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -97.42 -17.47 0.24 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.829 2.353 . . . . 0.0 112.845 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -91.02 -23.28 20.42 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.765 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -139.12 147.19 41.6 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 67.77 159.82 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.118 0.886 . . . . 0.0 112.957 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -129.78 93.42 34.51 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.43 -21.91 8.51 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.204 1.936 . . . . 0.0 110.487 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 131.6 -126.5 4.73 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.82 118.17 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.869 1.713 . . . . 0.0 109.452 173.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.64 59.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.44 137.92 20.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 m -113.38 138.96 49.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 157' ' ' VAL . 2.3 pp -108.73 135.94 49.12 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.952 0.406 . . . . 0.0 110.498 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.88 85.81 2.28 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.489 HG22 HD13 ' A' ' 155' ' ' LEU . 12.0 m -130.84 157.8 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.08 148.36 26.68 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 123.856 0.722 . . . . 0.0 112.374 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.13 -43.98 64.28 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.598 1.159 . . . . 0.0 112.014 -175.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.9 m -90.04 11.34 20.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.48 127.37 32.71 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 18.8 p-90 -60.18 -27.29 67.01 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 179' ' ' ILE . 98.0 mt -63.08 -25.7 68.49 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -95.44 1.13 53.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.409 0.623 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.85 -7.01 55.26 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.502 0.668 . . . . 0.0 109.758 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.28 144.36 27.76 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.06 131.37 19.27 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 122.046 1.831 . . . . 0.0 111.212 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.27 135.25 39.64 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.51 133.88 65.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.56 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.468 HD23 ' H ' ' A' ' 170' ' ' LEU . 2.4 pt? -68.28 -38.16 81.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.289 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -86.48 134.94 33.64 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.211 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -28.43 62.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.044 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -69.44 -22.83 63.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.416 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.1 0.94 56.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.069 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.75 152.84 21.37 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 200' ' ' LEU . 94.3 m-20 -114.44 -16.03 11.99 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.424 0.63 . . . . 0.0 109.979 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.0 p -145.23 128.23 16.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.234 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 179' ' ' ILE . 10.3 pt-20 -106.24 141.29 37.83 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.798 HD13 HG23 ' A' ' 202' ' ' VAL . 1.6 mp -116.7 116.72 53.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.513 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 52.5 p90 -115.73 159.85 20.85 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -100.94 138.56 37.82 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -157.59 132.85 8.9 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 67.35 20.88 9.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.157 0.983 . . . . 0.0 108.864 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 70.03 13.57 7.84 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.143 1.777 . . . . 0.0 111.822 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -112.8 164.73 13.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.92 136.62 41.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 179' ' ' ILE . 77.6 m95 -124.54 125.59 44.45 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.671 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.4 t -104.03 124.46 49.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -125.53 138.94 53.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' A' ' 124' ' ' LEU . 49.0 t -90.35 122.03 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.6 p -110.31 3.19 19.65 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.105 0.479 . . . . 0.0 112.166 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -131.11 169.92 15.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.51 108.06 20.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 124' ' ' LEU . 19.2 t -103.34 111.03 64.84 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.27 153.6 66.44 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.288 1.992 . . . . 0.0 111.296 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -65.22 126.33 27.83 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.81 -17.23 49.83 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.91 159.41 31.45 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.784 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 119' ' ' ARG . 47.3 mt -95.12 165.47 12.4 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.4 0.619 . . . . 0.0 109.757 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.2 pt? -134.46 146.01 49.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.967 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.75 151.11 32.4 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.798 HG23 HD13 ' A' ' 179' ' ' ILE . 7.7 p -99.72 129.81 49.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 O-C-N 123.855 0.722 . . . . 0.0 112.183 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -119.28 128.91 54.59 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.17 154.78 19.88 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 11.2 p -44.05 142.28 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.481 0.712 . . . . 0.0 112.432 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.6 p -80.43 -172.01 3.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.287 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -57.85 154.85 25.56 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 123.932 0.893 . . . . 0.0 108.887 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.65 -33.7 10.33 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.694 2.929 . . . . 0.0 113.947 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -131.05 83.76 2.13 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -154.65 47.68 0.52 Allowed Glycine 0 CA--C 1.492 -1.356 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.913 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 174.81 128.92 0.12 Allowed Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 125.229 1.411 . . . . 0.0 107.402 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -71.61 -50.62 0.28 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 121.34 1.36 . . . . 0.0 108.899 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 175.4 151.61 0.12 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -96.9 138.99 21.32 Favored Pre-proline 0 C--N 1.287 -2.13 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.204 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -37.06 98.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.619 1 C-N-CA 125.684 4.256 . . . . 0.0 116.23 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.03 101.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.125 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -71.13 88.71 0.81 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -62.7 -50.98 75.39 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.786 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.02 120.59 8.0 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 N-CA-C 107.317 -1.84 . . . . 0.0 107.317 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.45 -0.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.198 0.999 . . . . 0.0 110.358 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.7 120.91 81.87 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.57 115.12 2.46 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.589 2.193 . . . . 0.0 111.651 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -125.19 -51.33 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.873 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -113.36 99.92 1.04 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.68 170.21 8.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.321 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.444 -1.413 0 N-CA-C 112.437 0.13 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 8.4 p-90 -106.04 0.98 26.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 62.35 75.84 0.39 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.982 0.896 . . . . 0.0 111.739 -176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.84 174.78 27.46 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.96 161.7 38.45 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -76.46 -0.79 24.21 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -88.65 -24.76 22.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.157 0.979 . . . . 0.0 108.642 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.551 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.2 mm? -96.09 168.21 10.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.376 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.599 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 29.4 tt0 -150.38 128.16 11.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.6 tm? -93.02 118.61 31.38 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.41 135.75 55.03 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.74 101.94 10.43 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -110.46 119.34 38.86 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 67.83 18.4 9.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.813 1.292 . . . . 0.0 109.935 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.52 -4.35 79.67 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.451 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -114.53 174.9 5.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.243 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.54 136.55 34.22 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.016 0.436 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 43.7 t -147.18 148.45 31.54 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 200' ' ' LEU . 12.8 t -120.56 130.72 74.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.599 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -133.87 168.98 17.76 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.843 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.5 120.02 36.05 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -81.71 -40.08 23.3 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.49 145.66 24.64 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.0 m -66.06 118.17 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.406 ' HB2' HG12 ' A' ' 194' ' ' VAL . 82.6 mt -75.94 105.35 6.93 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.7 p -82.7 154.05 25.03 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.916 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.78 124.44 21.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.62 -10.83 57.78 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.649 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -75.42 143.54 42.65 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 m -150.76 171.53 17.04 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.551 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 27.2 m-90 -113.93 166.43 11.6 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.29 -177.47 33.9 Favored Glycine 0 N--CA 1.436 -1.33 0 O-C-N 123.817 0.698 . . . . 0.0 113.228 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.68 133.26 23.48 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 122.879 2.386 . . . . 0.0 112.627 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.01 152.45 24.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.81 120.71 37.65 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.42 -168.09 41.0 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.4 p -147.62 135.42 21.07 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 80.2 mt -88.01 101.23 11.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -95.38 98.07 10.29 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 153' ' ' VAL . 23.8 m -86.74 149.09 25.12 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.1 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.7 37.75 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.92 0.867 . . . . 0.0 109.402 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -93.86 11.89 27.83 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.6 0.714 . . . . 0.0 111.946 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.1 tp -155.49 152.4 28.88 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.0 m -60.46 133.53 91.13 Favored Pre-proline 0 CA--C 1.555 1.157 0 O-C-N 123.911 0.757 . . . . 0.0 109.71 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.97 -19.58 32.95 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 124.441 3.427 . . . . 0.0 116.705 -170.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.81 -14.72 29.33 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 110.088 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 77.8 mtp180 -104.26 159.82 15.39 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.53 -175.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 146' ' ' ARG . 13.4 mt-10 -179.88 78.66 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.095 2.158 . . . . 0.0 109.57 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.434 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 4.4 mp0 -107.55 -58.46 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.922 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 148' ' ' GLU . 2.2 Cg_endo -83.19 9.26 4.17 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.364 2.043 . . . . 0.0 112.155 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.51 -168.06 29.75 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.64 168.44 17.85 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.466 2.111 . . . . 0.0 111.344 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.16 60.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.605 0.717 . . . . 0.0 109.376 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 139' ' ' THR . 5.1 p -101.71 117.48 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 170.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.2 m -121.59 136.26 54.96 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.921 -0.487 . . . . 0.0 110.996 -173.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.01 101.01 11.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.977 0.894 . . . . 0.0 110.607 174.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.6 mmm -88.01 96.07 10.37 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.2 170.1 20.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.56 168.74 19.32 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.83 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -59.21 -34.46 72.19 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 124.192 0.997 . . . . 0.0 112.273 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.0 p -95.54 7.69 45.52 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.6 t -82.45 124.53 30.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.002 0.429 . . . . 0.0 110.013 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -61.37 -22.13 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.668 0.787 . . . . 0.0 112.78 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.55 -32.68 72.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.623 0.369 . . . . 0.0 111.957 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -93.84 2.72 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.924 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mtp -97.1 1.25 49.78 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.11 151.02 37.33 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.88 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.58 124.54 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.277 1.984 . . . . 0.0 110.052 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -81.8 138.8 35.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 21.1 m -136.74 148.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.168 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.05 -13.28 17.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.68 0.753 . . . . 0.0 109.114 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -98.77 134.91 40.99 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.636 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 8.5 pt-20 -83.73 -5.3 59.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.417 0.627 . . . . 0.0 110.358 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.04 -29.08 64.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.616 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.04 -26.45 13.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.103 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.493 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -83.87 110.86 18.71 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.812 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 200' ' ' LEU . 11.2 p30 -82.89 -25.08 32.82 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.327 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.8 m -127.82 145.5 50.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.39 145.38 50.27 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -102.99 120.64 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -134.0 163.86 28.6 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.628 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -104.58 123.71 48.03 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 40.8 ttmt -118.39 95.73 5.0 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.4 t70 59.02 72.13 0.55 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.962 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 t70 76.37 -27.97 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.119 -1.401 . . . . 0.0 113.998 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -100.36 151.85 21.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.305 -0.247 . . . . 0.0 111.063 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -93.58 128.46 39.74 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.568 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -122.14 138.05 54.6 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.96 124.32 52.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -125.24 147.19 49.19 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.61 118.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.5 p -101.61 -31.89 10.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.207 0.527 . . . . 0.0 110.89 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.26 141.87 51.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.72 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.339 0.59 . . . . 0.0 111.999 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 124' ' ' LEU . 10.4 p -119.06 126.9 26.81 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.2 170.84 14.97 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.619 2.213 . . . . 0.0 113.448 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.1 m -59.77 121.82 12.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.558 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.42 -6.8 57.83 Favored Glycine 0 N--CA 1.436 -1.349 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.248 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.9 153.07 44.97 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.52 138.84 31.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -106.04 159.35 16.13 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.104 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -134.45 143.3 47.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.11 117.87 42.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.598 0.713 . . . . 0.0 111.187 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.5 ttt180 -93.06 124.77 37.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.513 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.82 109.65 20.37 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.88 133.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.977 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.7 t -161.64 177.61 9.82 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -63.94 122.0 74.62 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.1 124.83 16.5 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.583 2.188 . . . . 0.0 110.956 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -74.4 -55.69 5.7 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.292 0.568 . . . . 0.0 109.529 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.37 90.06 0.74 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.329 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 214' ' ' HIS . . . -142.68 123.87 8.45 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -35.54 -57.48 0.49 Allowed 'Trans proline' 0 C--N 1.364 1.354 1 C-N-CA 125.383 4.055 . . . . 0.0 114.653 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -115.72 54.84 0.8 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.71 0.767 . . . . 0.0 111.85 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 211' ' ' ALA . 52.2 t-80 -71.33 -48.46 12.82 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.067 172.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.42 82.95 2.33 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 121.423 1.415 . . . . 0.0 111.549 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.19 94.13 4.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.97 -50.13 6.2 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.909 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.41 105.43 1.35 Allowed Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.52 117.92 4.73 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.116 1.878 . . . . 0.0 110.492 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 225' ' ' LEU . 34.8 m -92.36 161.06 2.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.246 0.546 . . . . 0.0 112.209 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -96.2 -47.34 0.25 Allowed Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.989 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.05 129.66 36.53 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.002 1.802 . . . . 0.0 112.744 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -90.7 -10.27 63.43 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -82.2 77.44 2.08 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.454 HD11 HG21 ' A' ' 220' ' ' VAL . 87.6 mt -123.98 89.75 3.14 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.722 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.73 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.442 -1.554 0 N-CA-C 109.185 -1.121 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.7 163.74 34.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 160' ' ' SER . 19.8 m -88.33 77.91 8.08 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.463 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.28 158.56 27.73 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.259 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.36 162.4 38.43 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.278 2.652 . . . . 0.0 111.977 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.91 -0.04 37.4 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.54 -20.37 50.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 200' ' ' LEU . 3.7 mm? -109.78 151.96 26.31 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.215 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -127.32 141.92 51.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.49 122.03 40.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.04 54.58 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.913 0.387 . . . . 0.0 110.59 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.57 104.56 14.41 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -106.25 94.38 5.13 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.777 0.799 . . . . 0.0 109.409 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.37 59.17 4.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.043 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.94 -22.18 19.62 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.962 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -87.82 128.85 35.34 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.449 -0.442 . . . . 0.0 111.86 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -82.54 113.71 20.45 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.544 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.7 p -122.28 144.86 48.73 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 17.8 m -107.68 125.42 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.19 0.519 . . . . 0.0 109.704 -177.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -138.65 150.75 46.56 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.02 127.77 34.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.57 -34.05 14.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.52 0.676 . . . . 0.0 109.795 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.27 163.67 12.42 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.1 m -88.71 128.47 35.61 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.512 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.431 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.2 mm? -90.27 127.81 36.25 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.2 p -112.22 158.9 19.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.05 118.76 8.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.978 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.21 -0.49 55.99 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.371 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.3 tp -82.38 139.7 33.92 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 74.3 p -144.67 157.36 44.23 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.02 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.613 ' HB2' ' SG ' ' A' ' 188' ' ' CYS . 26.3 m-90 -103.76 175.1 5.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.84 -165.66 37.74 Favored Glycine 0 C--N 1.307 -1.052 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.079 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 61.8 Cg_endo -79.46 123.32 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.187 1.925 . . . . 0.0 112.85 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.549 ' HE2' ' SG ' ' A' ' 188' ' ' CYS . 78.8 m-85 -98.84 159.09 15.2 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.62 104.22 14.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.351 1.072 . . . . 0.0 112.122 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.53 171.49 44.06 Favored Glycine 0 N--CA 1.409 -3.165 0 N-CA-C 106.785 -2.526 . . . . 0.0 106.785 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.7 m -132.46 137.78 47.36 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 118.096 0.948 . . . . 0.0 112.011 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 77.3 mt -86.49 116.62 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.24 111.82 23.58 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.705 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -96.96 102.96 14.84 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -78.92 3.17 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.36 13.75 7.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.035 1.334 . . . . 0.0 112.582 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp -108.45 -0.66 20.39 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.331 1.062 . . . . 0.0 109.036 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 m -106.28 107.85 60.65 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -96.84 -176.45 0.3 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.03 1.82 . . . . 0.0 111.167 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' A' ' 209' ' ' HIS . 45.5 mt-10 -103.35 -9.68 19.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.57 -7.98 59.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.067 0.937 . . . . 0.0 109.138 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -134.0 153.11 52.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.248 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.95 97.11 32.77 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.55 -0.3 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.536 2.157 . . . . 0.0 112.724 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.23 -146.16 27.48 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.27 52.1 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.737 2.958 . . . . 0.0 112.507 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.62 -17.16 59.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.06 132.92 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.6 m -125.1 141.15 52.29 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.065 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp -104.76 112.12 25.1 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 111.561 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.42 89.78 8.12 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.61 177.59 2.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.504 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.0 144.34 57.36 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.706 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -57.03 -29.68 63.58 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.259 1.023 . . . . 0.0 113.457 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 102' ' ' SER . 22.0 t -102.15 -3.33 27.62 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 122.099 -0.376 . . . . 0.0 110.278 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.6 t -65.88 119.86 12.05 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.522 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.4 p-90 -53.03 -26.89 17.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.315 1.046 . . . . 0.0 113.654 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.03 -30.83 66.44 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.156 0.582 . . . . 0.0 111.85 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -94.53 -7.35 41.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.89 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 162' ' ' TRP . 22.8 ptm -102.27 1.28 35.57 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.263 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 86.9 mt -82.69 152.8 67.11 Favored Pre-proline 0 N--CA 1.423 -1.795 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 8.4 Cg_exo -71.31 118.08 5.48 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.304 1.336 . . . . 0.0 110.376 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.68 132.07 35.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.037 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.05 164.46 23.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.509 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.3 tp -100.87 -31.3 11.22 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.355 0.598 . . . . 0.0 109.518 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.4 p -88.98 134.99 33.79 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.671 0.748 . . . . 0.0 112.09 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -71.45 -17.46 62.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.673 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.06 -32.77 63.44 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.399 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.76 -37.22 30.77 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.55 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -71.89 148.95 45.6 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.406 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -121.12 -10.03 9.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.057 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.0 m -152.8 136.96 16.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 203' ' ' ARG . 10.7 pt-20 -116.61 143.41 45.65 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.795 0.331 . . . . 0.0 111.588 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 188' ' ' CYS . 27.0 mm -102.03 122.99 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 51.7 p90 -131.68 160.06 36.53 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.6 tttt -144.03 118.52 9.7 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 64.9 26.71 12.83 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.829 0.823 . . . . 0.0 109.528 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.1 t70 71.21 -1.93 2.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.264 1.826 . . . . 0.0 111.969 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -90.75 155.74 18.58 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 71.9 mt -94.07 128.49 40.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.763 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 62.5 m95 -124.75 139.34 53.94 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 130' ' ' TRP . 4.9 p -121.67 128.45 51.87 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -118.13 144.84 45.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.326 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 124' ' ' LEU . 62.1 t -86.38 120.71 36.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.6 p -86.23 -45.39 11.34 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.398 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -136.29 151.84 50.07 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 120.807 0.337 . . . . 0.0 111.663 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 49.2 t -64.29 128.7 27.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.795 -172.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.64 117.67 22.75 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.82 165.61 32.3 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.482 2.122 . . . . 0.0 112.917 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 7.9 m -60.65 129.49 41.78 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.892 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.85 -17.58 48.83 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.32 150.36 23.57 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.693 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 11.1 mp -89.01 146.6 24.76 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -125.05 146.73 49.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.075 0.464 . . . . 0.0 110.402 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 43.2 m-85 -113.76 144.25 43.28 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.772 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.64 133.63 41.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.975 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 71.6 ttt180 -108.15 137.96 45.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.45 153.95 18.8 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 12.3 p -42.62 119.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 122.463 1.125 . . . . 0.0 112.527 -177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.4 m -106.04 103.93 13.52 Favored 'General case' 0 N--CA 1.396 -3.152 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -60.16 124.27 76.72 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.52 43.41 0.91 Allowed 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.246 2.631 . . . . 0.0 112.755 -175.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.514 ' HA ' ' OE1' ' A' ' 145' ' ' GLU . 78.0 m-70 70.77 102.79 0.06 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.106 1.363 . . . . 0.0 111.009 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -91.69 -47.52 3.42 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.621 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.0 14.32 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.92 -30.21 92.5 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.468 2.112 . . . . 0.0 114.509 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -84.35 -1.62 55.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.515 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -125.02 161.48 49.04 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.48 129.03 27.94 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.663 1.575 . . . . 0.0 110.411 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.33 -35.7 3.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.716 0.77 . . . . 0.0 109.676 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -95.43 20.68 9.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 122.082 0.944 . . . . 0.0 110.551 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLU . . . . . 0.569 ' OE1' ' HD2' ' A' ' 219' ' ' PRO . 7.1 tp10 -154.39 138.97 11.51 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.569 ' HD2' ' OE1' ' A' ' 218' ' ' GLU . 40.1 Cg_endo -67.39 158.15 58.39 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.833 1.688 . . . . 0.0 112.179 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.27 82.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.23 1.014 . . . . 0.0 109.962 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.83 -52.86 1.56 Allowed Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.235 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.84 168.01 18.1 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 121.205 1.27 . . . . 0.0 111.942 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.09 -137.47 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 112.61 -137.66 14.41 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 -29.12 9.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.045 0.45 . . . . 0.0 110.034 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.438 -1.784 0 N-CA-C 108.952 -1.211 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 1.4 p-90 -159.42 8.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.457 0.473 . . . . 0.0 111.291 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.0 m 58.95 41.1 21.66 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.981 0.912 . . . . 0.0 111.495 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.45 -169.38 22.83 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.266 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -85.81 175.65 5.82 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.122 2.548 . . . . 0.0 112.569 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.1 -19.45 43.6 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.22 0.533 . . . . 0.0 111.81 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -82.96 -16.96 45.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.781 0.801 . . . . 0.0 109.586 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 200' ' ' LEU . 4.1 mm? -121.8 152.94 38.96 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.242 -174.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.5 140.7 33.55 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.021 0.439 . . . . 0.0 111.158 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.56 99.01 11.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.06 130.25 50.13 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.6 mt -90.31 112.15 23.61 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.21 97.16 7.01 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 64.27 27.5 13.83 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.087 1.422 . . . . 0.0 109.024 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.46 -11.42 68.68 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.826 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -81.84 130.45 35.07 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -79.64 101.5 8.39 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.73 0.776 . . . . 0.0 110.115 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.8 m -110.14 122.61 48.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.556 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 166' ' ' LEU . 25.3 t -94.91 100.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -122.26 146.55 47.18 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.765 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.76 140.35 49.45 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.577 ' HA ' ' NE ' ' A' ' 121' ' ' ARG . 4.5 mmp_? -93.36 -36.74 12.36 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.35 155.95 26.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 m -75.07 105.21 5.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 96.8 mt -70.4 117.04 11.44 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -92.86 147.27 22.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.833 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.81 129.48 39.93 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.617 0.722 . . . . 0.0 111.083 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.96 -20.24 22.14 Favored Glycine 0 C--N 1.301 -1.361 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.807 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.72 125.55 27.14 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 m -134.29 149.93 50.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -92.14 175.24 6.93 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.173 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.28 150.67 48.93 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.929 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.12 127.34 25.32 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.199 2.599 . . . . 0.0 111.912 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 163' ' ' LEU . 55.9 m-85 -98.14 153.27 18.56 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.707 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -93.82 116.02 28.46 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.731 0.644 . . . . 0.0 110.024 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.46 45.31 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.8 m -144.58 134.73 24.14 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 117.682 0.741 . . . . 0.0 110.745 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.7 mt -84.6 102.73 10.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -103.89 111.16 23.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -167.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.9 m -71.48 130.57 41.6 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 167.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -129.98 171.41 12.81 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.196 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.44 85.28 5.24 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.415 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.6 OUTLIER 178.29 152.7 0.31 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.593 1.957 . . . . 0.0 105.85 170.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 p -109.59 110.08 59.72 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.362 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 17.0 Cg_exo -68.74 -10.68 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.795 2.33 . . . . 0.0 111.67 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.31 -12.16 47.37 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.443 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -155.95 -33.73 0.09 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.49 -67.87 0.62 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 144' ' ' PRO . 18.6 mm-40 -120.72 99.72 47.14 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.9 67.76 3.94 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.345 2.697 . . . . 0.0 112.409 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -162.35 -170.49 27.22 Favored Glycine 0 C--N 1.286 -2.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.846 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.83 81.92 2.07 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.336 2.691 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 142' ' ' LEU . . . -99.52 -40.6 7.76 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.774 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.94 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 t -164.32 179.83 6.55 Favored 'General case' 0 N--CA 1.421 -1.884 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.242 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.94 131.92 33.96 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.809 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 59.8 ttp -87.87 92.94 9.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.43 173.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.164 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.21 152.99 40.85 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.471 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.76 -24.22 65.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -91.98 10.52 28.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.871 0.367 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.95 111.14 21.15 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 25.4 p-90 -57.97 -21.02 42.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 113.385 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 133' ' ' PHE . 70.8 mt -59.45 -30.74 68.72 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.089 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -96.59 2.4 52.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.195 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 mmt -83.94 -21.32 31.86 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.65 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' HG11 ' A' ' 118' ' ' VAL . 8.3 mp -82.06 150.82 65.73 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 27.3 Cg_exo -63.31 127.16 19.34 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 121.787 1.658 . . . . 0.0 108.967 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -88.43 139.88 30.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.68 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 23.5 m -131.2 158.24 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.669 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 82.3 mt -101.96 -26.12 13.53 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.087 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.3 p -87.08 156.04 19.89 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.347 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 13.6 pt-20 -94.27 -19.31 20.81 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.799 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -51.8 -45.45 63.86 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.716 0.807 . . . . 0.0 111.173 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -88.47 -14.61 37.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.647 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.435 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -88.78 115.34 26.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.568 0.699 . . . . 0.0 111.126 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.19 -15.84 22.99 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-O 121.855 0.836 . . . . 0.0 109.295 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.5 m -139.28 146.58 40.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.31 155.47 48.55 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 122.584 0.353 . . . . 0.0 110.271 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.0 mm -112.92 123.57 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -128.15 149.36 50.46 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptt180 -97.24 133.14 42.26 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.097 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.71 126.68 15.45 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 58.72 30.22 19.67 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.393 1.058 . . . . 0.0 110.209 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.8 t70 76.49 -8.96 1.56 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.285 1.434 . . . . 0.0 112.601 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -93.05 154.03 18.35 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 80.0 mt -93.79 126.16 38.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.959 0.409 . . . . 0.0 110.081 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -116.28 124.43 50.16 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.389 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.89 110.96 23.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.01 144.82 39.52 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.74 113.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 173.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 t -80.63 -34.45 35.01 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.831 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -148.59 160.18 43.37 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 122.358 -0.214 . . . . 0.0 110.669 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 40.6 t -72.03 123.16 25.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 124.262 0.976 . . . . 0.0 112.716 -171.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 5.9 p -114.18 120.7 37.97 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 23.9 Cg_exo -65.53 158.25 54.05 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.015 2.477 . . . . 0.0 113.526 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.3 m -59.38 113.8 2.36 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.749 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.4 -22.95 14.44 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.942 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.99 152.13 43.46 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.6 155.76 16.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 107' ' ' LEU . 1.2 pt? -140.1 147.02 39.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.544 0.688 . . . . 0.0 111.22 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 5.8 m-85 -106.46 154.63 20.55 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.776 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.68 130.66 61.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.039 0.447 . . . . 0.0 110.266 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 ttp180 -102.54 139.68 37.82 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.104 -0.372 . . . . 0.0 110.43 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.86 134.71 38.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.8 p -42.44 111.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.4 p -98.2 111.4 23.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.185 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 151.35 87.78 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.7 43.35 1.47 Allowed 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 123.389 2.726 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 67.35 77.89 0.26 Allowed 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.004 1.322 . . . . 0.0 108.008 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -99.74 -28.7 7.3 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.487 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -142.72 110.19 5.66 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.4 -49.29 7.82 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.302 2.002 . . . . 0.0 109.547 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -125.3 105.26 8.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -58.49 -53.49 65.67 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.79 121.24 8.12 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 121.066 1.177 . . . . 0.0 110.336 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.3 87.73 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 122.863 1.316 . . . . 0.0 111.17 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.9 tt0 -138.45 136.76 36.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -95.08 109.44 44.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.708 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 217' ' ' GLN . 3.7 Cg_exo -77.79 130.17 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.07 84.4 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.843 0.83 . . . . 0.0 111.168 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.62 122.52 62.37 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.52 11.62 1.83 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.058 2.505 . . . . 0.0 114.735 -172.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.5 -70.35 3.19 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.135 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 164.21 -170.87 39.59 Favored Glycine 0 N--CA 1.419 -2.453 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 pp -141.56 142.9 33.51 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 122.859 0.464 . . . . 0.0 109.792 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.564 0 CA-C-O 118.585 -0.722 . . . . 0.0 109.819 -177.068 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.453 -0.864 0 N-CA-C 108.919 -1.223 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.526 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 8.3 p-90 -99.26 -46.75 5.43 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.344 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 162' ' ' TRP . 5.6 t -174.86 178.25 1.87 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.96 -41.45 8.68 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.41 115.47 2.47 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.758 2.779 . . . . 0.0 114.653 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 37.5 mt-10 -77.37 -3.04 38.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.674 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.0 mp0 -87.22 -14.75 40.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.965 0.888 . . . . 0.0 109.163 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.31 164.5 15.11 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.114 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -144.55 135.84 25.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.36 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -85.9 130.46 34.54 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.38 132.33 56.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.77 0.319 . . . . 0.0 110.328 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.0 mt -108.5 113.56 26.69 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.96 106.58 14.6 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 65.8 23.94 11.42 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.591 0.71 . . . . 0.0 110.675 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.47 78.8 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.868 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.35 121.27 26.48 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 116' ' ' ARG . 11.1 ptm180 -72.38 118.1 14.86 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.393 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.58 161.14 37.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.57 129.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.894 0.378 . . . . 0.0 110.256 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -125.57 140.82 52.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.584 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.69 119.81 25.68 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 8.3 ptm180 -75.34 -35.15 61.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.603 0.716 . . . . 0.0 111.285 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.6 pt? -122.5 176.59 5.82 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.5 m -83.22 110.46 18.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.911 0.386 . . . . 0.0 110.479 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 190' ' ' VAL . 85.8 mt -82.36 132.55 35.22 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -119.4 165.24 14.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.62 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 190' ' ' VAL . 56.7 mt-10 -62.35 117.69 6.47 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 124.171 0.988 . . . . 0.0 109.943 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.12 -21.82 7.28 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.326 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.5 tp -77.07 129.18 35.71 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -142.55 156.92 45.17 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.614 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -105.4 169.92 8.18 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.73 -174.09 38.83 Favored Glycine 0 N--CA 1.436 -1.329 0 O-C-N 123.898 0.749 . . . . 0.0 113.213 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.22 123.61 7.89 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.524 2.149 . . . . 0.0 113.375 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 163' ' ' LEU . 67.8 m-85 -97.06 134.47 40.37 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -86.94 96.21 10.17 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.724 0.773 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -166.42 171.21 41.34 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.2 m -133.27 138.59 46.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 118.555 1.178 . . . . 0.0 112.957 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.74 99.55 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -91.79 106.84 18.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.1 p -82.85 123.34 29.28 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.995 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.566 HH22 ' HB2' ' A' ' 148' ' ' GLU . 30.9 ttp85 -113.9 30.32 7.35 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.81 76.53 5.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.262 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.471 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 63.9 tp -156.98 111.41 2.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -87.96 107.32 15.35 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 123.609 0.568 . . . . 0.0 109.934 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 142' ' ' LEU . 2.8 Cg_exo -76.38 -75.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.259 1.973 . . . . 0.0 110.332 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -110.61 -9.01 14.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.119 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -148.79 155.48 41.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.75 -55.26 5.81 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.541 0.526 . . . . 0.0 109.742 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.566 ' HB2' HH22 ' A' ' 140' ' ' ARG . 31.9 mt-10 63.48 81.71 0.22 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.481 1.112 . . . . 0.0 111.301 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.13 41.38 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.688 3.592 . . . . 0.0 113.286 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' HA3' ' HD3' ' A' ' 151' ' ' PRO . . . -123.67 -112.33 2.02 Favored Glycine 0 C--N 1.283 -2.383 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.423 ' HD3' ' HA3' ' A' ' 150' ' ' GLY . 23.9 Cg_exo -68.91 47.13 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.81 3.007 . . . . 0.0 113.83 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -38.67 62.16 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.9 t -126.27 121.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.2 p -126.74 131.77 51.26 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.164 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -98.28 127.93 44.46 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.317 0.579 . . . . 0.0 111.124 175.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 ttm -108.9 98.12 7.65 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.445 HG12 ' HA3' ' A' ' 135' ' ' GLY . 34.3 m -139.25 164.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.859 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.72 156.39 39.06 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -50.43 -45.09 55.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.246 1.018 . . . . 0.0 110.996 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.6 t -85.78 8.72 18.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 39.0 t -89.14 96.71 10.83 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 102' ' ' SER . 5.9 p-90 -48.54 -17.79 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.558 1.943 . . . . 0.0 115.157 -173.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.42 HD11 ' CD2' ' A' ' 133' ' ' PHE . 48.2 mt -61.12 -30.28 70.28 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.979 0.418 . . . . 0.0 110.001 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.4 ptm180 -83.83 -10.33 58.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 59.8 mtt -89.68 -15.82 31.76 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 50.2 mt -82.99 133.68 47.92 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.78 131.59 22.99 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 121.619 1.546 . . . . 0.0 111.177 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -84.2 131.63 34.74 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 156.95 35.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.52 -2.49 30.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.44 0.638 . . . . 0.0 110.025 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.5 p -108.16 150.2 27.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.767 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.09 -5.44 57.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.06 -36.19 69.5 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.482 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.85 -28.36 14.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.197 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -74.88 111.72 10.37 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.76 -20.57 18.76 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.248 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 11.4 p -130.16 130.23 44.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.394 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.04 146.02 46.28 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.8 119.73 61.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.474 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 34.5 p90 -113.33 148.51 35.55 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -96.62 138.71 33.79 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -163.13 118.48 1.73 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.324 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.61 56.36 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 124.686 1.241 . . . . 0.0 111.635 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 62.83 16.26 8.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.686 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -137.76 170.64 15.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.13 137.85 51.77 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -120.98 128.75 53.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.7 t -101.2 123.83 45.94 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.425 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -121.6 143.18 49.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 124' ' ' LEU . 46.5 t -82.29 104.74 11.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.8 t -87.14 -26.31 23.67 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.341 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -141.15 145.83 36.23 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.78 120.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 4.4 p -112.14 117.48 47.72 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 21.8 Cg_exo -66.38 167.36 18.85 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.589 2.193 . . . . 0.0 113.188 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.2 m -64.71 129.48 39.96 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.585 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.95 71.13 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.766 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.31 154.54 21.48 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.916 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.6 mt -91.86 145.64 24.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -119.54 144.81 46.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.923 0.392 . . . . 0.0 110.71 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.54 151.84 34.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 177' ' ' SER . 12.0 p -106.99 139.52 28.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.288 0.566 . . . . 0.0 111.069 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.558 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 31.6 ttp85 -115.74 134.23 55.23 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.67 152.08 18.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 8.6 p -73.28 76.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 123.075 1.416 . . . . 0.0 112.989 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.4 m -160.79 137.42 8.73 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.788 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -96.19 146.04 30.62 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.76 -38.86 78.05 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.966 2.444 . . . . 0.0 111.072 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -151.68 -48.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 50.85 57.34 Favored Glycine 0 CA--C 1.488 -1.604 0 CA-C-N 113.585 -1.643 . . . . 0.0 114.613 170.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.27 114.9 29.33 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.76 -5.26 16.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.0 113.17 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -113.95 150.85 33.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -103.11 139.13 19.83 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -19.78 66.16 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.035 2.49 . . . . 0.0 113.058 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 12.3 m -97.65 88.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 111.721 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -86.96 -42.55 13.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 65.21 135.7 0.04 OUTLIER Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 126.18 1.792 . . . . 0.0 115.238 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.57 151.15 41.44 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.801 2.334 . . . . 0.0 110.767 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 31.0 m -104.07 164.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -102.62 99.6 13.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 4.1 Cg_exo -75.54 101.36 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.627 2.218 . . . . 0.0 112.367 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.86 -9.55 65.91 Favored Glycine 0 C--O 1.22 -0.757 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.792 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.67 -77.7 0.24 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.47 148.9 26.69 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.435 -1.212 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -102.19 90.04 3.79 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.26 174.26 22.59 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.527 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.05 166.51 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.214 2.609 . . . . 0.0 112.348 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 43.2 mm-40 -75.58 -10.53 59.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.032 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.1 -20.65 34.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.903 0.858 . . . . 0.0 109.464 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.17 162.69 15.18 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.85 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -148.5 132.78 17.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.081 0.467 . . . . 0.0 111.478 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.7 tm? -95.39 112.68 24.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.94 135.56 49.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 82.2 mt -101.78 101.74 12.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.585 0.707 . . . . 0.0 109.139 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -115.17 104.86 12.26 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.366 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.6 13.78 4.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.206 1.402 . . . . 0.0 110.38 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 -6.82 56.09 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.353 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 8.1 tt0 -85.21 137.92 32.69 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -88.66 109.29 20.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.734 0.646 . . . . 0.0 109.273 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.2 121.7 45.9 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.695 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 166' ' ' LEU . 16.0 m -89.26 97.05 6.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.883 0.849 . . . . 0.0 110.287 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -113.19 153.25 28.61 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.035 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.89 122.06 18.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 42.2 ttt180 -84.23 -50.6 7.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.17 173.9 7.0 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 m -89.36 108.56 19.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.9 mm? -74.98 110.07 8.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.094 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 p -83.17 134.61 34.97 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.109 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.88 123.6 14.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.009 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.77 -24.38 13.31 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.752 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.93 146.33 49.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.4 m -144.69 164.86 29.7 Favored 'General case' 0 C--N 1.283 -2.309 0 O-C-N 121.971 -0.456 . . . . 0.0 110.152 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -110.39 169.62 8.62 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.91 176.09 53.28 Favored Glycine 0 N--CA 1.433 -1.559 0 O-C-N 123.795 0.684 . . . . 0.0 111.905 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 51.1 Cg_endo -67.02 144.56 70.37 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 122.768 2.312 . . . . 0.0 113.187 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.32 154.49 32.24 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.26 127.9 46.44 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.91 0.862 . . . . 0.0 112.479 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.49 -157.78 30.25 Favored Glycine 0 N--CA 1.405 -3.405 0 N-CA-C 106.383 -2.687 . . . . 0.0 106.383 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.5 t -158.15 167.84 28.7 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 118.313 1.056 . . . . 0.0 108.807 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.277 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.415 -2.182 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.3 mtp -101.56 87.57 3.21 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.21 165.98 28.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -52.56 140.36 23.13 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 124.143 0.902 . . . . 0.0 109.89 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 43.4 mt-10 -65.4 -14.4 60.82 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.21 -14.12 22.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 53.2 t -64.66 133.41 52.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.491 0.663 . . . . 0.0 111.848 -174.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -58.72 -25.2 62.7 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.663 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.6 mt -59.28 -32.21 69.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.078 0.466 . . . . 0.0 111.39 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ptm180 -96.72 1.42 50.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.0 111.245 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 96.2 mmm -91.55 -20.09 22.06 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 118' ' ' VAL . 10.4 mp -85.43 146.84 45.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.953 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.53 134.61 36.18 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.265 1.977 . . . . 0.0 110.291 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.73 136.29 33.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 30.7 m -136.02 154.4 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.67 -10.89 17.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.516 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.9 p -94.93 169.03 10.42 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.654 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -95.59 -33.91 12.21 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.899 0.88 . . . . 0.0 111.242 -176.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 5.2 mm-40 -66.91 -38.83 86.97 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.67 -30.26 32.77 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.276 0.56 . . . . 0.0 109.892 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 203' ' ' ARG . . . -79.97 119.87 23.4 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-O 121.416 0.627 . . . . 0.0 111.223 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -104.37 -6.1 21.09 Favored 'General case' 0 C--N 1.27 -2.855 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.006 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.0 m -150.42 145.26 25.95 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -125.45 147.66 49.12 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.425 ' CD1' HD22 ' A' ' 163' ' ' LEU . 29.4 mm -110.1 124.79 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -133.72 155.68 49.32 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -102.55 137.87 40.21 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.14 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 85.5 tttt -140.15 112.87 8.04 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.38 57.31 4.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.257 1.027 . . . . 0.0 111.144 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 73.71 -14.77 0.62 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.746 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.11 158.87 17.86 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.073 -0.392 . . . . 0.0 110.355 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 72.7 mt -96.17 136.8 36.14 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.119 0.262 . . . . 0.0 110.372 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 52.2 m95 -124.52 145.01 49.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.1 t -118.04 130.92 56.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.06 147.44 50.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.9 119.64 37.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 p -95.81 -29.31 14.3 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -130.25 143.56 50.85 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 5.4 p -76.38 113.29 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.52 0.676 . . . . 0.0 111.1 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.4 t -97.58 125.47 44.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.513 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.76 151.33 57.41 Favored 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 121.868 1.712 . . . . 0.0 110.08 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.1 p -62.94 131.1 47.55 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.42 -19.88 52.01 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.84 148.98 35.7 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.96 154.53 19.77 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.1 pt? -136.13 149.68 48.77 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.06 0.457 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.97 155.86 21.22 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.4 ' CG2' HG12 ' A' ' 179' ' ' ILE . 8.8 p -107.22 128.54 62.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.381 0.61 . . . . 0.0 111.149 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 2.0 tmt_? -95.36 116.15 28.39 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.75 134.61 34.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.31 -1.151 0 CA-C-O 121.283 0.563 . . . . 0.0 111.068 177.558 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 p-90 . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.876 0.37 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m 65.44 25.52 11.92 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.22 1.008 . . . . 0.0 112.429 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.35 141.13 15.44 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.928 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HG2' HD23 ' A' ' 107' ' ' LEU . 7.9 Cg_exo -44.35 150.57 0.69 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.437 3.425 . . . . 0.0 113.027 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.32 -3.97 27.02 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 122' ' ' LEU . 12.2 mm-40 -81.04 -18.7 45.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.777 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.0 mm? -113.31 165.79 12.09 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.284 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -156.83 139.84 15.37 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.9 tm? -89.16 116.77 27.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.96 137.37 42.04 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.91 103.55 15.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -106.18 103.45 12.93 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.15 24.62 14.49 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.951 0.501 . . . . 0.0 111.329 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.68 -4.21 68.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.01 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.96 131.93 35.26 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -84.26 96.42 9.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.4 p -114.27 127.84 56.07 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-O 121.363 0.602 . . . . 0.0 109.798 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.97 118.78 36.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.009 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -115.71 147.57 40.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.54 119.18 32.28 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -80.06 -26.57 39.63 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 106' ' ' GLU . 3.7 mm? -110.35 140.05 44.94 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.586 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 m -69.86 122.19 18.78 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.255 0.55 . . . . 0.0 110.981 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.44 132.51 35.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.21 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 p -95.15 156.84 16.15 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.536 0.522 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.08 117.03 7.83 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.21 -16.57 22.38 Favored Glycine 0 C--N 1.303 -1.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.905 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.2 tp -64.68 125.62 25.33 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.8 m -136.6 144.31 44.05 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.777 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 29.4 m-90 -91.59 172.0 8.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.548 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.84 164.29 54.52 Favored Glycine 0 N--CA 1.435 -1.381 0 O-C-N 123.777 0.673 . . . . 0.0 112.163 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 17.7 Cg_endo -58.54 128.39 28.14 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.408 2.738 . . . . 0.0 113.028 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 51.2 m-85 -102.89 170.89 7.71 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -122.06 142.63 50.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 163.53 -149.38 16.76 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 106.129 -2.789 . . . . 0.0 106.129 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 156' ' ' MET . 24.8 p -161.25 131.2 4.91 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.664 1.232 . . . . 0.0 111.598 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.44 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 1.4 pt . . . . . 0 N--CA 1.395 -3.186 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.091 0.472 . . . . 0.0 112.087 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 136' ' ' SER . 48.2 ttm -97.17 96.36 8.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.5 m -130.32 159.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.608 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.87 170.13 15.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.569 0.543 . . . . 0.0 110.682 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.9 -8.42 58.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.982 0.896 . . . . 0.0 109.461 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 m -83.77 -2.93 57.33 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.633 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.5 t -109.09 116.79 32.62 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-O 121.77 0.795 . . . . 0.0 109.722 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 p-90 -70.04 -14.44 62.68 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.883 1.273 . . . . 0.0 112.129 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.74 -23.72 66.33 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.382 0.673 . . . . 0.0 112.392 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.95 -0.74 57.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.32 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 mmt -89.13 -13.54 38.23 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.292 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -83.08 144.03 46.65 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.01 142.53 38.69 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.237 1.958 . . . . 0.0 110.464 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -88.7 138.88 31.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.325 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.69 163.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.526 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.01 -46.14 37.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.9 p -115.03 173.01 6.71 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.87 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.74 -12.72 57.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.904 0.383 . . . . 0.0 110.402 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -68.76 -32.55 72.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.455 0.645 . . . . 0.0 110.154 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.89 -0.74 55.53 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.262 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.98 132.34 44.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.592 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -96.6 -12.72 23.6 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.3 m -149.08 132.88 16.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.419 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.27 138.89 38.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 202' ' ' VAL . 1.7 mp -110.76 114.57 47.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -131.36 175.6 9.0 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.257 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -123.43 132.0 53.82 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.586 0.708 . . . . 0.0 111.638 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 17.3 tppt? -136.91 126.82 25.8 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.41 28.26 17.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.447 1.092 . . . . 0.0 109.584 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.12 9.71 6.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.244 1.418 . . . . 0.0 114.15 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -104.7 152.86 22.0 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 40.3 mt -94.42 141.37 28.66 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.495 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 78.7 m95 -130.96 149.2 52.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.3 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.4 t -130.35 117.66 20.08 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 177' ' ' SER . 4.0 ptm180 -120.0 144.14 47.68 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.49 116.57 36.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 p -94.22 -37.23 11.65 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.536 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.44 171.25 7.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.477 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.58 106.28 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.728 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.57 108.8 62.29 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.63 176.93 9.33 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.848 2.366 . . . . 0.0 112.354 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.1 m -72.83 115.01 11.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.278 0.561 . . . . 0.0 109.899 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.49 -7.9 47.14 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.47 144.03 31.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.51 145.22 24.67 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.69 144.83 46.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.236 0.541 . . . . 0.0 110.397 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -118.04 152.72 34.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.051 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 179' ' ' ILE . 3.9 p -102.39 129.07 54.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 124.077 0.861 . . . . 0.0 113.103 -174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -109.97 108.07 18.19 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.592 HD13 ' H ' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -115.48 154.39 29.41 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 137' ' ' ILE . 59.2 t . . . . . 0 C--N 1.312 -1.031 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 t-105 . . . . . 0 N--CA 1.423 -1.82 0 CA-C-O 121.184 0.516 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -109.54 92.9 4.24 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -135.61 -168.94 11.7 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.036 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.1 170.24 13.82 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.551 2.834 . . . . 0.0 113.149 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -75.82 -30.62 59.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.904 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.96 -2.61 48.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.726 0.774 . . . . 0.0 111.974 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.89 161.91 18.11 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.616 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.31 148.74 29.89 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.86 122.02 44.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.4 48.55 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.775 0.321 . . . . 0.0 110.346 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 92.6 mt -99.21 101.35 12.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.78 110.29 20.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 67.73 13.09 9.14 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.995 0.902 . . . . 0.0 112.12 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.72 42.8 Favored Glycine 0 C--N 1.317 -0.525 0 O-C-N 121.681 -0.637 . . . . 0.0 112.464 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.7 tt0 -90.02 135.01 33.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -86.59 96.7 10.19 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.2 t -110.63 152.73 26.14 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.29 131.69 72.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -138.52 148.98 44.89 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.093 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.98 120.67 17.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -68.8 -45.97 69.88 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.14 -179.52 3.66 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.5 m -78.14 98.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.617 0.722 . . . . 0.0 109.21 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.9 tp -76.93 112.53 13.64 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 124.898 1.279 . . . . 0.0 108.891 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.4 t -87.8 142.95 27.42 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.466 0.651 . . . . 0.0 110.942 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.38 136.65 46.17 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.051 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.61 -16.02 21.7 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 tp -81.61 140.01 34.69 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.4 p -138.54 152.05 47.87 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -100.03 175.27 5.81 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 123.265 0.353 . . . . 0.0 110.142 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.53 -179.96 39.29 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.828 0.705 . . . . 0.0 113.297 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.58 123.46 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 113.13 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -99.34 158.47 15.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.4 123.39 40.03 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 170.44 -178.23 43.22 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.6 m -121.38 126.12 48.62 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.39 0.614 . . . . 0.0 111.943 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.2 mt . . . . . 0 C--N 1.312 -1.036 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 175.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.478 ' HG ' ' NE2' ' A' ' 168' ' ' GLN . 1.2 pp . . . . . 0 C--O 1.245 0.85 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.9 mmt -123.56 81.99 1.96 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.972 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.61 171.82 10.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -71.5 152.84 42.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -22.61 61.89 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.5 p -96.15 -8.21 33.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.7 t -73.26 124.59 25.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.5 p-90 -59.53 -21.55 60.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.005 0.922 . . . . 0.0 113.066 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.93 -29.44 69.62 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 122.674 0.39 . . . . 0.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 15.9 ptm180 -93.91 2.68 56.09 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.017 0.437 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 mmt -94.96 -11.03 29.29 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.7 mt -86.63 141.97 34.47 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 35.8 Cg_exo -63.6 131.8 32.93 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.436 2.091 . . . . 0.0 110.781 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' NE2' ' HG ' ' A' ' 155' ' ' LEU . 94.0 mt-30 -89.25 137.88 31.92 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.168 0.508 . . . . 0.0 112.031 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.92 171.07 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 92.1 mt -111.81 -25.01 9.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.2 p -104.09 150.92 23.87 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.958 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 15.9 pt-20 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.9 -20.08 58.31 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.193 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.83 -23.5 36.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.667 0.746 . . . . 0.0 109.229 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.63 22.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.533 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.417 ' C ' HG22 ' A' ' 191' ' ' THR . 16.7 p30 -114.96 -2.66 12.8 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.71 0.767 . . . . 0.0 109.344 172.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.3 p -145.43 136.18 24.45 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.339 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.457 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 16.0 pt-20 -136.03 143.52 44.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.345 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.0 mm -118.28 137.13 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -139.07 164.51 29.57 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -96.58 140.86 30.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.457 0.646 . . . . 0.0 110.06 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 57.6 tptt -140.46 118.53 11.92 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 53.12 47.17 25.1 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.772 1.295 . . . . 0.0 111.253 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.4 t70 70.59 -13.16 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.803 1.641 . . . . 0.0 113.513 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.89 152.0 20.28 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 44.5 mt -97.24 132.73 42.71 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.643 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 69.4 m95 -121.2 122.76 40.68 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.456 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.67 124.0 37.38 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.574 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -119.64 142.14 48.7 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 123.331 0.394 . . . . 0.0 110.008 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.53 104.43 12.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.417 HG22 ' C ' ' A' ' 176' ' ' ASN . 4.0 t -84.89 -18.52 34.49 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.068 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -142.3 142.03 32.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.77 116.61 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.775 0.798 . . . . 0.0 111.057 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.66 120.45 55.83 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.56 172.38 14.41 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.331 2.021 . . . . 0.0 111.957 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.0 m -67.58 112.16 4.57 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.89 -5.45 53.61 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.979 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.9 138.58 33.4 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.86 128.76 36.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 200' ' ' LEU . 3.8 mp -82.71 153.66 25.21 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.295 0.569 . . . . 0.0 112.226 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.1 126.82 32.61 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.41 129.62 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 123.96 0.788 . . . . 0.0 111.678 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 61.0 ttt180 -104.66 133.55 49.31 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.462 HD11 HD23 ' A' ' 155' ' ' LEU . 2.7 mm? -112.75 154.03 26.83 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--N 1.297 -1.707 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.123 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 t -90.84 77.89 6.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.87 164.29 24.73 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.08 166.12 16.77 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.69 2.26 . . . . 0.0 112.885 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -74.68 -12.1 60.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.592 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 122' ' ' LEU . 31.8 mp0 -80.88 -12.48 59.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.729 0.776 . . . . 0.0 109.393 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.69 157.7 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.237 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.5 141.56 46.77 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.98 120.29 29.18 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.8 129.42 56.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.103 0.478 . . . . 0.0 111.455 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.47 108.49 20.43 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -109.76 95.54 5.67 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 51.38 59.35 4.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.141 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.03 -1.5 86.57 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.803 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.4 140.63 47.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 117.276 0.538 . . . . 0.0 110.736 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -80.75 111.51 17.26 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.868 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.59 169.16 11.73 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 166' ' ' LEU . 59.0 t -123.95 129.95 74.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -119.48 145.82 45.97 Favored 'General case' 0 N--CA 1.394 -3.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.0 20.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -89.1 -44.4 10.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 106' ' ' GLU . 4.4 mm? -109.21 165.2 11.8 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 51.0 m -91.84 110.15 21.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.5 mm? -84.02 123.87 30.47 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 t -101.27 157.51 16.73 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 149.39 50.69 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.878 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.14 -26.97 21.38 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.086 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.4 tp -75.25 142.35 43.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -139.78 162.35 35.34 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -100.45 174.99 5.84 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.292 0.637 . . . . 0.0 109.731 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.39 171.14 55.1 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 119.526 -0.597 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 57.7 Cg_endo -73.09 123.33 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.247 1.964 . . . . 0.0 114.054 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.528 ' HE1' ' HG ' ' A' ' 188' ' ' CYS . 48.8 m-85 -94.72 149.96 20.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -106.36 106.26 16.7 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.861 0.839 . . . . 0.0 112.189 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.1 -145.02 4.12 Favored Glycine 0 C--N 1.291 -1.949 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -153.45 161.3 42.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.34 1.07 . . . . 0.0 110.832 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 C--N 1.316 -0.873 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.082 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.429 -1.488 0 CA-C-O 121.543 0.687 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -96.3 86.72 4.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.675 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.93 165.62 28.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.182 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -70.09 160.25 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.9 63.96 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 112.245 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 p -88.47 -9.37 52.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 53.1 t -75.97 126.81 31.71 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.023 0.439 . . . . 0.0 110.188 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 7.8 p-90 -54.01 -30.87 49.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 188' ' ' CYS . 88.2 mt -59.62 -30.28 68.59 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.35 -2.9 44.77 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.47 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.8 ptp -107.48 4.56 26.3 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.727 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 73.5 mt -83.99 148.86 54.84 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.8 118.23 5.23 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.901 1.734 . . . . 0.0 110.056 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -81.68 129.16 34.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.36 146.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.408 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.04 0.77 25.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.579 0.704 . . . . 0.0 109.466 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.3 p -100.03 134.49 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.585 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.25 -34.37 68.2 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-O 121.167 0.508 . . . . 0.0 110.727 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.95 -12.91 61.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.81 -20.4 17.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.62 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -88.6 127.97 35.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.081 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 192' ' ' LYS . 86.3 m-20 -94.54 -11.41 29.59 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.205 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 p -152.42 129.43 11.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.475 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.36 134.04 52.32 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.054 0.455 . . . . 0.0 110.25 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 188' ' ' CYS . 29.8 mm -102.17 125.24 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 187' ' ' TRP . 32.4 p90 -130.29 154.03 48.03 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.606 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.551 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -102.66 127.25 49.86 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -137.26 128.04 27.17 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.06 23.41 11.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.76 17.55 11.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.445 1.498 . . . . 0.0 113.376 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -109.61 159.37 17.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 3.4 mm? -93.39 131.36 38.65 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 180' ' ' TYR . 51.2 m95 -128.23 139.56 52.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.528 ' HG ' ' HE1' ' A' ' 133' ' ' PHE . 49.1 m -109.05 112.77 25.14 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.742 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.4 131.63 54.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.74 126.46 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.0 p -106.54 -19.1 13.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 176' ' ' ASN . 68.0 mttm -140.02 146.03 38.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.445 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 76.7 t -69.16 115.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 123.864 0.727 . . . . 0.0 109.717 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -108.8 120.22 46.75 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 153.58 49.41 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.228 1.952 . . . . 0.0 111.988 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.3 m -63.14 122.72 16.79 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.61 -18.1 25.13 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.558 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.78 159.09 23.66 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.579 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.76 153.65 20.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.208 0.528 . . . . 0.0 110.783 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.3 pt? -123.52 148.85 45.89 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.37 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -114.25 145.08 42.2 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.411 HG23 HG12 ' A' ' 179' ' ' ILE . 14.3 p -102.15 125.63 56.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 123.948 0.78 . . . . 0.0 110.75 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.2 ttt180 -97.74 134.0 41.5 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.02 135.9 38.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.304 -1.377 0 CA-C-O 122.555 1.169 . . . . 0.0 111.915 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 36.2 t-105 . . . . . 0 N--CA 1.405 -2.72 0 CA-C-O 121.799 0.809 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -145.2 123.98 12.62 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 104' ' ' PRO . . . -171.95 -141.83 3.52 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 118.526 -1.797 . . . . 0.0 113.592 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' A' ' 103' ' ' GLY . 7.4 Cg_endo -82.56 159.2 16.8 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.125 2.55 . . . . 0.0 112.339 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.46 -20.58 39.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.1 -15.45 63.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.324 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.633 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.8 mm? -119.53 147.77 44.06 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.697 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.36 141.32 33.83 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -94.3 100.1 12.21 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.11 146.24 32.93 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -172.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 9.0 mp -108.19 110.49 22.13 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.694 176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 117.33 31.42 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.32 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.66 23.75 14.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.048 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.64 2.22 63.35 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.071 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 53.2 tt0 -98.35 137.96 36.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.1 102.64 14.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.3 t -130.8 165.11 23.7 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.077 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -91.0 107.98 19.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.375 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.5 140.82 36.99 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.34 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.84 113.51 7.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -50.17 30.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.08 169.25 8.9 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 m -74.46 112.57 10.77 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.223 0.535 . . . . 0.0 110.46 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 200' ' ' LEU . 75.4 mt -84.71 114.7 22.22 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.4 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.6 p -88.81 155.26 19.66 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.165 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.55 141.33 55.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.105 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.97 -17.75 58.7 Favored Glycine 0 C--N 1.297 -1.606 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.266 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.67 117.02 9.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.7 m -129.3 141.11 51.19 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -99.37 170.95 8.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.9 -168.56 22.19 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.85 0.719 . . . . 0.0 113.937 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.2 Cg_endo -75.16 144.02 29.24 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.343 2.029 . . . . 0.0 112.864 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 163' ' ' LEU . 76.8 m-85 -123.34 162.52 22.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.199 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -94.38 125.12 38.83 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 -178.74 35.02 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.952 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -126.19 158.85 34.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 204' ' ' LEU . 60.2 mt . . . . . 0 N--CA 1.428 -1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 109.819 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 204' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.581 0 CA-C-O 121.668 0.747 . . . . 0.0 111.952 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.65 90.91 8.55 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 m -110.93 178.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.207 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.615 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 23.5 t70 -66.94 144.5 56.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -10.07 49.74 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -95.51 -12.44 25.79 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.604 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 158' ' ' ASP . 94.0 m -69.94 111.01 5.35 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-O 121.614 0.721 . . . . 0.0 112.926 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.633 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 19.8 p-90 -54.48 -26.15 29.53 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 125.514 1.526 . . . . 0.0 112.569 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 133' ' ' PHE . 75.3 mt -54.21 -32.66 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.464 1.106 . . . . 0.0 112.549 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -85.47 -2.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.618 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 95.9 mmm -86.53 -16.27 37.46 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.577 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.16 143.26 52.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.99 131.35 20.73 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 121.607 1.538 . . . . 0.0 109.426 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -83.95 129.93 34.91 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -112.94 137.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.685 0.755 . . . . 0.0 112.531 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.54 -18.77 56.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.524 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 4.7 p -95.4 134.92 37.66 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.092 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.06 -17.32 37.79 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.72 0.771 . . . . 0.0 109.515 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -66.89 -41.37 87.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.093 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -77.66 -29.21 51.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.52 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.51 140.17 57.02 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.556 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 200' ' ' LEU . 85.1 m-20 -107.81 -15.48 14.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.533 0.682 . . . . 0.0 109.74 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.7 m -149.36 142.96 25.45 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -116.72 151.56 36.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.893 0.378 . . . . 0.0 111.001 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 163' ' ' LEU . 33.6 mm -115.96 115.52 49.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -113.19 163.03 15.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -109.92 141.74 42.23 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -148.25 121.27 8.83 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 65.69 20.98 11.6 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.045 0.938 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 73.71 15.68 3.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.743 1.617 . . . . 0.0 111.31 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -109.08 147.87 31.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 70.4 mt -93.87 141.22 28.76 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.851 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.89 136.33 50.27 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.9 126.07 54.71 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 123.282 0.364 . . . . 0.0 110.806 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -123.88 137.22 54.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.63 125.2 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.0 p -90.85 -39.91 12.06 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 175' ' ' ALA . 48.9 mtmt -119.49 153.66 34.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.84 108.69 8.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.66 112.63 48.16 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 121.124 0.487 . . . . 0.0 110.247 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 164.32 35.02 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.441 2.094 . . . . 0.0 112.488 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.3 t -58.6 123.25 15.67 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.679 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.2 -30.69 5.14 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.47 147.32 49.73 Favored Glycine 0 N--CA 1.443 -0.861 0 O-C-N 124.045 0.497 . . . . 0.0 112.157 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.5 mt -105.34 120.39 41.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 176' ' ' ASN . 5.3 mp -73.1 136.49 44.9 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -118.47 137.69 53.0 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.0 130.78 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.487 0.661 . . . . 0.0 111.949 -173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.4 tpt180 -104.77 130.84 52.78 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 155' ' ' LEU . 83.8 mt -103.19 124.43 48.59 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.434 -1.26 0 CA-C-O 122.416 1.103 . . . . 0.0 108.661 178.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 5.1 p-90 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 121.536 0.684 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.263 79.1 p 65.94 -51.02 0.4 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.171 2.189 . . . . 0.0 114.669 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.68 -73.05 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.228 -1.463 . . . . 0.0 114.446 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -70.65 119.99 6.75 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.717 1.611 . . . . 0.0 114.443 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 0.4 OUTLIER -81.99 -10.31 59.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.345 177.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.15 -7.74 55.47 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.063 1.345 . . . . 0.0 109.619 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 0.2 OUTLIER -110.96 138.39 47.43 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 39.7 tt0 -113.57 119.19 36.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.354 0.597 . . . . 0.0 112.242 -176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.6 tm? -96.49 110.58 22.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.577 ' HB1' HE21 ' A' ' 112' ' ' GLN . . . -117.49 114.8 24.01 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.088 0.471 . . . . 0.0 110.997 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 116' ' ' ARG . 90.4 mt -91.67 105.0 17.41 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.145 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.577 HE21 ' HB1' ' A' ' 110' ' ' ALA . 82.2 mm-40 -105.83 105.9 16.16 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 64.44 21.79 12.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.119 0.968 . . . . 0.0 110.861 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.91 2.35 59.55 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.861 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -100.55 137.57 38.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 117.291 0.545 . . . . 0.0 110.181 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HA ' HD23 ' A' ' 111' ' ' LEU . 3.2 ptp180 -84.68 113.34 21.22 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.616 0.722 . . . . 0.0 112.635 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.3 t -115.3 143.99 44.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 57.0 t -121.51 112.85 37.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 80.9 mtt180 -118.57 160.1 22.38 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.703 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.17 126.46 32.64 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -64.64 -37.44 87.58 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.516 0.674 . . . . 0.0 110.201 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.95 171.3 14.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -66.61 112.13 4.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.48 117.85 21.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.2 p -79.82 147.34 31.82 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.101 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.27 139.25 54.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.74 -18.8 56.38 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.363 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.26 125.37 26.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m -129.62 149.06 51.55 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -92.1 165.38 13.19 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.097 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.61 158.74 35.76 Favored Glycine 0 N--CA 1.441 -1.002 0 O-C-N 124.41 1.069 . . . . 0.0 112.853 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 123.6 12.03 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.083 2.522 . . . . 0.0 112.681 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -96.36 152.61 18.44 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.83 141.85 31.1 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.791 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.28 -158.78 28.66 Favored Glycine 0 C--N 1.281 -2.514 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -147.28 162.38 39.06 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 C--N 1.313 -0.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.42 -1.926 0 CA-C-O 120.683 0.278 . . . . 0.0 110.806 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.19 95.37 5.16 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 155' ' ' LEU . 26.8 m -133.95 -178.63 2.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.445 -176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.557 ' O ' ' HD3' ' A' ' 164' ' ' ARG . 11.0 t70 -55.48 142.22 33.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.088 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -55.8 -30.48 61.42 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.8 p -105.95 5.33 30.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.826 0.346 . . . . 0.0 111.899 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.6 t -66.33 124.38 22.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -51.24 -29.23 13.78 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.0 mt -57.09 -35.45 69.42 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.06 0.544 . . . . 0.0 111.508 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' A' ' 158' ' ' ASP . 16.5 ptm180 -97.31 -2.47 42.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.518 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 93.6 mmm -92.63 -28.32 16.77 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.3 152.54 70.76 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.83 124.72 14.56 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 121.686 1.591 . . . . 0.0 109.653 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -88.86 132.15 34.79 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.573 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.565 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 33.9 m -125.37 164.37 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.1 mt -111.75 -8.11 14.18 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.188 0.518 . . . . 0.0 110.638 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.9 p -93.2 134.6 35.23 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.052 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.26 -9.21 58.69 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.143 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -80.02 -34.9 37.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.649 0.261 . . . . 0.0 110.783 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.02 23.69 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.614 0.721 . . . . 0.0 109.319 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.656 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -78.11 123.32 26.73 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.763 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 200' ' ' LEU . 54.2 m-80 -90.02 -14.75 33.25 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.061 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.3 m -134.53 136.83 43.34 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.677 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.92 136.67 54.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.271 0.558 . . . . 0.0 110.665 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.73 HD13 HG13 ' A' ' 202' ' ' VAL . 1.4 mp -103.32 120.71 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.545 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -132.1 151.4 51.79 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.057 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -88.11 141.25 28.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -155.25 111.89 3.23 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.3 t70 57.2 65.36 1.39 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.266 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.66 8.04 2.78 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.136 -1.393 . . . . 0.0 114.283 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.37 156.53 45.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.3 mt -101.61 131.92 47.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -120.51 150.24 41.16 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.1 t -125.32 114.27 18.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -111.02 146.04 37.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.5 t -83.06 112.46 20.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t -92.17 -34.16 14.43 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.97 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -123.48 135.59 54.14 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.98 108.36 2.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.558 0.536 . . . . 0.0 111.045 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.46 128.14 27.57 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.264 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.29 169.01 17.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.877 2.385 . . . . 0.0 112.779 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.4 t -67.38 131.5 45.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.29 -13.78 64.19 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.413 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.66 154.56 45.62 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 8.8 mp -96.86 142.43 28.86 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.447 0.642 . . . . 0.0 110.753 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 176' ' ' ASN . 1.1 pt? -123.22 164.38 18.84 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.392 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -136.03 158.74 43.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.73 HG13 HD13 ' A' ' 179' ' ' ILE . 23.3 t -100.05 119.18 47.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 124.484 1.115 . . . . 0.0 111.361 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 1.1 tmm_? -106.73 128.0 53.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.24 138.96 31.19 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 122.897 1.332 . . . . 0.0 112.714 179.843 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.505 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 162' ' ' TRP . 36.6 m -91.48 93.12 8.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.18 -175.52 38.53 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.687 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.04 151.44 9.62 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.11 2.54 . . . . 0.0 111.966 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 1.6 pm0 -78.42 -0.36 28.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.54 -22.76 60.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.9 161.2 17.26 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.566 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 34.9 tt0 -144.25 122.67 12.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.758 0.313 . . . . 0.0 110.718 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.3 tm? -88.23 109.69 20.13 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 171.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.44 157.75 18.15 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.4 mt -118.03 97.93 6.06 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -113.39 117.51 31.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 66.15 12.51 8.57 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.444 1.116 . . . . 0.0 110.062 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.83 69.06 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.057 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -82.32 136.73 34.97 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 122.665 -0.314 . . . . 0.0 110.185 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.95 110.41 16.46 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.9 p -129.95 136.94 50.04 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.414 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.5 t -96.54 105.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -110.84 149.2 30.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.16 15.15 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 24.3 ttt180 -73.92 -43.22 59.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.83 152.81 25.27 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.7 m -68.41 116.38 8.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 88.6 mt -86.77 113.12 22.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.879 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 p -90.66 144.37 25.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -64.64 148.46 50.9 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.41 -34.1 5.9 Favored Glycine 0 C--N 1.282 -2.434 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.9 tp -65.75 138.55 58.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.2 m -147.55 154.96 41.37 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -98.35 173.11 7.14 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 123.564 0.54 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.6 -179.05 37.94 Favored Glycine 0 N--CA 1.437 -1.289 0 O-C-N 123.81 0.694 . . . . 0.0 112.97 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 123.72 10.08 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.635 2.223 . . . . 0.0 112.579 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' CD2' HD11 ' A' ' 163' ' ' LEU . 80.3 m-85 -96.6 150.01 21.13 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.338 0.589 . . . . 0.0 110.806 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.616 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 147.6 -174.27 27.41 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.0 m -139.15 160.52 39.59 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.989 0.894 . . . . 0.0 111.993 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 170.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.601 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.4 ptm -123.6 85.72 2.46 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.953 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.616 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -136.86 164.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.025 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.02 158.24 29.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.96 -19.24 65.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -73.06 -14.22 61.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.494 0.664 . . . . 0.0 109.381 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.8 t -87.25 100.31 12.6 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.456 ' HB3' ' O ' ' A' ' 102' ' ' SER . 16.1 p-90 -44.83 -28.4 0.64 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 114.234 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 133' ' ' PHE . 82.5 mt -52.8 -37.35 59.7 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.89 0.876 . . . . 0.0 112.416 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HD2' HG23 ' A' ' 157' ' ' VAL . 15.3 ptm180 -87.33 1.07 54.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.111 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 92.0 mmm -92.61 -8.8 43.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.249 0.547 . . . . 0.0 110.23 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.96 155.18 49.97 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.63 118.67 5.67 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.888 1.725 . . . . 0.0 110.089 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.87 136.18 38.02 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.925 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 21.8 m -138.24 149.07 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.34 -10.29 16.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.44 0.638 . . . . 0.0 109.76 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.8 p -88.54 134.55 33.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.86 -29.67 61.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.564 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.25 -32.06 69.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.774 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.32 -20.44 24.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.909 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.08 154.29 24.45 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.777 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 6.1 m-20 -119.66 -12.75 9.22 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.444 0.64 . . . . 0.0 110.066 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.8 m -154.28 145.67 23.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.69 147.58 49.3 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.1 0.476 . . . . 0.0 111.467 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.59 131.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.06 167.2 21.39 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -97.79 139.64 33.36 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.9 tttt -165.22 138.26 4.52 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 65.72 16.6 10.56 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.845 0.858 . . . . 0.0 110.767 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.19 64.24 0.86 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 111.283 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -173.06 172.92 3.8 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.729 -1.578 . . . . 0.0 106.832 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.81 139.12 40.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.8 m95 -123.29 133.2 54.18 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.7 t -102.7 117.73 35.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -115.8 144.8 43.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.88 132.46 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.0 p -104.42 -39.07 6.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.302 0.572 . . . . 0.0 111.998 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -108.98 149.53 29.08 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.958 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 59.2 t -77.18 98.23 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 t -85.95 125.95 67.06 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 144.99 42.54 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 122.136 1.891 . . . . 0.0 111.689 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.6 p -62.61 116.4 5.13 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.386 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.19 -8.14 30.96 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.569 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.84 33.76 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.0 mt -103.26 163.11 12.45 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 176' ' ' ASN . 1.2 pt? -141.15 148.45 40.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -111.44 144.77 40.12 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.77 123.01 53.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.306 0.574 . . . . 0.0 110.529 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.609 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 55.1 ttt180 -98.04 137.31 37.03 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.805 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.32 138.3 35.78 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.321 -0.666 0 CA-C-O 122.666 1.222 . . . . 0.0 112.817 -178.076 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CE2' ' HB2' ' A' ' 109' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -87.83 82.85 7.2 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.89 171.95 29.85 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.23 158.21 11.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.496 2.797 . . . . 0.0 112.012 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.07 -2.29 47.61 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.67 -19.98 54.45 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 160.18 16.18 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 113.506 -1.679 . . . . 0.0 108.9 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' A' ' 119' ' ' ARG . 36.6 tt0 -136.39 131.2 33.87 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.323 0.582 . . . . 0.0 111.493 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.488 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.5 tm? -96.36 114.31 25.97 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.83 142.91 45.5 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 79.1 mt -99.77 122.47 42.81 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 10.1 tt0 -121.5 107.19 12.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 13.14 2.77 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.139 1.376 . . . . 0.0 112.439 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.78 2.39 30.46 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.209 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.4 pt20 -95.65 151.71 19.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.5 ptt180 -98.2 105.23 17.35 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.245 0.545 . . . . 0.0 109.628 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 8.2 p -111.04 138.4 47.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.5 117.31 45.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' A' ' 108' ' ' GLU . 3.2 ptm180 -127.18 154.27 45.01 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.558 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.4 121.02 19.81 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -78.02 -43.53 29.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.24 170.09 10.26 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.805 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -69.8 107.68 3.62 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.256 0.551 . . . . 0.0 111.058 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 83.6 mt -74.52 113.75 12.12 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.2 p -85.56 155.47 21.16 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.287 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.51 129.75 40.57 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.117 0.484 . . . . 0.0 109.809 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.74 61.93 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.386 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.67 126.97 30.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 188' ' ' CYS . 36.9 p -135.59 147.51 48.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -97.69 168.18 10.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.934 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.11 159.14 53.47 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.833 0.708 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 23.6 Cg_endo -59.33 123.75 14.08 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 123.471 2.781 . . . . 0.0 112.762 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -92.99 150.65 20.4 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.912 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -90.6 105.0 17.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.146 0.498 . . . . 0.0 110.038 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.84 -168.64 39.11 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -146.9 166.61 26.23 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 C--N 1.298 -1.652 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.0 ttt -102.08 82.05 2.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.21 178.69 4.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.814 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.18 146.27 54.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 123.567 0.542 . . . . 0.0 110.798 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -53.36 -38.83 63.67 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.36 1.064 . . . . 0.0 112.223 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 3.34 54.44 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.77 0.319 . . . . 0.0 110.903 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.42 126.62 31.11 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -54.67 -31.1 57.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 179' ' ' ILE . 49.0 mt -56.13 -40.06 73.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -87.36 -6.52 58.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.4 ptp -100.46 5.41 44.19 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.968 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.88 143.2 31.19 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.53 129.96 16.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.909 1.739 . . . . 0.0 110.786 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -79.99 150.39 30.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.113 0.482 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 m -138.71 147.57 25.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.25 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.97 -21.93 20.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.8 p -94.99 134.83 37.24 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.241 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.4 -6.02 59.25 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.149 0.5 . . . . 0.0 111.651 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.99 -29.4 64.18 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.28 -29.74 18.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.793 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.86 124.67 25.87 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.708 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.22 -18.11 15.65 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.44 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.2 p -141.17 134.33 29.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -120.73 147.68 44.98 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.939 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.456 ' CD1' HD22 ' A' ' 163' ' ' LEU . 18.9 mm -111.1 114.35 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 11.9 p90 -125.84 154.97 41.88 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.472 ' HG2' HG21 ' A' ' 205' ' ' VAL . 33.0 ptt180 -94.26 135.94 35.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.195 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 52.2 tttm -137.31 122.57 19.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 3.8 m-20 66.63 22.16 10.53 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.6 t70 68.96 5.59 5.13 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.473 1.909 . . . . 0.0 112.214 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -95.8 155.17 16.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 78.5 mt -93.58 123.44 36.9 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.633 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 55.4 m95 -116.46 137.34 52.24 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' SER . 50.9 t -108.7 119.86 40.77 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -123.14 142.26 51.08 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.781 0.324 . . . . 0.0 110.295 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.49 128.56 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.008 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.1 p -98.35 -47.57 5.38 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -113.9 140.17 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.885 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 48.9 t -74.55 111.46 10.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.239 0.542 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.12 122.84 40.94 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.259 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.02 174.03 13.5 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.529 2.153 . . . . 0.0 112.256 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.9 m -59.45 125.99 25.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.39 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.05 63.37 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.783 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.5 144.78 17.43 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.65 142.14 27.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.4 pt? -110.88 147.26 34.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.23 148.33 37.55 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.8 134.47 46.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 123.653 0.595 . . . . 0.0 111.088 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -109.2 139.33 44.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.35 154.5 18.14 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.145 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 181' ' ' ARG . 14.2 p . . . . . 0 C--O 1.246 0.9 0 C-N-CA 126.064 1.746 . . . . 0.0 114.286 -175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.1 t -86.74 84.57 7.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -142.71 177.7 21.61 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.841 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.77 173.3 9.43 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.714 2.943 . . . . 0.0 112.991 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.62 -27.34 51.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 111.511 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.05 -22.93 62.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.095 0.95 . . . . 0.0 110.265 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.48 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.9 mm? -102.31 155.03 18.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.688 -173.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -139.64 135.58 33.43 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.405 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.2 114.99 28.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.74 52.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.0 mt -93.25 109.98 21.5 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -106.3 109.43 21.35 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 66.72 22.82 10.3 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.81 1.29 . . . . 0.0 109.036 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.13 -9.84 72.18 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.542 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -89.91 130.33 36.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 122.618 -0.342 . . . . 0.0 110.419 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.42 103.52 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.816 0.817 . . . . 0.0 111.28 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 39.8 m -112.95 153.14 28.48 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.015 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.46 130.99 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -142.4 158.85 43.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.09 113.82 24.1 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -76.01 -33.26 59.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.73 150.43 26.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -69.25 124.39 23.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.128 0.49 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.47 114.1 23.78 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.4 p -88.1 147.39 24.95 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.003 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.46 126.91 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.238 0.542 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.11 -7.72 48.48 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.506 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.32 126.12 30.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -128.8 148.48 50.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -97.81 173.94 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.449 0.166 . . . . 0.0 110.984 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.28 166.53 54.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.06 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.65 130.58 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.149 2.566 . . . . 0.0 113.826 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -107.06 173.74 6.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -120.16 139.05 53.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.68 -176.09 34.85 Favored Glycine 0 N--CA 1.405 -3.37 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.741 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.4 m -126.52 143.88 51.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 179' ' ' ILE . 43.2 mm . . . . . 0 N--CA 1.431 -1.413 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.735 0 CA-C-O 122.165 0.983 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 47.6 ttm -80.07 87.71 5.43 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.94 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.31 -174.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.78 155.39 21.04 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.636 -0.825 . . . . 0.0 108.948 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.19 -21.27 66.74 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.7 t -93.01 -7.06 46.86 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.315 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.8 t -71.26 125.14 26.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 109.93 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.48 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 9.7 p-90 -61.9 -21.51 64.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.443 HD22 HG12 ' A' ' 179' ' ' ILE . 60.7 mt -62.13 -31.98 72.52 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.645 0.378 . . . . 0.0 111.593 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -85.92 -4.38 59.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -96.3 -5.31 40.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.093 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.2 mt -90.05 147.28 36.81 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.44 122.16 7.28 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 121.966 1.777 . . . . 0.0 111.205 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.14 129.13 35.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.753 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.16 146.54 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.783 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.31 -8.65 26.74 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.046 0.451 . . . . 0.0 109.925 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.9 p -104.47 134.84 46.98 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.464 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.41 -27.09 62.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.522 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 173' ' ' GLU . 2.1 mp0 -62.68 -25.97 68.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.985 0.914 . . . . 0.0 110.834 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.52 -38.64 12.39 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.62 135.49 52.94 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.705 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 200' ' ' LEU . 8.3 p30 -124.17 -10.71 7.56 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.254 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 m -141.61 124.36 16.04 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 188' ' ' CYS . 11.7 pt-20 -108.51 145.06 35.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.564 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 202' ' ' VAL . 2.0 mp -111.1 119.87 60.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -135.01 154.56 51.69 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.654 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -88.23 124.0 33.41 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.195 0.521 . . . . 0.0 109.989 176.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.668 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 64.5 tttp -132.94 97.98 4.17 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.2 t70 57.25 72.51 0.51 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.723 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.7 t70 73.46 -5.73 1.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.251 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -130.28 164.26 24.97 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.0 110.3 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.5 mt -98.22 134.44 41.26 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.668 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 49.7 m95 -124.72 152.73 43.39 Favored 'General case' 0 C--N 1.268 -2.949 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 50.3 t -128.89 128.88 44.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -123.69 147.34 47.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.0 t -91.15 115.57 30.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.3 p -86.42 -47.35 9.4 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.226 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -123.3 144.27 49.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.73 120.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.823 0.702 . . . . 0.0 112.473 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.2 p -114.79 120.62 37.07 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.98 162.32 41.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.378 2.052 . . . . 0.0 113.436 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.0 p -56.57 113.36 1.58 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.781 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.91 -14.05 19.62 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.91 159.12 34.01 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.657 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.52 150.15 20.66 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -114.28 153.86 28.98 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.35 142.02 50.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.796 HG23 HD13 ' A' ' 179' ' ' ILE . 5.9 p -96.6 127.68 48.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.87 0.843 . . . . 0.0 111.887 -174.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.576 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.2 ttt180 -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 173.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.92 148.28 24.12 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 110.843 179.471 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -80.51 35.73 0.35 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.021 0.928 . . . . 0.0 111.968 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.8 153.01 16.95 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.993 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.89 152.93 27.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.479 3.453 . . . . 0.0 113.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.11 -0.37 39.77 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.217 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -80.98 -13.43 58.89 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.65 160.08 24.0 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.334 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 121' ' ' ARG . 47.7 mt-10 -130.99 139.48 50.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.664 0.269 . . . . 0.0 111.167 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.23 94.86 6.7 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 168.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.44 130.93 50.89 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.323 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -100.78 113.33 26.15 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -126.43 114.38 18.1 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 71.69 12.86 6.31 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.506 1.146 . . . . 0.0 110.228 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.61 5.04 69.51 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.063 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -94.35 118.89 32.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -73.02 105.29 4.42 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.396 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.9 121.82 42.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.497 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.23 107.17 18.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -119.84 158.89 25.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.388 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 125.65 30.83 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.452 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 8.6 tpm_? -81.63 -48.52 11.64 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.2 mt -110.72 157.18 20.04 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.2 t -76.93 112.03 13.12 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-O 121.266 0.555 . . . . 0.0 109.896 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.56 110.43 7.84 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -109.38 166.85 10.56 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.03 132.79 51.64 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.08 -31.84 4.97 Favored Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.1 tp -85.12 132.02 34.36 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -146.25 154.22 41.48 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -91.49 172.65 8.36 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.146 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.93 169.76 54.34 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 20.7 Cg_endo -58.32 123.46 13.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.274 2.649 . . . . 0.0 112.745 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 91.5 m-85 -92.16 147.73 22.71 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.16 95.95 6.19 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.823 1.297 . . . . 0.0 112.771 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.05 -155.34 10.09 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -151.82 164.26 37.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.501 1.15 . . . . 0.0 111.06 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.4 mt . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 174.042 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 204' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.431 -1.391 0 CA-C-O 120.962 0.411 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.1 tpt -122.47 87.22 2.71 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.492 HG22 HD13 ' A' ' 155' ' ' LEU . 34.8 m -129.52 167.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.495 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.81 156.69 39.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 123.877 0.735 . . . . 0.0 109.721 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -29.98 71.23 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.31 0.644 . . . . 0.0 110.026 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.2 t -77.99 -11.96 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.58 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.98 119.09 22.35 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.62 0.724 . . . . 0.0 109.729 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -64.19 -19.99 65.7 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.128 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.401 HD22 HD11 ' A' ' 179' ' ' ILE . 73.5 mt -59.03 -31.35 68.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.696 0.398 . . . . 0.0 112.045 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -87.36 -5.11 59.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.5 mtp -89.86 -9.95 47.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.013 0.435 . . . . 0.0 110.407 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.97 149.79 46.32 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 31.9 Cg_exo -60.05 118.75 5.67 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.195 1.93 . . . . 0.0 110.442 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -81.86 124.55 29.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.355 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.03 147.09 28.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.64 1.07 17.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.673 0.749 . . . . 0.0 109.46 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 174.74 7.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.758 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' NH1' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -95.72 -52.47 4.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.237 -177.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -71.07 -39.34 72.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.44 68.38 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.421 0.451 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.72 121.08 26.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.355 0.598 . . . . 0.0 111.339 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -106.13 -5.73 19.14 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.668 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 45.5 m -149.1 140.71 23.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 203' ' ' ARG . 16.2 pt-20 -136.63 155.5 49.83 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.07 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 163' ' ' LEU . 21.8 mm -112.57 129.96 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.431 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 17.3 p90 -140.02 163.31 33.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.459 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -99.06 138.64 35.87 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 121.725 0.774 . . . . 0.0 110.519 177.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 65.2 tttp -145.8 114.38 6.78 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t70 66.82 25.54 9.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.195 1.398 . . . . 0.0 109.007 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 73.56 8.31 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.516 1.526 . . . . 0.0 112.442 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -102.73 152.24 21.46 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 82.6 mt -94.19 129.9 40.62 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.678 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 65.6 m95 -121.82 141.2 51.47 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.526 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 52.8 t -109.04 119.88 40.86 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -117.87 150.3 39.42 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.49 120.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 p -96.01 -32.89 12.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.774 0.321 . . . . 0.0 111.343 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.62 148.11 52.58 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.74 102.62 5.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.794 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.01 126.71 56.34 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.95 170.94 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.55 2.166 . . . . 0.0 113.036 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.8 m -60.69 127.41 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.39 0.23 82.62 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.01 158.08 23.74 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -100.32 146.79 26.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -115.57 151.16 35.42 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.623 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -123.03 133.19 54.35 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.1 p -97.4 122.81 49.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.744 0.652 . . . . 0.0 111.367 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 172' ' ' GLU . 43.8 ttp180 -97.79 140.46 32.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.85 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.603 HD21 HD23 ' A' ' 155' ' ' LEU . 78.6 mt -107.71 127.23 53.49 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 13.0 p . . . . . 0 C--N 1.312 -1.061 0 CA-C-O 121.643 0.735 . . . . 0.0 111.65 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.491 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 1.1 p-90 . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.4 m -88.03 88.16 7.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.672 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.77 178.45 29.9 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.91 160.58 30.51 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.618 2.879 . . . . 0.0 112.946 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.2 -7.95 59.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.504 0.668 . . . . 0.0 111.426 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.51 -24.13 42.46 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.65 162.46 14.13 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.851 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.17 136.87 32.25 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.896 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -90.32 104.81 17.34 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.7 153.6 21.62 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.7 mt -115.54 112.3 22.01 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -105.0 104.53 14.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 64.55 19.07 11.69 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.464 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.63 -8.83 43.98 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.094 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -94.77 143.25 26.6 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -75.23 133.83 41.29 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.088 0.471 . . . . 0.0 109.874 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.08 121.37 17.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.35 106.81 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -110.05 156.43 20.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.856 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.77 122.07 40.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.335 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.16 -46.46 23.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.1 mt -101.53 139.78 36.72 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.9 t -70.65 126.98 31.11 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.84 145.8 50.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.159 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 p -93.4 150.9 20.11 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.052 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.46 124.07 23.3 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.94 60.19 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.818 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.47 122.02 15.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.0 m -131.53 138.54 48.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -92.18 169.32 10.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.45 179.83 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 123.9 0.75 . . . . 0.0 114.25 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 73.7 Cg_endo -75.44 138.45 22.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.786 2.324 . . . . 0.0 112.536 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 163' ' ' LEU . 56.2 m-85 -114.0 149.07 35.91 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -89.4 99.44 12.44 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -154.28 -152.44 6.1 Favored Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.7 m -150.93 134.18 16.12 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.411 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.437 -1.098 0 CA-C-O 122.287 1.042 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.9 mtm -79.43 83.12 5.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.649 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.539 HG12 ' HA3' ' A' ' 135' ' ' GLY . 22.9 m -126.38 150.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.626 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.54 160.38 25.31 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.301 0.64 . . . . 0.0 111.287 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -52.82 -32.45 44.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.543 0.737 . . . . 0.0 111.67 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.0 m -85.0 9.81 13.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.199 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 48.3 t -100.1 100.24 11.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 8.6 p-90 -56.43 -19.59 15.75 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.773 1.229 . . . . 0.0 113.205 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.449 HD22 HD11 ' A' ' 179' ' ' ILE . 65.0 mt -59.66 -28.16 67.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.374 0.669 . . . . 0.0 111.473 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 8.6 ptm180 -85.06 -2.64 58.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.933 0.397 . . . . 0.0 110.984 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.8 mtt -93.79 -13.99 26.73 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.94 142.13 36.21 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.579 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.23 133.24 27.98 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 122.114 1.876 . . . . 0.0 110.872 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -84.97 128.77 34.77 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.187 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.66 138.33 52.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.564 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.87 -21.31 23.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 p -87.99 134.81 33.65 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.014 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.4 -17.71 31.66 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.35 -34.63 74.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.34 -15.35 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.452 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.95 118.13 19.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.106 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 0.8 OUTLIER -91.41 -30.33 16.57 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.0 p -133.72 136.93 44.96 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.953 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.92 146.01 45.29 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.215 0.531 . . . . 0.0 112.019 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.449 HD11 HD22 ' A' ' 163' ' ' LEU . 28.9 mm -104.96 120.92 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -126.19 145.17 50.49 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptp180 -91.42 139.87 30.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -142.23 115.11 8.68 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 67.45 27.28 8.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.595 1.188 . . . . 0.0 107.879 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 68.69 4.88 4.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.054 2.142 . . . . 0.0 111.98 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -90.97 151.89 20.91 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 8.0 mp -93.58 125.76 38.37 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 120.821 0.343 . . . . 0.0 111.158 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -122.92 139.21 54.29 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.532 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.9 t -113.8 116.79 29.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -115.05 135.08 54.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.754 0.311 . . . . 0.0 110.414 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.58 126.11 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.2 p -108.13 -23.42 11.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.321 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -128.78 150.26 50.37 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.035 0.445 . . . . 0.0 111.749 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.04 125.97 37.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.56 127.85 61.46 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-O 120.704 0.287 . . . . 0.0 111.231 -171.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.15 134.06 53.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 111.462 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 18.3 m -75.91 110.06 10.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.217 0.532 . . . . 0.0 109.959 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.57 0.84 32.66 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -114.32 165.05 12.02 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 69.1 mt -101.47 155.23 18.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.218 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.1 pt? -99.28 143.82 29.1 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.576 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -110.93 148.08 33.25 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.63 130.2 53.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.88 0.848 . . . . 0.0 111.291 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 69.9 ttt180 -105.18 122.25 45.51 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.699 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.61 118.65 32.69 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.539 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.298 -1.633 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.294 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.462 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.672 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 m -102.53 100.11 10.18 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.507 -0.746 . . . . 0.0 109.534 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.39 -174.59 22.37 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.5 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.53 163.66 26.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.463 2.775 . . . . 0.0 111.825 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.12 -15.64 55.34 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.188 0.518 . . . . 0.0 111.604 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.95 -15.91 60.66 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 200' ' ' LEU . 3.4 mm? -109.41 151.38 26.74 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.416 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.83 123.77 12.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.207 0.527 . . . . 0.0 111.898 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.46 109.92 20.42 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.12 142.45 47.42 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 56.5 mt -102.2 127.87 48.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -124.09 94.32 4.18 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 60.93 25.92 15.86 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.414 0.626 . . . . 0.0 111.364 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.19 -8.31 38.29 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 74.7 mt-30 -81.39 126.52 31.72 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -86.77 95.92 10.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.2 p -111.44 122.93 49.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.514 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.22 111.14 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -110.37 156.47 20.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.56 133.11 34.08 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -83.04 -32.35 26.9 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.13 169.5 9.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -92.23 105.38 17.61 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.88 124.46 32.38 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.15 0.5 . . . . 0.0 110.858 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -72.24 151.39 42.89 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.739 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.95 140.76 56.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.96 10.39 58.74 Favored Glycine 0 C--N 1.299 -1.501 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.608 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.0 tp -101.34 126.5 48.11 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t -122.53 158.78 29.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -95.69 174.4 6.99 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.662 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.97 177.93 49.5 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 124.209 0.943 . . . . 0.0 112.166 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.02 132.12 20.72 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.711 2.274 . . . . 0.0 114.039 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -110.39 149.71 29.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -106.04 119.32 38.89 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.627 0.727 . . . . 0.0 111.236 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -170.87 -160.62 19.83 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -148.51 134.63 19.27 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 118.397 1.099 . . . . 0.0 111.089 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.379 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.421 -1.876 0 CA-C-O 122.159 0.981 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.78 87.93 6.32 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.892 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.404 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -128.95 168.96 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.703 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.12 148.19 22.6 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.255 1.022 . . . . 0.0 111.455 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 46.0 mt-10 -63.4 -20.03 65.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.343 0.592 . . . . 0.0 110.581 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 m -83.03 -20.43 35.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.063 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.4 t -74.35 131.36 41.05 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.52 0.676 . . . . 0.0 111.295 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 p-90 -66.16 -20.49 66.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.012 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.45 -30.28 71.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.699 0.285 . . . . 0.0 111.487 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 17.0 ptm180 -96.4 2.24 52.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.622 . . . . 0.0 110.467 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mmm -99.02 -1.64 39.25 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.199 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 83.2 mt -93.61 145.54 30.12 Favored Pre-proline 0 N--CA 1.425 -1.716 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.96 127.71 11.69 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.441 1.427 . . . . 0.0 109.883 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -84.13 135.22 34.48 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 27.1 m -135.47 160.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.3 pp -105.28 -19.52 13.78 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.794 0.807 . . . . 0.0 110.876 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.8 133.86 33.96 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.42 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 1.4 pm0 -76.99 -21.57 54.5 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.139 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -67.53 -25.57 65.89 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.3 -38.61 8.79 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.59 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -76.86 94.41 3.89 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 121.395 0.616 . . . . 0.0 111.109 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 200' ' ' LEU . 27.6 p30 -87.04 -13.9 43.05 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.451 175.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 m -126.88 124.51 39.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.33 150.33 37.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.1 mm -110.05 125.0 67.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.62 ' CE1' ' HG3' ' A' ' 189' ' ' ARG . 11.9 p90 -126.74 176.02 7.56 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.12 140.1 52.5 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.496 ' HG2' ' OD1' ' A' ' 183' ' ' ASP . 24.0 ttpp -156.37 132.05 9.59 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.496 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 4.1 m-20 60.32 34.66 20.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.315 0.646 . . . . 0.0 110.805 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 t70 67.62 17.49 9.91 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.436 1.495 . . . . 0.0 111.856 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -126.28 162.17 26.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.197 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.1 mt -97.18 140.4 31.73 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -134.0 153.08 52.02 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -125.88 128.13 47.12 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.602 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.62 ' HG3' ' CE1' ' A' ' 180' ' ' TYR . 51.4 mtp180 -103.44 145.52 29.88 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.96 100.41 11.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 166.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.8 t -82.41 -26.04 33.15 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.61 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.45 141.49 45.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.01 125.19 12.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 123.794 0.684 . . . . 0.0 111.715 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 7.5 p -110.67 114.85 54.34 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 11.1 Cg_exo -72.08 153.6 57.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.466 2.111 . . . . 0.0 112.565 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 p -61.46 115.84 4.21 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.464 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.66 -15.49 45.27 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -81.47 157.58 38.51 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.74 157.06 16.63 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.339 0.59 . . . . 0.0 110.377 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 107' ' ' LEU . 1.5 pt? -127.81 157.1 41.34 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.107 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -134.85 148.02 50.03 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.39 133.44 46.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.54 0.686 . . . . 0.0 112.215 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 27.2 ttt180 -117.39 147.76 42.37 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.09 153.0 33.51 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.099 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 m -96.97 91.64 5.7 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.32 -173.11 29.55 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.044 -1.075 . . . . 0.0 112.176 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -83.14 158.55 15.3 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.287 2.658 . . . . 0.0 112.567 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.07 -19.05 63.29 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.719 0.808 . . . . 0.0 111.837 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -80.21 -22.34 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.096 0.95 . . . . 0.0 109.5 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.52 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 4.3 mm? -108.4 160.47 15.85 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.266 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 12.8 tp10 -155.71 147.26 22.9 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.772 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 101' ' ' TRP . 1.3 tm? -99.38 103.55 15.35 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.1 146.42 23.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.45 104.62 13.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.43 99.4 8.98 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.57 23.38 11.76 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.213 1.005 . . . . 0.0 111.485 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.16 57.36 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.448 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.37 143.16 26.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.99 0.424 . . . . 0.0 111.475 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -82.98 134.17 35.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.844 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.7 m -131.84 121.53 24.25 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 166' ' ' LEU . 19.8 m -86.47 96.2 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.378 1.085 . . . . 0.0 110.602 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -114.02 158.89 20.59 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.372 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.23 18.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 77.7 ttt180 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.9 mt -119.99 155.53 32.66 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' OG ' ' A' ' 196' ' ' SER . 47.3 t -77.04 123.92 27.04 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.5 mm? -69.93 121.99 18.43 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.513 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.6 m -90.62 139.77 30.4 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.872 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.68 120.46 10.09 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.12 16.05 Favored Glycine 0 C--N 1.301 -1.381 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.241 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -64.04 126.88 29.11 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -136.69 145.68 45.02 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -91.72 175.05 7.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.62 -172.46 45.45 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.314 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.99 123.19 6.11 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.208 1.939 . . . . 0.0 112.49 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -103.81 150.39 24.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -104.41 107.13 17.9 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.774 0.797 . . . . 0.0 110.495 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.67 177.49 43.74 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.4 p -129.11 133.55 47.7 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 119.231 1.516 . . . . 0.0 113.127 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.6 mt . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 170.616 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 204' ' ' LEU . 1.8 pp . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.5 mmm -116.42 94.57 4.68 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.35 171.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.022 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.16 147.82 38.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 123.613 0.571 . . . . 0.0 110.473 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.26 -33.27 67.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 111.228 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -100.26 12.78 36.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.652 0.263 . . . . 0.0 111.155 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.4 t -79.52 132.97 36.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 24.4 p-90 -65.05 -23.21 67.12 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.06 -25.52 68.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.104 0.478 . . . . 0.0 112.199 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 1.6 ptm180 -95.04 3.17 55.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 mmt -96.47 -22.63 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 118' ' ' VAL . 9.9 mp -88.35 153.05 50.76 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.99 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.27 129.69 16.38 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.588 2.192 . . . . 0.0 111.61 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -82.51 138.13 34.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.99 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 175' ' ' ALA . 29.3 m -140.54 157.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 98.2 mt -115.53 -6.15 12.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 118.204 0.456 . . . . 0.0 112.106 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.8 p -87.85 151.34 22.92 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.393 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.19 -23.68 35.35 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.598 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -69.98 -39.06 76.15 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.433 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.58 -33.36 23.41 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.966 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.631 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -84.84 99.7 11.08 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-O 121.366 0.603 . . . . 0.0 112.499 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.443 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 5.6 p30 -74.76 -19.58 60.16 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.187 175.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.9 p -131.45 142.89 50.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.85 141.14 48.28 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 188' ' ' CYS . 9.4 mm -110.36 126.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -130.94 177.7 7.23 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -122.27 146.13 47.58 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.227 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.8 129.65 13.35 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.95 25.66 13.97 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.464 1.126 . . . . 0.0 109.401 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 69.36 13.63 8.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.331 1.452 . . . . 0.0 112.267 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.56 156.05 21.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.0 mt -93.6 135.26 35.05 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.219 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -126.32 139.57 53.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.69 ' SG ' HD12 ' A' ' 179' ' ' ILE . 53.1 m -116.46 123.49 47.63 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -124.83 148.11 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.725 0.298 . . . . 0.0 110.331 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 124' ' ' LEU . 67.1 t -98.06 121.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.0 p -114.25 -21.89 10.22 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 176' ' ' ASN . 64.6 mmtt -125.76 161.69 26.79 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.7 131.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.684 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.7 120.39 43.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.74 140.78 52.26 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.604 2.203 . . . . 0.0 111.791 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 123' ' ' SER . 7.5 m -63.38 114.71 4.02 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.29 -16.57 35.12 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.695 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.83 159.53 38.07 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.876 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.74 125.27 35.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 200' ' ' LEU . 0.7 OUTLIER -98.62 163.39 12.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.366 -178.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -121.41 144.95 48.39 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.933 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.08 121.97 52.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.187 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.631 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.1 ttm180 -100.4 137.12 39.25 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 155' ' ' LEU . 66.0 mt -96.55 145.97 25.24 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.317 -0.84 0 CA-C-O 121.938 0.875 . . . . 0.0 112.075 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.438 -1.034 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.8 t -89.82 96.15 10.56 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.02 -171.25 32.9 Favored Glycine 0 N--CA 1.42 -2.424 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.738 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.83 162.21 12.06 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.245 2.63 . . . . 0.0 111.597 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.28 -16.92 51.14 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.567 0.699 . . . . 0.0 110.539 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.36 -26.41 62.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.173 0.987 . . . . 0.0 109.368 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 1.6 mm? -94.37 156.88 16.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.808 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.44 134.34 37.61 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.185 0.517 . . . . 0.0 111.846 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.3 122.71 42.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.63 151.23 49.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.95 97.7 7.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 11.5 mm100 -109.44 132.88 53.71 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 66.61 12.89 9.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 123.766 0.666 . . . . 0.0 110.916 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.39 22.62 62.26 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.968 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.7 pt20 -133.09 167.98 19.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -75.1 120.0 20.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 38.1 t -122.16 146.57 47.11 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.81 120.06 63.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.294 0.568 . . . . 0.0 110.197 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -129.46 152.73 48.68 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.921 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.24 109.1 20.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -72.11 -48.9 40.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.3 mt -89.13 129.19 35.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.7 m -67.57 126.2 28.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 190' ' ' VAL . 58.6 mt -97.99 133.86 41.89 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.7 t -99.12 161.53 13.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.501 0.501 . . . . 0.0 110.205 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.95 128.87 37.87 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.214 0.606 . . . . 0.0 110.863 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.81 63.7 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.721 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.87 130.69 42.95 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -135.67 160.03 39.8 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.992 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -99.72 175.24 5.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.07 176.13 51.73 Favored Glycine 0 N--CA 1.441 -0.981 0 O-C-N 123.605 0.566 . . . . 0.0 112.56 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.47 123.38 10.14 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.669 2.246 . . . . 0.0 113.496 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.65 149.95 22.27 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.99 105.71 15.88 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.689 0.757 . . . . 0.0 112.335 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.73 8.23 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 p -145.5 138.78 26.34 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.583 0.692 . . . . 0.0 111.82 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 46.0 mt . . . . . 0 C--O 1.251 1.15 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.179 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 120.708 0.289 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.9 mtt -109.01 94.69 5.18 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.86 179.0 3.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.361 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.75 140.26 57.62 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 123.473 0.483 . . . . 0.0 111.284 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -51.72 -36.69 47.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.326 1.05 . . . . 0.0 113.399 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -103.6 9.97 37.15 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.819 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.516 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 41.0 t -78.68 137.31 37.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.154 0.502 . . . . 0.0 110.206 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' LEU . 9.1 p-90 -60.96 -27.11 68.01 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.3 mt -56.98 -32.49 66.14 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.088 0.47 . . . . 0.0 112.088 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.64 -1.17 47.3 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.586 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.4 mtp -95.52 -6.22 41.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 162' ' ' TRP . 8.8 mp -94.73 141.62 23.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.18 122.5 10.99 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.348 2.032 . . . . 0.0 111.389 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -79.26 127.84 32.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.21 156.46 23.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -83.68 -39.89 19.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.385 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.7 p -91.72 155.59 18.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.493 0.663 . . . . 0.0 112.532 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -87.23 -16.97 33.68 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.469 -177.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.9 -26.96 36.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.399 0.619 . . . . 0.0 109.426 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.37 -31.99 22.65 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.71 143.58 37.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' A' ' 200' ' ' LEU . 16.1 p30 -118.43 2.08 11.81 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.4 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.2 p -151.31 135.72 16.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 15.8 pt-20 -129.0 149.87 50.65 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.038 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 163' ' ' LEU . 24.1 mm -109.52 116.36 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -122.67 157.77 31.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -102.16 144.3 30.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.2 tttm -161.71 125.55 3.24 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 65.46 32.73 9.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.127 0.971 . . . . 0.0 111.148 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.1 t70 75.0 9.36 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.378 1.085 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.05 162.25 22.77 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.532 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.68 137.26 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.559 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.5 m95 -123.57 133.99 53.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 54.0 t -106.8 126.82 52.79 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -127.39 147.35 50.28 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.436 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 124' ' ' LEU . 60.0 t -84.14 115.12 25.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.003 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.8 p -80.83 -33.7 34.46 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 176' ' ' ASN . 20.2 ptmt -146.3 152.72 39.61 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.1 129.82 20.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 123.994 0.809 . . . . 0.0 111.697 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.59 125.2 36.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.69 164.3 16.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.127 2.551 . . . . 0.0 113.34 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.1 m -66.97 101.45 0.85 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.466 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.31 16.8 52.42 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.37 156.86 35.9 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 mp -95.13 141.09 29.16 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.502 0.668 . . . . 0.0 111.093 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 176' ' ' ASN . 3.2 mp -95.65 149.16 21.76 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.029 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.03 131.67 44.45 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.92 134.44 42.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.46 0.648 . . . . 0.0 111.612 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.419 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.9 ttt180 -104.61 142.05 35.34 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.912 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.86 139.83 32.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 CA--C 1.547 0.852 0 O-C-N 123.687 0.617 . . . . 0.0 110.821 179.412 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.477 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.434 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 m -91.58 82.42 5.31 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.61 160.69 14.39 Favored Glycine 0 N--CA 1.419 -2.453 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.96 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.553 ' HB2' ' OE1' ' A' ' 106' ' ' GLU . 60.7 Cg_endo -84.18 166.47 12.66 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.961 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -63.26 -19.36 64.5 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.801 0.84 . . . . 0.0 113.002 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 104' ' ' PRO . 23.7 mp0 -82.44 -17.99 43.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.611 0.72 . . . . 0.0 110.142 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.9 156.2 24.39 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.018 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.504 ' OE2' ' HD2' ' A' ' 119' ' ' ARG . 33.0 tt0 -141.59 126.27 17.96 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.813 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.18 108.72 20.85 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.24 154.59 50.87 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.769 0.319 . . . . 0.0 110.234 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.9 mp -91.99 101.29 13.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 121.879 0.847 . . . . 0.0 110.167 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.534 ' HB3' ' SG ' ' A' ' 117' ' ' CYS . 50.7 tt0 -106.17 124.62 49.87 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 113.795 -1.548 . . . . 0.0 106.998 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 69.67 12.35 8.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.67 1.224 . . . . 0.0 109.677 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.25 2.23 60.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.024 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 43.8 mt-30 -114.65 146.38 40.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 117.393 0.596 . . . . 0.0 110.147 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -75.86 119.94 20.53 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 112' ' ' GLN . 9.4 p -138.28 149.38 45.65 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.861 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.41 111.15 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 108' ' ' GLU . 3.4 ptp180 -116.69 158.65 23.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.96 124.8 28.6 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -77.26 -33.97 55.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.68 0.753 . . . . 0.0 109.587 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 pp -127.01 155.74 42.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -66.25 113.87 4.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.717 0.77 . . . . 0.0 111.734 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 190' ' ' VAL . 86.0 mt -79.64 138.66 37.47 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 t -127.19 159.04 35.5 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.83 125.28 22.34 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 124.03 0.831 . . . . 0.0 110.053 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.02 36.03 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.055 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.8 t -129.13 151.77 49.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -96.66 173.86 7.11 Favored 'General case' 0 C--N 1.267 -3.015 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.815 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.5 175.71 54.83 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.8 Cg_endo -69.25 129.93 19.04 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.737 2.292 . . . . 0.0 113.279 -177.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -107.28 160.44 15.61 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.96 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.86 132.64 34.78 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.743 0.782 . . . . 0.0 112.031 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 162.18 -177.62 38.3 Favored Glycine 0 N--CA 1.414 -2.81 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -144.91 129.48 18.02 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 117.414 0.607 . . . . 0.0 111.597 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.57 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 122.238 1.018 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.1 mtp -87.03 82.67 7.67 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.39 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.44 HG12 ' HA3' ' A' ' 135' ' ' GLY . 32.8 m -105.04 177.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.309 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 161' ' ' CYS . 10.7 t70 -49.37 141.48 8.83 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.089 0.868 . . . . 0.0 110.971 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.57 -20.51 47.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.8 m -114.35 7.37 16.36 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.061 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.2 t -69.76 129.22 38.99 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.949 0.404 . . . . 0.0 109.919 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.8 p-90 -56.08 -27.93 55.59 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.437 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.9 mt -60.86 -32.76 72.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.825 0.45 . . . . 0.0 112.012 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.7 ptm180 -93.05 -0.96 57.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.931 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.477 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 22.6 ptm -110.56 5.97 21.56 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.552 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 88.7 mt -81.6 143.84 51.69 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.25 126.05 13.17 Favored 'Trans proline' 0 C--O 1.253 1.266 0 C-N-CA 121.722 1.615 . . . . 0.0 109.839 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -87.52 139.78 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 0.0 111.864 -174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 152.27 32.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.584 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.3 tp -97.15 -8.36 30.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.673 0.749 . . . . 0.0 109.766 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.8 p -106.71 134.81 49.28 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.4 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.46 ' HB3' ' NE ' ' A' ' 203' ' ' ARG . 10.9 pt-20 -77.73 -21.73 51.43 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.855 -0.528 . . . . 0.0 111.332 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.55 -28.98 67.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.151 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.59 -10.98 49.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.966 0.412 . . . . 0.0 110.79 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -87.37 158.02 19.12 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.957 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.547 HD22 ' HA ' ' A' ' 200' ' ' LEU . 95.4 m-20 -122.16 -24.73 5.04 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.215 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.5 p -130.24 130.98 45.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.24 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.78 123.29 45.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.303 0.573 . . . . 0.0 110.247 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.791 HD13 HG23 ' A' ' 202' ' ' VAL . 1.8 mp -108.44 123.81 64.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.879 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -143.22 169.52 17.47 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 38.2 ptt180 -106.19 139.15 41.14 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.9 tttp -138.22 122.66 18.38 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.78 26.41 12.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.824 1.297 . . . . 0.0 107.958 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.86 67.78 0.88 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.319 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -159.49 158.22 31.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 4.3 mm? -93.33 129.37 39.47 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -129.36 150.18 50.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.3 t -135.46 114.35 12.05 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -103.64 138.9 39.66 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 124' ' ' LEU . 33.0 t -78.44 120.15 28.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 t -105.0 -1.0 26.29 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.42 ' O ' HG12 ' A' ' 190' ' ' VAL . 30.3 mmtp -139.69 176.51 8.67 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.55 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.5 t -112.12 112.06 52.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.57 140.61 57.59 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 121.867 1.712 . . . . 0.0 111.094 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.1 p -54.16 124.98 17.35 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.418 0.627 . . . . 0.0 111.411 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.5 -16.93 44.0 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.487 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.42 162.4 30.63 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 117' ' ' CYS . 7.7 mp -97.98 168.24 10.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.39 0.614 . . . . 0.0 111.304 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 176' ' ' ASN . 1.2 pt? -132.8 149.09 52.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.471 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.44 147.06 43.97 Favored 'General case' 0 C--O 1.253 1.287 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.791 HG23 HD13 ' A' ' 179' ' ' ILE . 5.1 p -96.79 128.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.838 0.828 . . . . 0.0 112.949 -173.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.46 ' NE ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 tpt180 -100.4 112.72 25.1 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.489 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.73 116.35 22.64 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.287 -2.133 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.164 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.446 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.433 -1.316 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 m -107.36 90.12 3.21 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.62 -176.94 20.84 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 158.04 40.0 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.93 2.42 . . . . 0.0 111.993 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.47 -16.75 57.2 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.257 1.023 . . . . 0.0 111.307 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 122' ' ' LEU . 11.0 mp0 -75.65 -20.33 58.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.446 1.117 . . . . 0.0 108.232 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.93 159.78 16.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.042 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 121' ' ' ARG . 24.8 mm-40 -137.09 132.04 33.56 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.962 0.505 . . . . 0.0 111.23 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 3.1 tm? -88.49 99.07 12.0 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 170.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.16 144.55 43.5 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.509 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.09 126.89 42.56 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.347 0.594 . . . . 0.0 110.781 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.86 92.23 4.08 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 36.16 73.22 0.09 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 126.392 1.877 . . . . 0.0 114.08 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.57 -18.7 56.89 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.06 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -112.27 123.59 50.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.871 0.836 . . . . 0.0 112.005 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -79.41 123.22 27.31 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.9 p -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.947 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.68 111.9 21.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 199' ' ' LEU . 15.2 ptp180 -127.06 157.16 40.37 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.239 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.11 121.19 17.03 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.0 ttt180 -86.12 -52.5 5.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 106' ' ' GLU . 9.3 mp -94.36 153.25 18.08 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.6 m -76.9 110.89 11.89 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.8 mm? -70.4 117.84 12.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.0 p -96.29 158.67 15.33 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.628 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.05 128.95 36.06 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 124.712 1.205 . . . . 0.0 111.698 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.83 -18.97 54.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.248 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.65 129.99 41.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 m -136.48 161.73 35.04 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -107.71 176.23 5.22 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.501 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.6 -171.63 39.67 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.985 0.803 . . . . 0.0 112.744 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.24 125.09 7.58 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.795 2.33 . . . . 0.0 113.827 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -102.3 168.55 9.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -106.34 135.58 47.59 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 120.955 0.407 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 156.78 179.21 31.58 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.2 m -139.03 146.05 40.36 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 117.902 0.851 . . . . 0.0 111.474 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.227 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 157' ' ' VAL . 2.3 pp . . . . . 0 N--CA 1.431 -1.395 0 CA-C-O 120.952 0.406 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.88 85.81 2.28 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.489 HG22 HD13 ' A' ' 155' ' ' LEU . 12.0 m -130.84 157.8 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.08 148.36 26.68 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 123.856 0.722 . . . . 0.0 112.374 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.13 -43.98 64.28 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.598 1.159 . . . . 0.0 112.014 -175.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.9 m -90.04 11.34 20.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.48 127.37 32.71 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 18.8 p-90 -60.18 -27.29 67.01 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 179' ' ' ILE . 98.0 mt -63.08 -25.7 68.49 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -95.44 1.13 53.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.409 0.623 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.85 -7.01 55.26 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.502 0.668 . . . . 0.0 109.758 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.28 144.36 27.76 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.06 131.37 19.27 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 122.046 1.831 . . . . 0.0 111.212 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.27 135.25 39.64 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.51 133.88 65.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.56 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 170' ' ' LEU . 2.4 pt? -68.28 -38.16 81.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.289 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -86.48 134.94 33.64 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.211 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -28.43 62.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.044 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -69.44 -22.83 63.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.416 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.1 0.94 56.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.069 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.75 152.84 21.37 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 200' ' ' LEU . 94.3 m-20 -114.44 -16.03 11.99 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.424 0.63 . . . . 0.0 109.979 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.0 p -145.23 128.23 16.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.234 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 179' ' ' ILE . 10.3 pt-20 -106.24 141.29 37.83 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.798 HD13 HG23 ' A' ' 202' ' ' VAL . 1.6 mp -116.7 116.72 53.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.513 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 52.5 p90 -115.73 159.85 20.85 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -100.94 138.56 37.82 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -157.59 132.85 8.9 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 67.35 20.88 9.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.157 0.983 . . . . 0.0 108.864 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 70.03 13.57 7.84 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.143 1.777 . . . . 0.0 111.822 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -112.8 164.73 13.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.92 136.62 41.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 179' ' ' ILE . 77.6 m95 -124.54 125.59 44.45 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.671 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.4 t -104.03 124.46 49.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -125.53 138.94 53.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' A' ' 124' ' ' LEU . 49.0 t -90.35 122.03 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.6 p -110.31 3.19 19.65 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.105 0.479 . . . . 0.0 112.166 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -131.11 169.92 15.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.51 108.06 20.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 124' ' ' LEU . 19.2 t -103.34 111.03 64.84 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.27 153.6 66.44 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.288 1.992 . . . . 0.0 111.296 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -65.22 126.33 27.83 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.81 -17.23 49.83 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.91 159.41 31.45 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.784 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 119' ' ' ARG . 47.3 mt -95.12 165.47 12.4 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.4 0.619 . . . . 0.0 109.757 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.2 pt? -134.46 146.01 49.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.967 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.75 151.11 32.4 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.798 HG23 HD13 ' A' ' 179' ' ' ILE . 7.7 p -99.72 129.81 49.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 O-C-N 123.855 0.722 . . . . 0.0 112.183 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -119.28 128.91 54.59 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.17 154.78 19.88 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 11.2 p . . . . . 0 CA--C 1.551 0.992 0 C-N-CA 123.481 0.712 . . . . 0.0 112.432 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 8.4 p-90 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 62.35 75.84 0.39 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.982 0.896 . . . . 0.0 111.739 -176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.84 174.78 27.46 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.96 161.7 38.45 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -76.46 -0.79 24.21 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -88.65 -24.76 22.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.157 0.979 . . . . 0.0 108.642 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.551 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.2 mm? -96.09 168.21 10.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.376 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.599 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 29.4 tt0 -150.38 128.16 11.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.6 tm? -93.02 118.61 31.38 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.41 135.75 55.03 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.74 101.94 10.43 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.46 119.34 38.86 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 67.83 18.4 9.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.813 1.292 . . . . 0.0 109.935 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.52 -4.35 79.67 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.451 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -114.53 174.9 5.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.243 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.54 136.55 34.22 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.016 0.436 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 43.7 t -147.18 148.45 31.54 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 200' ' ' LEU . 12.8 t -120.56 130.72 74.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.599 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -133.87 168.98 17.76 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.843 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.5 120.02 36.05 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -81.71 -40.08 23.3 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.49 145.66 24.64 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.0 m -66.06 118.17 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.406 ' HB2' HG12 ' A' ' 194' ' ' VAL . 82.6 mt -75.94 105.35 6.93 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.7 p -82.7 154.05 25.03 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.916 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.78 124.44 21.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.62 -10.83 57.78 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.649 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -75.42 143.54 42.65 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 m -150.76 171.53 17.04 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.551 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 27.2 m-90 -113.93 166.43 11.6 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.29 -177.47 33.9 Favored Glycine 0 N--CA 1.436 -1.33 0 O-C-N 123.817 0.698 . . . . 0.0 113.228 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.68 133.26 23.48 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 122.879 2.386 . . . . 0.0 112.627 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.01 152.45 24.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.81 120.71 37.65 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.42 -168.09 41.0 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.4 p -147.62 135.42 21.07 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 80.2 mt . . . . . 0 C--N 1.307 -1.253 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 170.592 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.43 -1.474 0 CA-C-O 121.977 0.894 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.6 mmm -88.01 96.07 10.37 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.2 170.1 20.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.56 168.74 19.32 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.83 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -59.21 -34.46 72.19 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 124.192 0.997 . . . . 0.0 112.273 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.0 p -95.54 7.69 45.52 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.6 t -82.45 124.53 30.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.002 0.429 . . . . 0.0 110.013 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -61.37 -22.13 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.668 0.787 . . . . 0.0 112.78 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.55 -32.68 72.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.623 0.369 . . . . 0.0 111.957 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -93.84 2.72 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.924 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mtp -97.1 1.25 49.78 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.11 151.02 37.33 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.88 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.58 124.54 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.277 1.984 . . . . 0.0 110.052 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -81.8 138.8 35.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 21.1 m -136.74 148.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.168 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.05 -13.28 17.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.68 0.753 . . . . 0.0 109.114 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -98.77 134.91 40.99 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.636 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 8.5 pt-20 -83.73 -5.3 59.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.417 0.627 . . . . 0.0 110.358 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.04 -29.08 64.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.616 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.04 -26.45 13.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.103 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.493 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -83.87 110.86 18.71 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.812 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 200' ' ' LEU . 11.2 p30 -82.89 -25.08 32.82 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.327 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.8 m -127.82 145.5 50.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.39 145.38 50.27 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -102.99 120.64 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -134.0 163.86 28.6 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.628 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -104.58 123.71 48.03 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 40.8 ttmt -118.39 95.73 5.0 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.4 t70 59.02 72.13 0.55 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.962 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 t70 76.37 -27.97 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.119 -1.401 . . . . 0.0 113.998 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -100.36 151.85 21.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.305 -0.247 . . . . 0.0 111.063 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -93.58 128.46 39.74 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.568 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -122.14 138.05 54.6 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.96 124.32 52.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -125.24 147.19 49.19 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.61 118.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.5 p -101.61 -31.89 10.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.207 0.527 . . . . 0.0 110.89 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.26 141.87 51.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.72 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.339 0.59 . . . . 0.0 111.999 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 124' ' ' LEU . 10.4 p -119.06 126.9 26.81 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.2 170.84 14.97 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.619 2.213 . . . . 0.0 113.448 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.1 m -59.77 121.82 12.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.558 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.42 -6.8 57.83 Favored Glycine 0 N--CA 1.436 -1.349 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.248 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.9 153.07 44.97 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.52 138.84 31.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -106.04 159.35 16.13 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.104 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -134.45 143.3 47.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.11 117.87 42.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.598 0.713 . . . . 0.0 111.187 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.5 ttt180 -93.06 124.77 37.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.513 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.82 109.65 20.37 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.292 -1.916 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.977 -177.56 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 160' ' ' SER . 19.8 m -88.33 77.91 8.08 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.463 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.28 158.56 27.73 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.259 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.36 162.4 38.43 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.278 2.652 . . . . 0.0 111.977 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.91 -0.04 37.4 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.54 -20.37 50.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 200' ' ' LEU . 3.7 mm? -109.78 151.96 26.31 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.215 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -127.32 141.92 51.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.49 122.03 40.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.04 54.58 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.913 0.387 . . . . 0.0 110.59 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.57 104.56 14.41 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -106.25 94.38 5.13 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.777 0.799 . . . . 0.0 109.409 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.37 59.17 4.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.043 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.94 -22.18 19.62 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.962 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.82 128.85 35.34 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.449 -0.442 . . . . 0.0 111.86 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -82.54 113.71 20.45 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.544 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.7 p -122.28 144.86 48.73 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 17.8 m -107.68 125.42 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.19 0.519 . . . . 0.0 109.704 -177.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -138.65 150.75 46.56 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.02 127.77 34.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.57 -34.05 14.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.52 0.676 . . . . 0.0 109.795 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.27 163.67 12.42 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.1 m -88.71 128.47 35.61 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.512 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.431 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.2 mm? -90.27 127.81 36.25 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.2 p -112.22 158.9 19.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.05 118.76 8.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.978 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.21 -0.49 55.99 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.371 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.3 tp -82.38 139.7 33.92 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 74.3 p -144.67 157.36 44.23 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.02 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.613 ' HB2' ' SG ' ' A' ' 188' ' ' CYS . 26.3 m-90 -103.76 175.1 5.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.84 -165.66 37.74 Favored Glycine 0 C--N 1.307 -1.052 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.079 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 61.8 Cg_endo -79.46 123.32 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.187 1.925 . . . . 0.0 112.85 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.549 ' HE2' ' SG ' ' A' ' 188' ' ' CYS . 78.8 m-85 -98.84 159.09 15.2 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.62 104.22 14.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.351 1.072 . . . . 0.0 112.122 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.53 171.49 44.06 Favored Glycine 0 N--CA 1.409 -3.165 0 N-CA-C 106.785 -2.526 . . . . 0.0 106.785 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.7 m -132.46 137.78 47.36 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 118.096 0.948 . . . . 0.0 112.011 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 77.3 mt . . . . . 0 N--CA 1.431 -1.412 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.661 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp . . . . . 0 N--CA 1.428 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 111.561 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.42 89.78 8.12 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.61 177.59 2.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.504 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.0 144.34 57.36 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.706 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -57.03 -29.68 63.58 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.259 1.023 . . . . 0.0 113.457 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 102' ' ' SER . 22.0 t -102.15 -3.33 27.62 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 122.099 -0.376 . . . . 0.0 110.278 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.6 t -65.88 119.86 12.05 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.522 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.4 p-90 -53.03 -26.89 17.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.315 1.046 . . . . 0.0 113.654 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.03 -30.83 66.44 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.156 0.582 . . . . 0.0 111.85 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -94.53 -7.35 41.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.89 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 162' ' ' TRP . 22.8 ptm -102.27 1.28 35.57 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.263 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 86.9 mt -82.69 152.8 67.11 Favored Pre-proline 0 N--CA 1.423 -1.795 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 8.4 Cg_exo -71.31 118.08 5.48 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.304 1.336 . . . . 0.0 110.376 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.68 132.07 35.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.037 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.05 164.46 23.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.509 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.3 tp -100.87 -31.3 11.22 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.355 0.598 . . . . 0.0 109.518 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.4 p -88.98 134.99 33.79 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.671 0.748 . . . . 0.0 112.09 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -71.45 -17.46 62.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.673 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.06 -32.77 63.44 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.399 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.76 -37.22 30.77 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.55 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -71.89 148.95 45.6 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.406 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -121.12 -10.03 9.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.057 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.0 m -152.8 136.96 16.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 203' ' ' ARG . 10.7 pt-20 -116.61 143.41 45.65 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.795 0.331 . . . . 0.0 111.588 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 188' ' ' CYS . 27.0 mm -102.03 122.99 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 51.7 p90 -131.68 160.06 36.53 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.6 tttt -144.03 118.52 9.7 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 64.9 26.71 12.83 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.829 0.823 . . . . 0.0 109.528 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.1 t70 71.21 -1.93 2.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.264 1.826 . . . . 0.0 111.969 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -90.75 155.74 18.58 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 71.9 mt -94.07 128.49 40.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.763 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 62.5 m95 -124.75 139.34 53.94 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 130' ' ' TRP . 4.9 p -121.67 128.45 51.87 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -118.13 144.84 45.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.326 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 124' ' ' LEU . 62.1 t -86.38 120.71 36.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.6 p -86.23 -45.39 11.34 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.398 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -136.29 151.84 50.07 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 120.807 0.337 . . . . 0.0 111.663 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 49.2 t -64.29 128.7 27.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.795 -172.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.64 117.67 22.75 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.82 165.61 32.3 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.482 2.122 . . . . 0.0 112.917 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 7.9 m -60.65 129.49 41.78 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.892 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.85 -17.58 48.83 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.32 150.36 23.57 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.693 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 11.1 mp -89.01 146.6 24.76 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -125.05 146.73 49.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.075 0.464 . . . . 0.0 110.402 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 43.2 m-85 -113.76 144.25 43.28 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.772 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.64 133.63 41.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.975 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 71.6 ttt180 -108.15 137.96 45.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.45 153.95 18.8 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 12.3 p . . . . . 0 C--O 1.245 0.823 0 CA-C-O 122.463 1.125 . . . . 0.0 112.527 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 1.4 p-90 . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 111.291 0.108 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.0 m 58.95 41.1 21.66 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.981 0.912 . . . . 0.0 111.495 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.45 -169.38 22.83 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.266 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -85.81 175.65 5.82 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.122 2.548 . . . . 0.0 112.569 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.1 -19.45 43.6 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.22 0.533 . . . . 0.0 111.81 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -82.96 -16.96 45.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.781 0.801 . . . . 0.0 109.586 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 200' ' ' LEU . 4.1 mm? -121.8 152.94 38.96 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.242 -174.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.5 140.7 33.55 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.021 0.439 . . . . 0.0 111.158 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.56 99.01 11.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.06 130.25 50.13 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.6 mt -90.31 112.15 23.61 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.21 97.16 7.01 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 64.27 27.5 13.83 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.087 1.422 . . . . 0.0 109.024 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.46 -11.42 68.68 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.826 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -81.84 130.45 35.07 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -79.64 101.5 8.39 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.73 0.776 . . . . 0.0 110.115 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.8 m -110.14 122.61 48.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.556 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 166' ' ' LEU . 25.3 t -94.91 100.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -122.26 146.55 47.18 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.765 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.76 140.35 49.45 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.577 ' NE ' ' HA ' ' A' ' 121' ' ' ARG . 4.5 mmp_? -93.36 -36.74 12.36 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.35 155.95 26.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 m -75.07 105.21 5.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 96.8 mt -70.4 117.04 11.44 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -92.86 147.27 22.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.833 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.81 129.48 39.93 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.617 0.722 . . . . 0.0 111.083 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.96 -20.24 22.14 Favored Glycine 0 C--N 1.301 -1.361 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.807 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.72 125.55 27.14 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 m -134.29 149.93 50.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -92.14 175.24 6.93 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.173 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.28 150.67 48.93 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.929 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.12 127.34 25.32 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.199 2.599 . . . . 0.0 111.912 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 163' ' ' LEU . 55.9 m-85 -98.14 153.27 18.56 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.707 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -93.82 116.02 28.46 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.731 0.644 . . . . 0.0 110.024 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.46 45.31 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.8 m -144.58 134.73 24.14 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 117.682 0.741 . . . . 0.0 110.745 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.7 mt . . . . . 0 C--N 1.309 -1.166 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 172.484 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.41 -2.468 0 CA-C-O 121.497 0.665 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 59.8 ttp -87.87 92.94 9.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.43 173.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.164 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.21 152.99 40.85 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.471 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.76 -24.22 65.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -91.98 10.52 28.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.871 0.367 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.95 111.14 21.15 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 25.4 p-90 -57.97 -21.02 42.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 113.385 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 133' ' ' PHE . 70.8 mt -59.45 -30.74 68.72 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.089 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -96.59 2.4 52.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.195 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 mmt -83.94 -21.32 31.86 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.65 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' HG11 ' A' ' 118' ' ' VAL . 8.3 mp -82.06 150.82 65.73 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 27.3 Cg_exo -63.31 127.16 19.34 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 121.787 1.658 . . . . 0.0 108.967 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -88.43 139.88 30.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.68 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 23.5 m -131.2 158.24 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.669 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 82.3 mt -101.96 -26.12 13.53 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.087 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.3 p -87.08 156.04 19.89 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.347 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 13.6 pt-20 -94.27 -19.31 20.81 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.799 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -51.8 -45.45 63.86 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.716 0.807 . . . . 0.0 111.173 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -88.47 -14.61 37.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.647 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.435 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -88.78 115.34 26.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.568 0.699 . . . . 0.0 111.126 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.19 -15.84 22.99 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-O 121.855 0.836 . . . . 0.0 109.295 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.5 m -139.28 146.58 40.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.31 155.47 48.55 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 122.584 0.353 . . . . 0.0 110.271 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.0 mm -112.92 123.57 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -128.15 149.36 50.46 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptt180 -97.24 133.14 42.26 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.097 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.71 126.68 15.45 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 58.72 30.22 19.67 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.393 1.058 . . . . 0.0 110.209 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.8 t70 76.49 -8.96 1.56 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.285 1.434 . . . . 0.0 112.601 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -93.05 154.03 18.35 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 80.0 mt -93.79 126.16 38.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.959 0.409 . . . . 0.0 110.081 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -116.28 124.43 50.16 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.389 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.89 110.96 23.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.01 144.82 39.52 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.74 113.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 173.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 t -80.63 -34.45 35.01 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.831 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -148.59 160.18 43.37 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 122.358 -0.214 . . . . 0.0 110.669 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 40.6 t -72.03 123.16 25.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 124.262 0.976 . . . . 0.0 112.716 -171.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 5.9 p -114.18 120.7 37.97 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 23.9 Cg_exo -65.53 158.25 54.05 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.015 2.477 . . . . 0.0 113.526 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.3 m -59.38 113.8 2.36 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.749 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.4 -22.95 14.44 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.942 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.99 152.13 43.46 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.6 155.76 16.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 107' ' ' LEU . 1.2 pt? -140.1 147.02 39.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.544 0.688 . . . . 0.0 111.22 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 5.8 m-85 -106.46 154.63 20.55 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.776 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.68 130.66 61.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.039 0.447 . . . . 0.0 110.266 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 ttp180 -102.54 139.68 37.82 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.104 -0.372 . . . . 0.0 110.43 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.86 134.71 38.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.526 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 8.3 p-90 . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 162' ' ' TRP . 5.6 t -174.86 178.25 1.87 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.96 -41.45 8.68 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.41 115.47 2.47 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.758 2.779 . . . . 0.0 114.653 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 37.5 mt-10 -77.37 -3.04 38.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.674 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.0 mp0 -87.22 -14.75 40.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.965 0.888 . . . . 0.0 109.163 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.31 164.5 15.11 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.114 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -144.55 135.84 25.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.36 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -85.9 130.46 34.54 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.38 132.33 56.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.77 0.319 . . . . 0.0 110.328 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.0 mt -108.5 113.56 26.69 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.96 106.58 14.6 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 65.8 23.94 11.42 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.591 0.71 . . . . 0.0 110.675 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.47 78.8 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.868 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.704 HE21 ' HA ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -82.35 121.27 26.48 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 116' ' ' ARG . 11.1 ptm180 -72.38 118.1 14.86 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.393 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.58 161.14 37.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.57 129.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.894 0.378 . . . . 0.0 110.256 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -125.57 140.82 52.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.584 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.69 119.81 25.68 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 8.3 ptm180 -75.34 -35.15 61.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.603 0.716 . . . . 0.0 111.285 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.6 pt? -122.5 176.59 5.82 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.5 m -83.22 110.46 18.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.911 0.386 . . . . 0.0 110.479 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 190' ' ' VAL . 85.8 mt -82.36 132.55 35.22 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -119.4 165.24 14.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.62 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 190' ' ' VAL . 56.7 mt-10 -62.35 117.69 6.47 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 124.171 0.988 . . . . 0.0 109.943 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.12 -21.82 7.28 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.326 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.5 tp -77.07 129.18 35.71 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -142.55 156.92 45.17 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.614 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -105.4 169.92 8.18 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.73 -174.09 38.83 Favored Glycine 0 N--CA 1.436 -1.329 0 O-C-N 123.898 0.749 . . . . 0.0 113.213 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.22 123.61 7.89 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.524 2.149 . . . . 0.0 113.375 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 163' ' ' LEU . 67.8 m-85 -97.06 134.47 40.37 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -86.94 96.21 10.17 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.724 0.773 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -166.42 171.21 41.34 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.2 m -133.27 138.59 46.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 118.555 1.178 . . . . 0.0 112.957 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt . . . . . 0 N--CA 1.437 -1.075 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.599 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp . . . . . 0 N--CA 1.427 -1.604 0 CA-C-O 121.317 0.579 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 ttm -108.9 98.12 7.65 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.445 HG12 ' HA3' ' A' ' 135' ' ' GLY . 34.3 m -139.25 164.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.859 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.72 156.39 39.06 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -50.43 -45.09 55.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.246 1.018 . . . . 0.0 110.996 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.6 t -85.78 8.72 18.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 39.0 t -89.14 96.71 10.83 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 102' ' ' SER . 5.9 p-90 -48.54 -17.79 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.558 1.943 . . . . 0.0 115.157 -173.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.42 HD11 ' CD2' ' A' ' 133' ' ' PHE . 48.2 mt -61.12 -30.28 70.28 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.979 0.418 . . . . 0.0 110.001 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.4 ptm180 -83.83 -10.33 58.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 59.8 mtt -89.68 -15.82 31.76 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 50.2 mt -82.99 133.68 47.92 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.78 131.59 22.99 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 121.619 1.546 . . . . 0.0 111.177 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -84.2 131.63 34.74 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 156.95 35.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.52 -2.49 30.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.44 0.638 . . . . 0.0 110.025 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.5 p -108.16 150.2 27.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.767 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.09 -5.44 57.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.06 -36.19 69.5 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.482 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.85 -28.36 14.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.197 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -74.88 111.72 10.37 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.76 -20.57 18.76 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.248 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 11.4 p -130.16 130.23 44.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.394 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.04 146.02 46.28 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.8 119.73 61.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' TYR . . . . . 0.474 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 34.5 p90 -113.33 148.51 35.55 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -96.62 138.71 33.79 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -163.13 118.48 1.73 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.324 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.61 56.36 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 124.686 1.241 . . . . 0.0 111.635 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 62.83 16.26 8.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.686 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -137.76 170.64 15.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.13 137.85 51.77 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -120.98 128.75 53.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.7 t -101.2 123.83 45.94 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.425 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -121.6 143.18 49.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 124' ' ' LEU . 46.5 t -82.29 104.74 11.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.8 t -87.14 -26.31 23.67 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.341 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -141.15 145.83 36.23 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.78 120.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 4.4 p -112.14 117.48 47.72 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 21.8 Cg_exo -66.38 167.36 18.85 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.589 2.193 . . . . 0.0 113.188 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.2 m -64.71 129.48 39.96 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.585 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.95 71.13 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.766 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.31 154.54 21.48 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.916 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.6 mt -91.86 145.64 24.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.5 pt? -119.54 144.81 46.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.923 0.392 . . . . 0.0 110.71 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.54 151.84 34.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 177' ' ' SER . 12.0 p -106.99 139.52 28.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.288 0.566 . . . . 0.0 111.069 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.558 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 31.6 ttp85 -115.74 134.23 55.23 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.67 152.08 18.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 8.6 p . . . . . 0 C--N 1.316 -0.886 0 CA-C-O 123.075 1.416 . . . . 0.0 112.989 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 N-CA-C 110.23 -0.719 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -169.89 171.75 7.02 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -102.19 90.04 3.79 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.26 174.26 22.59 Favored Glycine 0 N--CA 1.428 -1.864 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.527 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -85.05 166.51 11.16 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.214 2.609 . . . . 0.0 112.348 -176.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 43.2 mm-40 -75.58 -10.53 59.53 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.032 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -83.1 -20.65 34.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.903 0.858 . . . . 0.0 109.464 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.17 162.69 15.18 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.85 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -148.5 132.78 17.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.081 0.467 . . . . 0.0 111.478 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.7 tm? -95.39 112.68 24.35 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.94 135.56 49.93 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 82.2 mt -101.78 101.74 12.26 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.585 0.707 . . . . 0.0 109.139 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -115.17 104.86 12.26 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.366 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 73.6 13.78 4.37 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.206 1.402 . . . . 0.0 110.38 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.32 -6.82 56.09 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.353 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 8.1 tt0 -85.21 137.92 32.69 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -88.66 109.29 20.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.734 0.646 . . . . 0.0 109.273 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.2 121.7 45.9 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.695 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 166' ' ' LEU . 16.0 m -89.26 97.05 6.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.883 0.849 . . . . 0.0 110.287 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -113.19 153.25 28.61 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.035 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.89 122.06 18.55 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 174.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 105' ' ' GLU . 42.2 ttt180 -84.23 -50.6 7.73 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.17 173.9 7.0 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 m -89.36 108.56 19.7 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.9 mm? -74.98 110.07 8.97 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.094 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 p -83.17 134.61 34.97 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.109 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.88 123.6 14.82 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.009 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.77 -24.38 13.31 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.752 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -70.93 146.33 49.58 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.4 m -144.69 164.86 29.7 Favored 'General case' 0 C--N 1.283 -2.309 0 O-C-N 121.971 -0.456 . . . . 0.0 110.152 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -110.39 169.62 8.62 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.91 176.09 53.28 Favored Glycine 0 N--CA 1.433 -1.559 0 O-C-N 123.795 0.684 . . . . 0.0 111.905 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 51.1 Cg_endo -67.02 144.56 70.37 Favored 'Trans proline' 0 C--N 1.327 -0.579 0 C-N-CA 122.768 2.312 . . . . 0.0 113.187 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.32 154.49 32.24 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -100.26 127.9 46.44 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.91 0.862 . . . . 0.0 112.479 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 164.49 -157.78 30.25 Favored Glycine 0 N--CA 1.405 -3.405 0 N-CA-C 106.383 -2.687 . . . . 0.0 106.383 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 8.5 t -158.15 167.84 28.7 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 118.313 1.056 . . . . 0.0 108.807 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 61.2 mt -138.55 117.98 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -86.65 99.36 11.68 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.74 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 205' ' ' VAL . 31.8 p -62.87 154.21 30.83 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.123 -1.399 . . . . 0.0 111.138 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.447 ' HB3' ' CG2' ' A' ' 153' ' ' VAL . 29.5 ptt180 -90.52 114.85 27.14 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.818 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -99.55 12.34 36.72 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.227 1.013 . . . . 0.0 109.087 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.8 mt -124.43 169.49 11.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.978 -1.465 . . . . 0.0 108.6 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.4 m -100.96 113.39 65.78 Favored Pre-proline 0 C--N 1.281 -2.373 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.52 -15.38 48.23 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 123.676 2.917 . . . . 0.0 113.382 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 -12.04 59.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.367 1.08 . . . . 0.0 109.032 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.408 ' HB3' ' OE2' ' A' ' 147' ' ' GLU . 23.2 mtp180 -111.09 -74.99 0.63 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.987 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 146' ' ' ARG . 3.4 mp0 -125.47 147.1 49.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.801 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HB3' ' CB ' ' A' ' 152' ' ' ALA . 8.8 mm-40 63.97 71.45 0.6 Allowed Pre-proline 0 C--N 1.311 -1.094 0 C-N-CA 125.323 1.449 . . . . 0.0 114.795 173.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -104.49 8.86 0.28 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.902 2.402 . . . . 0.0 112.834 176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.445 ' HA3' ' HD3' ' A' ' 151' ' ' PRO . . . -115.47 -125.96 4.0 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.976 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.445 ' HD3' ' HA3' ' A' ' 150' ' ' GLY . 7.9 Cg_exo -73.66 5.51 3.31 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 123.843 3.028 . . . . 0.0 113.692 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' CB ' ' HB3' ' A' ' 148' ' ' GLU . . . -62.27 -32.37 73.07 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.182 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 140' ' ' ARG . 20.2 t -109.49 116.61 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.1 p -152.21 154.83 36.56 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 123.6 0.563 . . . . 0.0 109.593 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -97.48 130.77 44.54 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 82.3 mtp -101.56 87.57 3.21 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.21 165.98 28.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -52.56 140.36 23.13 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 124.143 0.902 . . . . 0.0 109.89 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 43.4 mt-10 -65.4 -14.4 60.82 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.21 -14.12 22.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 53.2 t -64.66 133.41 52.12 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.491 0.663 . . . . 0.0 111.848 -174.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -58.72 -25.2 62.7 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.663 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.486 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.6 mt -59.28 -32.21 69.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.078 0.466 . . . . 0.0 111.39 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.577 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 15.8 ptm180 -96.72 1.42 50.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.892 0.377 . . . . 0.0 111.245 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 96.2 mmm -91.55 -20.09 22.06 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.097 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 118' ' ' VAL . 10.4 mp -85.43 146.84 45.46 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.953 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.53 134.61 36.18 Favored 'Trans proline' 0 C--O 1.241 0.65 0 C-N-CA 122.265 1.977 . . . . 0.0 110.291 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.73 136.29 33.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.288 0.566 . . . . 0.0 111.635 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 30.7 m -136.02 154.4 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.985 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.7 tp -104.67 -10.89 17.19 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.516 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.9 p -94.93 169.03 10.42 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.654 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -95.59 -33.91 12.21 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.899 0.88 . . . . 0.0 111.242 -176.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 173' ' ' GLU . 5.2 mm-40 -66.91 -38.83 86.97 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.67 -30.26 32.77 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.276 0.56 . . . . 0.0 109.892 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 203' ' ' ARG . . . -79.97 119.87 23.4 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-O 121.416 0.627 . . . . 0.0 111.223 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -104.37 -6.1 21.09 Favored 'General case' 0 C--N 1.27 -2.855 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.006 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.0 m -150.42 145.26 25.95 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -125.45 147.66 49.12 Favored 'General case' 0 C--O 1.252 1.213 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.425 ' CD1' HD22 ' A' ' 163' ' ' LEU . 29.4 mm -110.1 124.79 67.14 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -133.72 155.68 49.32 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -102.55 137.87 40.21 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.14 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 85.5 tttt -140.15 112.87 8.04 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.2 t70 57.38 57.31 4.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.257 1.027 . . . . 0.0 111.144 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 73.71 -14.77 0.62 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 113.697 -1.592 . . . . 0.0 113.746 173.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.11 158.87 17.86 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.073 -0.392 . . . . 0.0 110.355 -174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 72.7 mt -96.17 136.8 36.14 Favored 'General case' 0 C--O 1.21 -1.007 0 O-C-N 123.119 0.262 . . . . 0.0 110.372 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 52.2 m95 -124.52 145.01 49.8 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.1 t -118.04 130.92 56.45 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -127.06 147.44 50.15 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.5 t -89.9 119.64 37.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 11.5 p -95.81 -29.31 14.3 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -130.25 143.56 50.85 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 5.4 p -76.38 113.29 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.52 0.676 . . . . 0.0 111.1 -177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.4 t -97.58 125.47 44.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.513 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.76 151.33 57.41 Favored 'Trans proline' 0 C--O 1.252 1.183 0 C-N-CA 121.868 1.712 . . . . 0.0 110.08 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 16.1 p -62.94 131.1 47.55 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.057 0.456 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 99.42 -19.88 52.01 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -76.84 148.98 35.7 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.4 mt -89.96 154.53 19.77 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.1 pt? -136.13 149.68 48.77 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.06 0.457 . . . . 0.0 110.937 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -109.97 155.86 21.22 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.4 ' CG2' HG12 ' A' ' 179' ' ' ILE . 8.8 p -107.22 128.54 62.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.381 0.61 . . . . 0.0 111.149 -176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 2.0 tmt_? -95.36 116.15 28.39 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.7 mp -83.75 134.61 34.73 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.49 ' O ' HG22 ' A' ' 139' ' ' THR . 8.9 p -61.38 124.68 16.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-O 121.283 0.563 . . . . 0.0 111.068 177.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.5 p -133.8 69.53 1.47 Allowed 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.902 0.858 . . . . 0.0 109.061 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.1 123.3 63.13 Favored Pre-proline 0 N--CA 1.424 -1.749 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.585 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.76 92.58 0.37 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.695 1.597 . . . . 0.0 108.438 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.54 -23.11 63.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.158 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 100.35 -45.76 1.43 Allowed Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 51.9 68.66 3.01 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 124.95 1.3 . . . . 0.0 111.435 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -101.24 16.91 0.32 Allowed 'Trans proline' 0 N--CA 1.442 -1.545 0 C-N-CA 122.848 2.365 . . . . 0.0 111.927 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 213' ' ' ARG . 1.8 mmp_? 66.19 -171.7 0.19 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.416 0.687 . . . . 0.0 109.64 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -99.46 133.78 21.67 Favored Pre-proline 0 C--N 1.291 -1.974 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.11 100.95 0.12 Allowed 'Trans proline' 0 C--O 1.245 0.861 0 C-N-CA 122.861 2.374 . . . . 0.0 112.694 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.55 -28.35 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -88.39 110.06 20.5 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.38 149.87 81.98 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.742 -176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -63.34 132.97 38.16 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.792 1.662 . . . . 0.0 109.616 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.92 114.95 4.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.406 0.622 . . . . 0.0 110.747 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 64.76 76.74 0.31 Allowed Pre-proline 0 C--O 1.248 0.988 0 C-N-CA 125.16 1.384 . . . . 0.0 110.118 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.26 178.77 6.55 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 122.911 2.407 . . . . 0.0 112.06 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 109.42 -67.17 0.23 Allowed Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.94 -156.56 27.31 Favored Glycine 0 C--O 1.256 1.469 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.975 -178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 70.75 -49.93 0.67 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.852 1.661 . . . . 0.0 112.574 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.621 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.421 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo . . . . . 0 N--CA 1.451 -1.009 0 N-CA-C 108.023 -1.568 . . . . 0.0 108.023 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.463 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 p-90 -115.96 -1.04 12.62 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.137 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m 65.44 25.52 11.92 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.22 1.008 . . . . 0.0 112.429 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.35 141.13 15.44 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.277 -0.964 . . . . 0.0 111.928 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.425 ' HG2' HD23 ' A' ' 107' ' ' LEU . 7.9 Cg_exo -44.35 150.57 0.69 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 124.437 3.425 . . . . 0.0 113.027 176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.32 -3.97 27.02 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 122' ' ' LEU . 12.2 mm-40 -81.04 -18.7 45.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.777 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.0 mm? -113.31 165.79 12.09 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.284 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -156.83 139.84 15.37 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.9 tm? -89.16 116.77 27.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.96 137.37 42.04 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -97.91 103.55 15.51 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -106.18 103.45 12.93 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 63.15 24.62 14.49 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.951 0.501 . . . . 0.0 111.329 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.68 -4.21 68.79 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.01 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -81.96 131.93 35.26 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -84.26 96.42 9.0 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.4 p -114.27 127.84 56.07 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-O 121.363 0.602 . . . . 0.0 109.798 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.4 t -90.97 118.78 36.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.009 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -115.71 147.57 40.73 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.54 119.18 32.28 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -80.06 -26.57 39.63 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 106' ' ' GLU . 3.7 mm? -110.35 140.05 44.94 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.251 -1.341 . . . . 0.0 107.586 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.1 m -69.86 122.19 18.78 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.255 0.55 . . . . 0.0 110.981 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.44 132.51 35.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.21 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.3 p -95.15 156.84 16.15 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 123.536 0.522 . . . . 0.0 111.038 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.08 117.03 7.83 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.21 -16.57 22.38 Favored Glycine 0 C--N 1.303 -1.305 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.905 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.2 tp -64.68 125.62 25.33 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.8 m -136.6 144.31 44.05 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.777 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 29.4 m-90 -91.59 172.0 8.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.548 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.84 164.29 54.52 Favored Glycine 0 N--CA 1.435 -1.381 0 O-C-N 123.777 0.673 . . . . 0.0 112.163 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 17.7 Cg_endo -58.54 128.39 28.14 Favored 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.408 2.738 . . . . 0.0 113.028 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.51 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 51.2 m-85 -102.89 170.89 7.71 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -122.06 142.63 50.16 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 163.53 -149.38 16.76 Favored Glycine 0 N--CA 1.423 -2.201 0 N-CA-C 106.129 -2.789 . . . . 0.0 106.129 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 156' ' ' MET . 24.8 p -161.25 131.2 4.91 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.664 1.232 . . . . 0.0 111.598 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 207' ' ' GLU . 1.4 pt -144.39 97.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.395 -3.186 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.642 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 3.9 pt20 -149.47 97.37 2.63 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.698 0.761 . . . . 0.0 112.522 175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.1 t -77.57 163.23 26.46 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' HA ' ' HE ' ' A' ' 140' ' ' ARG . 2.5 mmp_? -103.05 -67.74 0.87 Allowed 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -133.24 87.51 2.4 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.7 tp -90.41 127.15 36.12 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.286 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.6 m -100.81 110.66 61.45 Favored Pre-proline 0 N--CA 1.411 -2.392 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.655 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 41.5 Cg_exo -61.88 -23.79 76.38 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.662 2.241 . . . . 0.0 109.567 175.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.99 -27.63 68.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.116 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.461 ' C ' ' HD3' ' A' ' 146' ' ' ARG . 2.6 tmt_? -89.68 -48.91 6.97 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.829 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -135.51 90.23 2.59 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 144' ' ' PRO . 42.3 mt-10 -116.35 -46.4 0.05 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.856 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.421 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 41.8 Cg_exo -61.63 -40.8 43.75 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 121.459 1.439 . . . . 0.0 112.149 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.74 92.88 0.3 Allowed Glycine 0 N--CA 1.433 -1.54 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.538 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.22 124.58 11.88 Favored 'Trans proline' 0 C--O 1.252 1.212 0 C-N-CA 122.732 2.288 . . . . 0.0 112.112 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.11 -30.39 10.26 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 206' ' ' THR . 10.1 t -90.95 116.91 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -126.69 -177.85 4.16 Favored 'General case' 0 C--O 1.197 -1.667 0 C-N-CA 125.304 1.441 . . . . 0.0 108.42 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.34 134.14 44.03 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.83 -1.148 . . . . 0.0 112.087 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 136' ' ' SER . 48.2 ttm -97.17 96.36 8.38 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.5 m -130.32 159.52 42.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.608 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.87 170.13 15.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.569 0.543 . . . . 0.0 110.682 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -78.9 -8.42 58.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.982 0.896 . . . . 0.0 109.461 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 m -83.77 -2.93 57.33 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.633 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.5 t -109.09 116.79 32.62 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-O 121.77 0.795 . . . . 0.0 109.722 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 p-90 -70.04 -14.44 62.68 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.883 1.273 . . . . 0.0 112.129 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -61.74 -23.72 66.33 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 123.382 0.673 . . . . 0.0 112.392 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.95 -0.74 57.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.32 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.3 mmt -89.13 -13.54 38.23 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.292 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.2 mp -83.08 144.03 46.65 Favored Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.01 142.53 38.69 Favored 'Trans proline' 0 C--O 1.252 1.206 0 C-N-CA 122.237 1.958 . . . . 0.0 110.464 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -88.7 138.88 31.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.325 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.69 163.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.526 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.01 -46.14 37.1 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.9 p -115.03 173.01 6.71 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.87 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -82.74 -12.72 57.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.904 0.383 . . . . 0.0 110.402 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -68.76 -32.55 72.39 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.455 0.645 . . . . 0.0 110.154 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -93.89 -0.74 55.53 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.262 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.98 132.34 44.37 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.592 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -96.6 -12.72 23.6 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.3 m -149.08 132.88 16.97 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.419 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -102.27 138.89 38.61 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.682 HD13 HG23 ' A' ' 202' ' ' VAL . 1.7 mp -110.76 114.57 47.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -131.36 175.6 9.0 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.257 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -123.43 132.0 53.82 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-O 121.586 0.708 . . . . 0.0 111.638 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.495 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 17.3 tppt? -136.91 126.82 25.8 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.41 28.26 17.89 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.447 1.092 . . . . 0.0 109.584 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.12 9.71 6.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.244 1.418 . . . . 0.0 114.15 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -104.7 152.86 22.0 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 40.3 mt -94.42 141.37 28.66 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.495 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 78.7 m95 -130.96 149.2 52.69 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.3 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.4 t -130.35 117.66 20.08 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 177' ' ' SER . 4.0 ptm180 -120.0 144.14 47.68 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.49 116.57 36.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 p -94.22 -37.23 11.65 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.536 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -108.44 171.25 7.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.477 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.8 t -81.58 106.28 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.728 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.57 108.8 62.29 Favored Pre-proline 0 C--N 1.316 -0.854 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.63 176.93 9.33 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.848 2.366 . . . . 0.0 112.354 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 17.1 m -72.83 115.01 11.61 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.278 0.561 . . . . 0.0 109.899 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 104.49 -7.9 47.14 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.47 144.03 31.18 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.51 145.22 24.67 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.69 144.83 46.99 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.236 0.541 . . . . 0.0 110.397 176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -118.04 152.72 34.98 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.051 -176.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 179' ' ' ILE . 3.9 p -102.39 129.07 54.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 124.077 0.861 . . . . 0.0 113.103 -174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -109.97 108.07 18.19 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.592 ' H ' HD13 ' A' ' 204' ' ' LEU . 0.0 OUTLIER -115.48 154.39 29.41 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -168.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.412 ' HB ' HD12 ' A' ' 137' ' ' ILE . 59.2 t -82.33 150.68 4.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.506 ' HB ' ' CG1' ' A' ' 153' ' ' VAL . 1.5 p -87.8 149.0 24.43 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 -173.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -56.69 157.26 10.55 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -176.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 138' ' ' GLN . 2.0 Cg_endo -43.32 111.98 0.27 Allowed 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 124.435 3.423 . . . . 0.0 114.749 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 74.4 m80 73.12 -72.53 0.11 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.102 1.361 . . . . 0.0 111.832 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 150.66 67.02 0.01 OUTLIER Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 75.33 87.41 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.692 0 C-N-CA 127.014 2.126 . . . . 0.0 111.193 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.64 53.68 2.78 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.105 2.536 . . . . 0.0 112.17 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -122.3 93.46 3.99 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -95.5 132.07 28.32 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -39.93 -47.89 3.79 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 124.689 3.593 . . . . 0.0 112.646 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.16 98.34 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.819 0 CA-C-O 121.917 0.865 . . . . 0.0 110.593 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -96.1 9.37 41.1 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.52 ' HB3' ' HD3' ' A' ' 219' ' ' PRO . 34.5 tt0 -49.5 -52.08 53.09 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.699 176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 218' ' ' GLU . 3.0 Cg_endo -86.62 118.14 1.51 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 CA-C-N 120.157 1.092 . . . . 0.0 109.416 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.7 m -102.85 -2.03 9.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.45 120.75 80.27 Favored Pre-proline 0 N--CA 1.428 -1.537 0 CA-C-N 114.399 -1.273 . . . . 0.0 108.289 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.89 -42.55 11.26 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.682 1.588 . . . . 0.0 109.212 174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -118.01 96.46 0.68 Allowed Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -135.95 113.02 1.03 Allowed Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.097 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 58.0 tp 174.64 -46.96 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.192 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.254 177.206 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo . . . . . 0 N--CA 1.429 -2.298 0 N-CA-C 108.619 -1.339 . . . . 0.0 108.619 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.477 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 6.5 t-105 -91.36 106.84 18.79 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-O 121.184 0.516 . . . . 0.0 110.731 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.1 m -109.54 92.9 4.24 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 171.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -135.61 -168.94 11.7 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.036 -175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.1 170.24 13.82 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.551 2.834 . . . . 0.0 113.149 -177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -75.82 -30.62 59.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.904 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.96 -2.61 48.46 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.726 0.774 . . . . 0.0 111.974 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.89 161.91 18.11 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.616 -176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -149.31 148.74 29.89 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -103.86 122.02 44.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.4 48.55 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 120.775 0.321 . . . . 0.0 110.346 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 92.6 mt -99.21 101.35 12.65 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.78 110.29 20.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.7 t70 67.73 13.09 9.14 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.995 0.902 . . . . 0.0 112.12 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.7 0.72 42.8 Favored Glycine 0 C--N 1.317 -0.525 0 O-C-N 121.681 -0.637 . . . . 0.0 112.464 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 47.7 tt0 -90.02 135.01 33.91 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -86.59 96.7 10.19 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 28.2 t -110.63 152.73 26.14 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 m -121.29 131.69 72.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -138.52 148.98 44.89 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.093 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.98 120.67 17.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -68.8 -45.97 69.88 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.14 -179.52 3.66 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.5 m -78.14 98.41 5.8 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.617 0.722 . . . . 0.0 109.21 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.9 tp -76.93 112.53 13.64 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 124.898 1.279 . . . . 0.0 108.891 -178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.4 t -87.8 142.95 27.42 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.466 0.651 . . . . 0.0 110.942 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -72.38 136.65 46.17 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.051 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.61 -16.02 21.7 Favored Glycine 0 C--N 1.295 -1.717 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 56.0 tp -81.61 140.01 34.69 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.4 p -138.54 152.05 47.87 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 23.4 m-90 -100.03 175.27 5.81 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 123.265 0.353 . . . . 0.0 110.142 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.53 -179.96 39.29 Favored Glycine 0 N--CA 1.441 -1.0 0 O-C-N 123.828 0.705 . . . . 0.0 113.297 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -71.58 123.46 9.47 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.793 2.329 . . . . 0.0 113.13 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -99.34 158.47 15.69 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.4 123.39 40.03 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 170.44 -178.23 43.22 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.6 m -121.38 126.12 48.62 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.39 0.614 . . . . 0.0 111.943 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.515 ' HA ' ' OG1' ' A' ' 206' ' ' THR . 31.2 mt -140.65 118.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 175.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.589 ' H ' HG23 ' A' ' 206' ' ' THR . 26.8 tp60 -149.05 103.16 3.32 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.501 ' HB ' HG12 ' A' ' 205' ' ' VAL . 1.7 t -61.2 155.77 20.02 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 123.613 0.765 . . . . 0.0 109.526 168.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 140' ' ' ARG . 2.8 mmp_? -117.83 -4.22 11.15 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.65 64.35 0.8 Allowed 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 124.803 1.241 . . . . 0.0 109.962 -178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.0 mt -85.64 178.12 7.48 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.055 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.572 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 20.1 m -66.6 112.1 8.56 Favored Pre-proline 0 C--N 1.296 -1.723 0 O-C-N 123.66 0.6 . . . . 0.0 111.707 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.2 -11.21 21.12 Favored 'Trans proline' 0 C--N 1.363 1.304 0 C-N-CA 122.855 2.37 . . . . 0.0 111.235 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 143' ' ' SER . 10.0 pt-20 -73.47 -17.99 61.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.313 -1.312 . . . . 0.0 111.35 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 143' ' ' SER . 25.0 ptt85 -90.25 161.06 15.86 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -126.81 143.58 51.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HG2' ' H ' ' A' ' 150' ' ' GLY . 41.4 tt0 -152.19 123.92 3.81 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.19 7.05 4.65 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.038 2.492 . . . . 0.0 112.026 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.462 ' H ' ' HG2' ' A' ' 148' ' ' GLU . . . -101.33 133.72 11.44 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.506 ' HA ' HD21 ' A' ' 170' ' ' LEU . 4.6 Cg_exo -71.24 83.52 0.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.996 1.797 . . . . 0.0 113.295 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.18 -47.26 36.83 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 206' ' ' THR . 88.1 t -75.84 117.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.624 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 206' ' ' THR . 1.3 p -134.32 -179.62 5.69 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.927 -171.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.478 ' HG ' ' NE2' ' A' ' 168' ' ' GLN . 1.2 pp -126.27 148.47 49.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 25.9 mmt -123.56 81.99 1.96 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.527 -0.76 . . . . 0.0 108.972 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.61 171.82 10.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -71.5 152.84 42.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.064 0.459 . . . . 0.0 111.163 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -22.61 61.89 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.5 p -96.15 -8.21 33.79 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.7 t -73.26 124.59 25.97 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.0 0.429 . . . . 0.0 110.139 -176.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.477 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.5 p-90 -59.53 -21.55 60.39 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.005 0.922 . . . . 0.0 113.066 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 83.9 mt -60.93 -29.44 69.62 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 122.674 0.39 . . . . 0.0 111.557 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 15.9 ptm180 -93.91 2.68 56.09 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.017 0.437 . . . . 0.0 110.933 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.5 mmt -94.96 -11.03 29.29 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.7 mt -86.63 141.97 34.47 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.375 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 35.8 Cg_exo -63.6 131.8 32.93 Favored 'Trans proline' 0 C--O 1.24 0.588 0 C-N-CA 122.436 2.091 . . . . 0.0 110.781 175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' NE2' ' HG ' ' A' ' 155' ' ' LEU . 94.0 mt-30 -89.25 137.88 31.92 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.168 0.508 . . . . 0.0 112.031 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.92 171.07 16.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' A' ' 151' ' ' PRO . 92.1 mt -111.81 -25.01 9.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 31.2 p -104.09 150.92 23.87 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.958 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 15.9 pt-20 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -75.9 -20.08 58.31 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.381 0.61 . . . . 0.0 110.193 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -81.83 -23.5 36.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.667 0.746 . . . . 0.0 109.229 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -93.2 147.63 22.72 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.533 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.417 ' C ' HG22 ' A' ' 191' ' ' THR . 16.7 p30 -114.96 -2.66 12.8 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-O 121.71 0.767 . . . . 0.0 109.344 172.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.3 p -145.43 136.18 24.45 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.339 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.457 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 16.0 pt-20 -136.03 143.52 44.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.345 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.0 mm -118.28 137.13 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -139.07 164.51 29.57 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -96.58 140.86 30.58 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-O 121.457 0.646 . . . . 0.0 110.06 175.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 57.6 tptt -140.46 118.53 11.92 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 171.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 53.12 47.17 25.1 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.772 1.295 . . . . 0.0 111.253 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 34.4 t70 70.59 -13.16 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 125.803 1.641 . . . . 0.0 113.513 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.89 152.0 20.28 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 44.5 mt -97.24 132.73 42.71 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.118 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.643 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 69.4 m95 -121.2 122.76 40.68 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.456 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 51.9 t -93.67 124.0 37.38 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.574 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -119.64 142.14 48.7 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 123.331 0.394 . . . . 0.0 110.008 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.53 104.43 12.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.417 HG22 ' C ' ' A' ' 176' ' ' ASN . 4.0 t -84.89 -18.52 34.49 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.068 -172.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -142.3 142.03 32.49 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.77 116.61 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-O 121.775 0.798 . . . . 0.0 111.057 177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.9 t -100.66 120.45 55.83 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.56 172.38 14.41 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.331 2.021 . . . . 0.0 111.957 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 20.0 m -67.58 112.16 4.57 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 101.89 -5.45 53.61 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.979 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.9 138.58 33.4 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 41.2 mt -89.86 128.76 36.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 200' ' ' LEU . 3.8 mp -82.71 153.66 25.21 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.295 0.569 . . . . 0.0 112.226 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -133.1 126.82 32.61 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.3 p -97.41 129.62 47.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 123.96 0.788 . . . . 0.0 111.678 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.457 ' HB3' ' CB ' ' A' ' 178' ' ' GLU . 61.0 ttt180 -104.66 133.55 49.31 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 173.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.462 HD11 HD23 ' A' ' 155' ' ' LEU . 2.7 mm? -112.75 154.03 26.83 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.501 HG12 ' HB ' ' A' ' 139' ' ' THR . 20.4 t -115.82 55.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 153' ' ' VAL . 17.8 m -123.94 107.52 11.43 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.136 0.974 . . . . 0.0 111.222 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -103.72 149.43 37.11 Favored Pre-proline 0 C--N 1.284 -2.242 0 O-C-N 121.762 -0.586 . . . . 0.0 109.589 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -91.94 -175.21 0.64 Allowed 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 122.418 2.079 . . . . 0.0 110.322 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' A' ' 210' ' ' GLY . 15.9 t-80 64.21 -160.52 0.29 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.06 0.944 . . . . 0.0 109.163 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' A' ' 209' ' ' HIS . . . -175.65 -87.46 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.483 0 N-CA-C 108.266 -1.934 . . . . 0.0 108.266 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -135.34 139.83 32.62 Favored Pre-proline 0 C--N 1.292 -1.897 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -82.24 134.99 8.19 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.602 1.535 . . . . 0.0 110.046 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.57 -29.05 19.16 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.016 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.624 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 39.8 m80 67.92 173.74 0.08 OUTLIER Pre-proline 0 CA--C 1.568 1.648 0 O-C-N 123.93 0.769 . . . . 0.0 109.765 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 214' ' ' HIS . 57.5 Cg_endo -70.34 41.45 0.35 Allowed 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 122.341 2.027 . . . . 0.0 114.766 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 14.1 p -72.31 -24.57 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-O 121.686 0.755 . . . . 0.0 110.568 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 217' ' ' GLN . 4.6 pm0 -90.71 1.89 56.45 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.353 0.597 . . . . 0.0 110.513 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -112.38 141.78 25.77 Favored Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.14 118.74 4.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.188 2.592 . . . . 0.0 113.103 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 46.1 t -91.8 -33.79 5.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 222' ' ' PRO . 13.7 mm-40 63.1 103.56 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 CA-C-N 113.067 -1.879 . . . . 0.0 112.25 -178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 221' ' ' GLU . 25.1 Cg_endo -62.14 124.97 15.37 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.535 2.157 . . . . 0.0 112.374 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -111.66 78.58 0.25 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.7 -125.02 2.2 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp 61.35 87.16 0.1 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.355 1.062 . . . . 0.0 110.864 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 N--CA 1.446 -1.318 0 N-CA-C 108.677 -1.317 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.61 157.4 46.69 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.3 t -90.84 77.89 6.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -134.87 164.29 24.73 Favored Glycine 0 N--CA 1.42 -2.384 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.08 166.12 16.77 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.69 2.26 . . . . 0.0 112.885 -176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -74.68 -12.1 60.34 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.592 -174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' HD23 ' A' ' 122' ' ' LEU . 31.8 mp0 -80.88 -12.48 59.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.729 0.776 . . . . 0.0 109.393 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.69 157.7 26.01 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.237 -172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.5 141.56 46.77 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.98 120.29 29.18 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.8 129.42 56.59 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.103 0.478 . . . . 0.0 111.455 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.47 108.49 20.43 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -109.76 95.54 5.67 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 51.38 59.35 4.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.838 -1.074 . . . . 0.0 113.141 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 82.03 -1.5 86.57 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.803 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -113.4 140.63 47.9 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 117.276 0.538 . . . . 0.0 110.736 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -80.75 111.51 17.26 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.868 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 68.7 m -123.59 169.16 11.73 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 166' ' ' LEU . 59.0 t -123.95 129.95 74.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -119.48 145.82 45.97 Favored 'General case' 0 N--CA 1.394 -3.244 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -72.04 122.0 20.15 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -89.1 -44.4 10.37 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 106' ' ' GLU . 4.4 mm? -109.21 165.2 11.8 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 51.0 m -91.84 110.15 21.49 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 3.5 mm? -84.02 123.87 30.47 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.434 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.2 t -101.27 157.51 16.73 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 149.39 50.69 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 120.95 0.405 . . . . 0.0 110.878 -177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.14 -26.97 21.38 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.086 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.4 tp -75.25 142.35 43.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -139.78 162.35 35.34 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 120.84 0.352 . . . . 0.0 110.842 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.9 m-90 -100.45 174.99 5.84 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.292 0.637 . . . . 0.0 109.731 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.39 171.14 55.1 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 119.526 -0.597 . . . . 0.0 111.765 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 57.7 Cg_endo -73.09 123.33 8.76 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.247 1.964 . . . . 0.0 114.054 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.528 ' HE1' ' HG ' ' A' ' 188' ' ' CYS . 48.8 m-85 -94.72 149.96 20.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -106.36 106.26 16.7 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.861 0.839 . . . . 0.0 112.189 -174.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -159.1 -145.02 4.12 Favored Glycine 0 C--N 1.291 -1.949 0 N-CA-C 107.624 -2.19 . . . . 0.0 107.624 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.8 m -153.45 161.3 42.41 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 118.34 1.07 . . . . 0.0 110.832 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 43.7 mt -122.23 118.99 57.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -89.61 100.93 13.63 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.4 t -95.43 162.41 13.67 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -167.52 -45.38 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.94 41.7 17.28 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.609 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 68.5 tp -73.5 100.24 3.22 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.232 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.9 m -98.47 107.08 40.24 Favored Pre-proline 0 C--N 1.298 -1.642 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 147' ' ' GLU . 50.7 Cg_exo -56.03 -71.52 0.04 OUTLIER 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.817 2.345 . . . . 0.0 113.113 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -112.63 -35.84 5.39 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.135 -0.626 . . . . 0.0 112.637 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 147' ' ' GLU . 1.8 tmm_? -152.37 -53.38 0.12 Allowed 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.627 -175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 38.6 tt0 -111.53 157.75 19.98 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 -175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -83.13 110.67 25.09 Favored Pre-proline 0 C--N 1.315 -0.91 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -71.23 -28.07 19.03 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.593 2.195 . . . . 0.0 113.859 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -165.96 -118.41 0.44 Allowed Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 119.982 -1.104 . . . . 0.0 112.353 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.2 78.58 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.775 2.317 . . . . 0.0 113.618 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.8 -18.52 27.53 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.119 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 98.6 t -146.98 126.95 4.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 105.145 -2.168 . . . . 0.0 105.145 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.5 m -133.44 134.65 43.87 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.13 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.7 125.14 30.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 0.0 110.38 175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -96.3 86.72 4.28 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.675 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.93 165.62 28.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.182 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -70.09 160.25 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.9 63.96 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 112.245 -177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.9 p -88.47 -9.37 52.71 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 53.1 t -75.97 126.81 31.71 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.023 0.439 . . . . 0.0 110.188 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 7.8 p-90 -54.01 -30.87 49.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 188' ' ' CYS . 88.2 mt -59.62 -30.28 68.59 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -96.35 -2.9 44.77 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.47 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 21.8 ptp -107.48 4.56 26.3 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.831 -0.747 . . . . 0.0 110.727 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 73.5 mt -83.99 148.86 54.84 Favored Pre-proline 0 N--CA 1.435 -1.187 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 173.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.8 118.23 5.23 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 121.901 1.734 . . . . 0.0 110.056 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -81.68 129.16 34.61 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.36 146.91 33.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.408 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -106.04 0.77 25.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.579 0.704 . . . . 0.0 109.466 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.3 p -100.03 134.49 42.86 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.585 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -72.25 -34.37 68.2 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-O 121.167 0.508 . . . . 0.0 110.727 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -72.95 -12.91 61.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.81 -20.4 17.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.62 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.511 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -88.6 127.97 35.57 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.081 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 192' ' ' LYS . 86.3 m-20 -94.54 -11.41 29.59 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.205 176.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 p -152.42 129.43 11.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.475 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -109.36 134.04 52.32 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.054 0.455 . . . . 0.0 110.25 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 188' ' ' CYS . 29.8 mm -102.17 125.24 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 187' ' ' TRP . 32.4 p90 -130.29 154.03 48.03 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.606 -176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.551 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.1 OUTLIER -102.66 127.25 49.86 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -137.26 128.04 27.17 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 66.06 23.41 11.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.76 17.55 11.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.445 1.498 . . . . 0.0 113.376 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -109.61 159.37 17.17 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 3.4 mm? -93.39 131.36 38.65 Favored 'General case' 0 CA--C 1.482 -1.653 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 180' ' ' TYR . 51.2 m95 -128.23 139.56 52.38 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.528 ' HG ' ' HE1' ' A' ' 133' ' ' PHE . 49.1 m -109.05 112.77 25.14 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.742 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -107.4 131.63 54.06 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 48.5 t -83.74 126.46 40.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.0 p -106.54 -19.1 13.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 176' ' ' ASN . 68.0 mttm -140.02 146.03 38.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.445 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 76.7 t -69.16 115.13 7.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 123.864 0.727 . . . . 0.0 109.717 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -108.8 120.22 46.75 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.58 153.58 49.41 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.228 1.952 . . . . 0.0 111.988 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 50.3 m -63.14 122.72 16.79 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 111.61 -18.1 25.13 Favored Glycine 0 N--CA 1.422 -2.248 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.558 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.78 159.09 23.66 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.579 -178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.76 153.65 20.91 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.208 0.528 . . . . 0.0 110.783 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 200' ' ' LEU . 1.3 pt? -123.52 148.85 45.89 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.37 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -114.25 145.08 42.2 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.411 HG23 HG12 ' A' ' 179' ' ' ILE . 14.3 p -102.15 125.63 56.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 O-C-N 123.948 0.78 . . . . 0.0 110.75 -176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.2 ttt180 -97.74 134.0 41.5 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.02 135.9 38.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.11 97.05 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.555 1.169 . . . . 0.0 111.915 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 4.94 40.61 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.41 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.03 120.39 22.54 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -68.68 32.62 0.16 Allowed 'Trans proline' 0 N--CA 1.499 1.834 0 C-N-CA 124.141 3.227 . . . . 0.0 115.535 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.469 ' HB3' ' CE1' ' A' ' 214' ' ' HIS . 32.8 m170 74.33 137.1 0.06 Allowed 'General case' 0 C--O 1.244 0.769 0 C-N-CA 125.214 1.406 . . . . 0.0 113.257 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 168.91 36.23 0.02 OUTLIER Glycine 0 N--CA 1.428 -1.888 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.608 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.462 ' HB3' ' HD3' ' A' ' 212' ' ' PRO . . . -124.34 -55.06 0.03 OUTLIER Pre-proline 0 C--O 1.213 -0.846 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.98 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.462 ' HD3' ' HB3' ' A' ' 211' ' ' ALA . 64.4 Cg_endo -102.52 -170.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 121.599 1.533 . . . . 0.0 110.053 174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -105.66 153.87 21.23 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 209' ' ' HIS . 36.4 m80 -113.08 145.02 32.26 Favored Pre-proline 0 C--N 1.291 -1.953 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -172.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.27 132.51 39.05 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.445 2.097 . . . . 0.0 112.458 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 51.9 t 66.8 87.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 125.146 1.379 . . . . 0.0 111.681 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -103.92 -16.39 15.37 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.344 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.13 128.97 89.85 Favored Pre-proline 0 N--CA 1.439 -0.997 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.359 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.3 155.49 55.93 Favored 'Trans proline' 0 C--O 1.254 1.276 0 C-N-CA 122.375 2.05 . . . . 0.0 111.518 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.47 167.04 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.67 149.77 38.82 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.52 116.2 4.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.102 1.868 . . . . 0.0 111.333 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -78.37 145.72 29.56 Favored Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.891 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 82.77 -95.9 1.84 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.8 tp -158.94 135.4 9.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.634 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 175.693 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.429 -2.287 0 N-CA-C 111.477 -0.24 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 36.2 t-105 -115.93 109.94 18.29 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 121.799 0.809 . . . . 0.0 111.342 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.7 m -145.2 123.98 12.62 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.403 ' HA3' ' HD3' ' A' ' 104' ' ' PRO . . . -171.95 -141.83 3.52 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 118.526 -1.797 . . . . 0.0 113.592 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HD3' ' HA3' ' A' ' 103' ' ' GLY . 7.4 Cg_endo -82.56 159.2 16.8 Favored 'Trans proline' 0 N--CA 1.443 -1.454 0 C-N-CA 123.125 2.55 . . . . 0.0 112.339 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.46 -20.58 39.97 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -68.1 -15.45 63.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 113.857 -1.52 . . . . 0.0 109.324 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.633 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.8 mm? -119.53 147.77 44.06 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.697 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.36 141.32 33.83 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -94.3 100.1 12.21 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 103.865 -2.643 . . . . 0.0 103.865 174.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.11 146.24 32.93 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.802 -172.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 9.0 mp -108.19 110.49 22.13 Favored 'General case' 0 N--CA 1.415 -2.181 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.694 176.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.44 117.33 31.42 Favored 'General case' 0 C--N 1.275 -2.663 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.32 178.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.2 t70 62.66 23.75 14.13 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.048 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.64 2.22 63.35 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.071 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 53.2 tt0 -98.35 137.96 36.29 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.1 102.64 14.45 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.3 t -130.8 165.11 23.7 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 118.867 -1.133 . . . . 0.0 111.077 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.6 t -91.0 107.98 19.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.375 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -103.5 140.82 36.99 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.34 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.84 113.51 7.15 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 170.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -50.17 30.36 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.08 169.25 8.9 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.9 m -74.46 112.57 10.77 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.223 0.535 . . . . 0.0 110.46 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 200' ' ' LEU . 75.4 mt -84.71 114.7 22.22 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.4 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.6 p -88.81 155.26 19.66 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.165 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -59.55 141.33 55.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.105 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 95.97 -17.75 58.7 Favored Glycine 0 C--N 1.297 -1.606 0 C-N-CA 120.034 -1.079 . . . . 0.0 112.266 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.67 117.02 9.03 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.7 m -129.3 141.11 51.19 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -99.37 170.95 8.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.367 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.9 -168.56 22.19 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.85 0.719 . . . . 0.0 113.937 -174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.2 Cg_endo -75.16 144.02 29.24 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.343 2.029 . . . . 0.0 112.864 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.549 ' CD2' HD11 ' A' ' 163' ' ' LEU . 76.8 m-85 -123.34 162.52 22.56 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.199 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -94.38 125.12 38.83 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 -178.74 35.02 Favored Glycine 0 N--CA 1.421 -2.341 0 C-N-CA 119.526 -1.321 . . . . 0.0 113.952 176.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 18.1 m -126.19 158.85 34.56 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 204' ' ' LEU . 60.2 mt -97.65 147.51 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-O 121.233 0.539 . . . . 0.0 109.819 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.417 ' HG2' HG22 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -72.07 98.37 2.08 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 175.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.417 ' HA ' ' OG1' ' A' ' 206' ' ' THR . 9.6 t -89.35 162.69 15.67 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.626 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? 65.95 47.45 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.97 0.891 . . . . 0.0 110.08 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.47 41.63 0.63 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.586 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 64.2 tp -79.8 98.56 7.1 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.4 m -58.8 117.15 18.66 Favored Pre-proline 0 C--N 1.302 -1.49 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.4 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -96.98 -154.8 0.04 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.125 0 C-N-CA 122.789 2.326 . . . . 0.0 110.312 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -83.71 -44.89 13.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.198 0.523 . . . . 0.0 109.805 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -89.11 177.79 6.54 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.9 129.02 37.9 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 125.514 1.525 . . . . 0.0 111.949 -175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 67.78 148.84 0.12 Allowed Pre-proline 0 N--CA 1.478 0.975 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -74.86 -5.95 17.49 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.503 2.135 . . . . 0.0 110.397 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.82 116.73 0.71 Allowed Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.546 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.04 -5.97 17.09 Favored 'Trans proline' 0 N--CA 1.48 0.704 0 C-N-CA 122.657 2.238 . . . . 0.0 112.381 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.77 -11.15 37.48 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.329 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.417 HG22 ' HG2' ' A' ' 138' ' ' GLN . 11.1 p -123.62 119.98 58.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.631 0.729 . . . . 0.0 109.736 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.5 m -146.67 158.09 43.84 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 204' ' ' LEU . 0.4 OUTLIER -63.14 104.87 0.63 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.668 0.747 . . . . 0.0 111.952 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.3 ttt -87.65 90.91 8.55 Favored 'General case' 0 N--CA 1.415 -2.185 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.8 m -110.93 178.78 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.207 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.615 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 23.5 t70 -66.94 144.5 56.19 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -10.07 49.74 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -95.51 -12.44 25.79 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.604 175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 158' ' ' ASP . 94.0 m -69.94 111.01 5.35 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-O 121.614 0.721 . . . . 0.0 112.926 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.633 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 19.8 p-90 -54.48 -26.15 29.53 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 125.514 1.526 . . . . 0.0 112.569 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 133' ' ' PHE . 75.3 mt -54.21 -32.66 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.464 1.106 . . . . 0.0 112.549 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -85.47 -2.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.212 -0.995 . . . . 0.0 111.618 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 95.9 mmm -86.53 -16.27 37.46 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.577 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.16 143.26 52.32 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.99 131.35 20.73 Favored 'Trans proline' 0 C--O 1.249 1.053 0 C-N-CA 121.607 1.538 . . . . 0.0 109.426 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -83.95 129.93 34.91 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.0 m -112.94 137.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.685 0.755 . . . . 0.0 112.531 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -77.54 -18.77 56.66 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.524 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 4.7 p -95.4 134.92 37.66 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.799 -1.092 . . . . 0.0 110.092 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -85.06 -17.32 37.79 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.72 0.771 . . . . 0.0 109.515 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -66.89 -41.37 87.3 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.093 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -77.66 -29.21 51.47 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.52 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.51 140.17 57.02 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.556 -177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 200' ' ' LEU . 85.1 m-20 -107.81 -15.48 14.55 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.533 0.682 . . . . 0.0 109.74 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.7 m -149.36 142.96 25.45 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -116.72 151.56 36.13 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.893 0.378 . . . . 0.0 111.001 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.459 HD11 HD22 ' A' ' 163' ' ' LEU . 33.6 mm -115.96 115.52 49.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -113.19 163.03 15.28 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -109.92 141.74 42.23 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -148.25 121.27 8.83 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 65.69 20.98 11.6 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.045 0.938 . . . . 0.0 109.952 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 29.4 t70 73.71 15.68 3.96 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.743 1.617 . . . . 0.0 111.31 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -109.08 147.87 31.72 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 70.4 mt -93.87 141.22 28.76 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.851 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -128.89 136.33 50.27 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.9 126.07 54.71 Favored 'General case' 0 C--N 1.316 -0.872 0 O-C-N 123.282 0.364 . . . . 0.0 110.806 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -123.88 137.22 54.68 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.63 125.2 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 21.0 p -90.85 -39.91 12.06 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 175' ' ' ALA . 48.9 mtmt -119.49 153.66 34.97 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.84 108.69 8.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.66 112.63 48.16 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-O 121.124 0.487 . . . . 0.0 110.247 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.81 164.32 35.02 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.441 2.094 . . . . 0.0 112.488 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.3 t -58.6 123.25 15.67 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.679 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.2 -30.69 5.14 Favored Glycine 0 N--CA 1.425 -2.086 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.47 147.32 49.73 Favored Glycine 0 N--CA 1.443 -0.861 0 O-C-N 124.045 0.497 . . . . 0.0 112.157 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.5 mt -105.34 120.39 41.44 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 176' ' ' ASN . 5.3 mp -73.1 136.49 44.9 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -118.47 137.69 53.0 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.3 p -98.0 130.78 46.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.487 0.661 . . . . 0.0 111.949 -173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.581 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.4 tpt180 -104.77 130.84 52.78 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 155' ' ' LEU . 83.8 mt -103.19 124.43 48.59 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 34.7 t -84.92 81.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-O 122.416 1.103 . . . . 0.0 108.661 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 139' ' ' THR . 5.1 t -83.06 157.5 22.84 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 113.268 -1.787 . . . . 0.0 109.814 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -121.79 113.2 31.79 Favored Pre-proline 0 N--CA 1.42 -1.972 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.866 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.41 131.39 2.48 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 122.47 2.113 . . . . 0.0 108.754 170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -86.88 91.03 8.53 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.35 -26.29 23.77 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.718 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -104.69 112.13 65.29 Favored Pre-proline 0 C--N 1.308 -1.221 0 CA-C-N 116.852 0.326 . . . . 0.0 110.612 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.02 -21.62 13.84 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.232 1.955 . . . . 0.0 110.601 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -139.6 112.59 8.07 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.159 -178.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.433 ' HB3' ' HD3' ' A' ' 215' ' ' PRO . 12.2 t-80 -87.66 -63.66 0.21 Allowed Pre-proline 0 C--N 1.297 -1.694 0 CA-C-O 118.556 -0.735 . . . . 0.0 112.541 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 214' ' ' HIS . 74.2 Cg_endo -83.73 -17.04 6.27 Favored 'Trans proline' 0 C--N 1.371 1.73 0 CA-C-N 121.283 1.494 . . . . 0.0 112.082 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.2 t 67.51 -69.75 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.375 1.47 . . . . 0.0 112.116 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -107.41 -179.31 3.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.08 134.25 80.9 Favored Pre-proline 0 C--N 1.315 -0.929 0 O-C-N 123.342 0.401 . . . . 0.0 110.95 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.54 122.86 12.55 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.608 2.206 . . . . 0.0 110.534 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -93.55 124.47 46.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -124.95 123.13 25.52 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.245 -175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.83 -26.27 59.91 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.384 2.056 . . . . 0.0 110.599 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 113.14 -110.73 2.57 Favored Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -85.62 99.13 2.34 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 pp -112.38 165.37 12.26 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -178.763 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo . . . . . 0 N--CA 1.444 -1.441 0 N-CA-C 108.428 -1.412 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 5.1 p-90 -59.88 109.15 0.87 Allowed 'General case' 0 C--N 1.317 -0.841 0 O-C-N 124.019 0.824 . . . . 0.0 111.407 178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . 0.263 79.1 p 65.94 -51.02 0.4 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.171 2.189 . . . . 0.0 114.669 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.68 -73.05 0.04 OUTLIER Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.228 -1.463 . . . . 0.0 114.446 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -70.65 119.99 6.75 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.717 1.611 . . . . 0.0 114.443 -173.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 0.4 OUTLIER -81.99 -10.31 59.29 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.345 177.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -76.15 -7.74 55.47 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.063 1.345 . . . . 0.0 109.619 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 0.2 OUTLIER -110.96 138.39 47.43 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.501 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 39.7 tt0 -113.57 119.19 36.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.354 0.597 . . . . 0.0 112.242 -176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.51 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.6 tm? -96.49 110.58 22.93 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 104.694 -2.336 . . . . 0.0 104.694 173.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.577 ' HB1' HE21 ' A' ' 112' ' ' GLN . . . -117.49 114.8 24.01 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.088 0.471 . . . . 0.0 110.997 -175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 116' ' ' ARG . 90.4 mt -91.67 105.0 17.41 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.145 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.577 HE21 ' HB1' ' A' ' 110' ' ' ALA . 82.2 mm-40 -105.83 105.9 16.16 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 64.44 21.79 12.56 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.119 0.968 . . . . 0.0 110.861 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.91 2.35 59.55 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.861 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -100.55 137.57 38.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 117.291 0.545 . . . . 0.0 110.181 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HA ' HD23 ' A' ' 111' ' ' LEU . 3.2 ptp180 -84.68 113.34 21.22 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.616 0.722 . . . . 0.0 112.635 -176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.3 t -115.3 143.99 44.42 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 57.0 t -121.51 112.85 37.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 80.9 mtt180 -118.57 160.1 22.38 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.703 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -83.17 126.46 32.64 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -64.64 -37.44 87.58 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.516 0.674 . . . . 0.0 110.201 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -135.95 171.3 14.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 m -66.61 112.13 4.0 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.6 mt -80.48 117.85 21.58 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.2 p -79.82 147.34 31.82 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.101 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.27 139.25 54.38 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.74 -18.8 56.38 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.363 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.4 tp -68.26 125.37 26.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m -129.62 149.06 51.55 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -92.1 165.38 13.19 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.097 177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.61 158.74 35.76 Favored Glycine 0 N--CA 1.441 -1.002 0 O-C-N 124.41 1.069 . . . . 0.0 112.853 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 123.6 12.03 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 123.083 2.522 . . . . 0.0 112.681 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -96.36 152.61 18.44 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 178.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.83 141.85 31.1 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.791 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.28 -158.78 28.66 Favored Glycine 0 C--N 1.281 -2.514 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.5 m -147.28 162.38 39.06 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 69.2 mt -129.08 114.08 31.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -86.82 101.66 13.56 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.442 ' HA ' HG23 ' A' ' 153' ' ' VAL . 5.6 m -87.13 87.34 7.42 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 122.633 1.206 . . . . 0.0 110.108 -174.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -84.85 80.35 9.3 Favored 'General case' 0 C--N 1.27 -2.891 0 CA-C-N 113.429 -1.714 . . . . 0.0 108.394 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.39 76.58 5.97 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.982 0.896 . . . . 0.0 109.41 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 42.6 tp -98.81 105.22 17.34 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.028 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 p -71.92 114.71 31.24 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -91.1 -155.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.088 0 C-N-CA 122.205 1.937 . . . . 0.0 112.05 -174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -97.5 -10.65 24.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -114.9 -169.04 1.47 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.664 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -78.17 -58.86 3.03 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.067 0.46 . . . . 0.0 110.199 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 150' ' ' GLY . 43.2 tt0 -94.84 123.4 57.83 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.494 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.24 -15.13 18.25 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.376 2.051 . . . . 0.0 111.546 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.508 ' H ' ' HG2' ' A' ' 148' ' ' GLU . . . 94.14 -159.31 23.46 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -74.09 60.89 4.77 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.175 2.583 . . . . 0.0 112.147 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.12 -49.94 17.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 139' ' ' THR . 2.5 p -79.13 118.46 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.018 175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 m -130.81 142.34 50.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -87.83 151.99 22.44 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.806 177.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.19 95.37 5.16 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.484 HG22 HD13 ' A' ' 155' ' ' LEU . 26.8 m -133.95 -178.63 2.74 Favored 'Isoleucine or valine' 0 C--O 1.252 1.226 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.445 -176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.557 ' O ' ' HD3' ' A' ' 164' ' ' ARG . 11.0 t70 -55.48 142.22 33.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.088 177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -55.8 -30.48 61.42 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.8 p -105.95 5.33 30.4 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.826 0.346 . . . . 0.0 111.899 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.6 t -66.33 124.38 22.55 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -51.24 -29.23 13.78 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 68.0 mt -57.09 -35.45 69.42 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 123.06 0.544 . . . . 0.0 111.508 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' A' ' 158' ' ' ASP . 16.5 ptm180 -97.31 -2.47 42.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.518 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 93.6 mmm -92.63 -28.32 16.77 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.807 0.337 . . . . 0.0 111.072 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.3 152.54 70.76 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.83 124.72 14.56 Favored 'Trans proline' 0 C--O 1.25 1.115 0 C-N-CA 121.686 1.591 . . . . 0.0 109.653 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -88.86 132.15 34.79 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.573 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.565 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 33.9 m -125.37 164.37 24.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 67.1 mt -111.75 -8.11 14.18 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.188 0.518 . . . . 0.0 110.638 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.9 p -93.2 134.6 35.23 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.052 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -84.26 -9.21 58.69 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.143 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -80.02 -34.9 37.98 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.649 0.261 . . . . 0.0 110.783 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -83.88 -36.02 23.69 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.614 0.721 . . . . 0.0 109.319 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.656 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -78.11 123.32 26.73 Favored 'General case' 0 CA--C 1.473 -1.986 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.763 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' A' ' 200' ' ' LEU . 54.2 m-80 -90.02 -14.75 33.25 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.061 176.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 36.3 m -134.53 136.83 43.34 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.677 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -121.92 136.67 54.94 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.271 0.558 . . . . 0.0 110.665 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.73 HD13 HG13 ' A' ' 202' ' ' VAL . 1.4 mp -103.32 120.71 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.545 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -132.1 151.4 51.79 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.057 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.473 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -88.11 141.25 28.71 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -155.25 111.89 3.23 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.3 t70 57.2 65.36 1.39 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.266 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.66 8.04 2.78 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 114.136 -1.393 . . . . 0.0 114.283 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.37 156.53 45.38 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 51.3 mt -101.61 131.92 47.55 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -120.51 150.24 41.16 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.1 t -125.32 114.27 18.69 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -111.02 146.04 37.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 73.5 t -83.06 112.46 20.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 3.6 t -92.17 -34.16 14.43 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.97 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -123.48 135.59 54.14 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.98 108.36 2.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 O-C-N 123.558 0.536 . . . . 0.0 111.045 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.46 128.14 27.57 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.264 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.29 169.01 17.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.877 2.385 . . . . 0.0 112.779 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 35.4 t -67.38 131.5 45.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 90.29 -13.78 64.19 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.413 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -75.66 154.56 45.62 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 8.8 mp -96.86 142.43 28.86 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.447 0.642 . . . . 0.0 110.753 -177.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' HA ' HD22 ' A' ' 176' ' ' ASN . 1.1 pt? -123.22 164.38 18.84 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.392 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -136.03 158.74 43.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.73 HG13 HD13 ' A' ' 179' ' ' ILE . 23.3 t -100.05 119.18 47.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 O-C-N 124.484 1.115 . . . . 0.0 111.361 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.656 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 1.1 tmm_? -106.73 128.0 53.85 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.24 138.96 31.19 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.28 93.9 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.897 1.332 . . . . 0.0 112.714 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.5 m -98.31 99.68 10.91 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -63.6 142.79 98.0 Favored Pre-proline 0 C--N 1.311 -1.107 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.144 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.37 109.36 0.43 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.991 2.46 . . . . 0.0 110.155 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -101.68 137.22 40.28 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.432 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 91.14 27.96 16.8 Favored Glycine 0 C--N 1.305 -1.187 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 71.72 145.45 0.11 Allowed Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 125.348 1.459 . . . . 0.0 112.227 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.38 154.64 68.95 Favored 'Trans proline' 0 C--O 1.248 1.006 0 C-N-CA 121.772 1.648 . . . . 0.0 108.859 173.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.64 91.56 7.49 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.888 -174.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -135.38 135.21 22.01 Favored Pre-proline 0 C--N 1.297 -1.694 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.91 -57.9 1.32 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.052 1.835 . . . . 0.0 109.258 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.39 123.82 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.133 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.96 108.02 20.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 219' ' ' PRO . 18.2 mm-40 -92.77 121.01 66.87 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.441 -173.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 218' ' ' GLU . 12.9 Cg_exo -71.27 132.04 20.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.359 2.039 . . . . 0.0 109.82 173.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.0 t -102.68 123.34 55.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 120.838 0.351 . . . . 0.0 110.136 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -113.57 122.34 35.4 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.97 155.18 48.08 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 122.061 1.841 . . . . 0.0 111.452 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -90.69 55.45 3.42 Favored Glycine 0 C--N 1.3 -1.438 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -150.85 81.1 0.19 Allowed Glycine 0 N--CA 1.42 -2.424 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.62 104.17 4.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.439 -1.709 0 N-CA-C 112.432 0.128 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.505 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.7 OUTLIER -154.81 166.81 32.29 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.118 -176.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 162' ' ' TRP . 36.6 m -91.48 93.12 8.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -169.18 -175.52 38.53 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.407 -0.901 . . . . 0.0 111.687 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.04 151.44 9.62 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.11 2.54 . . . . 0.0 111.966 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 1.6 pm0 -78.42 -0.36 28.92 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.54 -22.76 60.0 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.9 161.2 17.26 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 113.402 -1.726 . . . . 0.0 108.566 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 34.9 tt0 -144.25 122.67 12.38 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.758 0.313 . . . . 0.0 110.718 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.3 tm? -88.23 109.69 20.13 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 171.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.44 157.75 18.15 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.4 mt -118.03 97.93 6.06 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -113.39 117.51 31.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.9 t70 66.15 12.51 8.57 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 122.444 1.116 . . . . 0.0 110.062 -177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.83 69.06 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.057 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -82.32 136.73 34.97 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 122.665 -0.314 . . . . 0.0 110.185 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.3 mmt180 -80.95 110.41 16.46 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 19.9 p -129.95 136.94 50.04 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.414 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.5 t -96.54 105.9 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -110.84 149.2 30.92 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.4 112.16 15.15 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.488 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 24.3 ttt180 -73.92 -43.22 59.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -177.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -109.83 152.81 25.27 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.7 m -68.41 116.38 8.91 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 88.6 mt -86.77 113.12 22.34 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.879 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 p -90.66 144.37 25.81 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -64.64 148.46 50.9 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 107.41 -34.1 5.9 Favored Glycine 0 C--N 1.282 -2.434 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 63.9 tp -65.75 138.55 58.02 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.2 m -147.55 154.96 41.37 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -98.35 173.11 7.14 Favored 'General case' 0 C--N 1.285 -2.224 0 O-C-N 123.564 0.54 . . . . 0.0 109.952 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.6 -179.05 37.94 Favored Glycine 0 N--CA 1.437 -1.289 0 O-C-N 123.81 0.694 . . . . 0.0 112.97 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.61 123.72 10.08 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.635 2.223 . . . . 0.0 112.579 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' CD2' HD11 ' A' ' 163' ' ' LEU . 80.3 m-85 -96.6 150.01 21.13 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -95.39 120.23 35.27 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.338 0.589 . . . . 0.0 110.806 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.616 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 147.6 -174.27 27.41 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.0 m -139.15 160.52 39.59 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.989 0.894 . . . . 0.0 111.993 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.2 mt -118.37 130.8 72.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -79.42 97.57 6.42 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.908 0.861 . . . . 0.0 110.324 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -84.38 132.61 34.57 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.475 -177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 140' ' ' ARG 0.333 11.5 mmt180 56.71 47.79 17.55 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-O 122.262 1.03 . . . . 0.0 113.069 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -80.97 97.5 7.49 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.46 114.14 27.49 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.084 -174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.2 m -74.72 162.86 71.8 Favored Pre-proline 0 C--N 1.292 -1.903 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.812 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.89 -149.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.259 1.973 . . . . 0.0 109.651 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -85.84 20.38 2.22 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.581 -0.7 . . . . 0.0 111.197 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -75.68 159.94 30.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.229 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 149' ' ' PRO . 10.3 pt-20 -64.73 139.67 58.79 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.795 175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -98.19 102.56 14.37 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 147' ' ' GLU . 24.3 Cg_exo -65.93 -42.02 12.38 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.72 2.28 . . . . 0.0 112.578 -175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -170.51 -127.29 0.93 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.87 100.03 0.49 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.243 1.962 . . . . 0.0 111.579 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.14 -29.48 31.59 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 64.6 t -91.22 117.84 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 172.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.464 ' HA ' ' CD2' ' A' ' 204' ' ' LEU . 14.3 t -150.27 179.62 7.96 Favored 'General case' 0 N--CA 1.416 -2.15 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.63 151.72 21.67 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.89 -173.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 22.4 ptm -123.6 85.72 2.46 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.953 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.616 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -136.86 164.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.025 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.02 158.24 29.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.96 -19.24 65.8 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -73.06 -14.22 61.36 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.494 0.664 . . . . 0.0 109.381 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 42.8 t -87.25 100.31 12.6 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.456 ' HB3' ' O ' ' A' ' 102' ' ' SER . 16.1 p-90 -44.83 -28.4 0.64 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.945 1.698 . . . . 0.0 114.234 -176.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 133' ' ' PHE . 82.5 mt -52.8 -37.35 59.7 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.89 0.876 . . . . 0.0 112.416 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.437 ' HD2' HG23 ' A' ' 157' ' ' VAL . 15.3 ptm180 -87.33 1.07 54.38 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.111 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 92.0 mmm -92.61 -8.8 43.16 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.249 0.547 . . . . 0.0 110.23 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mp -88.96 155.18 49.97 Favored Pre-proline 0 C--O 1.247 0.959 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -65.63 118.67 5.67 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.888 1.725 . . . . 0.0 110.089 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -77.87 136.18 38.02 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.925 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 21.8 m -138.24 149.07 24.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.34 -10.29 16.42 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.44 0.638 . . . . 0.0 109.76 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 2.8 p -88.54 134.55 33.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.167 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.86 -29.67 61.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.924 0.392 . . . . 0.0 111.564 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -70.25 -32.06 69.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.774 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.32 -20.44 24.05 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.909 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.609 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.08 154.29 24.45 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.777 -175.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 6.1 m-20 -119.66 -12.75 9.22 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.444 0.64 . . . . 0.0 110.066 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.8 m -154.28 145.67 23.03 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -125.69 147.58 49.3 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.1 0.476 . . . . 0.0 111.467 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 13.0 mm -110.59 131.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -135.06 167.2 21.39 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -97.79 139.64 33.36 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.9 tttt -165.22 138.26 4.52 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 65.72 16.6 10.56 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.845 0.858 . . . . 0.0 110.767 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 30.1 t70 63.19 64.24 0.86 Allowed 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 126.329 1.852 . . . . 0.0 111.283 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -173.06 172.92 3.8 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 113.729 -1.578 . . . . 0.0 106.832 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 84.5 mt -105.81 139.12 40.87 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.8 m95 -123.29 133.2 54.18 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.7 t -102.7 117.73 35.29 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -115.8 144.8 43.48 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 50.7 t -89.88 132.46 34.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 18.0 p -104.42 -39.07 6.57 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.302 0.572 . . . . 0.0 111.998 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -108.98 149.53 29.08 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.348 -0.387 . . . . 0.0 109.958 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 59.2 t -77.18 98.23 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 26.5 t -85.95 125.95 67.06 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.29 144.99 42.54 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 C-N-CA 122.136 1.891 . . . . 0.0 111.689 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.6 p -62.61 116.4 5.13 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.386 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 110.19 -8.14 30.96 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.569 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -92.59 171.84 33.76 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 82.0 mt -103.26 163.11 12.45 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 176' ' ' ASN . 1.2 pt? -141.15 148.45 40.06 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-O 120.935 0.398 . . . . 0.0 111.046 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -111.44 144.77 40.12 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.7 p -100.77 123.01 53.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.306 0.574 . . . . 0.0 110.529 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.609 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 55.1 ttt180 -98.04 137.31 37.03 Favored 'General case' 0 CA--C 1.486 -1.516 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.805 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.464 ' CD2' ' HA ' ' A' ' 154' ' ' THR . 6.9 mp -98.32 138.3 35.78 Favored 'General case' 0 C--N 1.27 -2.869 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 4.4 p -50.63 104.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 122.666 1.222 . . . . 0.0 112.817 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.5 m -95.5 115.08 26.94 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 114.11 -1.404 . . . . 0.0 107.516 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -86.68 113.95 55.54 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.57 149.0 73.73 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 123.185 2.59 . . . . 0.0 112.303 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -99.1 120.61 39.77 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -83.55 81.41 1.74 Allowed Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.95 112.68 14.2 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -91.01 19.51 1.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.664 2.243 . . . . 0.0 111.366 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.444 ' HA ' ' HE ' ' A' ' 213' ' ' ARG . 2.5 mmp_? -125.08 93.27 3.83 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.358 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.491 ' HB3' ' HD3' ' A' ' 215' ' ' PRO . 72.6 t60 -81.48 -60.63 0.41 Allowed Pre-proline 0 C--N 1.312 -1.041 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.747 173.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 214' ' ' HIS . 2.5 Cg_endo -83.88 123.09 3.13 Favored 'Trans proline' 0 N--CA 1.442 -1.543 0 C-N-CA 121.17 1.247 . . . . 0.0 109.313 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.63 63.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 122.608 1.194 . . . . 0.0 111.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -152.75 108.1 3.27 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.082 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -119.92 166.54 14.67 Favored Pre-proline 0 C--N 1.292 -1.927 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -64.08 157.93 50.61 Favored 'Trans proline' 0 C--O 1.249 1.056 0 N-CA-C 108.289 -1.466 . . . . 0.0 108.289 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.36 123.1 15.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.636 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 71.11 152.81 0.14 Allowed Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.78 1.232 . . . . 0.0 111.475 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.8 -36.74 43.37 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 123.307 2.671 . . . . 0.0 112.098 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 115.22 -30.3 6.84 Favored Glycine 0 CA--C 1.491 -1.441 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 175.66 130.14 1.29 Allowed Glycine 0 N--CA 1.414 -2.831 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 98.1 mt -113.18 -42.17 3.57 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.265 1.919 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 176.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.541 0.858 0 N-CA-C 113.057 0.368 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CE2' ' HB2' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -161.08 157.7 26.51 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 121.656 -0.653 . . . . 0.0 109.293 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 t -87.83 82.85 7.2 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -149.89 171.95 29.85 Favored Glycine 0 N--CA 1.419 -2.448 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.212 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.23 158.21 11.21 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.496 2.797 . . . . 0.0 112.012 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -81.07 -2.29 47.61 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.67 -19.98 54.45 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.81 160.18 16.18 Favored 'General case' 0 N--CA 1.416 -2.162 0 CA-C-N 113.506 -1.679 . . . . 0.0 108.9 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' A' ' 119' ' ' ARG . 36.6 tt0 -136.39 131.2 33.87 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.323 0.582 . . . . 0.0 111.493 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.488 ' HB2' ' CE2' ' A' ' 101' ' ' TRP . 2.5 tm? -96.36 114.31 25.97 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.83 142.91 45.5 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 79.1 mt -99.77 122.47 42.81 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 10.1 tt0 -121.5 107.19 12.15 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 59.1 13.14 2.77 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.139 1.376 . . . . 0.0 112.439 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.78 2.39 30.46 Favored Glycine 0 N--CA 1.436 -1.32 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.209 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.676 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.4 pt20 -95.65 151.71 19.1 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.424 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.5 ptt180 -98.2 105.23 17.35 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.245 0.545 . . . . 0.0 109.628 176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 8.2 p -111.04 138.4 47.51 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.5 117.31 45.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' A' ' 108' ' ' GLU . 3.2 ptm180 -127.18 154.27 45.01 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.558 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.4 121.02 19.81 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -78.02 -43.53 29.15 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 pp -122.24 170.09 10.26 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.805 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -69.8 107.68 3.62 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.256 0.551 . . . . 0.0 111.058 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 83.6 mt -74.52 113.75 12.12 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.2 p -85.56 155.47 21.16 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.287 -175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.51 129.75 40.57 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.117 0.484 . . . . 0.0 109.809 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.22 -12.74 61.93 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.386 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.2 tp -65.67 126.97 30.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 188' ' ' CYS . 36.9 p -135.59 147.51 48.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 120.836 0.351 . . . . 0.0 110.926 -178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -97.69 168.18 10.5 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.934 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.11 159.14 53.47 Favored Glycine 0 N--CA 1.442 -0.956 0 O-C-N 123.833 0.708 . . . . 0.0 112.699 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 23.6 Cg_endo -59.33 123.75 14.08 Favored 'Trans proline' 0 C--O 1.247 0.938 0 C-N-CA 123.471 2.781 . . . . 0.0 112.762 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -92.99 150.65 20.4 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.912 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -90.6 105.0 17.52 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.146 0.498 . . . . 0.0 110.038 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.84 -168.64 39.11 Favored Glycine 0 N--CA 1.421 -2.313 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -146.9 166.61 26.23 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.0 mt -127.79 118.85 50.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -111.63 120.01 40.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.369 0.604 . . . . 0.0 111.348 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.9 t -91.21 140.7 29.56 Favored 'General case' 0 N--CA 1.409 -2.487 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.122 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -127.34 68.39 1.29 Allowed 'General case' 0 C--N 1.281 -2.403 0 CA-C-O 122.655 1.217 . . . . 0.0 109.012 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.23 82.92 6.97 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 114.056 -1.429 . . . . 0.0 109.779 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 59.0 tp -128.76 116.7 19.91 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.8 m -77.68 109.92 11.23 Favored Pre-proline 0 C--N 1.293 -1.854 0 O-C-N 123.79 0.681 . . . . 0.0 110.089 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.76 -51.0 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.353 2.035 . . . . 0.0 111.221 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -107.85 -46.73 3.73 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -164.45 -45.99 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 122.287 1.042 . . . . 0.0 108.196 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -127.37 159.97 32.83 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 114.036 -1.438 . . . . 0.0 107.146 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.66 130.96 56.39 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -53.02 -32.56 58.77 Favored 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 123.732 2.954 . . . . 0.0 114.084 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.4 -142.79 3.5 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.43 110.41 2.85 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.947 2.431 . . . . 0.0 110.883 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.32 -18.45 19.96 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.422 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.2 t -75.88 130.11 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 m -118.72 141.12 48.91 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 122.227 -0.295 . . . . 0.0 110.672 -173.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 155' ' ' LEU . 2.3 mp -89.24 124.6 34.54 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.0 ttt -102.08 82.05 2.18 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.21 178.69 4.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.814 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.18 146.27 54.55 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 123.567 0.542 . . . . 0.0 110.798 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -53.36 -38.83 63.67 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.36 1.064 . . . . 0.0 112.223 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.2 t -95.39 3.34 54.44 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.77 0.319 . . . . 0.0 110.903 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.1 t -74.42 126.62 31.11 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 7.5 p-90 -54.67 -31.1 57.16 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.456 HD22 ' CD1' ' A' ' 179' ' ' ILE . 49.0 mt -56.13 -40.06 73.19 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -87.36 -6.52 58.45 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.4 ptp -100.46 5.41 44.19 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.968 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.8 mt -88.88 143.2 31.19 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -71.53 129.96 16.5 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.909 1.739 . . . . 0.0 110.786 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -79.99 150.39 30.46 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.113 0.482 . . . . 0.0 111.179 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 m -138.71 147.57 25.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.25 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.97 -21.93 20.27 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.8 p -94.99 134.83 37.24 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.241 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -85.4 -6.02 59.25 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.149 0.5 . . . . 0.0 111.651 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -71.99 -29.4 64.18 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -89.28 -29.74 18.97 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.793 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.86 124.67 25.87 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.708 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -102.22 -18.11 15.65 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.44 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 21.2 p -141.17 134.33 29.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -120.73 147.68 44.98 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.939 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.456 ' CD1' HD22 ' A' ' 163' ' ' LEU . 18.9 mm -111.1 114.35 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.316 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 11.9 p90 -125.84 154.97 41.88 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.472 ' HG2' HG21 ' A' ' 205' ' ' VAL . 33.0 ptt180 -94.26 135.94 35.1 Favored 'General case' 0 N--CA 1.409 -2.492 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.195 177.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 52.2 tttm -137.31 122.57 19.32 Favored 'General case' 0 C--N 1.27 -2.858 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 176.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 3.8 m-20 66.63 22.16 10.53 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -174.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.6 t70 68.96 5.59 5.13 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.473 1.909 . . . . 0.0 112.214 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -95.8 155.17 16.86 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 78.5 mt -93.58 123.44 36.9 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.633 -175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 55.4 m95 -116.46 137.34 52.24 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 129' ' ' SER . 50.9 t -108.7 119.86 40.77 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -123.14 142.26 51.08 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.781 0.324 . . . . 0.0 110.295 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 61.4 t -83.49 128.56 38.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.008 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.1 p -98.35 -47.57 5.38 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.721 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -113.9 140.17 48.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.885 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 48.9 t -74.55 111.46 10.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.239 0.542 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.12 122.84 40.94 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.259 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.02 174.03 13.5 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.529 2.153 . . . . 0.0 112.256 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 38.9 m -59.45 125.99 25.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.39 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 93.18 6.05 63.37 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.783 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -95.5 144.78 17.43 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 57.3 mt -91.65 142.14 27.94 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 200' ' ' LEU . 1.4 pt? -110.88 147.26 34.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -176.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -114.23 148.33 37.55 Favored 'General case' 0 C--O 1.255 1.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.0 p -104.8 134.47 46.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 O-C-N 123.653 0.595 . . . . 0.0 111.088 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -109.2 139.33 44.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.35 154.5 18.14 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.145 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 181' ' ' ARG . 14.2 p -39.49 132.24 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.9 0 C-N-CA 126.064 1.746 . . . . 0.0 114.286 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.9 t -77.14 179.84 6.05 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.337 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -137.74 165.11 36.41 Favored Pre-proline 0 C--N 1.292 -1.903 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -72.01 94.99 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.121 -1.531 . . . . 0.0 108.121 169.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -102.98 122.18 44.07 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.053 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 160.85 -100.18 0.18 Allowed Glycine 0 N--CA 1.424 -2.159 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -172.73 153.91 2.8 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.7 123.89 13.54 Favored 'Trans proline' 0 C--O 1.254 1.292 0 C-N-CA 122.614 2.209 . . . . 0.0 108.733 171.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 213' ' ' ARG . 2.8 tmt_? 76.34 102.1 0.07 Allowed 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.519 1.128 . . . . 0.0 108.314 -169.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.567 ' O ' ' HA ' ' A' ' 219' ' ' PRO . 22.3 t-80 -121.75 138.14 28.13 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.74 -66.76 0.1 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.114 2.543 . . . . 0.0 114.61 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 19.4 m -119.49 130.59 73.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.439 ' HA ' ' OE1' ' A' ' 217' ' ' GLN . 6.4 tp60 68.37 118.07 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.462 1.105 . . . . 0.0 108.605 -173.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.466 ' N ' ' HD3' ' A' ' 219' ' ' PRO . 1.0 OUTLIER 68.09 52.5 0.57 Allowed Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 124.354 1.061 . . . . 0.0 109.686 -169.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 214' ' ' HIS . 45.0 Cg_endo -94.99 162.45 1.68 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.553 2.169 . . . . 0.0 114.481 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 76.5 t 71.67 -65.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 C-N-CA 125.768 1.627 . . . . 0.0 113.829 176.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.546 ' H ' ' HD2' ' A' ' 222' ' ' PRO . 1.9 tm-20 -158.59 -52.47 0.01 OUTLIER Pre-proline 0 C--N 1.262 -3.217 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.885 -174.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 221' ' ' GLU . 11.1 Cg_endo -56.05 138.67 83.36 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 121.728 1.618 . . . . 0.0 111.597 177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -153.66 -86.19 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 119.705 -1.236 . . . . 0.0 112.69 -177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -157.24 135.97 4.67 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -82.97 97.26 8.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.985 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.114 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.556 -0.978 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.2 OUTLIER -169.68 162.88 9.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -178.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.1 t -86.74 84.57 7.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -142.71 177.7 21.61 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.841 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.77 173.3 9.43 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.714 2.943 . . . . 0.0 112.991 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -77.62 -27.34 51.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 0.0 111.511 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -71.05 -22.93 62.07 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 122.095 0.95 . . . . 0.0 110.265 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.48 ' HG ' ' CZ3' ' A' ' 162' ' ' TRP . 1.9 mm? -102.31 155.03 18.5 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.688 -173.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -139.64 135.58 33.43 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.405 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -100.2 114.99 28.82 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.02 140.74 52.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 61.0 mt -93.25 109.98 21.5 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -106.3 109.43 21.35 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 66.72 22.82 10.3 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.81 1.29 . . . . 0.0 109.036 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.13 -9.84 72.18 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.542 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -89.91 130.33 36.14 Favored 'General case' 0 C--N 1.312 -1.04 0 O-C-N 122.618 -0.342 . . . . 0.0 110.419 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -72.42 103.52 3.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.816 0.817 . . . . 0.0 111.28 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 39.8 m -112.95 153.14 28.48 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.015 -178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.46 130.99 66.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -142.4 158.85 43.25 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.09 113.82 24.1 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -76.01 -33.26 59.67 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -107.73 150.43 26.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 m -69.25 124.39 23.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.128 0.49 . . . . 0.0 110.44 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.47 114.1 23.78 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.4 p -88.1 147.39 24.95 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.003 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.46 126.91 29.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.238 0.542 . . . . 0.0 110.283 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 104.11 -7.72 48.48 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.506 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.32 126.12 30.76 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.5 m -128.8 148.48 50.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -97.81 173.94 6.85 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.449 0.166 . . . . 0.0 110.984 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -74.28 166.53 54.76 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.06 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.65 130.58 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.149 2.566 . . . . 0.0 113.826 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -107.06 173.74 6.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -120.16 139.05 53.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.68 -176.09 34.85 Favored Glycine 0 N--CA 1.405 -3.37 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.741 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.4 m -126.52 143.88 51.05 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 179' ' ' ILE . 43.2 mm -88.41 144.87 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.519 ' HG2' HD22 ' A' ' 204' ' ' LEU . 4.6 pt20 -78.25 108.32 11.48 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 121.914 0.864 . . . . 0.0 109.716 176.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 58.8 m -135.36 139.87 44.58 Favored 'General case' 0 N--CA 1.391 -3.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -87.43 92.26 9.02 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.695 0.759 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -98.06 11.4 37.74 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.858 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.4 tp 69.13 165.95 0.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 112.975 -1.921 . . . . 0.0 112.911 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.0 t -123.03 142.98 39.54 Favored Pre-proline 0 N--CA 1.423 -1.813 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.58 -16.91 18.7 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.127 1.885 . . . . 0.0 111.791 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' A' ' 146' ' ' ARG . 10.4 pt-20 -111.48 -38.03 5.06 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.766 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.483 ' HG3' ' HG3' ' A' ' 145' ' ' GLU . 60.7 mtt180 -105.08 -166.26 1.21 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -100.8 -150.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -69.97 141.97 90.05 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -68.38 -36.77 14.97 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 121.64 1.56 . . . . 0.0 112.564 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.32 -121.98 5.68 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.46 0.64 9.8 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.639 2.226 . . . . 0.0 111.044 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.03 -16.11 61.06 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.782 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.49 131.68 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 172.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.426 ' CA ' ' HB3' ' A' ' 138' ' ' GLN . 10.6 t -143.32 179.64 6.96 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -174.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 92.47 0.13 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 122.165 0.983 . . . . 0.0 110.869 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 47.6 ttm -80.07 87.71 5.43 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.94 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.31 -174.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.78 155.39 21.04 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.636 -0.825 . . . . 0.0 108.948 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.19 -21.27 66.74 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -174.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 12.7 t -93.01 -7.06 46.86 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.315 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.8 t -71.26 125.14 26.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.988 0.423 . . . . 0.0 109.93 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.48 ' CZ3' ' HG ' ' A' ' 107' ' ' LEU . 9.7 p-90 -61.9 -21.51 64.79 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -175.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD22 HG12 ' A' ' 179' ' ' ILE . 60.7 mt -62.13 -31.98 72.52 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.645 0.378 . . . . 0.0 111.593 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -85.92 -4.38 59.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.348 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -96.3 -5.31 40.42 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.093 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 57.2 mt -90.05 147.28 36.81 Favored Pre-proline 0 N--CA 1.434 -1.241 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.44 122.16 7.28 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 121.966 1.777 . . . . 0.0 111.205 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -77.14 129.13 35.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.753 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 23.2 m -121.16 146.54 25.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.783 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.31 -8.65 26.74 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.046 0.451 . . . . 0.0 109.925 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.9 p -104.47 134.84 46.98 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.464 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.41 -27.09 62.13 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.522 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 173' ' ' GLU . 2.1 mp0 -62.68 -25.97 68.42 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 123.985 0.914 . . . . 0.0 110.834 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -91.52 -38.64 12.39 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.422 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -67.62 135.49 52.94 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.705 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 200' ' ' LEU . 8.3 p30 -124.17 -10.71 7.56 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.254 176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.5 m -141.61 124.36 16.04 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 188' ' ' CYS . 11.7 pt-20 -108.51 145.06 35.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.564 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.796 HD13 HG23 ' A' ' 202' ' ' VAL . 2.0 mp -111.1 119.87 60.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -135.01 154.56 51.69 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.12 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.654 ' HD2' ' O ' ' A' ' 181' ' ' ARG . 0.2 OUTLIER -88.23 124.0 33.41 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.195 0.521 . . . . 0.0 109.989 176.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.668 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 64.5 tttp -132.94 97.98 4.17 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.2 t70 57.25 72.51 0.51 Allowed 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.723 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.7 t70 73.46 -5.73 1.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.506 -1.224 . . . . 0.0 114.251 172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -130.28 164.26 24.97 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.728 -0.608 . . . . 0.0 110.3 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.5 mt -98.22 134.44 41.26 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.668 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 49.7 m95 -124.72 152.73 43.39 Favored 'General case' 0 C--N 1.268 -2.949 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 50.3 t -128.89 128.88 44.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -123.69 147.34 47.52 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.0 t -91.15 115.57 30.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 16.3 p -86.42 -47.35 9.4 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.226 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -123.3 144.27 49.54 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.73 120.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.823 0.702 . . . . 0.0 112.473 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.2 p -114.79 120.62 37.07 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 173.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.98 162.32 41.29 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.378 2.052 . . . . 0.0 113.436 -176.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.0 p -56.57 113.36 1.58 Allowed 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.781 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.91 -14.05 19.62 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.91 159.12 34.01 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.657 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 70.1 mt -93.52 150.15 20.66 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -114.28 153.86 28.98 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.35 142.02 50.92 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.796 HG23 HD13 ' A' ' 179' ' ' ILE . 5.9 p -96.6 127.68 48.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.87 0.843 . . . . 0.0 111.887 -174.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.576 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.2 ttt180 -108.77 129.04 55.37 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 173.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.519 HD22 ' HG2' ' A' ' 138' ' ' GLN . 5.7 mp -98.92 148.28 24.12 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 10.1 p -55.63 119.84 2.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.851 0.834 . . . . 0.0 110.843 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 m -84.77 144.55 28.41 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.619 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 208' ' ' PRO . 12.6 pt-20 -49.49 140.44 13.74 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 124.509 1.124 . . . . 0.0 111.563 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 207' ' ' GLU . 22.7 Cg_exo -63.03 93.1 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 122.828 2.352 . . . . 0.0 112.844 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.29 -27.14 38.56 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 106.07 -4.24 38.52 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -100.88 111.23 62.91 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 114.717 -0.742 . . . . 0.0 109.313 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.56 -15.42 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.0 1.8 . . . . 0.0 112.034 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 69.73 -70.37 0.15 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.695 1.598 . . . . 0.0 110.587 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -88.25 132.62 38.91 Favored Pre-proline 0 C--N 1.299 -1.616 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.23 99.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 122.446 2.097 . . . . 0.0 112.232 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.53 19.06 2.79 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.433 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -68.58 -54.61 15.54 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -84.66 125.33 71.56 Favored Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.54 116.24 4.44 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.091 1.194 . . . . 0.0 112.631 -173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.71 0.1 4.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.681 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -114.05 134.85 22.09 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.129 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.12 104.46 0.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.639 2.226 . . . . 0.0 111.012 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 89.34 -51.29 3.67 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.812 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.78 -58.61 5.01 Favored Glycine 0 C--N 1.318 -0.444 0 N-CA-C 112.204 -0.358 . . . . 0.0 112.204 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 87.1 mt -104.07 -29.24 11.01 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 179.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo . . . . . 0 N--CA 1.441 -1.594 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -116.43 153.79 31.47 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 p -80.51 35.73 0.35 Allowed 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 124.021 0.928 . . . . 0.0 111.968 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -108.8 153.01 16.95 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.993 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.89 152.93 27.05 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 124.479 3.453 . . . . 0.0 113.587 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.11 -0.37 39.77 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.217 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -80.98 -13.43 58.89 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 174.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.65 160.08 24.0 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 113.756 -1.566 . . . . 0.0 110.334 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 121' ' ' ARG . 47.7 mt-10 -130.99 139.48 50.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.664 0.269 . . . . 0.0 111.167 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.23 94.86 6.7 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 168.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.44 130.93 50.89 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.323 -172.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 80.7 mt -100.78 113.33 26.15 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -126.43 114.38 18.1 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 71.69 12.86 6.31 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.506 1.146 . . . . 0.0 110.228 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.61 5.04 69.51 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.063 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -94.35 118.89 32.28 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -73.02 105.29 4.42 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.396 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 33.9 m -116.9 121.82 42.55 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.497 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.23 107.17 18.38 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -119.84 158.89 25.68 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.388 -174.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.66 125.65 30.83 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.452 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 8.6 tpm_? -81.63 -48.52 11.64 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 93.2 mt -110.72 157.18 20.04 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.2 t -76.93 112.03 13.12 Favored 'General case' 0 N--CA 1.412 -2.37 0 CA-C-O 121.266 0.555 . . . . 0.0 109.896 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.56 110.43 7.84 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.6 t -109.38 166.85 10.56 Favored 'General case' 0 N--CA 1.409 -2.481 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.03 132.79 51.64 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.201 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 121.08 -31.84 4.97 Favored Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 48.1 tp -85.12 132.02 34.36 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.0 m -146.25 154.22 41.48 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -91.49 172.65 8.36 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.146 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.93 169.76 54.34 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.326 -0.709 . . . . 0.0 111.326 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 20.7 Cg_endo -58.32 123.46 13.67 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 123.274 2.649 . . . . 0.0 112.745 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 186' ' ' LEU . 91.5 m-85 -92.16 147.73 22.71 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -105.16 95.95 6.19 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.823 1.297 . . . . 0.0 112.771 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.05 -155.34 10.09 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 106.447 -2.661 . . . . 0.0 106.447 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 55.0 m -151.82 164.26 37.42 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.501 1.15 . . . . 0.0 111.06 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.4 mt -123.76 121.52 62.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 156' ' ' MET . 1.2 pp0? -119.83 142.62 48.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.395 0.617 . . . . 0.0 112.14 -176.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 153' ' ' VAL . 10.4 p -94.45 87.26 5.1 Favored 'General case' 0 N--CA 1.406 -2.637 0 CA-C-O 122.115 0.96 . . . . 0.0 111.926 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 66.81 69.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 113.359 -1.746 . . . . 0.0 111.406 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.29 24.49 2.5 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.032 0.92 . . . . 0.0 108.732 175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.8 tp -150.56 -54.64 0.15 Allowed 'General case' 0 CA--C 1.5 -0.978 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.314 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 12.9 m -84.16 107.77 11.92 Favored Pre-proline 0 C--N 1.275 -2.646 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.469 177.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 143' ' ' SER . 35.0 Cg_endo -96.91 -58.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.558 1.704 0 N-CA-C 117.362 2.024 . . . . 0.0 117.362 -173.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -89.75 9.81 25.82 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 58.13 60.68 2.59 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.377 1.084 . . . . 0.0 111.196 -177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -101.92 -20.85 14.69 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -72.71 161.16 80.67 Favored Pre-proline 0 N--CA 1.428 -1.563 0 CA-C-N 112.418 -2.174 . . . . 0.0 108.263 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -46.35 -48.99 12.36 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.896 3.064 . . . . 0.0 113.097 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -174.25 83.59 0.08 OUTLIER Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.39 79.63 2.94 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 122.336 2.024 . . . . 0.0 114.104 -176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.42 -28.91 13.05 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 171.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 139' ' ' THR . 7.9 p -146.0 139.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.474 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.9 m -140.66 144.71 35.84 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 204' ' ' LEU . 0.8 OUTLIER -90.05 147.9 23.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.742 176.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.407 ' HB2' HE21 ' A' ' 138' ' ' GLN . 3.1 tpt -122.47 87.22 2.71 Favored 'General case' 0 N--CA 1.406 -2.671 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.492 HG22 HD13 ' A' ' 155' ' ' LEU . 34.8 m -129.52 167.82 23.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.495 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.81 156.69 39.24 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 123.877 0.735 . . . . 0.0 109.721 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.13 -29.98 71.23 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.31 0.644 . . . . 0.0 110.026 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.2 t -77.99 -11.96 59.95 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.58 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.98 119.09 22.35 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.62 0.724 . . . . 0.0 109.729 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -64.19 -19.99 65.7 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.923 -1.035 . . . . 0.0 113.128 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.401 HD22 HD11 ' A' ' 179' ' ' ILE . 73.5 mt -59.03 -31.35 68.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.696 0.398 . . . . 0.0 112.045 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -87.36 -5.11 59.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.5 mtp -89.86 -9.95 47.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.013 0.435 . . . . 0.0 110.407 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.6 mp -87.97 149.79 46.32 Favored Pre-proline 0 C--N 1.311 -1.086 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 200' ' ' LEU . 31.9 Cg_exo -60.05 118.75 5.67 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 122.195 1.93 . . . . 0.0 110.442 176.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -81.86 124.55 29.79 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.355 -175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.03 147.09 28.58 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.64 1.07 17.78 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.673 0.749 . . . . 0.0 109.46 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.4 p -89.66 174.74 7.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.758 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' NH1' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -95.72 -52.47 4.08 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.237 -177.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -71.07 -39.34 72.24 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.44 68.38 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 123.421 0.451 . . . . 0.0 111.714 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -83.72 121.08 26.8 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 121.355 0.598 . . . . 0.0 111.339 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -106.13 -5.73 19.14 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.668 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 45.5 m -149.1 140.71 23.45 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 203' ' ' ARG . 16.2 pt-20 -136.63 155.5 49.83 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.07 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 163' ' ' LEU . 21.8 mm -112.57 129.96 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.431 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 17.3 p90 -140.02 163.31 33.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -99.06 138.64 35.87 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 121.725 0.774 . . . . 0.0 110.519 177.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.606 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 65.2 tttp -145.8 114.38 6.78 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.7 t70 66.82 25.54 9.58 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.195 1.398 . . . . 0.0 109.007 -176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 73.56 8.31 5.05 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.516 1.526 . . . . 0.0 112.442 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -102.73 152.24 21.46 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 175.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 82.6 mt -94.19 129.9 40.62 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.678 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 65.6 m95 -121.82 141.2 51.47 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.526 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 52.8 t -109.04 119.88 40.86 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -117.87 150.3 39.42 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.49 120.05 46.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 33.4 p -96.01 -32.89 12.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.774 0.321 . . . . 0.0 111.343 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.62 148.11 52.58 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 41.5 t -79.74 102.62 5.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.794 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 6.3 p -90.01 126.71 56.34 Favored Pre-proline 0 C--N 1.298 -1.65 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -82.95 170.94 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.55 2.166 . . . . 0.0 113.036 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.8 m -60.69 127.41 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.884 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 88.39 0.23 82.62 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 111.494 -0.642 . . . . 0.0 111.494 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -93.01 158.08 23.74 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -100.32 146.79 26.53 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.102 0.477 . . . . 0.0 109.875 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 200' ' ' LEU . 1.5 pt? -115.57 151.16 35.42 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.623 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -123.03 133.19 54.35 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 10.1 p -97.4 122.81 49.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 O-C-N 123.744 0.652 . . . . 0.0 111.367 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.487 ' NH1' ' HA ' ' A' ' 172' ' ' GLU . 43.8 ttp180 -97.79 140.46 32.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.85 175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.603 HD21 HD23 ' A' ' 155' ' ' LEU . 78.6 mt -107.71 127.23 53.49 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 13.0 p -64.84 133.82 29.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.643 0.735 . . . . 0.0 111.65 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 m -116.63 140.07 49.81 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -84.1 135.9 41.58 Favored Pre-proline 0 C--N 1.308 -1.208 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.224 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 207' ' ' GLU . 4.9 Cg_exo -80.22 35.16 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.729 2.286 . . . . 0.0 111.163 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 68.26 -66.39 0.23 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.256 1.823 . . . . 0.0 110.025 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 177.29 127.49 1.06 Allowed Glycine 0 N--CA 1.419 -2.49 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.491 ' HB3' ' HD3' ' A' ' 212' ' ' PRO . . . -64.5 -49.84 69.04 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 116.774 0.287 . . . . 0.0 111.316 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 211' ' ' ALA . 16.9 Cg_endo -100.43 -141.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.466 2.111 . . . . 0.0 107.196 170.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -66.94 -63.45 1.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.768 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -117.43 134.08 23.17 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -79.03 88.64 1.44 Allowed 'Trans proline' 0 N--CA 1.445 -1.367 0 C-N-CA 121.948 1.765 . . . . 0.0 110.672 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . 0.253 11.6 m 56.01 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 126.435 1.894 . . . . 0.0 111.806 -172.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -139.83 -70.38 0.4 Allowed 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.241 -177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.544 ' HB3' ' HD3' ' A' ' 219' ' ' PRO . 40.9 tt0 -122.67 -53.94 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.152 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.825 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 218' ' ' GLU . 6.2 Cg_endo -93.07 158.93 2.64 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.283 1.322 . . . . 0.0 111.172 175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.9 t 70.86 114.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.853 1.261 . . . . 0.0 112.763 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 222' ' ' PRO . 41.7 tt0 -101.1 -52.73 0.17 Allowed Pre-proline 0 C--N 1.311 -1.087 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.307 176.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 221' ' ' GLU . 2.9 Cg_endo -85.86 124.67 2.63 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.458 1.439 . . . . 0.0 110.606 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 96.15 95.11 1.79 Allowed Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.457 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 165.81 -65.66 0.21 Allowed Glycine 0 C--N 1.297 -1.618 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.5 tp -103.98 -41.89 5.73 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 172.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 179.376 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo . . . . . 0 N--CA 1.455 -0.792 0 N-CA-C 108.62 -1.338 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.491 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 1.1 p-90 -123.66 154.6 39.15 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 176.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.4 m -88.03 88.16 7.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.672 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -152.77 178.45 29.9 Favored Glycine 0 N--CA 1.417 -2.568 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.91 160.58 30.51 Favored 'Trans proline' 0 C--N 1.325 -0.673 0 C-N-CA 123.618 2.879 . . . . 0.0 112.946 -176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.2 -7.95 59.66 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.504 0.668 . . . . 0.0 111.426 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.51 -24.13 42.46 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.65 162.46 14.13 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 113.293 -1.776 . . . . 0.0 109.851 -175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -141.17 136.87 32.25 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.896 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 1.7 tm? -90.32 104.81 17.34 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 172.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.7 153.6 21.62 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.7 mt -115.54 112.3 22.01 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -105.0 104.53 14.29 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 64.55 19.07 11.69 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.464 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.63 -8.83 43.98 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 116.097 -0.501 . . . . 0.0 113.094 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -94.77 143.25 26.6 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -75.23 133.83 41.29 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.088 0.471 . . . . 0.0 109.874 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.08 121.37 17.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -88.35 106.81 16.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -110.05 156.43 20.54 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.856 -177.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.77 122.07 40.43 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.335 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.16 -46.46 23.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 87.1 mt -101.53 139.78 36.72 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.9 t -70.65 126.98 31.11 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.1 mt -70.84 145.8 50.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.159 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 p -93.4 150.9 20.11 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.052 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -70.46 124.07 23.3 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.68 -8.94 60.19 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.818 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.47 122.02 15.77 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.0 m -131.53 138.54 48.97 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -92.18 169.32 10.7 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.45 179.83 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 123.9 0.75 . . . . 0.0 114.25 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 73.7 Cg_endo -75.44 138.45 22.02 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.786 2.324 . . . . 0.0 112.536 -176.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.414 ' CD2' HD11 ' A' ' 163' ' ' LEU . 56.2 m-85 -114.0 149.07 35.91 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -89.4 99.44 12.44 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.539 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -154.28 -152.44 6.1 Favored Glycine 0 N--CA 1.42 -2.369 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.04 176.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 31.7 m -150.93 134.18 16.12 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.2 mt -84.84 134.29 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.34 97.71 2.08 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 122.563 1.173 . . . . 0.0 112.71 -174.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.9 p -103.51 94.44 5.47 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.774 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.405 ' H ' ' NE ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -82.44 122.75 28.42 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.994 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -97.01 27.57 3.98 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.605 0.717 . . . . 0.0 110.489 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.95 175.83 6.7 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.6 t -103.78 137.48 19.25 Favored Pre-proline 0 C--N 1.283 -2.309 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.84 -9.87 24.65 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.982 1.788 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.26 -20.88 23.58 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.238 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -118.71 131.3 56.14 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 67.46 -78.25 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.254 0.971 . . . . 0.0 112.284 169.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.09 102.71 55.04 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 122.982 0.513 . . . . 0.0 110.098 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -82.03 -9.0 11.95 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -99.56 177.94 29.77 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.24 81.85 2.36 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 121.969 1.779 . . . . 0.0 111.762 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.49 86.02 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.934 0.873 . . . . 0.0 108.797 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.36 120.05 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.0 t -126.43 167.3 15.76 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.75 100.0 0.26 Allowed 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 122.287 1.042 . . . . 0.0 112.72 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.9 mtm -79.43 83.12 5.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.649 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.539 HG12 ' HA3' ' A' ' 135' ' ' GLY . 22.9 m -126.38 150.36 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.626 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.54 160.38 25.31 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.301 0.64 . . . . 0.0 111.287 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -52.82 -32.45 44.29 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.543 0.737 . . . . 0.0 111.67 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.0 m -85.0 9.81 13.61 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.199 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.576 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 48.3 t -100.1 100.24 11.07 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 8.6 p-90 -56.43 -19.59 15.75 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.773 1.229 . . . . 0.0 113.205 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.449 HD22 HD11 ' A' ' 179' ' ' ILE . 65.0 mt -59.66 -28.16 67.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.374 0.669 . . . . 0.0 111.473 -178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 8.6 ptm180 -85.06 -2.64 58.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.933 0.397 . . . . 0.0 110.984 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.8 mtt -93.79 -13.99 26.73 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.486 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.94 142.13 36.21 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.579 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.23 133.24 27.98 Favored 'Trans proline' 0 C--O 1.247 0.962 0 C-N-CA 122.114 1.876 . . . . 0.0 110.872 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -84.97 128.77 34.77 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.187 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.66 138.33 52.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.564 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.0 mp -88.87 -21.31 23.73 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 9.0 p -87.99 134.81 33.65 Favored 'General case' 0 N--CA 1.413 -2.277 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.014 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.4 -17.71 31.66 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -69.35 -34.63 74.89 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.097 0.475 . . . . 0.0 110.767 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.34 -15.35 43.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.452 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.95 118.13 19.95 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.106 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.436 ' HB2' ' HB2' ' A' ' 200' ' ' LEU . 0.8 OUTLIER -91.41 -30.33 16.57 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.766 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.0 p -133.72 136.93 44.96 Favored 'General case' 0 C--O 1.248 1.009 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.953 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.92 146.01 45.29 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.215 0.531 . . . . 0.0 112.019 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.449 HD11 HD22 ' A' ' 163' ' ' LEU . 28.9 mm -104.96 120.92 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.0 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -126.19 145.17 50.49 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptp180 -91.42 139.87 30.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -142.23 115.11 8.68 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 67.45 27.28 8.06 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.595 1.188 . . . . 0.0 107.879 -173.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 19.3 t70 68.69 4.88 4.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 127.054 2.142 . . . . 0.0 111.98 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -90.97 151.89 20.91 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 8.0 mp -93.58 125.76 38.37 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-O 120.821 0.343 . . . . 0.0 111.158 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -122.92 139.21 54.29 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.532 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.9 t -113.8 116.79 29.91 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -115.05 135.08 54.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.754 0.311 . . . . 0.0 110.414 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.5 t -86.58 126.11 40.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 41.2 p -108.13 -23.42 11.98 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.321 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -128.78 150.26 50.37 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.035 0.445 . . . . 0.0 111.749 -176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.04 125.97 37.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.56 127.85 61.46 Favored Pre-proline 0 C--N 1.309 -1.161 0 CA-C-O 120.704 0.287 . . . . 0.0 111.231 -171.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.15 134.06 53.72 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 111.462 174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 18.3 m -75.91 110.06 10.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.217 0.532 . . . . 0.0 109.959 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.57 0.84 32.66 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -114.32 165.05 12.02 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 69.1 mt -101.47 155.23 18.19 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.218 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 200' ' ' LEU . 1.1 pt? -99.28 143.82 29.1 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.01 -0.996 . . . . 0.0 108.576 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -110.93 148.08 33.25 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 13.1 p -102.63 130.2 53.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.88 0.848 . . . . 0.0 111.291 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 69.9 ttt180 -105.18 122.25 45.51 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.699 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -95.61 118.65 32.69 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 120.241 -0.583 . . . . 0.0 109.539 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.84 103.98 7.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 70.6 p -102.83 145.9 29.08 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.434 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -76.27 122.77 87.41 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.24 -62.36 0.08 OUTLIER 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 121.875 1.717 . . . . 0.0 110.674 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.424 ' CG ' ' H ' ' A' ' 210' ' ' GLY . 22.5 t-80 -178.85 -169.87 0.17 Allowed 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 209' ' ' HIS . . . 111.42 -107.22 2.12 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -142.04 75.17 20.92 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 116.772 0.286 . . . . 0.0 111.172 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.73 -41.99 9.81 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.639 1.559 . . . . 0.0 110.832 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.61 19.58 3.32 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 55.8 m80 75.3 132.34 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.874 1.67 . . . . 0.0 109.95 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.99 -44.49 24.4 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 121.757 1.638 . . . . 0.0 108.602 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 13.9 m -152.64 154.3 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -107.11 -54.34 2.48 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.601 0.715 . . . . 0.0 109.553 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -162.21 107.88 1.12 Allowed Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.7 118.4 5.29 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.903 1.735 . . . . 0.0 112.031 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 65.2 t -67.91 123.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 61.13 82.15 0.23 Allowed Pre-proline 0 C--O 1.22 -0.461 0 O-C-N 124.373 1.045 . . . . 0.0 110.411 -171.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.65 105.33 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.336 1.357 . . . . 0.0 110.395 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -81.01 88.32 1.36 Allowed Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.047 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.19 9.07 59.35 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.482 ' H ' HD23 ' A' ' 225' ' ' LEU . 2.3 pt? -127.71 164.95 20.98 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.13 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 N--CA 1.438 -1.771 0 N-CA-C 110.133 -0.756 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.462 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.3 OUTLIER -122.49 149.6 43.67 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.4 m -102.53 100.11 10.18 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.507 -0.746 . . . . 0.0 109.534 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -151.39 -174.59 22.37 Favored Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.5 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -78.53 163.66 26.72 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.463 2.775 . . . . 0.0 111.825 -177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -81.12 -15.64 55.34 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.188 0.518 . . . . 0.0 111.604 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.95 -15.91 60.66 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 200' ' ' LEU . 3.4 mm? -109.41 151.38 26.74 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.416 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -145.83 123.77 12.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-O 121.207 0.527 . . . . 0.0 111.898 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.46 109.92 20.42 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.12 142.45 47.42 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 56.5 mt -102.2 127.87 48.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -124.09 94.32 4.18 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 60.93 25.92 15.86 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.414 0.626 . . . . 0.0 111.364 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.19 -8.31 38.29 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.084 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 74.7 mt-30 -81.39 126.52 31.72 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -86.77 95.92 10.0 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 9.2 p -111.44 122.93 49.13 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.514 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.22 111.14 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -110.37 156.47 20.73 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.56 133.11 34.08 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -83.04 -32.35 26.9 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.2 mp -119.13 169.5 9.88 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 21.1 m -92.23 105.38 17.61 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.0 mp -85.88 124.46 32.38 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.15 0.5 . . . . 0.0 110.858 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.8 m -72.24 151.39 42.89 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.739 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.95 140.76 56.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 93.96 10.39 58.74 Favored Glycine 0 C--N 1.299 -1.501 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.608 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.0 tp -101.34 126.5 48.11 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 19.8 t -122.53 158.78 29.12 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -95.69 174.4 6.99 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.662 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.97 177.93 49.5 Favored Glycine 0 N--CA 1.436 -1.364 0 O-C-N 124.209 0.943 . . . . 0.0 112.166 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.02 132.12 20.72 Favored 'Trans proline' 0 C--O 1.247 0.934 0 C-N-CA 122.711 2.274 . . . . 0.0 114.039 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -110.39 149.71 29.86 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -106.04 119.32 38.89 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.627 0.727 . . . . 0.0 111.236 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -170.87 -160.62 19.83 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 34.9 m -148.51 134.63 19.27 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 118.397 1.099 . . . . 0.0 111.089 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 73.6 mt -106.6 113.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.92 105.87 14.28 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -62.76 138.47 58.53 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.035 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.589 ' HG2' ' H ' ' A' ' 142' ' ' LEU . 48.8 ttp85 65.45 -86.9 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.738 1.215 . . . . 0.0 111.174 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 50.26 22.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.441 1.096 . . . . 0.0 112.348 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.589 ' H ' ' HG2' ' A' ' 140' ' ' ARG . 14.7 tp -70.18 156.51 39.12 Favored 'General case' 0 C--O 1.251 1.151 0 C-N-CA 124.581 1.152 . . . . 0.0 108.448 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.6 m -115.42 105.38 52.32 Favored Pre-proline 0 N--CA 1.42 -1.946 0 C-N-CA 118.826 -1.149 . . . . 0.0 113.481 -175.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HD2' ' OE1' ' A' ' 145' ' ' GLU . 0.9 OUTLIER -95.51 -7.78 1.47 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.901 2.401 . . . . 0.0 110.462 166.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.432 ' OE1' ' HD2' ' A' ' 144' ' ' PRO . 14.7 mp0 -107.33 -44.33 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -94.22 179.9 5.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.853 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -68.76 -14.01 62.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.625 1.17 . . . . 0.0 113.94 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 73.6 113.6 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 124.553 1.141 . . . . 0.0 108.384 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.66 7.64 4.12 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.636 2.224 . . . . 0.0 112.947 -174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 103.9 -111.39 3.86 Favored Glycine 0 N--CA 1.418 -2.548 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 213' ' ' ARG . 36.6 Cg_endo -69.41 105.74 1.48 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 110.335 174.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.2 -47.41 35.7 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.509 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 206' ' ' THR . 40.2 t -75.35 117.72 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.2 m -125.1 136.21 53.43 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.48 104.91 16.39 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-O 122.159 0.981 . . . . 0.0 109.053 172.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 65.7 mtt -81.78 87.93 6.32 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.892 -177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.404 HG12 ' HA3' ' A' ' 135' ' ' GLY . 31.1 m -128.95 168.96 21.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.703 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.12 148.19 22.6 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.255 1.022 . . . . 0.0 111.455 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 164' ' ' ARG . 46.0 mt-10 -63.4 -20.03 65.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.343 0.592 . . . . 0.0 110.581 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 m -83.03 -20.43 35.03 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.063 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 44.4 t -74.35 131.36 41.05 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.52 0.676 . . . . 0.0 111.295 -173.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.462 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 13.6 p-90 -66.16 -20.49 66.16 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.899 -1.046 . . . . 0.0 113.012 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.6 mt -63.45 -30.28 71.43 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.699 0.285 . . . . 0.0 111.487 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 159' ' ' GLU . 17.0 ptm180 -96.4 2.24 52.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.622 . . . . 0.0 110.467 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mmm -99.02 -1.64 39.25 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.199 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 83.2 mt -93.61 145.54 30.12 Favored Pre-proline 0 N--CA 1.425 -1.716 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.96 127.71 11.69 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 121.441 1.427 . . . . 0.0 109.883 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -84.13 135.22 34.48 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.9 -175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.454 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 27.1 m -135.47 160.68 39.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.3 pp -105.28 -19.52 13.78 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.794 0.807 . . . . 0.0 110.876 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.8 133.86 33.96 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.42 -178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 1.4 pm0 -76.99 -21.57 54.5 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.139 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -67.53 -25.57 65.89 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.242 0.544 . . . . 0.0 110.393 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -99.3 -38.61 8.79 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.59 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -76.86 94.41 3.89 Favored 'General case' 0 CA--C 1.481 -1.695 0 CA-C-O 121.395 0.616 . . . . 0.0 111.109 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 200' ' ' LEU . 27.6 p30 -87.04 -13.9 43.05 Favored 'General case' 0 C--N 1.268 -2.955 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.451 175.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.4 m -126.88 124.51 39.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.33 150.33 37.85 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 27.1 mm -110.05 125.0 67.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.62 ' CE1' ' HG3' ' A' ' 189' ' ' ARG . 11.9 p90 -126.74 176.02 7.56 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -127.12 140.1 52.5 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.496 ' HG2' ' OD1' ' A' ' 183' ' ' ASP . 24.0 ttpp -156.37 132.05 9.59 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.496 ' OD1' ' HG2' ' A' ' 182' ' ' LYS . 4.1 m-20 60.32 34.66 20.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.315 0.646 . . . . 0.0 110.805 178.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 32.1 t70 67.62 17.49 9.91 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.436 1.495 . . . . 0.0 111.856 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -126.28 162.17 26.09 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.502 -0.749 . . . . 0.0 109.197 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.1 mt -97.18 140.4 31.73 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -134.0 153.08 52.02 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 54.0 t -125.88 128.13 47.12 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.602 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.62 ' HG3' ' CE1' ' A' ' 180' ' ' TYR . 51.4 mtp180 -103.44 145.52 29.88 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.96 100.41 11.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.634 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 166.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.8 t -82.41 -26.04 33.15 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.61 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.45 141.49 45.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.2 t -57.01 125.19 12.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 O-C-N 123.794 0.684 . . . . 0.0 111.715 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 7.5 p -110.67 114.85 54.34 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 11.1 Cg_exo -72.08 153.6 57.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.466 2.111 . . . . 0.0 112.565 -178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.2 p -61.46 115.84 4.21 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.236 0.541 . . . . 0.0 110.464 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.66 -15.49 45.27 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -81.47 157.58 38.51 Favored Glycine 0 N--CA 1.427 -1.963 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.5 mt -92.74 157.06 16.63 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.339 0.59 . . . . 0.0 110.377 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.408 HD11 HD11 ' A' ' 107' ' ' LEU . 1.5 pt? -127.81 157.1 41.34 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.107 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -134.85 148.02 50.03 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 14.9 p -102.39 133.44 46.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.54 0.686 . . . . 0.0 112.215 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.49 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 27.2 ttt180 -117.39 147.76 42.37 Favored 'General case' 0 C--O 1.21 -1.021 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 174.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 mp -117.09 153.0 33.51 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 206' ' ' THR . 7.4 p -62.66 114.28 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 170.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.434 ' O ' HG11 ' A' ' 153' ' ' VAL . 91.7 m 71.55 91.17 0.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -164.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 207' ' ' GLU . 0.4 OUTLIER -83.13 150.73 61.82 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.815 -172.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.87 103.34 1.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.378 2.052 . . . . 0.0 111.613 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -107.76 159.8 16.21 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.068 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.15 -51.66 0.73 Allowed Glycine 0 C--N 1.294 -1.801 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -163.8 95.22 1.03 Allowed Pre-proline 0 C--N 1.312 -1.039 0 C-N-CA 123.879 0.872 . . . . 0.0 108.771 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.41 35.57 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.075 2.517 . . . . 0.0 112.903 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.489 ' O ' ' HD3' ' A' ' 151' ' ' PRO . 4.3 ptm180 -80.28 128.97 34.16 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.38 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -88.58 127.25 57.2 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.75 118.81 5.76 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.452 2.101 . . . . 0.0 111.789 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 27.0 m -78.53 -25.96 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.842 0.829 . . . . 0.0 108.989 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -131.59 119.79 21.96 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -80.39 131.31 62.21 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.065 -175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -63.63 119.29 6.3 Favored 'Trans proline' 0 C--O 1.253 1.238 0 C-N-CA 122.856 2.37 . . . . 0.0 112.151 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -102.43 107.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.32 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.57 142.71 77.96 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.1 139.72 85.77 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.852 2.368 . . . . 0.0 112.312 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -80.01 -78.89 0.88 Allowed Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.593 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 85.01 -55.47 4.98 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 111.731 -0.547 . . . . 0.0 111.731 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 -38.42 71.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.372 0.606 . . . . 0.0 109.584 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.152 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--O 1.243 0.756 0 N-CA-C 108.828 -1.258 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.52 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.4 OUTLIER 178.09 -179.94 0.3 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.5 m -96.97 91.64 5.7 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -161.32 -173.11 29.55 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 120.044 -1.075 . . . . 0.0 112.176 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -83.14 158.55 15.3 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 123.287 2.658 . . . . 0.0 112.567 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -70.07 -19.05 63.29 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 123.719 0.808 . . . . 0.0 111.837 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -80.21 -22.34 41.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 122.096 0.95 . . . . 0.0 109.5 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.52 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 4.3 mm? -108.4 160.47 15.85 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.266 -177.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 121' ' ' ARG . 12.8 tp10 -155.71 147.26 22.9 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.772 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.461 ' HB2' ' CG ' ' A' ' 101' ' ' TRP . 1.3 tm? -99.38 103.55 15.35 Favored 'General case' 0 N--CA 1.411 -2.375 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.1 146.42 23.66 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.45 104.62 13.72 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.43 99.4 8.98 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.57 23.38 11.76 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.213 1.005 . . . . 0.0 111.485 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.16 57.36 Favored Glycine 0 N--CA 1.431 -1.692 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.448 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -91.37 143.16 26.92 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 120.99 0.424 . . . . 0.0 111.475 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -82.98 134.17 35.07 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.844 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.7 m -131.84 121.53 24.25 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 166' ' ' LEU . 19.8 m -86.47 96.2 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.378 1.085 . . . . 0.0 110.602 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -114.02 158.89 20.59 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.372 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -73.66 120.23 18.97 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.574 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 77.7 ttt180 -83.24 -39.51 20.81 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 78.9 mt -119.99 155.53 32.66 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.428 ' HB2' ' OG ' ' A' ' 196' ' ' SER . 47.3 t -77.04 123.92 27.04 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.5 mm? -69.93 121.99 18.43 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.513 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 48.6 m -90.62 139.77 30.4 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.872 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.68 120.46 10.09 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.51 -23.12 16.05 Favored Glycine 0 C--N 1.301 -1.381 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.241 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 49.9 tp -64.04 126.88 29.11 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.4 m -136.69 145.68 45.02 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -91.72 175.05 7.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.62 -172.46 45.45 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.268 -0.492 . . . . 0.0 113.314 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.99 123.19 6.11 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.208 1.939 . . . . 0.0 112.49 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -103.81 150.39 24.15 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -104.41 107.13 17.9 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.774 0.797 . . . . 0.0 110.495 178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -170.67 177.49 43.74 Favored Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.4 p -129.11 133.55 47.7 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 119.231 1.516 . . . . 0.0 113.127 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.6 mt -110.1 95.52 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -89.66 98.81 11.98 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.878 -172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.5 t -71.79 142.41 49.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -143.65 89.02 2.03 Favored 'General case' 0 C--N 1.283 -2.323 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.165 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -95.53 90.65 5.82 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 143' ' ' SER . 17.6 tp -119.07 -144.27 0.37 Allowed 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.559 ' H ' ' HG ' ' A' ' 142' ' ' LEU . 18.8 m -68.25 124.56 90.04 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.62 -42.73 42.02 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.794 2.996 . . . . 0.0 113.95 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.39 -20.09 63.82 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.496 ' NH1' ' HB2' ' A' ' 148' ' ' GLU . 7.0 ttt180 62.87 -76.32 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.101 1.36 . . . . 0.0 112.121 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 177.38 -42.34 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -171.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' HB2' ' NH1' ' A' ' 146' ' ' ARG . 44.8 mt-10 -139.12 157.41 71.26 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.66 -17.8 53.0 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.788 2.325 . . . . 0.0 111.891 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.58 142.21 45.21 Favored Glycine 0 C--O 1.251 1.187 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.502 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.91 113.5 3.78 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.876 2.384 . . . . 0.0 113.489 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.58 -7.65 56.06 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.965 0.888 . . . . 0.0 109.148 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.7 p -89.32 126.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.7 m -151.18 146.78 26.34 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.442 HD23 HD21 ' A' ' 204' ' ' LEU . 1.8 pp -80.53 142.7 33.91 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 96.5 mmm -116.42 94.57 4.68 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.35 171.21 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.022 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.16 147.82 38.39 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 123.613 0.571 . . . . 0.0 110.473 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.26 -33.27 67.43 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 111.228 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.4 m -100.26 12.78 36.28 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.652 0.263 . . . . 0.0 111.155 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 49.4 t -79.52 132.97 36.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 24.4 p-90 -65.05 -23.21 67.12 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.06 -25.52 68.41 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.104 0.478 . . . . 0.0 112.199 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 1.6 ptm180 -95.04 3.17 55.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.916 0.388 . . . . 0.0 111.145 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 mmt -96.47 -22.63 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.746 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.435 ' HA ' HG21 ' A' ' 118' ' ' VAL . 9.9 mp -88.35 153.05 50.76 Favored Pre-proline 0 C--O 1.246 0.878 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.99 -178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.27 129.69 16.38 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.588 2.192 . . . . 0.0 111.61 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -82.51 138.13 34.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.99 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 175' ' ' ALA . 29.3 m -140.54 157.26 24.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 176.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 98.2 mt -115.53 -6.15 12.24 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 118.204 0.456 . . . . 0.0 112.106 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.8 p -87.85 151.34 22.92 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.393 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.19 -23.68 35.35 Favored 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.598 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -69.98 -39.06 76.15 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.433 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -84.58 -33.36 23.41 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.346 -0.542 . . . . 0.0 109.966 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.631 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -84.84 99.7 11.08 Favored 'General case' 0 CA--C 1.48 -1.744 0 CA-C-O 121.366 0.603 . . . . 0.0 112.499 -177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.443 ' HA ' ' CG ' ' A' ' 192' ' ' LYS . 5.6 p30 -74.76 -19.58 60.16 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.187 175.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.9 p -131.45 142.89 50.09 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.85 141.14 48.28 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.69 HD12 ' SG ' ' A' ' 188' ' ' CYS . 9.4 mm -110.36 126.45 67.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -130.94 177.7 7.23 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -122.27 146.13 47.58 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 120.901 0.381 . . . . 0.0 110.227 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.8 129.65 13.35 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 176.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.8 t70 63.95 25.66 13.97 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 122.464 1.126 . . . . 0.0 109.401 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 69.36 13.63 8.46 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.331 1.452 . . . . 0.0 112.267 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -110.56 156.05 21.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 76.0 mt -93.6 135.26 35.05 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 120.831 0.348 . . . . 0.0 110.219 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -126.32 139.57 53.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.69 ' SG ' HD12 ' A' ' 179' ' ' ILE . 53.1 m -116.46 123.49 47.63 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -124.83 148.11 48.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.725 0.298 . . . . 0.0 110.331 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 124' ' ' LEU . 67.1 t -98.06 121.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.0 p -114.25 -21.89 10.22 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 176' ' ' ASN . 64.6 mmtt -125.76 161.69 26.79 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.7 131.46 34.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-O 120.915 0.388 . . . . 0.0 110.684 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.9 t -110.7 120.39 43.86 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.74 140.78 52.26 Favored 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.604 2.203 . . . . 0.0 111.791 178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.428 ' OG ' ' HB2' ' A' ' 123' ' ' SER . 7.5 m -63.38 114.71 4.02 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.739 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 108.29 -16.57 35.12 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.695 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.83 159.53 38.07 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.876 -178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.7 mp -90.74 125.27 35.64 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 200' ' ' LEU . 0.7 OUTLIER -98.62 163.39 12.68 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.366 -178.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -121.41 144.95 48.39 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.933 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.08 121.97 52.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.187 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.631 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 25.1 ttm180 -100.4 137.12 39.25 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.442 HD21 HD23 ' A' ' 155' ' ' LEU . 66.0 mt -96.55 145.97 25.24 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.22 121.9 2.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.938 0.875 . . . . 0.0 112.075 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.2 p -90.62 178.5 6.06 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.37 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -72.12 124.49 90.92 Favored Pre-proline 0 C--N 1.314 -0.963 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.856 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.3 120.56 7.4 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 122.639 2.226 . . . . 0.0 113.213 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -110.68 -4.25 15.47 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 93.04 -60.24 2.33 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -147.96 134.31 9.87 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.25 -28.53 79.24 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.22 1.946 . . . . 0.0 112.207 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -117.92 99.46 6.93 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.071 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 49.35 82.07 0.25 Allowed Pre-proline 0 N--CA 1.487 1.409 0 C-N-CA 124.845 1.258 . . . . 0.0 114.331 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.54 -42.14 0.96 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.988 1.792 . . . . 0.0 112.651 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 40.0 t 58.96 67.77 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 122.146 0.974 . . . . 0.0 109.437 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.98 -17.43 3.93 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.387 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -153.71 114.6 2.61 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.98 118.28 4.97 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 121.557 1.505 . . . . 0.0 110.148 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.61 107.88 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.803 0.811 . . . . 0.0 110.256 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 43.9 mt-10 -89.82 -49.97 0.37 Allowed Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 221' ' ' GLU . 55.7 Cg_exo -58.0 130.72 39.61 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 121.789 1.66 . . . . 0.0 111.158 177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -75.7 134.86 17.06 Favored Glycine 0 N--CA 1.434 -1.473 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.364 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 102.36 -3.78 50.93 Favored Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 121.161 -0.542 . . . . 0.0 111.762 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mp -101.41 172.0 7.24 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 122.509 -0.406 . . . . 0.0 111.572 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.264 1.83 0 C-N-CA 125.458 1.503 . . . . 0.0 111.54 -178.215 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.441 -1.573 0 N-CA-C 109.158 -1.132 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.419 ' CZ2' ' HB3' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -157.71 162.06 38.56 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.8 t -89.82 96.15 10.56 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -167.02 -171.25 32.9 Favored Glycine 0 N--CA 1.42 -2.424 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.738 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.83 162.21 12.06 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.245 2.63 . . . . 0.0 111.597 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.28 -16.92 51.14 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.567 0.699 . . . . 0.0 110.539 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -71.36 -26.41 62.8 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.173 0.987 . . . . 0.0 109.368 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' CZ2' ' A' ' 101' ' ' TRP . 1.6 mm? -94.37 156.88 16.28 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.808 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.44 134.34 37.61 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.185 0.517 . . . . 0.0 111.846 -177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -99.3 122.71 42.83 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -127.63 151.23 49.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 86.6 mt -106.95 97.7 7.45 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.48 ' O ' ' HG2' ' A' ' 115' ' ' GLN . 11.5 mm100 -109.44 132.88 53.71 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 66.61 12.89 9.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 123.766 0.666 . . . . 0.0 110.916 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.39 22.62 62.26 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.968 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 3.7 pt20 -133.09 167.98 19.34 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 -75.1 120.0 20.02 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 38.1 t -122.16 146.57 47.11 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.81 120.06 63.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.294 0.568 . . . . 0.0 110.197 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -129.46 152.73 48.68 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.921 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.24 109.1 20.63 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -72.11 -48.9 40.52 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 86.3 mt -89.13 129.19 35.77 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.7 m -67.57 126.2 28.58 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.484 ' HB3' HG21 ' A' ' 190' ' ' VAL . 58.6 mt -97.99 133.86 41.89 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.316 -173.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.7 t -99.12 161.53 13.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.501 0.501 . . . . 0.0 110.205 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.95 128.87 37.87 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.214 0.606 . . . . 0.0 110.863 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.81 63.7 Favored Glycine 0 C--N 1.309 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.721 176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.3 tp -69.87 130.69 42.95 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -135.67 160.03 39.8 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.992 -178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -99.72 175.24 5.87 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.304 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.07 176.13 51.73 Favored Glycine 0 N--CA 1.441 -0.981 0 O-C-N 123.605 0.566 . . . . 0.0 112.56 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.47 123.38 10.14 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.669 2.246 . . . . 0.0 113.496 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.65 149.95 22.27 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -106.99 105.71 15.88 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.689 0.757 . . . . 0.0 112.335 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.73 8.23 Favored Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 13.9 p -145.5 138.78 26.34 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.583 0.692 . . . . 0.0 111.82 -178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.423 HG22 HG23 ' A' ' 139' ' ' THR . 46.0 mt -138.76 96.61 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.251 1.15 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.66 98.63 10.79 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.369 1.081 . . . . 0.0 109.912 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.423 HG23 HG22 ' A' ' 137' ' ' ILE . 4.3 p -86.16 109.98 19.26 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.182 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -115.02 -78.56 0.58 Allowed 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 52.39 30.17 7.84 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.044 0.938 . . . . 0.0 112.027 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.0 tp -108.17 103.39 12.57 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.8 p -123.34 105.82 33.49 Favored Pre-proline 0 N--CA 1.421 -1.897 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.962 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -71.46 -28.52 17.75 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.14 2.56 . . . . 0.0 111.057 175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -88.23 -8.79 54.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.099 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 60.99 30.41 19.59 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.972 0.909 . . . . 0.0 112.044 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -63.32 -28.13 69.8 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.189 0.519 . . . . 0.0 111.084 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 152' ' ' ALA . 26.7 tt0 -154.5 92.72 2.92 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 174.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.23 73.04 5.47 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 123.163 2.575 . . . . 0.0 111.064 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 178.9 -162.87 30.18 Favored Glycine 0 C--N 1.28 -2.58 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.218 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.33 88.44 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.601 0 C-N-CA 121.779 1.653 . . . . 0.0 111.486 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.538 ' HA ' ' OE2' ' A' ' 148' ' ' GLU . . . -62.85 -45.98 90.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.913 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.0 p -104.15 126.0 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.7 p -98.1 172.92 7.3 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.916 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.07 137.91 58.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.355 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 64.9 mtt -109.01 94.69 5.18 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -123.86 179.0 3.04 Favored 'Isoleucine or valine' 0 C--O 1.251 1.15 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.361 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.75 140.26 57.62 Favored 'General case' 0 C--N 1.315 -0.935 0 O-C-N 123.473 0.483 . . . . 0.0 111.284 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -51.72 -36.69 47.9 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.326 1.05 . . . . 0.0 113.399 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.9 t -103.6 9.97 37.15 Favored 'General case' 0 N--CA 1.427 -1.613 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.819 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.516 ' SG ' ' HG ' ' A' ' 163' ' ' LEU . 41.0 t -78.68 137.31 37.74 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.154 0.502 . . . . 0.0 110.206 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.446 ' O ' HD13 ' A' ' 166' ' ' LEU . 9.1 p-90 -60.96 -27.11 68.01 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.516 ' HG ' ' SG ' ' A' ' 161' ' ' CYS . 70.3 mt -56.98 -32.49 66.14 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.088 0.47 . . . . 0.0 112.088 -175.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.64 -1.17 47.3 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.586 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.4 mtp -95.52 -6.22 41.02 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.12 0.486 . . . . 0.0 110.586 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 162' ' ' TRP . 8.8 mp -94.73 141.62 23.62 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.18 122.5 10.99 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.348 2.032 . . . . 0.0 111.389 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -79.26 127.84 32.56 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.6 m -120.21 156.46 23.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -83.68 -39.89 19.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.385 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.7 p -91.72 155.59 18.18 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.493 0.663 . . . . 0.0 112.532 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 0.1 OUTLIER -87.23 -16.97 33.68 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.469 -177.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.9 -26.96 36.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.399 0.619 . . . . 0.0 109.426 178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -85.37 -31.99 22.65 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -77.71 143.58 37.97 Favored 'General case' 0 CA--C 1.489 -1.374 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.407 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.479 HD21 ' HA ' ' A' ' 200' ' ' LEU . 16.1 p30 -118.43 2.08 11.81 Favored 'General case' 0 C--N 1.278 -2.53 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.4 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 30.2 p -151.31 135.72 16.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' CB ' ' HB3' ' A' ' 203' ' ' ARG . 15.8 pt-20 -129.0 149.87 50.65 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.038 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.408 ' CD1' HD22 ' A' ' 163' ' ' LEU . 24.1 mm -109.52 116.36 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -122.67 157.77 31.51 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 21.4 ptt-85 -102.16 144.3 30.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.2 tttm -161.71 125.55 3.24 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 65.46 32.73 9.33 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.127 0.971 . . . . 0.0 111.148 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 31.1 t70 75.0 9.36 3.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 122.378 1.085 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -123.05 162.25 22.77 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.532 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.5 mt -103.68 137.26 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.559 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 66.5 m95 -123.57 133.99 53.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 178' ' ' GLU . 54.0 t -106.8 126.82 52.79 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -127.39 147.35 50.28 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.436 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 124' ' ' LEU . 60.0 t -84.14 115.12 25.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.003 178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 10.8 p -80.83 -33.7 34.46 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.08 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 176' ' ' ASN . 20.2 ptmt -146.3 152.72 39.61 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.3 t -58.1 129.82 20.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 123.994 0.809 . . . . 0.0 111.697 -175.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.59 125.2 36.62 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -61.69 164.3 16.37 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.127 2.551 . . . . 0.0 113.34 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.1 m -66.97 101.45 0.85 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.466 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.31 16.8 52.42 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -82.37 156.86 35.9 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.4 mp -95.13 141.09 29.16 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.502 0.668 . . . . 0.0 111.093 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' A' ' 176' ' ' ASN . 3.2 mp -95.65 149.16 21.76 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.029 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -131.03 131.67 44.45 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 11.2 p -101.92 134.44 42.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.46 0.648 . . . . 0.0 111.612 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.419 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 43.9 ttt180 -104.61 142.05 35.34 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.452 -0.795 . . . . 0.0 108.912 177.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.86 139.83 32.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 12.0 p -59.14 144.17 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.687 0.617 . . . . 0.0 110.821 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.0 t -97.26 148.48 23.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.65 116.22 65.79 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.13 122.47 11.51 Favored 'Trans proline' 0 C--O 1.246 0.887 0 C-N-CA 123.216 2.611 . . . . 0.0 111.647 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -92.29 -58.06 2.5 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.324 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -111.84 79.84 0.26 Allowed Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.015 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -119.03 95.98 49.79 Favored Pre-proline 0 C--N 1.309 -1.17 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.24 -52.76 2.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.717 2.278 . . . . 0.0 112.495 -177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -110.21 125.8 53.45 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.444 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -117.94 117.68 35.25 Favored Pre-proline 0 C--N 1.294 -1.805 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.75 166.96 16.53 Favored 'Trans proline' 0 C--O 1.25 1.087 0 C-N-CA 122.409 2.073 . . . . 0.0 112.088 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 52.5 t -74.6 122.54 28.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.93 -27.32 9.3 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.433 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.09 117.63 59.94 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -67.14 144.95 71.26 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 121.863 1.709 . . . . 0.0 110.929 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.27 123.56 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.352 0.596 . . . . 0.0 109.435 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -89.91 113.65 57.82 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.499 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -83.88 33.1 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.932 2.421 . . . . 0.0 110.617 178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 75.96 36.63 40.85 Favored Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.1 134.93 12.15 Favored Glycine 0 N--CA 1.423 -2.171 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.262 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.44 -26.97 41.69 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.837 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.234 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.446 -1.276 0 N-CA-C 112.379 0.107 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.477 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 0.5 OUTLIER -134.31 161.94 33.58 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -175.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.1 m -91.58 82.42 5.31 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.61 160.69 14.39 Favored Glycine 0 N--CA 1.419 -2.453 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.96 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.553 ' HB2' ' OE1' ' A' ' 106' ' ' GLU . 60.7 Cg_endo -84.18 166.47 12.66 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.961 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -63.26 -19.36 64.5 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.801 0.84 . . . . 0.0 113.002 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 104' ' ' PRO . 23.7 mp0 -82.44 -17.99 43.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.611 0.72 . . . . 0.0 110.142 -178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -113.9 156.2 24.39 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.018 -172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.504 ' OE2' ' HD2' ' A' ' 119' ' ' ARG . 33.0 tt0 -141.59 126.27 17.96 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.813 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -95.18 108.72 20.85 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 172.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.24 154.59 50.87 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.769 0.319 . . . . 0.0 110.234 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 115' ' ' GLN . 8.9 mp -91.99 101.29 13.84 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-O 121.879 0.847 . . . . 0.0 110.167 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.534 ' HB3' ' SG ' ' A' ' 117' ' ' CYS . 50.7 tt0 -106.17 124.62 49.87 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 113.795 -1.548 . . . . 0.0 106.998 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 69.67 12.35 8.06 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.67 1.224 . . . . 0.0 109.677 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.25 2.23 60.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.024 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 43.8 mt-30 -114.65 146.38 40.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 117.393 0.596 . . . . 0.0 110.147 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -75.86 119.94 20.53 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 112' ' ' GLN . 9.4 p -138.28 149.38 45.65 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.861 -178.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -96.41 111.15 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 108' ' ' GLU . 3.4 ptp180 -116.69 158.65 23.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -78.96 124.8 28.6 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -77.26 -33.97 55.82 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.68 0.753 . . . . 0.0 109.587 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 pp -127.01 155.74 42.73 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 174.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.1 m -66.25 113.87 4.9 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.717 0.77 . . . . 0.0 111.734 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 190' ' ' VAL . 86.0 mt -79.64 138.66 37.47 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.0 t -127.19 159.04 35.5 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.83 125.28 22.34 Favored 'General case' 0 CA--C 1.511 -0.532 0 O-C-N 124.03 0.831 . . . . 0.0 110.053 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 108.53 -13.02 36.03 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.055 177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.5 tp -78.97 121.01 24.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.8 t -129.13 151.77 49.45 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 27.4 m-90 -96.66 173.86 7.11 Favored 'General case' 0 C--N 1.267 -3.015 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.815 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.5 175.71 54.83 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 56.8 Cg_endo -69.25 129.93 19.04 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.737 2.292 . . . . 0.0 113.279 -177.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -107.28 160.44 15.61 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.96 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -83.86 132.64 34.78 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.743 0.782 . . . . 0.0 112.031 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.44 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 162.18 -177.62 38.3 Favored Glycine 0 N--CA 1.414 -2.81 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 175.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 68.0 m -144.91 129.48 18.02 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 117.414 0.607 . . . . 0.0 111.597 176.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.3 mt -94.82 97.52 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.88 134.44 44.83 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.594 -177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.2 m -67.15 113.49 5.14 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -123.92 39.65 3.91 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.81 73.42 9.98 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.633 0.73 . . . . 0.0 109.274 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.6 mt -146.78 172.32 13.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.433 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 t -103.79 135.19 19.4 Favored Pre-proline 0 N--CA 1.415 -2.223 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 143' ' ' SER . 6.9 Cg_endo -87.63 -156.02 0.06 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.546 2.164 . . . . 0.0 110.419 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -85.64 -6.67 59.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.978 0.894 . . . . 0.0 109.682 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -96.52 176.37 6.05 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.133 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -84.77 -55.1 4.27 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -88.78 121.36 69.93 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.959 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.52 -40.67 1.02 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 121.394 1.396 . . . . 0.0 109.591 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.6 -153.76 37.24 Favored Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.17 71.99 6.44 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.397 2.065 . . . . 0.0 109.46 172.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.71 -20.88 49.05 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.161 -176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.92 120.04 23.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.3 m -120.45 138.23 53.91 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.339 -172.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.89 91.48 8.62 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 122.238 1.018 . . . . 0.0 110.274 174.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 85.1 mtp -87.03 82.67 7.67 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.489 -0.757 . . . . 0.0 109.39 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.44 HG12 ' HA3' ' A' ' 135' ' ' GLY . 32.8 m -105.04 177.41 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.309 -177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 161' ' ' CYS . 10.7 t70 -49.37 141.48 8.83 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 124.089 0.868 . . . . 0.0 110.971 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -58.57 -20.51 47.36 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.8 m -114.35 7.37 16.36 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.061 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 158' ' ' ASP . 42.2 t -69.76 129.22 38.99 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 120.949 0.404 . . . . 0.0 109.919 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.468 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.8 p-90 -56.08 -27.93 55.59 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.437 -177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 74.9 mt -60.86 -32.76 72.16 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.825 0.45 . . . . 0.0 112.012 -177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.7 ptm180 -93.05 -0.96 57.0 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.931 -176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.477 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 22.6 ptm -110.56 5.97 21.56 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.552 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 88.7 mt -81.6 143.84 51.69 Favored Pre-proline 0 N--CA 1.437 -1.118 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.25 126.05 13.17 Favored 'Trans proline' 0 C--O 1.253 1.266 0 C-N-CA 121.722 1.615 . . . . 0.0 109.839 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -87.52 139.78 30.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.322 0.582 . . . . 0.0 111.864 -174.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 152.27 32.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.584 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 39.3 tp -97.15 -8.36 30.3 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.673 0.749 . . . . 0.0 109.766 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 11.8 p -106.71 134.81 49.28 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.4 178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.46 ' HB3' ' NE ' ' A' ' 203' ' ' ARG . 10.9 pt-20 -77.73 -21.73 51.43 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 121.855 -0.528 . . . . 0.0 111.332 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -68.55 -28.98 67.44 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.151 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -87.59 -10.98 49.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.966 0.412 . . . . 0.0 110.79 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -87.37 158.02 19.12 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.957 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.547 HD22 ' HA ' ' A' ' 200' ' ' LEU . 95.4 m-20 -122.16 -24.73 5.04 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.215 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.5 p -130.24 130.98 45.29 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.24 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.78 123.29 45.5 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.303 0.573 . . . . 0.0 110.247 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.791 HD13 HG23 ' A' ' 202' ' ' VAL . 1.8 mp -108.44 123.81 64.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.879 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -143.22 169.52 17.47 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.585 HH21 ' HG2' ' A' ' 207' ' ' GLU . 38.2 ptt180 -106.19 139.15 41.14 Favored 'General case' 0 N--CA 1.403 -2.776 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 62.9 tttp -138.22 122.66 18.38 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t70 64.78 26.41 12.99 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.824 1.297 . . . . 0.0 107.958 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.86 67.78 0.88 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.319 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -159.49 158.22 31.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 4.3 mm? -93.33 129.37 39.47 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -173.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.534 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -129.36 150.18 50.83 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.3 t -135.46 114.35 12.05 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.108 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -103.64 138.9 39.66 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 124' ' ' LEU . 33.0 t -78.44 120.15 28.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.3 t -105.0 -1.0 26.29 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.478 0.656 . . . . 0.0 110.321 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.42 ' O ' HG12 ' A' ' 190' ' ' VAL . 30.3 mmtp -139.69 176.51 8.67 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.55 117.18 43.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.5 t -112.12 112.06 52.75 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.57 140.61 57.59 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 121.867 1.712 . . . . 0.0 111.094 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.1 p -54.16 124.98 17.35 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.418 0.627 . . . . 0.0 111.411 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 105.5 -16.93 44.0 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.487 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.42 162.4 30.63 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.412 HD21 ' HB2' ' A' ' 117' ' ' CYS . 7.7 mp -97.98 168.24 10.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.39 0.614 . . . . 0.0 111.304 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 176' ' ' ASN . 1.2 pt? -132.8 149.09 52.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.471 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -118.44 147.06 43.97 Favored 'General case' 0 C--O 1.253 1.287 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.791 HG23 HD13 ' A' ' 179' ' ' ILE . 5.1 p -96.79 128.11 48.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.838 0.828 . . . . 0.0 112.949 -173.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.46 ' NE ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 tpt180 -100.4 112.72 25.1 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.489 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.73 116.35 22.64 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -80.71 104.49 9.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.2 t -65.45 164.31 14.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.111 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.585 ' HG2' HH21 ' A' ' 181' ' ' ARG . 7.1 tp10 -116.65 104.28 51.54 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.74 142.15 31.73 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.147 1.898 . . . . 0.0 110.842 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -104.09 -54.51 2.54 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.757 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -96.38 -62.59 0.95 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.568 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -95.47 115.24 65.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 122.088 0.155 . . . . 0.0 110.775 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.15 99.3 0.78 Allowed 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 122.759 2.306 . . . . 0.0 112.008 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 61.24 -95.53 0.05 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.025 1.33 . . . . 0.0 112.259 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -149.33 118.54 3.9 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.24 164.32 17.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.761 1.641 . . . . 0.0 110.033 175.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.19 6.39 10.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 62.02 59.85 1.61 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 113.3 -1.773 . . . . 0.0 109.889 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 219' ' ' PRO . 1.9 mp0 -51.97 -50.39 78.6 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.383 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 218' ' ' GLU . 5.2 Cg_exo -82.73 117.97 2.73 Favored 'Trans proline' 0 C--N 1.365 1.442 0 N-CA-C 108.102 -1.538 . . . . 0.0 108.102 168.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.78 -11.77 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.053 0.93 . . . . 0.0 111.199 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.77 116.55 64.01 Favored Pre-proline 0 C--N 1.274 -2.682 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.422 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.8 163.32 37.73 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.552 2.168 . . . . 0.0 111.944 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -83.64 53.04 4.81 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -130.13 170.98 20.63 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 94.0 mt -79.78 -57.27 3.74 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 117.721 0.761 . . . . 0.0 110.511 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.236 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.451 -1.024 0 CA-C-O 119.925 -0.114 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.446 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 0.5 OUTLIER -168.14 169.55 10.94 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.1 m -107.36 90.12 3.21 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -146.62 -176.94 20.84 Favored Glycine 0 N--CA 1.42 -2.414 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -178.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.6 158.04 40.0 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.93 2.42 . . . . 0.0 111.993 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.47 -16.75 57.2 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 124.257 1.023 . . . . 0.0 111.307 -176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 122' ' ' LEU . 11.0 mp0 -75.65 -20.33 58.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 122.446 1.117 . . . . 0.0 108.232 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.93 159.78 16.53 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.657 -1.61 . . . . 0.0 110.042 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.487 ' HG2' ' HB2' ' A' ' 121' ' ' ARG . 24.8 mm-40 -137.09 132.04 33.56 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.962 0.505 . . . . 0.0 111.23 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 3.1 tm? -88.49 99.07 12.0 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 103.966 -2.605 . . . . 0.0 103.966 170.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -115.16 144.55 43.5 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.509 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.09 126.89 42.56 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 121.347 0.594 . . . . 0.0 110.781 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.86 92.23 4.08 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 36.16 73.22 0.09 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 126.392 1.877 . . . . 0.0 114.08 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.57 -18.7 56.89 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.06 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -112.27 123.59 50.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.871 0.836 . . . . 0.0 112.005 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -79.41 123.22 27.31 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 24.9 p -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.516 -0.473 . . . . 0.0 110.947 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.68 111.9 21.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 199' ' ' LEU . 15.2 ptp180 -127.06 157.16 40.37 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.239 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -70.11 121.19 17.03 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.487 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . 47.0 ttt180 -86.12 -52.5 5.64 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 106' ' ' GLU . 9.3 mp -94.36 153.25 18.08 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.6 m -76.9 110.89 11.89 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.496 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.8 mm? -70.4 117.84 12.45 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.0 p -96.29 158.67 15.33 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.628 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -55.05 128.95 36.06 Favored 'General case' 0 C--O 1.254 1.308 0 C-N-CA 124.712 1.205 . . . . 0.0 111.698 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.83 -18.97 54.47 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.882 -0.599 . . . . 0.0 113.248 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.65 129.99 41.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.3 m -136.48 161.73 35.04 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.273 -176.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -107.71 176.23 5.22 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.501 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.6 -171.63 39.67 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.985 0.803 . . . . 0.0 112.744 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.24 125.09 7.58 Favored 'Trans proline' 0 C--O 1.251 1.127 0 C-N-CA 122.795 2.33 . . . . 0.0 113.827 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -102.3 168.55 9.26 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -106.34 135.58 47.59 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 120.955 0.407 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.444 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . 156.78 179.21 31.58 Favored Glycine 0 N--CA 1.422 -2.258 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 41.2 m -139.03 146.05 40.36 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 117.902 0.851 . . . . 0.0 111.474 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.9 mt -108.66 132.91 55.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -91.68 98.73 11.81 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.428 0.455 . . . . 0.0 109.788 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.9 p -75.91 119.87 20.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.348 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 69.03 90.2 0.1 Allowed 'General case' 0 C--O 1.242 0.669 0 O-C-N 124.529 1.143 . . . . 0.0 109.389 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -141.25 166.95 23.36 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.6 mt 56.04 -150.63 0.42 Allowed 'General case' 0 C--O 1.238 0.46 0 O-C-N 124.062 0.851 . . . . 0.0 110.399 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.4 m -125.65 106.13 26.71 Favored Pre-proline 0 N--CA 1.417 -2.119 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -97.42 -17.47 0.24 Allowed 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.829 2.353 . . . . 0.0 112.845 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -91.02 -23.28 20.42 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.211 0.529 . . . . 0.0 109.765 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -139.12 147.19 41.6 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 67.77 159.82 0.16 Allowed 'General case' 0 CA--C 1.551 1.012 0 O-C-N 124.118 0.886 . . . . 0.0 112.957 176.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -129.78 93.42 34.51 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.43 -21.91 8.51 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.204 1.936 . . . . 0.0 110.487 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 131.6 -126.5 4.73 Favored Glycine 0 N--CA 1.426 -1.97 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.82 118.17 5.18 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.869 1.713 . . . . 0.0 109.452 173.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.64 59.91 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.4 t -90.44 137.92 20.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.3 m -113.38 138.96 49.3 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.489 HD13 HG22 ' A' ' 157' ' ' VAL . 2.3 pp -108.73 135.94 49.12 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.952 0.406 . . . . 0.0 110.498 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 26.3 mmt -113.88 85.81 2.28 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.489 HG22 HD13 ' A' ' 155' ' ' LEU . 12.0 m -130.84 157.8 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -58.08 148.36 26.68 Favored 'General case' 0 C--N 1.311 -1.098 0 O-C-N 123.856 0.722 . . . . 0.0 112.374 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -52.13 -43.98 64.28 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 124.598 1.159 . . . . 0.0 112.014 -175.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 36.9 m -90.04 11.34 20.98 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 51.6 t -76.48 127.37 32.71 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.446 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 18.8 p-90 -60.18 -27.29 67.01 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 179' ' ' ILE . 98.0 mt -63.08 -25.7 68.49 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -95.44 1.13 53.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.409 0.623 . . . . 0.0 110.817 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.85 -7.01 55.26 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.502 0.668 . . . . 0.0 109.758 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.28 144.36 27.76 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.06 131.37 19.27 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 122.046 1.831 . . . . 0.0 111.212 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -76.27 135.25 39.64 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.51 133.88 65.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.56 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 170' ' ' LEU . 2.4 pt? -68.28 -38.16 81.42 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.289 177.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 1.2 p -86.48 134.94 33.64 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.211 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -28.43 62.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.044 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -69.44 -22.83 63.63 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.416 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -94.1 0.94 56.17 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.069 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -103.75 152.84 21.37 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.644 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 200' ' ' LEU . 94.3 m-20 -114.44 -16.03 11.99 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.424 0.63 . . . . 0.0 109.979 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.0 p -145.23 128.23 16.52 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.234 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.406 ' C ' HD12 ' A' ' 179' ' ' ILE . 10.3 pt-20 -106.24 141.29 37.83 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.798 HD13 HG23 ' A' ' 202' ' ' VAL . 1.6 mp -116.7 116.72 53.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.513 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 52.5 p90 -115.73 159.85 20.85 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -100.94 138.56 37.82 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -157.59 132.85 8.9 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 67.35 20.88 9.92 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.157 0.983 . . . . 0.0 108.864 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 70.03 13.57 7.84 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.143 1.777 . . . . 0.0 111.822 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -112.8 164.73 13.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 79.9 mt -101.92 136.62 41.44 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 179' ' ' ILE . 77.6 m95 -124.54 125.59 44.45 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.671 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 53.4 t -104.03 124.46 49.06 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -125.53 138.94 53.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.496 HG11 ' HB3' ' A' ' 124' ' ' LEU . 49.0 t -90.35 122.03 41.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 22.6 p -110.31 3.19 19.65 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.105 0.479 . . . . 0.0 112.166 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -131.11 169.92 15.23 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 89.1 t -93.51 108.06 20.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 124' ' ' LEU . 19.2 t -103.34 111.03 64.84 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.27 153.6 66.44 Favored 'Trans proline' 0 C--O 1.244 0.787 0 C-N-CA 122.288 1.992 . . . . 0.0 111.296 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.4 m -65.22 126.33 27.83 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.81 -17.23 49.83 Favored Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.91 159.41 31.45 Favored Glycine 0 N--CA 1.439 -1.165 0 C-N-CA 121.157 -0.544 . . . . 0.0 111.784 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 119' ' ' ARG . 47.3 mt -95.12 165.47 12.4 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.4 0.619 . . . . 0.0 109.757 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 200' ' ' LEU . 1.2 pt? -134.46 146.01 49.38 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 115.517 -0.765 . . . . 0.0 108.967 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -113.75 151.11 32.4 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.798 HG23 HD13 ' A' ' 179' ' ' ILE . 7.7 p -99.72 129.81 49.74 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 O-C-N 123.855 0.722 . . . . 0.0 112.183 -173.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -119.28 128.91 54.59 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.17 154.78 19.88 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 11.2 p -44.05 142.28 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 123.481 0.712 . . . . 0.0 112.432 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.6 p -80.43 -172.01 3.33 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.287 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -57.85 154.85 25.56 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 123.932 0.893 . . . . 0.0 108.887 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.65 -33.7 10.33 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 123.694 2.929 . . . . 0.0 113.947 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -131.05 83.76 2.13 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -154.65 47.68 0.52 Allowed Glycine 0 CA--C 1.492 -1.356 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.913 -176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 174.81 128.92 0.12 Allowed Pre-proline 0 C--N 1.314 -0.96 0 C-N-CA 125.229 1.411 . . . . 0.0 107.402 178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -71.61 -50.62 0.28 Allowed 'Trans proline' 0 C--O 1.24 0.62 0 C-N-CA 121.34 1.36 . . . . 0.0 108.899 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 175.4 151.61 0.12 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -96.9 138.99 21.32 Favored Pre-proline 0 C--N 1.287 -2.13 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.204 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -37.06 98.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.619 1 C-N-CA 125.684 4.256 . . . . 0.0 116.23 -172.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 15.4 m -102.03 101.14 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.125 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -71.13 88.71 0.81 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -62.7 -50.98 75.39 Favored Pre-proline 0 N--CA 1.444 -0.767 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.786 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.02 120.59 8.0 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 N-CA-C 107.317 -1.84 . . . . 0.0 107.317 165.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.45 -0.41 3.43 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 122.198 0.999 . . . . 0.0 110.358 -175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.7 120.91 81.87 Favored Pre-proline 0 N--CA 1.433 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -60.57 115.12 2.46 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.589 2.193 . . . . 0.0 111.651 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -125.19 -51.33 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.854 -0.688 . . . . 0.0 111.873 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -113.36 99.92 1.04 Allowed Glycine 0 N--CA 1.433 -1.563 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.68 170.21 8.35 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.47 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.321 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.444 -1.413 0 N-CA-C 112.437 0.13 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.42 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 8.4 p-90 -106.04 0.98 26.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -172.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 m 62.35 75.84 0.39 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.982 0.896 . . . . 0.0 111.739 -176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -147.84 174.78 27.46 Favored Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.96 161.7 38.45 Favored 'Trans proline' 0 C--N 1.325 -0.658 0 C-N-CA 122.489 2.126 . . . . 0.0 111.919 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -76.46 -0.79 24.21 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -173.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -88.65 -24.76 22.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.157 0.979 . . . . 0.0 108.642 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.551 HD21 ' CZ2' ' A' ' 130' ' ' TRP . 3.2 mm? -96.09 168.21 10.75 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.376 -173.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.599 ' OE1' ' HD2' ' A' ' 119' ' ' ARG . 29.4 tt0 -150.38 128.16 11.69 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.42 ' HB2' ' CD2' ' A' ' 101' ' ' TRP . 2.6 tm? -93.02 118.61 31.38 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 173.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.41 135.75 55.03 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.74 101.94 10.43 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -110.46 119.34 38.86 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -176.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 67.83 18.4 9.68 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 122.813 1.292 . . . . 0.0 109.935 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.52 -4.35 79.67 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.451 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -114.53 174.9 5.72 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.243 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -83.54 136.55 34.22 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.016 0.436 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 43.7 t -147.18 148.45 31.54 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 176.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG12 HD21 ' A' ' 200' ' ' LEU . 12.8 t -120.56 130.72 74.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.599 ' HD2' ' OE1' ' A' ' 108' ' ' GLU . 1.0 OUTLIER -133.87 168.98 17.76 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.843 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.5 120.02 36.05 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -81.71 -40.08 23.3 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.49 145.66 24.64 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.0 m -66.06 118.17 9.44 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.406 ' HB2' HG12 ' A' ' 194' ' ' VAL . 82.6 mt -75.94 105.35 6.93 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.7 p -82.7 154.05 25.03 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.916 -175.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.78 124.44 21.98 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.62 -10.83 57.78 Favored Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.649 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.5 tp -75.42 143.54 42.65 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.2 m -150.76 171.53 17.04 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.551 ' CZ2' HD21 ' A' ' 107' ' ' LEU . 27.2 m-90 -113.93 166.43 11.6 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.29 -177.47 33.9 Favored Glycine 0 N--CA 1.436 -1.33 0 O-C-N 123.817 0.698 . . . . 0.0 113.228 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.68 133.26 23.48 Favored 'Trans proline' 0 C--O 1.252 1.195 0 C-N-CA 122.879 2.386 . . . . 0.0 112.627 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -109.01 152.45 24.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.81 120.71 37.65 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.42 -168.09 41.0 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.4 p -147.62 135.42 21.07 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 80.2 mt -88.01 101.23 11.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -95.38 98.07 10.29 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -175.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 153' ' ' VAL . 23.8 m -86.74 149.09 25.12 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.1 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.7 37.75 9.82 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 121.92 0.867 . . . . 0.0 109.402 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -93.86 11.89 27.83 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.6 0.714 . . . . 0.0 111.946 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.1 tp -155.49 152.4 28.88 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -176.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.0 m -60.46 133.53 91.13 Favored Pre-proline 0 CA--C 1.555 1.157 0 O-C-N 123.911 0.757 . . . . 0.0 109.71 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -56.97 -19.58 32.95 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 124.441 3.427 . . . . 0.0 116.705 -170.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -91.81 -14.72 29.33 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 110.088 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.452 ' O ' ' HG3' ' A' ' 147' ' ' GLU . 77.8 mtp180 -104.26 159.82 15.39 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.53 -175.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 146' ' ' ARG . 13.4 mt-10 -179.88 78.66 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.095 2.158 . . . . 0.0 109.57 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.434 ' HB2' ' HD3' ' A' ' 149' ' ' PRO . 4.4 mp0 -107.55 -58.46 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.922 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.434 ' HD3' ' HB2' ' A' ' 148' ' ' GLU . 2.2 Cg_endo -83.19 9.26 4.17 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.364 2.043 . . . . 0.0 112.155 -174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.51 -168.06 29.75 Favored Glycine 0 N--CA 1.417 -2.574 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.64 168.44 17.85 Favored 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 122.466 2.111 . . . . 0.0 111.344 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.16 60.47 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.605 0.717 . . . . 0.0 109.376 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 139' ' ' THR . 5.1 p -101.71 117.48 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 170.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.2 m -121.59 136.26 54.96 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 121.921 -0.487 . . . . 0.0 110.996 -173.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.01 101.01 11.44 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.977 0.894 . . . . 0.0 110.607 174.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 91.6 mmm -88.01 96.07 10.37 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -135.2 170.1 20.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 177.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -78.56 168.74 19.32 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.409 -0.917 . . . . 0.0 111.83 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -59.21 -34.46 72.19 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 124.192 0.997 . . . . 0.0 112.273 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.0 p -95.54 7.69 45.52 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 48.6 t -82.45 124.53 30.14 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.002 0.429 . . . . 0.0 110.013 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . . . . . . . . . 16.3 p-90 -61.37 -22.13 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.668 0.787 . . . . 0.0 112.78 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.1 mt -61.55 -32.68 72.76 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.623 0.369 . . . . 0.0 111.957 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -93.84 2.72 56.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.924 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 86.9 mtp -97.1 1.25 49.78 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.11 151.02 37.33 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.88 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.58 124.54 11.69 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.277 1.984 . . . . 0.0 110.052 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -81.8 138.8 35.07 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.769 0.319 . . . . 0.0 111.4 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 21.1 m -136.74 148.68 26.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.168 178.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.05 -13.28 17.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.68 0.753 . . . . 0.0 109.114 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.1 p -98.77 134.91 40.99 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.636 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 8.5 pt-20 -83.73 -5.3 59.16 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.417 0.627 . . . . 0.0 110.358 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.04 -29.08 64.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.616 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -100.04 -26.45 13.97 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.103 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.493 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -83.87 110.86 18.71 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.812 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.451 HD21 ' HA ' ' A' ' 200' ' ' LEU . 11.2 p30 -82.89 -25.08 32.82 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 119.938 -0.705 . . . . 0.0 110.327 173.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.8 m -127.82 145.5 50.91 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.39 145.38 50.27 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 34.7 mm -102.99 120.64 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -134.0 163.86 28.6 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.628 ' H ' ' HD3' ' A' ' 181' ' ' ARG . 0.0 OUTLIER -104.58 123.71 48.03 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 40.8 ttmt -118.39 95.73 5.0 Favored 'General case' 0 C--N 1.271 -2.837 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 13.4 t70 59.02 72.13 0.55 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.962 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 17.1 t70 76.37 -27.97 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.119 -1.401 . . . . 0.0 113.998 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -100.36 151.85 21.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.305 -0.247 . . . . 0.0 111.063 -173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 80.7 mt -93.58 128.46 39.74 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.568 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 64.7 m95 -122.14 138.05 54.6 Favored 'General case' 0 C--N 1.276 -2.627 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 42.5 t -112.96 124.32 52.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -125.24 147.19 49.19 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.61 118.78 40.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 38.5 p -101.61 -31.89 10.61 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.207 0.527 . . . . 0.0 110.89 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -126.26 141.87 51.75 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.72 128.14 38.98 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.339 0.59 . . . . 0.0 111.999 -173.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.406 HG12 ' HB2' ' A' ' 124' ' ' LEU . 10.4 p -119.06 126.9 26.81 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.2 170.84 14.97 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.619 2.213 . . . . 0.0 113.448 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.1 m -59.77 121.82 12.65 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.558 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 100.42 -6.8 57.83 Favored Glycine 0 N--CA 1.436 -1.349 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.248 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.9 153.07 44.97 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 51.9 mt -91.52 138.84 31.25 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 200' ' ' LEU . 2.0 pt? -106.04 159.35 16.13 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.104 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -134.45 143.3 47.45 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.11 117.87 42.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 121.598 0.713 . . . . 0.0 111.187 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 76.5 ttt180 -93.06 124.77 37.27 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.513 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -88.82 109.65 20.37 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.5 t -90.88 133.68 31.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.977 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.7 t -161.64 177.61 9.82 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -63.94 122.0 74.62 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.1 124.83 16.5 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.583 2.188 . . . . 0.0 110.956 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.8 t60 -74.4 -55.69 5.7 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.292 0.568 . . . . 0.0 109.529 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.37 90.06 0.74 Allowed Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.329 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 214' ' ' HIS . . . -142.68 123.87 8.45 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -35.54 -57.48 0.49 Allowed 'Trans proline' 0 C--N 1.364 1.354 1 C-N-CA 125.383 4.055 . . . . 0.0 114.653 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -115.72 54.84 0.8 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.71 0.767 . . . . 0.0 111.85 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 211' ' ' ALA . 52.2 t-80 -71.33 -48.46 12.82 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.067 172.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.42 82.95 2.33 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 121.423 1.415 . . . . 0.0 111.549 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.19 94.13 4.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.97 -50.13 6.2 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.909 -175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -160.41 105.43 1.35 Allowed Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.52 117.92 4.73 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 122.116 1.878 . . . . 0.0 110.492 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 225' ' ' LEU . 34.8 m -92.36 161.06 2.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.246 0.546 . . . . 0.0 112.209 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -96.2 -47.34 0.25 Allowed Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.989 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -55.05 129.66 36.53 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.002 1.802 . . . . 0.0 112.744 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -90.7 -10.27 63.43 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -82.2 77.44 2.08 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.454 HD11 HG21 ' A' ' 220' ' ' VAL . 87.6 mt -123.98 89.75 3.14 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.722 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.73 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.442 -1.554 0 N-CA-C 109.185 -1.121 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.7 163.74 34.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 160' ' ' SER . 19.8 m -88.33 77.91 8.08 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.463 177.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -150.28 158.56 27.73 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.259 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.36 162.4 38.43 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.278 2.652 . . . . 0.0 111.977 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -80.91 -0.04 37.4 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -78.54 -20.37 50.81 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 200' ' ' LEU . 3.7 mm? -109.78 151.96 26.31 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 113.266 -1.788 . . . . 0.0 109.215 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -127.32 141.92 51.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.49 122.03 40.07 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.03 127.04 54.58 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.913 0.387 . . . . 0.0 110.59 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.57 104.56 14.41 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -106.25 94.38 5.13 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 121.777 0.799 . . . . 0.0 109.409 177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 55.37 59.17 4.08 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.043 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.94 -22.18 19.62 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 114.809 -1.087 . . . . 0.0 113.962 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -87.82 128.85 35.34 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 122.449 -0.442 . . . . 0.0 111.86 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -82.54 113.71 20.45 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.544 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.7 p -122.28 144.86 48.73 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 199' ' ' LEU . 17.8 m -107.68 125.42 64.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-O 121.19 0.519 . . . . 0.0 109.704 -177.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -138.65 150.75 46.56 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.02 127.77 34.11 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -92.57 -34.05 14.19 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.52 0.676 . . . . 0.0 109.795 176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.27 163.67 12.42 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 172.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.1 m -88.71 128.47 35.61 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.512 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.431 ' HB3' HG11 ' A' ' 190' ' ' VAL . 3.2 mm? -90.27 127.81 36.25 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.2 p -112.22 158.9 19.14 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -63.05 118.76 8.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.978 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.21 -0.49 55.99 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.371 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 40.3 tp -82.38 139.7 33.92 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 74.3 p -144.67 157.36 44.23 Favored 'General case' 0 N--CA 1.424 -1.774 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.02 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.613 ' HB2' ' SG ' ' A' ' 188' ' ' CYS . 26.3 m-90 -103.76 175.1 5.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.84 -165.66 37.74 Favored Glycine 0 C--N 1.307 -1.052 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.079 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 186' ' ' LEU . 61.8 Cg_endo -79.46 123.32 5.4 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.187 1.925 . . . . 0.0 112.85 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.549 ' HE2' ' SG ' ' A' ' 188' ' ' CYS . 78.8 m-85 -98.84 159.09 15.2 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -103.62 104.22 14.24 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.351 1.072 . . . . 0.0 112.122 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.53 171.49 44.06 Favored Glycine 0 N--CA 1.409 -3.165 0 N-CA-C 106.785 -2.526 . . . . 0.0 106.785 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 69.7 m -132.46 137.78 47.36 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 118.096 0.948 . . . . 0.0 112.011 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 77.3 mt -86.49 116.62 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -93.24 111.82 23.58 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.705 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -96.96 102.96 14.84 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -78.92 3.17 17.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -174.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.36 13.75 7.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.035 1.334 . . . . 0.0 112.582 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp -108.45 -0.66 20.39 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 122.331 1.062 . . . . 0.0 109.036 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.3 m -106.28 107.85 60.65 Favored Pre-proline 0 N--CA 1.419 -1.983 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -96.84 -176.45 0.3 Allowed 'Trans proline' 0 N--CA 1.422 -2.697 0 C-N-CA 122.03 1.82 . . . . 0.0 111.167 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.514 ' OE1' ' HA ' ' A' ' 209' ' ' HIS . 45.5 mt-10 -103.35 -9.68 19.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.391 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -81.57 -7.98 59.66 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 122.067 0.937 . . . . 0.0 109.138 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -134.0 153.11 52.0 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.248 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -110.95 97.11 32.77 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -89.55 -0.3 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.536 2.157 . . . . 0.0 112.724 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 80.23 -146.16 27.48 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.27 52.1 2.25 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.737 2.958 . . . . 0.0 112.507 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.62 -17.16 59.33 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.06 132.92 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.6 m -125.1 141.15 52.29 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.065 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp -104.76 112.12 25.1 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-O 121.822 0.82 . . . . 0.0 111.561 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.4 mmt -87.42 89.78 8.12 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.61 177.59 2.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.504 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.0 144.34 57.36 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.706 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -57.03 -29.68 63.58 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.259 1.023 . . . . 0.0 113.457 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 102' ' ' SER . 22.0 t -102.15 -3.33 27.62 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 122.099 -0.376 . . . . 0.0 110.278 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 49.6 t -65.88 119.86 12.05 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.522 ' O ' ' HG ' ' A' ' 166' ' ' LEU . 9.4 p-90 -53.03 -26.89 17.15 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.315 1.046 . . . . 0.0 113.654 -175.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.03 -30.83 66.44 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.156 0.582 . . . . 0.0 111.85 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -94.53 -7.35 41.45 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.89 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.471 ' HG2' ' HA ' ' A' ' 162' ' ' TRP . 22.8 ptm -102.27 1.28 35.57 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.263 -177.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 86.9 mt -82.69 152.8 67.11 Favored Pre-proline 0 N--CA 1.423 -1.795 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 8.4 Cg_exo -71.31 118.08 5.48 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.304 1.336 . . . . 0.0 110.376 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -81.68 132.07 35.28 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.037 -178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.05 164.46 23.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.509 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.3 tp -100.87 -31.3 11.22 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.355 0.598 . . . . 0.0 109.518 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.4 p -88.98 134.99 33.79 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.671 0.748 . . . . 0.0 112.09 -177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 0.0 OUTLIER -71.45 -17.46 62.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.673 -179.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -74.06 -32.77 63.44 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.399 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -80.76 -37.22 30.77 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.55 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -71.89 148.95 45.6 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.406 -179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -121.12 -10.03 9.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.057 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.0 m -152.8 136.96 16.47 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 203' ' ' ARG . 10.7 pt-20 -116.61 143.41 45.65 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.795 0.331 . . . . 0.0 111.588 179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 188' ' ' CYS . 27.0 mm -102.03 122.99 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 205' ' ' VAL . 51.7 p90 -131.68 160.06 36.53 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.71 137.23 41.21 Favored 'General case' 0 N--CA 1.425 -1.683 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.365 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.569 ' HB3' ' CD1' ' A' ' 187' ' ' TRP . 88.6 tttt -144.03 118.52 9.7 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 64.9 26.71 12.83 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.829 0.823 . . . . 0.0 109.528 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 39.1 t70 71.21 -1.93 2.56 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.264 1.826 . . . . 0.0 111.969 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -90.75 155.74 18.58 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 132' ' ' PRO . 71.9 mt -94.07 128.49 40.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.763 -176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 182' ' ' LYS . 62.5 m95 -124.75 139.34 53.94 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 130' ' ' TRP . 4.9 p -121.67 128.45 51.87 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -118.13 144.84 45.34 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.326 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 124' ' ' LEU . 62.1 t -86.38 120.71 36.53 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 13.6 p -86.23 -45.39 11.34 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.398 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -136.29 151.84 50.07 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 120.807 0.337 . . . . 0.0 111.663 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 49.2 t -64.29 128.7 27.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.795 -172.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 4.7 p -126.64 117.67 22.75 Favored Pre-proline 0 C--N 1.295 -1.782 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.82 165.61 32.3 Favored 'Trans proline' 0 C--O 1.251 1.174 0 C-N-CA 122.482 2.122 . . . . 0.0 112.917 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 7.9 m -60.65 129.49 41.78 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.892 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 103.85 -17.58 48.83 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.32 150.36 23.57 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.693 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 118' ' ' VAL . 11.1 mp -89.01 146.6 24.76 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -125.05 146.73 49.3 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.075 0.464 . . . . 0.0 110.402 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 43.2 m-85 -113.76 144.25 43.28 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.772 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 15.0 p -99.64 133.63 41.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.456 0.646 . . . . 0.0 110.975 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 71.6 ttt180 -108.15 137.96 45.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.45 153.95 18.8 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 180' ' ' TYR . 12.3 p -42.62 119.39 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 122.463 1.125 . . . . 0.0 112.527 -177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.4 m -106.04 103.93 13.52 Favored 'General case' 0 N--CA 1.396 -3.152 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -60.16 124.27 76.72 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.52 43.41 0.91 Allowed 'Trans proline' 0 N--CA 1.487 1.124 0 C-N-CA 123.246 2.631 . . . . 0.0 112.755 -175.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.514 ' HA ' ' OE1' ' A' ' 145' ' ' GLU . 78.0 m-70 70.77 102.79 0.06 Allowed 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 125.106 1.363 . . . . 0.0 111.009 -175.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -91.69 -47.52 3.42 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.621 -174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.25 -51.0 14.32 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.92 -30.21 92.5 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.468 2.112 . . . . 0.0 114.509 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -84.35 -1.62 55.76 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.515 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -125.02 161.48 49.04 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.48 129.03 27.94 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.663 1.575 . . . . 0.0 110.411 176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 22.2 t -103.33 -35.7 3.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 121.716 0.77 . . . . 0.0 109.676 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -95.43 20.68 9.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 122.082 0.944 . . . . 0.0 110.551 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . 0.569 ' OE1' ' HD2' ' A' ' 219' ' ' PRO . 7.1 tp10 -154.39 138.97 11.51 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 103.273 -2.862 . . . . 0.0 103.273 177.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.569 ' HD2' ' OE1' ' A' ' 218' ' ' GLU . 40.1 Cg_endo -67.39 158.15 58.39 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 121.833 1.688 . . . . 0.0 112.179 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.27 82.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 122.23 1.014 . . . . 0.0 109.962 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.83 -52.86 1.56 Allowed Pre-proline 0 C--N 1.301 -1.517 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.235 -177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.84 168.01 18.1 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 121.205 1.27 . . . . 0.0 111.942 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 114.09 -137.47 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 112.61 -137.66 14.41 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.71 -29.12 9.76 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.045 0.45 . . . . 0.0 110.034 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 N--CA 1.438 -1.784 0 N-CA-C 108.952 -1.211 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 162' ' ' TRP . 1.4 p-90 -159.42 8.65 0.11 Allowed 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.457 0.473 . . . . 0.0 111.291 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.0 m 58.95 41.1 21.66 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.981 0.912 . . . . 0.0 111.495 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -106.45 -169.38 22.83 Favored Glycine 0 N--CA 1.433 -1.55 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.266 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -85.81 175.65 5.82 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.122 2.548 . . . . 0.0 112.569 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.1 -19.45 43.6 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.22 0.533 . . . . 0.0 111.81 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -82.96 -16.96 45.27 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.781 0.801 . . . . 0.0 109.586 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 200' ' ' LEU . 4.1 mm? -121.8 152.94 38.96 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.242 -174.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -141.5 140.7 33.55 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.021 0.439 . . . . 0.0 111.158 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.56 99.01 11.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.06 130.25 50.13 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 60.6 mt -90.31 112.15 23.61 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.21 97.16 7.01 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.3 t70 64.27 27.5 13.83 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.087 1.422 . . . . 0.0 109.024 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.46 -11.42 68.68 Favored Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.826 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -81.84 130.45 35.07 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -79.64 101.5 8.39 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.73 0.776 . . . . 0.0 110.115 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 62.8 m -110.14 122.61 48.02 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.556 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG11 ' HG ' ' A' ' 166' ' ' LEU . 25.3 t -94.91 100.69 11.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -122.26 146.55 47.18 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.765 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.76 140.35 49.45 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.577 ' NE ' ' HA ' ' A' ' 121' ' ' ARG . 4.5 mmp_? -93.36 -36.74 12.36 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.8 mt -115.35 155.95 26.41 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 m -75.07 105.21 5.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 193' ' ' VAL . 96.8 mt -70.4 117.04 11.44 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.269 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -92.86 147.27 22.99 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.833 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -64.81 129.48 39.93 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-O 121.617 0.722 . . . . 0.0 111.083 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 111.96 -20.24 22.14 Favored Glycine 0 C--N 1.301 -1.361 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.807 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.2 tp -70.72 125.55 27.14 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.5 m -134.29 149.93 50.94 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -92.14 175.24 6.93 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.173 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.28 150.67 48.93 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.929 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.12 127.34 25.32 Favored 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.199 2.599 . . . . 0.0 111.912 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.426 ' CD2' HD11 ' A' ' 163' ' ' LEU . 55.9 m-85 -98.14 153.27 18.56 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.707 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -93.82 116.02 28.46 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 123.731 0.644 . . . . 0.0 110.024 177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.46 45.31 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 48.8 m -144.58 134.73 24.14 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 117.682 0.741 . . . . 0.0 110.745 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.7 mt -84.6 102.73 10.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -103.89 111.16 23.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 -167.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.9 m -71.48 130.57 41.6 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 167.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -129.98 171.41 12.81 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.196 -169.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.44 85.28 5.24 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.415 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.6 OUTLIER 178.29 152.7 0.31 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.593 1.957 . . . . 0.0 105.85 170.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 14.6 p -109.59 110.08 59.72 Favored Pre-proline 0 C--N 1.293 -1.885 0 C-N-CA 120.254 -0.578 . . . . 0.0 112.362 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 148' ' ' GLU . 17.0 Cg_exo -68.74 -10.68 29.79 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.795 2.33 . . . . 0.0 111.67 178.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.31 -12.16 47.37 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.443 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -155.95 -33.73 0.09 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.49 -67.87 0.62 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 144' ' ' PRO . 18.6 mm-40 -120.72 99.72 47.14 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.9 67.76 3.94 Favored 'Trans proline' 0 C--O 1.246 0.892 0 C-N-CA 123.345 2.697 . . . . 0.0 112.409 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -162.35 -170.49 27.22 Favored Glycine 0 C--N 1.286 -2.202 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.846 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.83 81.92 2.07 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.336 2.691 . . . . 0.0 111.239 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 142' ' ' LEU . . . -99.52 -40.6 7.76 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.774 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.94 130.71 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 t -164.32 179.83 6.55 Favored 'General case' 0 N--CA 1.421 -1.884 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.242 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.94 131.92 33.96 Favored 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.809 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 59.8 ttp -87.87 92.94 9.31 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.43 173.79 11.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.164 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.21 152.99 40.85 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.471 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.76 -24.22 65.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -91.98 10.52 28.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.871 0.367 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 35.5 t -87.95 111.14 21.15 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 25.4 p-90 -57.97 -21.02 42.38 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 113.385 -175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 133' ' ' PHE . 70.8 mt -59.45 -30.74 68.72 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.929 0.492 . . . . 0.0 111.089 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -96.59 2.4 52.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.195 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 23.2 mmt -83.94 -21.32 31.86 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.65 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.46 ' HG ' HG11 ' A' ' 118' ' ' VAL . 8.3 mp -82.06 150.82 65.73 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.488 ' HB2' ' CD2' ' A' ' 201' ' ' TYR . 27.3 Cg_exo -63.31 127.16 19.34 Favored 'Trans proline' 0 C--O 1.245 0.841 0 C-N-CA 121.787 1.658 . . . . 0.0 108.967 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -88.43 139.88 30.03 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 120.887 0.375 . . . . 0.0 111.68 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 175' ' ' ALA . 23.5 m -131.2 158.24 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.669 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 82.3 mt -101.96 -26.12 13.53 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.087 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 18.3 p -87.08 156.04 19.89 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.347 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 203' ' ' ARG . 13.6 pt-20 -94.27 -19.31 20.81 Favored 'General case' 0 C--O 1.199 -1.574 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.799 -178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -51.8 -45.45 63.86 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.716 0.807 . . . . 0.0 111.173 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -88.47 -14.61 37.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.647 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.435 ' HB2' ' CG2' ' A' ' 169' ' ' VAL . . . -88.78 115.34 26.25 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.568 0.699 . . . . 0.0 111.126 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -95.19 -15.84 22.99 Favored 'General case' 0 C--N 1.276 -2.6 0 CA-C-O 121.855 0.836 . . . . 0.0 109.295 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.5 m -139.28 146.58 40.54 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -138.31 155.47 48.55 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 122.584 0.353 . . . . 0.0 110.271 -177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.0 mm -112.92 123.57 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -128.15 149.36 50.46 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 185' ' ' ALA . 16.7 ptt180 -97.24 133.14 42.26 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.097 178.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.71 126.68 15.45 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 58.72 30.22 19.67 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 124.393 1.058 . . . . 0.0 110.209 -171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.8 t70 76.49 -8.96 1.56 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.285 1.434 . . . . 0.0 112.601 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 181' ' ' ARG . . . -93.05 154.03 18.35 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 133' ' ' PHE . 80.0 mt -93.79 126.16 38.82 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.959 0.409 . . . . 0.0 110.081 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -116.28 124.43 50.16 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.389 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.89 110.96 23.29 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -111.01 144.82 39.52 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.74 113.25 22.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 173.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 4.9 t -80.63 -34.45 35.01 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.831 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -148.59 160.18 43.37 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 122.358 -0.214 . . . . 0.0 110.669 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 124' ' ' LEU . 40.6 t -72.03 123.16 25.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 124.262 0.976 . . . . 0.0 112.716 -171.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 5.9 p -114.18 120.7 37.97 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 23.9 Cg_exo -65.53 158.25 54.05 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 123.015 2.477 . . . . 0.0 113.526 -177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.3 m -59.38 113.8 2.36 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.749 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 113.4 -22.95 14.44 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.942 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -74.99 152.13 43.46 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 9.1 mp -95.6 155.76 16.61 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 107' ' ' LEU . 1.2 pt? -140.1 147.02 39.64 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.544 0.688 . . . . 0.0 111.22 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 167' ' ' PRO . 5.8 m-85 -106.46 154.63 20.55 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 114.333 -1.303 . . . . 0.0 107.776 178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.68 130.66 61.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.039 0.447 . . . . 0.0 110.266 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.423 ' CZ ' ' HB3' ' A' ' 172' ' ' GLU . 22.5 ttp180 -102.54 139.68 37.82 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 122.104 -0.372 . . . . 0.0 110.43 178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.86 134.71 38.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 171.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 9.8 p -42.44 111.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.4 p -98.2 111.4 23.74 Favored 'General case' 0 N--CA 1.42 -1.938 0 CA-C-N 113.989 -1.459 . . . . 0.0 108.185 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.29 151.35 87.78 Favored Pre-proline 0 C--N 1.309 -1.154 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.7 43.35 1.47 Allowed 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 123.389 2.726 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 67.35 77.89 0.26 Allowed 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.004 1.322 . . . . 0.0 108.008 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -99.74 -28.7 7.3 Favored Glycine 0 CA--C 1.493 -1.332 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.487 -178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -142.72 110.19 5.66 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.4 -49.29 7.82 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.302 2.002 . . . . 0.0 109.547 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -125.3 105.26 8.97 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -58.49 -53.49 65.67 Favored Pre-proline 0 C--O 1.24 0.571 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.79 121.24 8.12 Favored 'Trans proline' 0 C--N 1.363 1.305 0 C-N-CA 121.066 1.177 . . . . 0.0 110.336 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.3 87.73 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.778 0 CA-C-O 122.863 1.316 . . . . 0.0 111.17 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.513 ' O ' ' HD3' ' A' ' 219' ' ' PRO . 28.9 tt0 -138.45 136.76 36.53 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -95.08 109.44 44.54 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.708 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 217' ' ' GLN . 3.7 Cg_exo -77.79 130.17 10.39 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 170.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.07 84.4 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.843 0.83 . . . . 0.0 111.168 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -93.62 122.52 62.37 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.52 11.62 1.83 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.058 2.505 . . . . 0.0 114.735 -172.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 83.5 -70.35 3.19 Favored Glycine 0 CA--C 1.501 -0.799 0 C-N-CA 120.615 -0.803 . . . . 0.0 111.135 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 164.21 -170.87 39.59 Favored Glycine 0 N--CA 1.419 -2.453 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.8 pp -141.56 142.9 33.51 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 122.859 0.464 . . . . 0.0 109.792 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.564 0 CA-C-O 118.585 -0.722 . . . . 0.0 109.819 -177.068 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.453 -0.864 0 N-CA-C 108.919 -1.223 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.526 ' HE3' ' SD ' ' A' ' 165' ' ' MET . 8.3 p-90 -99.26 -46.75 5.43 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.344 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 162' ' ' TRP . 5.6 t -174.86 178.25 1.87 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -82.96 -41.45 8.68 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 117.957 1.943 . . . . 0.0 117.957 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.41 115.47 2.47 Favored 'Trans proline' 0 C--N 1.392 2.846 0 CA-C-N 121.758 2.779 . . . . 0.0 114.653 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' O ' ' HD3' ' A' ' 121' ' ' ARG . 37.5 mt-10 -77.37 -3.04 38.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.674 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.0 mp0 -87.22 -14.75 40.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.965 0.888 . . . . 0.0 109.163 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.31 164.5 15.11 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.114 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -144.55 135.84 25.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.179 0.514 . . . . 0.0 110.36 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -85.9 130.46 34.54 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -118.38 132.33 56.27 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.77 0.319 . . . . 0.0 110.328 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 77.0 mt -108.5 113.56 26.69 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.96 106.58 14.6 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 65.8 23.94 11.42 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.591 0.71 . . . . 0.0 110.675 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.53 -8.47 78.8 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.868 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.704 ' HA ' HE21 ' A' ' 115' ' ' GLN . 0.0 OUTLIER -82.35 121.27 26.48 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.419 ' HG2' ' H ' ' A' ' 116' ' ' ARG . 11.1 ptm180 -72.38 118.1 14.86 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.393 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 78.9 m -137.58 161.14 37.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 16.9 m -113.57 129.43 69.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 120.894 0.378 . . . . 0.0 110.256 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -125.57 140.82 52.42 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.584 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.69 119.81 25.68 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 106' ' ' GLU . 8.3 ptm180 -75.34 -35.15 61.22 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.603 0.716 . . . . 0.0 111.285 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.6 pt? -122.5 176.59 5.82 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.5 m -83.22 110.46 18.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 120.911 0.386 . . . . 0.0 110.479 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' HB3' HG21 ' A' ' 190' ' ' VAL . 85.8 mt -82.36 132.55 35.22 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -119.4 165.24 14.58 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.62 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 190' ' ' VAL . 56.7 mt-10 -62.35 117.69 6.47 Favored 'General case' 0 C--O 1.249 1.067 0 C-N-CA 124.171 0.988 . . . . 0.0 109.943 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 123.12 -21.82 7.28 Favored Glycine 0 C--N 1.303 -1.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.326 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 47.5 tp -77.07 129.18 35.71 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.3 p -142.55 156.92 45.17 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.614 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -105.4 169.92 8.18 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.73 -174.09 38.83 Favored Glycine 0 N--CA 1.436 -1.329 0 O-C-N 123.898 0.749 . . . . 0.0 113.213 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.22 123.61 7.89 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.524 2.149 . . . . 0.0 113.375 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.42 ' CD2' HD11 ' A' ' 163' ' ' LEU . 67.8 m-85 -97.06 134.47 40.37 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -86.94 96.21 10.17 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.724 0.773 . . . . 0.0 110.899 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' HA3' HG12 ' A' ' 157' ' ' VAL . . . -166.42 171.21 41.34 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.2 m -133.27 138.59 46.51 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 118.555 1.178 . . . . 0.0 112.957 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.74 99.55 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -91.79 106.84 18.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 22.1 p -82.85 123.34 29.28 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.995 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.566 HH22 ' HB2' ' A' ' 148' ' ' GLU . 30.9 ttp85 -113.9 30.32 7.35 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.81 76.53 5.3 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.262 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.471 ' O ' ' HD3' ' A' ' 144' ' ' PRO . 63.9 tp -156.98 111.41 2.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 21.0 m -87.96 107.32 15.35 Favored Pre-proline 0 C--N 1.302 -1.493 0 O-C-N 123.609 0.568 . . . . 0.0 109.934 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 142' ' ' LEU . 2.8 Cg_exo -76.38 -75.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.259 1.973 . . . . 0.0 110.332 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -110.61 -9.01 14.56 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.119 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -148.79 155.48 41.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.75 -55.26 5.81 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 123.541 0.526 . . . . 0.0 109.742 176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.566 ' HB2' HH22 ' A' ' 140' ' ' ARG . 31.9 mt-10 63.48 81.71 0.22 Allowed Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.481 1.112 . . . . 0.0 111.301 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.13 41.38 0.57 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 124.688 3.592 . . . . 0.0 113.286 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.423 ' HA3' ' HD3' ' A' ' 151' ' ' PRO . . . -123.67 -112.33 2.02 Favored Glycine 0 C--N 1.283 -2.383 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.423 ' HD3' ' HA3' ' A' ' 150' ' ' GLY . 23.9 Cg_exo -68.91 47.13 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.81 3.007 . . . . 0.0 113.83 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.75 -38.67 62.16 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.9 t -126.27 121.2 58.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.2 p -126.74 131.77 51.26 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.314 -0.554 . . . . 0.0 112.164 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -98.28 127.93 44.46 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 121.317 0.579 . . . . 0.0 111.124 175.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.2 ttm -108.9 98.12 7.65 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.445 HG12 ' HA3' ' A' ' 135' ' ' GLY . 34.3 m -139.25 164.97 24.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.859 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -69.72 156.39 39.06 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.561 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -50.43 -45.09 55.64 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.246 1.018 . . . . 0.0 110.996 178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.6 t -85.78 8.72 18.86 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.579 0.704 . . . . 0.0 111.137 -174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 164' ' ' ARG . 39.0 t -89.14 96.71 10.83 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 102' ' ' SER . 5.9 p-90 -48.54 -17.79 0.19 Allowed 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 126.558 1.943 . . . . 0.0 115.157 -173.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.42 HD11 ' CD2' ' A' ' 133' ' ' PHE . 48.2 mt -61.12 -30.28 70.28 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.979 0.418 . . . . 0.0 110.001 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 161' ' ' CYS . 17.4 ptm180 -83.83 -10.33 58.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.816 0.341 . . . . 0.0 110.841 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.526 ' SD ' ' HE3' ' A' ' 101' ' ' TRP . 59.8 mtt -89.68 -15.82 31.76 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 162' ' ' TRP . 50.2 mt -82.99 133.68 47.92 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.78 131.59 22.99 Favored 'Trans proline' 0 C--O 1.241 0.643 0 C-N-CA 121.619 1.546 . . . . 0.0 111.177 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -84.2 131.63 34.74 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.4 m -125.89 156.95 35.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.52 -2.49 30.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.44 0.638 . . . . 0.0 110.025 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.5 p -108.16 150.2 27.54 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.767 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.09 -5.44 57.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -72.06 -36.19 69.5 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.482 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -95.85 -28.36 14.76 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.197 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 203' ' ' ARG . . . -74.88 111.72 10.37 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.608 -177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -95.76 -20.57 18.76 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.248 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 202' ' ' VAL . 11.4 p -130.16 130.23 44.48 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.394 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -120.04 146.02 46.28 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 28.6 mm -112.8 119.73 61.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.474 ' HA ' ' CG1' ' A' ' 205' ' ' VAL . 34.5 p90 -113.33 148.51 35.55 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -96.62 138.71 33.79 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -163.13 118.48 1.73 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.324 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 37.0 t70 61.61 56.36 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 124.686 1.241 . . . . 0.0 111.635 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 62.83 16.26 8.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.686 176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -137.76 170.64 15.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -176.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 81.2 mt -116.13 137.85 51.77 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -120.98 128.75 53.01 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 50.7 t -101.2 123.83 45.94 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.425 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -121.6 143.18 49.46 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' A' ' 124' ' ' LEU . 46.5 t -82.29 104.74 11.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 170.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 8.8 t -87.14 -26.31 23.67 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.341 -172.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -141.15 145.83 36.23 Favored 'General case' 0 CA--C 1.507 -0.7 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.78 120.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.844 -174.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 195' ' ' PRO . 4.4 p -112.14 117.48 47.72 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 194' ' ' VAL . 21.8 Cg_exo -66.38 167.36 18.85 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.589 2.193 . . . . 0.0 113.188 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.2 m -64.71 129.48 39.96 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.585 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.95 71.13 Favored Glycine 0 N--CA 1.434 -1.49 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.766 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -94.31 154.54 21.48 Favored Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.916 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.6 mt -91.86 145.64 24.4 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 200' ' ' LEU . 1.5 pt? -119.54 144.81 46.85 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.923 0.392 . . . . 0.0 110.71 -178.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.54 151.84 34.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 177' ' ' SER . 12.0 p -106.99 139.52 28.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.288 0.566 . . . . 0.0 111.069 -176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.558 ' HB2' ' CB ' ' A' ' 175' ' ' ALA . 31.6 ttp85 -115.74 134.23 55.23 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 77.0 mt -95.67 152.08 18.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 180' ' ' TYR . 8.6 p -73.28 76.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-O 123.075 1.416 . . . . 0.0 112.989 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.4 m -160.79 137.42 8.73 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 113.646 -1.615 . . . . 0.0 107.788 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -96.19 146.04 30.62 Favored Pre-proline 0 N--CA 1.421 -1.877 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -52.76 -38.86 78.05 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.966 2.444 . . . . 0.0 111.072 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -151.68 -48.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 50.85 57.34 Favored Glycine 0 CA--C 1.488 -1.604 0 CA-C-N 113.585 -1.643 . . . . 0.0 114.613 170.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -70.27 114.9 29.33 Favored Pre-proline 0 N--CA 1.437 -1.099 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.76 -5.26 16.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.618 2.212 . . . . 0.0 113.17 -174.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -113.95 150.85 33.16 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -103.11 139.13 19.83 Favored Pre-proline 0 C--N 1.294 -1.823 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -61.58 -19.78 66.16 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 123.035 2.49 . . . . 0.0 113.058 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 12.3 m -97.65 88.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 121.96 0.886 . . . . 0.0 111.721 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -86.96 -42.55 13.06 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 65.21 135.7 0.04 OUTLIER Pre-proline 0 C--O 1.243 0.717 0 C-N-CA 126.18 1.792 . . . . 0.0 115.238 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.57 151.15 41.44 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.801 2.334 . . . . 0.0 110.767 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 31.0 m -104.07 164.0 3.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -102.62 99.6 13.8 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 4.1 Cg_exo -75.54 101.36 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.627 2.218 . . . . 0.0 112.367 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.86 -9.55 65.91 Favored Glycine 0 C--O 1.22 -0.757 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.792 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 111.67 -77.7 0.24 Allowed Glycine 0 N--CA 1.433 -1.562 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.47 148.9 26.69 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.445 . . . . . . . . 0 0 . 1 stop_ save_